2014 WCC Programme by UICC

PROGRAMME

2014 WORLD CANCER CONGRESS

3 - 6 DECEMBER MELBOURNE CONVENTION AND EXHIBITION CENTRE

Joining Forces... Accelerating

Progress

The American Cancer Society is dedicated to preventing cancer, saving lives, diminishing suffering, and building a global movement to fight cancer. We are committed to reducing the burden of cancer in the developing world by scaling up and implementing cost-effective, evidence-based cancer control programs and policies to achieve measurable results and lifesaving impact.

global.cancer.org

CONTENTS About UICC Committees Welcome Notes General Information Sponsors, Partners and Collaborators Networking Events About Australia About Melbourne Global Village Social Media Congress Programme Track Descriptions NCD Programme Session Types Keynote Speakers UICC Sessions Big Debates Big sCreen Master Courses Programme by Day Thursday 4th Dec Friday 5th Dec Saturday 6th Dec List of Reviewers Indexes

4 7 11 18 37 55 59 63 71 105 110 112 114 116 118 125 134 137 140

143 148 219 298 350 354 3

ABOUT UICC

UICC unites the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda. A membership organisation founded in 1933 and based in Geneva, UICC’s growing membership of over 800 organisations across 155 countries features the world’s major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, the International Agency for Research on Cancer, and others, UICC is tackling the growing cancer crisis on a global scale. WORLD CANCER DECLARATION Next year alone, nearly nine million people will die of cancer*, and left unchecked, the number of deaths will increase to 13 million per year by 2030. UICC is committed to reducing the global cancer burden through delivering the targets of the World Cancer Declaration.

THIS CALL TO ACTION SETS OUT NINE TARGETS TO BE ACHIEVED BY 2025 INCLUDING: • Strengthening health systems for effective cancer control • Reducing exposure to cancer risk factors • Universal access to screening and early detection of cancer • Universal availability of pain control and distress management.

GOVERNANCE UICC is governed by its member organisations, which meet in a General Assembly, held in conjunction with the World Cancer Congress, every two years. Between Assemblies, a board of 17 directors, elected by the General Assembly, acts as the executive body of UICC.

WORKING IN PARTNERSHIP UICC works closely with key international UN agencies including: the World Health Organization (WHO), with whom we are in official relations, the International Agency for Research on Cancer (IARC), the Programme of Action for Cancer Therapy (PACT), and has consultative status with the UN Economic and Social Council (ECOSOC). In addition to this, UICC offers corporate partners a unique opportunity to demonstrate social responsibility on a global scale. *All cancers excluding non-melanoma skin cancers (Globocan 2012, http://globocan.iarc.fr)

DOWNLOADED THE 2014 WCC APP? USE IT TODAY TO JOIN FORCES AND ACCELERATE PROGRESS

bit.ly.com/2014wccapp

COMMITTEES

ORGANISING COMMITTEE

EX OFFICIO

Chair: Prof. Mary Gospodarowicz – President, Union for International Cancer Control (UICC), Switzerland; Medical Director, Princess Margaret Cancer Centre, Canada

Dr Cary Adams – Chief Executive Officer, Union for International Cancer Control (UICC), Switzerland

Prof. Sanchia Aranda – Director, Cancer Services and Information, Deputy CEO, Cancer Institute New South Wales, Australia Dr Heather Bryant – Vice-President of Cancer Control, Canadian Partnership Against Cancer, Canada Dr Franco Cavalli – Director of Oncology, Institute of Southern Switzerland (IOSI), Switzerland Dr Eduardo Cazap – President, Latin American and Caribbean Society of Medical Oncology (SLACOM), Argentina Dr Anil D’Cruz – Director, Tata Memorial Hospital, India Dr Tezer Kutluk – President, Turkish Association for Cancer Research and Control, Turkey; Presidentelect, Union for International Cancer Control (UICC), Switzerland Prof. Gilbert Lenoir – Board Member and Past President, the French League Against Cancer, France Prof. Ian Olver – Chief Executive Officer, Cancer Council Australia, Australia Dr Kazuo Tajima – Director, Aichi Cancer Center Research Institute, Japan Dr Xishan Hao – Chief Physician of Oncology, Chinese Anti-Cancer Association (CACA), China

Mr Yani Amar – Congress and Events Coordinator, Union for International Cancer Control (UICC), Switzerland Ms Marion Gilodi – Business Development Manager, Union for International Cancer Control (UICC), Switzerland Ms Jessica Mathieu – Head of Congress and Events, Union for International Cancer Control (UICC), Switzerland Ms Vanessa Von Der Muhll – Head of Communications, Marketing and Web, Union for International Cancer Control (UICC), Switzerland

PROGRAMME COMMITTEE

Track 4 - Cancer Control Systems

Co-Chair: Prof. Sanchia Aranda – Director Cancer Services and Information, Deputy CEO, Cancer Institute New South Wales, Australia

Dr Susan O’Reilly – National Director, National Cancer Control Programme, Ireland

Co-Chair: Dr Heather Bryant – Vice-President, Cancer Control, Canadian Partnership Against Cancer, Canada

Prof. Ian Olver – Chief Executive Officer, Cancer Council Australia, Australia Ex-Officio

Dr Eduardo Franco – Department of Oncology, Faculty of Medicine, McGill University, Canada

Ms Kristen De Caria – Programme Coordinator, Union for International Cancer Control (UICC) and Canadian Partnership against Cancer, Toronto, Canada

Mr Terry Slevin – Director Education and Research, Cancer Council Western Australia, Australia

ABSTRACT COMMITTEE

Track 1 - Cancer Prevention And Screening

Track 2 - Cancer Diagnosis And Treatment Prof. Bettina Borisch – Pathologist, Director, World Public Health Association, Switzerland Prof. Stephen Taplin – Academic Specialist in screening and diagnosis, National Cancer Institute, United States

Chair: Prof. David Hill – Former Chief Executive Officer, Cancer Council Victoria, Australia; Past-President, Union for International Cancer Control (UICC), Switzerland Prof. Anil D’Cruz – Director, Tata Memorial Hospital, India; UICC Board Member

Track 3 - Cancer Survivorship And Palliative Care Prof. David Currow – Chief Cancer Officer and Chief Executive Officer, Cancer Institute New South Wales, Australia Prof. Michael Jefford – Deputy Head of the Department of Medical Oncology, Peter MacCallum Cancer Centre; Senior Clinical Consultant, Cancer Council Victoria, Australia 9

HOST COMMITTEE Chair: Prof. Ian Olver – Chief Executive Officer, Cancer Council Australia, Australia Prof. Hideyuki Akaza – Director, UICC-ARO; ViceDirector of the Asian Pacific Federation of Cancer Research and Control (APFOCC), Japan Prof. Sanchia Aranda – Director, Cancer Services and Information, Deputy CEO, Cancer Institute New South Wales, Australia Dr Vijay Arnand Reddy Palkonda – Director and Senior Consultant, Apollo Cancer Hospital, Hyderabad, India Prof. Jeff Dunn – Chief Executive Officer, Cancer Council Queensland, Australia Mr Todd Harper – Chief Executive Officer, Cancer Council Victoria, Australia Mr Dalton Kelly – Chief Executive Officer, New Zealand Cancer Society, New Zeland

Ms Iris Leung – Chief Executive Officer, The Hong Kong Anti-Cancer Society, Hong Kong Ms Hung-Ju Lin – Research & Development Specialist, The Hope Foundation for Cancer Care Dr Anthony Lowe – Chief Executive Officer, Prostate Cancer Foundation of Australia, Australia Ms Nicola Quin – Director Policy and Advocacy, Cancer Council Victoria, Australia Dr Chao-Nan (Miles Qian) – Professor and Vice President, Sun Yat-sen University Cancer Center, China Dr Saunthari Somasundaram – President, National Cancer Society of Malaysia, Malaysia Mr Glen Turner – Head of Media and Communications, Cancer Council Australia, Australia

WELCOME NOTES

PRESIDENT AND CEO OF UICC Dear friends, UICC and its hosts, Cancer Council Australia are delighted to welcome you to the 2014 World Cancer Congress taking place in the beautiful city of Melbourne, Australia. The Congress represents a unique platform for the international cancer control community to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer on communities around the world. The theme for the 2014 Congress is â&#x20AC;&#x2DC;Joining forces - Accelerating progressâ&#x20AC;&#x2122;, which has been a true inspiration in the design of the programme, as the aim is to rapidly convert learning into concrete actions for your own organisations.

Professor Mary Gospodarowicz

President Union for International Cancer Control (UICC)

Over the course of the four-day event you will experience extensive networking and meeting opportunities and we encourage you to make the most of these. There will be compact sessions to promote greater interactivity between presenters and delegates, poster presentations in the heart of the Global Village and, for the first time, we will have a track dedicated to the way in which UICC members have used film and advertising to educate and influence the general public. We are very confident that everyone who attends the 2014 World Cancer Congress will leave Melbourne inspired and full of new ideas to continue their own efforts in the fight against cancer. This is a truly international event that will bring together a unique group of people who have much in common. We are looking forward to joining forces and accelerating progress through your active participation.

Dr Cary Adams

Chief Executive Officer Union for International Cancer Control (UICC)

PROGRAMME CHAIRS Welcome to the World Cancer Congress! This biennial meeting builds UICC’s role as a convenor and ‘connector’ of individuals and organisations committed to reducing the global cancer burden. This is a Congress for all who wish to have an impact on preventable suffering and death from cancer. We trust that you will learn much, meet many new colleagues with common interests, and take advantage of the many opportunities to share your experiences in cancer control with others. The theme of the Congress is ‘Joining Forces Accelerating Progress’. We are learning quickly in international cancer control and this Congress provides an opportunity to focus on what we can actually implement with partners to maximise the impact of this new knowledge. Importantly, we want to move away from talking about problems to implementing solutions. This exciting and innovative programme provides you with great opportunities to identify solutions suitable for implementation in your setting.

• The scientific programme offers inspiring plenary presentations from world-renowned speakers. You will hear about innovations in cancer research and cancer control, international experience in disease control initiatives, and of the huge potential to accelerate knowledge creation through ‘big data’. • Each ‘track’ – Prevention and Screening, Diagnosis and Treatment, Survivorship and Palliative Care, and Cancer Control Systems – offers an array of sub-plenary speakers, symposia, abstract presentations and e-posters, put together by our conference Track Chairs. Building on the success from the rapid-fire abstract sessions from the last Congress, we will have several opportunities to learn at a breakneck pace! • A new feature is a collection of ‘Big Debates’ in controversial areas of cancer control. Come and hear some provocative hot topics discussed in an engaging way. • The ‘Big sCreen’ will show films relevant to cancer control at several points in the programme. These may educate and inspire you and may make you aware of resources you never considered before. Importantly, many of these resources started in one country and have been taken up in others – a tangible example of the benefits of sharing.

• Make the Global Village your ‘home away from home’ during the Congress week. A vibrant hub of activity and facilities, it is also close to all session rooms and houses the ePoster Pods. Make sure you visit the Yarning Space offered in partnership between the Victorian Department of Health and the Victorian Aboriginal Community Controlled Health Organisation, as well as the Bupa Health Lounge. • A large number of excellent abstracts have been accepted as electronic posters (e-Posters). To make it easy to find posters that interest you and connect with the author, it is possible to search electronically by a customised set of keywords. We believe this will render the volume of abstracts particularly useful to delegates and assist you in making connections with people in the global cancer control community who share your areas of interest.

Prof. Sanchia Aranda Programme Co-Chair Director, Cancer Services and Information, Deputy CEO, Cancer Institute New South Wales

• The programme also includes special streams in advocacy and fundraising and in non-communicable diseases, both of which have many opportunities for networking and learning. We are honoured by your presence and, with our Track Chair colleagues, welcome you to the 2014 World Cancer Congress. We hope that you find food for thought – but just as importantly, we hope you identify the tools and energy to put new cancer control initiatives into action when you return home. We also hope you take the opportunity to attend the many social events to catch up with old friends and make some new ones. Let’s join forces to accelerate progress and reduce the burden of this deadly disease throughout the world.

Dr Heather Bryant Programme Co-Chair Vice-President of Cancer Control, Canadian Partnership Against Cancer

LOCAL HOST COMMITTEE CHAIR On behalf of the Host Committee, Cancer Council Australia and our state and territory Cancer Council members, I welcome you to Melbourne, Australia for the 2014 World Cancer Congress. The Host Committee is widely represented, including regional participants from South East Asia and India. New Zealand has also joined and helps support the Western Pacific countries. This reflects the bringing together of a rich mix of developed and developing nations to share experiences and support each other in cancer control initiatives, cancer management and advocacy for evidence-based cancer polices. This is timely, as we all face the challenges of controlling non-communicable diseases, now a priority for the United Nations. This is the very practical face of the congress theme, â&#x20AC;&#x2DC;Joining Forces - Accelerating Progressâ&#x20AC;&#x2122;. The first step is to promote communication, which allows each country to know what the other has to offer. Developed nations may lead the way in cancer research, but often low-income countries have innovative solutions in the best use of limited resources. For example, in cancer control, Australia has led the world in introducing plain packaging of tobacco products and vaccinating girls and boys against HPV. We have also seen the successful implementation of three population screening programmes in breast, cervical and bowel cancer. Yet there are still big challenges, including one of the worldâ&#x20AC;&#x2122;s worst obesity rates and cancer outcomes in our Indigenous peoples that are comparable to those in low-resource settings.

All nations face challenges in cancer prevention, detection and care. Strong cancer plans, as exemplified by those in the United Kingdom, can be the stimulus for accelerated cancer policy implementation. There are lessons to be learned in their development and implementation. Of course, we are limited in what we can achieve by income and we all face an increasingly challenging fundraising environment. This year, the Congress puts a spotlight on innovative fundraising campaigns, which I expect will be of great interest. The philanthropic funding of cancer research, which can be seen occurring in the United States, is a model worth pursuing in other nations. As a host committee, we want you to be stimulated by the programme, to network and form ongoing relationships and enjoy both the Congress and the entertainment. We hope that you have an opportunity to explore Melbourne and more widely, Australia and our region. We trust that you will continue to engage with UICC as a convenor of the global health community. Prof. Ian Olver AM Local Host Committee Chair CEO Cancer Council Australia

LORD MAYOR OF MELBOURNE Welcome to Melbourne, Australia’s cultural and knowledge capital, for the 23rd World Cancer Congress. Melbourne’s charm is characterised by its enchanting laneways, stunning waterfront precincts and trendy neighbourhoods, and provides an endless choice of shopping hot spots, award-winning restaurants and cafés. Our city offers an abundance of unique activities: enjoy the non-stop action at Federation Square or take a stroll through world heritage listed gardens. Whatever your desire, you will find it on your doorstep. Home to people of more than 200 different nationalities speaking more than 230 different languages and dialects and practising more than 120 different faiths, Melbourne is recognised as one of the most diverse cities in the world. It is an advantage our visitors appreciate: in Melbourne you will always feel welcome. On behalf of the City of Melbourne, I hope you enjoy your stay with us and experience the full spectrum of life, colour and excitement that makes Melbourne so unique.

Mr Robert Doyle Lord Mayor

VICTORIAN DEPARTMENT OF HEALTH The Victorian Government is pleased to welcome delegates and visitors to Melbourne for the 23rd World Cancer Congress. I ask that you join me in acknowledging and paying respect to the traditional custodians of the land on which this conference takes place, and to their elders past and present. Cancer has fast become one of the most significant global causes of mortality and morbidity. The theme of this Congress, â&#x20AC;&#x2DC;Joining Forces - Accelerating Progressâ&#x20AC;&#x2122;, calls on us to work together to share advancements in policy, science and research to improve health systems and health and wellbeing outcomes around the world. Victoria is well-placed to share its experiences and expertise in this field, as we continue to work to deliver better, more integrated and patient-centred healthcare. Victoria has a strong record of cancer reforms that have been developed and delivered in partnership with the community to support cancer prevention, early detection, treatment and survivorship. Victoria is also home to an incredible and innovative biotechnology and medical research sector, which includes over 200 biotechnology companies, a network of 11 major independent medical research institutes, seven major teaching hospitals and 10 universities with medical specialties. The Victorian Comprehensive Cancer Centre Project will also deliver a new $1 billion facility purpose-built for cancer research, treatment and care in Melbourne in 2016.

This Congress is an important opportunity for all of us here to learn from each other. It will help us to identify ways to improve health outcomes by reducing the number of preventable cancers; detecting more cancers earlier and ensuring those with cancer and their families receive the treatment and support they need. Meeting together in Melbourne is an opportunity for old relationships and partnerships to be renewed and for new ones to be formed. As you enjoy the world-class conference facilities and the wonderful restaurants and entertainment our city offers, I hope that the debates and conversations around our collective endeavours to tackle cancer fill the air. I wish both organisers and participants a productive and enjoyable conference experience. Dr Pradeep Philip Secretary Department of Health, Victoria

GENERAL INFORMATION

ABSTRACT E-LIBRARY

ACCOMMODATION

The abstract e-library is available via worldcancercongress.org and the smartphone app, allowing delegates to search via title, author, presentation type and keyword.

UICC has secured hotel rooms near the Melbourne Convention and Exhibition Centre (MCEC) at exclusive discounted rates. UICC’s partner agency for the event, ASN Events, based in Melbourne, manages all hotel reservations and delegate registration.

Abstracts from the 2014 World Cancer Congress are also published by Wiley. These are freely accessible and citable worldwide: http://onlinelibrary.wiley.com

Please visit the General Enquiries desk at the Registration, located in front of the Global Village on level 2.

Headquarter Hotel – Crown Metropol The Crown Metropol has been selected as the 2014 World Cancer Congress Headquarter Hotel. Crown Metropol, 8 Whiteman Street Southbank, Melbourne Victoria 3006 ACCOMMODATION WITHIN THE MELBOURNE CONVENTION AND EXHIBITION CENTRE PRECINCT

G E ID BR E G RID D N SA

IDGE ST

MER HA ALL H

RTS EA E TH ENTR C

KA 8 8 RE EUDECK Y SK

GH NA VA KA

THB

FA W

LEVA DA

ME ELIZA MURD BETH CENT OCH RE

ACCA

MILE

S ST

DODD S ST

MALTH THEA OUSE TRE

WEL

4 STAR ACCOMMODATION 1. Citigate Melbourne 2. Quality Hotel Batman’s Hill on Collins 3.5 STAR ACCOMMODATION 1. Mercure Welcome Melbourne (not shown on map)

4.5 STAR ACCOMMODATION 1. Crown Promenade Hotel 2. Crowne Plaza Melbourne 3. Holiday Inn Flinders Melbourne 4. Rendezvous Hotel Melbourne 5. Vibe Savoy Hotel Melbourne

MOOR E ST

N KA VA

Southbank

BOU

IWAK AUDITI ORIUM

AG H

N A EM IT H

ANK

SOU

STURT

NS B R QUEE

UAY

HGAT

E AV

FED S

NT AG U

HGAT

5 STAR ACCOMMODATION 1. Crown Metropol 2. Hilton Melbourne South Wharf

SOUT

IDE

OK CO

T YS RA

SON

ES ST

SOUT

JOHN

AV DEGR

PO W

LS TO

AY W

R LA

EDGE

ESTE

RUTL

CH MAN

RE CENT

T NS STO

PL SON WAT

AN SW

E ED

K DE A BLOC ARCA ELIZ PL &

EY PL

DAM

S G

SSE RU

HOW

AY USEW CADE

EAT

SIDE AV

MEN

1 N KI

E NN URIO BO IT RE EL IB T M XH EN E C

REE WAY

NION

WES TGA TE F

HE CA

T N EN OWINM X CR TA PLE R TE OM EN C

WHARF

H PL

T N EN OWINM X CR TA PLE R TE OM EN C

RLD WOADEE TR NTR CE

MELBOURNE CONVENTION CENTRE

BLIG

DFO

L AR

M TH

M AC

BOND

LEY

SID

RE CLA

RIVER ESPLANA DE

RRA'S EDG E

E PL TABL

SOUTH

A ST

Yarra River

MARINA YE

EEN

N IAN

GEO

GE LA

V LIC PO

RIVER

O K PR

ERS

N TO SIO ERS MISAFAR SE

HNO. 8 BERT H

SOU

N THBA

R RO AU

VIL

NO. 9 BE RT

E RN OU M LB IU ME UAR AQ

RIV

T S S ICTOCREIANTRE

DER

FLIN

2 Y WA

KET

T RS

MAR

LLIN

Y CIT UARE SQ

LAN

FLIN

VIL

AL W

NE UR UM LBO ALL ENAE ME WN H E ATHEATR TO TH ENT REGEATRE TH

E GRAV PL

PRES

FLIN

T SS

EQUI

BANK

T MS LIA

T SS

LIN

L CO

T GS

N SPE

H LA A SS OR OD GO T AY ES ILW LAG

R AU

VIE ER AT W

BATMANS HILL DVE

E TH B HU

RIA TO VIC REEN G

KIN

E OM

IA OR UR BO

CIS

FRAN

L CO

LIT

R OU

T SS

LIN

TLE

LAN E

D NA

PEDE

ON ATI RM TORIA INFO VIC

BRID

WIL

ESP TH

STRI

KE ST

LIT

BOUR

NEWCERY CHAN LA

AY W IL

AY W

ETIHAD STADIUM

TLE

ROYA

ST ER NC ING SPE OPP SH H AC L COMINA TER S BU L SKYMINA TER

N LA

E DJ UN

N LO

L SDA

OF RY T TO OR HISANSPAL TR MUR

RBO

HA ER

E LA WAR

T ES

EN SP

L ITA R DIG BOU R HA

APARTMENTS 1. Plum Serviced Apartments Southbank 2. Clarion Suites Gateway

CIL

South Melbourne MELBOURME CONVENTION AND EXHIBITION CENTRE - 1 Convention Centre Place, South Wharf, Victoria 3006 RY

NT VE CO

APP / SMARTPHONE APPLICATION The official app for participants of the 2014 World Cancer Congress is available as a free download from bit.ly/2014wccapp or by searching for ‘World Cancer Congress’ in the iTunes App Store or on Google Play. The app provides access to the most up-to-date version of the programme, the list of participants, speakers, exhibitors and abstracts - on the move and even when offline. Other services such as messaging and contact exchange are also available depending on network connectivity.

To make the most of the app, we encourage participants to: • Take advantage of the eNetworking functionality of the app, by connecting to other participants who have similar interests and work activities; use the messaging service, the meeting request and contact exchange functions to take the opportunity to connect and schedule meetings with like-minded people attending the Congress • Check and search the full programme of sessions by day or track to quickly find information of interest and create your own agenda • Browse the list of speakers, their biographies and what sessions they will be presenting in • Discover the Global Village and easily find the Exhibitors • Learn more about the Sponsor activities and interact with other participants on social media • Access maps and other logistical information for the Congress, supporting documents, presentations and more NB: To use certain features of this app, you must be a registered participant of the 2014 World Cancer Congress. For information on how to obtain your username and password, please visit worldcancercongress.org.

BADGES

Lost Badges

Badges must be worn at all times during the Congress, including during social activities. Your delegate badge will give you access to all sessions including Lunch and Learn activities, the Big sCreen and Film Premieres, the Global Village, the Welcome Reception and Opening Ceremony, the Australian Performance Showcase, the closing concert ‘Inspiring Lives, Inspiring Music’ and access to all COSA sessions on Thursday, 4th December.

Name badges must be worn at all times. If a badge has been lost or forgotten and a new badge has to be reprinted, they can be issued at the registration desk upon a deposit of AU$100. If the original badge is returned within 24 hours the deposit will be returned.

Accompanying persons have access to official Congress social events (Opening Ceremony, Welcome Reception, Half day City Tour or Half day Walking Tour), Australian Performance Showcase and Closing Concert ‘Inspiring Lives; Inspiring Music’, but not to session rooms or the Global Village. Exhibitors have access to the Global Village and to the official Congress social events, The Big sCreen and film premieres, but not to session rooms. Badges have the following colour coding: Delegate

Blue

Speakers

Purple

Accompanying Person

Salmon

Exhibitors

Pink

Press/Media

Grey

UICC/Staff/Volunteers

Orange

Consumer

Yellow

Name changes Individuals who have already registered may transfer their registration to another person. The new registrant has to provide written permission for the transfer from the original registrant, and a handling fee of AU$40 will be charged. Please visit the registration desk in the foyer on Level 2, outside the Global Village for more information. Reprinting on-site In the event of a spelling mistake on the badge, and if a reprinting is required, an AU$20 administrative fee will be charged.

No-shows at the Congress will be charged the full fee.

CONTACTS

DELEGATE BAGS amar@uicc.org

Registration

bd@asnevents.net.au

Exhibition and Sponsorship

gilodi@uicc.org

Hotel Accommodation, Tours and Transfers

Delegates, Speakers and Consumers are entitled to one bag each. Exhibitors are entitled to one bag per stand.

bd@asnevents.net.au

CLOAKROOMS

Travel Grants

ovide@uicc.org

Speaker Services

amar@uicc.org

Press and Media

uiccpress@rdcomms.com

COSA ANNUAL SCIENTIFIC MEETING The Clinical Oncology Society of Australia’s (COSA) 41st Annual Scientific Meeting (ASM) will be held in conjunction with the 2014 World Cancer Congress (WCC). The COSA ASM will be held on 2 - 4 December, with Thursday 4th being a joint day where delegates can attend sessions from both conferences. On that day, a number of sessions have been developed jointly with the COSA and the WCC Programme Committees. All joint sessions will be held on Thursday 4th December, in Plenary Hall 2. The theme for COSA’s 41st ASM will highlight cancer survivorship, supportive care and palliative care. The disease theme will concentrate on lung cancer and metastases. For the full daily COSA programme, please consult the website: www.cosa2014.org/program

The official 2014 World Cancer Congress delegate bags are available at the point of registration in the Foyer, Level 2.

General Enquiries and Congress Programme

If you would like to leave any bags or belongings whilst you attend the sessions, a cloakroom is located at MCEC off the main Convention Centre foyer on Ground Level near the Porte Cochere entrance. This service is provided directly by the Melbourne Convention and Exhibition Centre and UICC will not be held liable in case of any loss, theft or damage to your belongings. Delegates also have the option to leave their belongings at their respective hotels, with the Concierge.

CONGRESS VENUE The 2014 World Cancer Congress is taking place at Melbourne Convention and Exhibition Centre (MCEC). MCEC is located on the banks of the iconic Yarra River in South Wharf. It is a short walk from Melbourne’s central business district and just a 20-minute drive from Melbourne Airport.

WHERE IS MCEC? Convention Centre 1 Convention Place South Wharf Victoria, 3006 Australia

E-POSTERS An electronic poster (e-Poster) is a poster available for viewing on rotation on large screens in the â&#x20AC;&#x2DC;ePoster Podsâ&#x20AC;&#x2122; which will be located in the Global Village, Level 2 and in the Foyer in front of Room 203. There are six e-Poster pods in total, and three different categories: 1. Scientific studies Describing the collection, analysis and interpretation of cancer-relevant data (clinical, behavioural, epidemiological, etc.) 2. Awareness campaign, advocacy report and practice policy Describing innovative programmes in detection, care, support, prevention and organisation 3. Fundraising campaign reports Describing programmes to build public support to fund or donate to cancer control causes Participants will have access to all e-Posters on the monitors at anytime, within the Global Village opening hours, and there will be dedicated e-Poster presentation sessions during each networking break.

As posters will be presented electronically at this Congress, presenters should not bring a large hard copy for static display. e-Posters should have been uploaded in advance of the Congress. However, if you have not yet uploaded your e-Poster, please go to the Speakerâ&#x20AC;&#x2122;s Service Centre in Room 112, Level 1 at least 90 minutes before your presentation is due to start.

FINAL PROGRAMME Upon on-site registration a copy of the Final Programme is provided free of charge to delegates who requested a copy during their online registration via worldcancercongress.org. If available, additional copies can be purchased for AU$50 from the Registration Desk in the Melbourne Room Foyer, Level 2. If you selected an electronic copy of the Final Programme, please download it from www.worldcancercongress.org.

To enhance connections between delegates, the dedicated Congress smartphone application will allow delegates to search and view abstracts by title. Abstract authors may use this to connect with other delegates with similar interests to arrange to make a more detailed presentation of their work to individuals or small groups at convenient locations at MCEC, using hand-outs, their own laptop, or screens available in the Global Village.

FOOD AND BEVERAGES AND LUNCHTIME ACTIVITIES Global Village Catering Outlet Breakfast, tea and coffee, healthy snacks as well as a wide range of different lunch options are available to purchase from the food outlet located in the Global Village (Melbourne Room, Level 2). The opening hours of the food outlet are as follows: Global Village food kiosk Wednesday 3rd December

15:00 - 19:00

Thursday 4 December

08.00 - 16:00

Friday 5th December

08:00 - 16:00

Saturday 6th December

08:00 - 15:00

Lunch & Learn Satellite Sessions This is your chance to get a bite to eat whilst networking with others attending a session, watching e-Poster presentations and engaging in workshops.

NCD Café The NCD Café welcomes you for a coffee or healthy snack whilst providing a unique space for interactive sessions with global health experts. Visit the NCD Café in the Foyer on the Ground Floor. Bupa Healthy Breaks Every morning, Bupa will be offering complimentary healthy tea breaks in the Global Village. Claim your free coffee or tea, whole fruit and healthy treat using the Bupa coupons you will receive upon registration.

GLOBAL VILLAGE

INSTITUTIONAL TOURS

The Global Village, located in the Melbourne Room on Level 2, will provide a central and dynamic environment, where people can network and exchange ideas with fellow participants.

Melbourne features some of the leading cancer institutions in the world, which welcomed delegates on institutional visits.

Several activities will take place in the Global Village, including: • Congress Welcome Reception and Closing Cocktail • The UICC stand • The international exhibition • e-Poster presentations in the dedicated e-Poster pods • Bupa Health Lounge • The UICC Lounge facilitating informal discussions • Literature display stand • A catering area, including Bupa Healthy Morning Breaks. • The WCC Photo booth • The Surf Station *The Global Village opening hours are as follows: Global Village opening hours (exhibition) Wednesday 3rd December

15:00 - 19:00

Thursday 4 December

08.00 - 18:00

Friday 5 December

08:00 - 18:00

Saturday 6 December

08:00 - 17:00

Thank you to the following participating organisations: • • • • • • • •

Walter and Eliza Hall Institute, Melbourne (WEHI) Movember Royal Children’s Hospital, Melbourne Olivia Newton John Cancer and Wellness Centre, Melbourne Cancer Council Victoria Department of Health of Victoria Victorian Cytology Service Peter MacCallum Cancer Centre

STAY HEALTHY AT THE CONGRESS WITH BUPA

EN 15-MJOY A IN FRE UTE MAS E S ON UAGE S!

• Receive a healthy morning tea on us. Check your registration pack for your coupon, for your free coffee Home Call us or tea and healthy snack. Parking Request a call back • Enjoy a free 15-minute neck and shoulder massage.

Make a claim

File/save/stored item

• Experience our range of health apps including FoodSwitch. Email us

Valet parking

• Take the mini-golf challenge. For every hole-in-one, we’llWeb make a donation to Cancer Council Vaccination centre Australia. chat

Refresh/update

Disabledin access Visit us/pop Visit theby Bupa Health Lounge the Global Village. Membership/card

Write to us

Hospital

Renew membership

INSURANCE

Please note

The organiser, UICC, does not accept responsibility for individual medical, travel or personal insurance. Participants are strongly advised to make their own arrangements for health and travel insurance.

*Wireless is a less secure service and download speeds vary depending on the number of users at any one time. Wireless signal strength can also vary depending on geographical location and other items interfering with the signal.

INTERNET ACCESS AND WIFI M Connect – Free wireless internet Visitors to Melbourne Convention and Exhibition Centre have access to free wireless internet. The M Connect service: • Requires individual users to subscribe (free of charge) to the service via a log-in page, and agree to a set of terms and conditions. Users need to re-subscribe (free of charge) to the service after 12 hours, or once their 100MB download limit is reached. • Is shared by all event attendees and general public in the centre throughout the event

How to connect to M Connect: Connecting to the wireless network varies depending upon the device being used. Please follow the below steps: 1. Select the M Connect wireless service as you would normally do using your wireless device. 2. Open your preferred internet browser (Safari, Firefox, Internet Explorer etc.). 3. Complete the information on the log-in page that appears in your browser (see below).

• Has a maximum bandwidth of 512kbps*. The actual bandwidth will be influenced by the number and density of concurrent users. • Is delivered by in-house wireless access points (WAPs) and provides coverage throughout the venue including meeting rooms, exhibition bays, Plenary and all other public spaces. • Is suitable for basic internet browsing, web-based email, Facebook, Twitter, MSN Messenger, Yahoo Messenger, Skype, Google Talk and IMAP/POP3/SMTP email. • Is not suitable for streaming video, VPN connections, peer-to-peer file sharing or running internet-based workshops. • Operates between 6.00am and 12 midnight. 28

4. Select ‘Generate Account’. 5. Select ‘Login’ on the guest account page. 6. Read the terms and conditions page and choose “accept” in order to connect. 7. Commence using M Connect.

WIFI Hotspots in Melbourne

LIABILITY

Save money with free WiFi access. Most Melbourne WiFi hotspots are free, or free with purchase of a drink or snack.

UICC reserves the right to postpone, modify the dates, and partially close down the event or to cancel the event, including the exhibit, or to transfer it to another site, if unforeseen circumstances justify such action. Should any contingency prevent the exhibition/event from taking place, UICC will not be held liable for expenses incurred other than those paid to UICC in connection herewith. In these events, the contract is regarded as valid for new dates and/or new duration and/or new location.

Federation Square, by the Yarra River in Melbourne city has free WiFi. Find a comfortable spot in the square and log on. Free WiFi is also available across the road at Flinders St. Railway Station. Select the “Metro Wi-Fi” network. Public libraries and museums across town offer free WiFi access. Use the list below as a guide to finding hotspot locations across town. Queen Victoria Market Food Court, on the corner of Queen and Victoria streets in Melbourne, also has free WiFi. Other WiFi locations You’ll find wireless internet hotspots around the city at many cafes, bars and restaurants. Pick up a list of locations from Melbourne Visitor Centre. FREE WIFI • • • • • • • • • •

City Library Federation Square Melbourne Airport Melbourne Museum Melbourne Visitor Centre NGV International North Melbourne Library Queen Vic Market State Library Victoria The Hub Docklands

Unexpected cancellation of the event: UICC reserves the right to cancel the 2014 World Cancer Congress without notice or compensation due to circumstances outside its control, including (but not limited to) acts of God, civil commotion, strike, work to rule or go slow, lock-outs, hostilities, fire, flood, drought or inability to procure materials, venues or services except at increased prices due to any of the foregoing causes. In the event of force majeure, UICC is free of all responsibility. Should it become impossible for UICC to hold the 2014 World Cancer Congress, so long as this is due to force majeure and not to any cause attributable to UICC, UICC shall only be obliged to reimburse the payments received, subject to deduction of any costs it has incurred in preparing the event.

LOST AND FOUND For lost or found objects, please address inquiries to a security officer or at the WCC Registration Desk, located in the Foyer, Level 2, in front of the Global Village (Melbourne Room).

MOBILE PHONES

PHOTOGRAPHY AND FILMING

Delegates are kindly requested to keep their mobile phones switched to silent during all sessions and e-Poster presentations.

The World Cancer Congress is an open and public event. Professional photographers employed by UICC, the hosts and other members of UICC will be taking pictures and footage at the event.

OFFICIAL LANGUAGE The official language of the World Cancer Congress is English.

ONLINE DAILY NEWS

All photos and footage produced are to be used in print and/or electronic form, solely for non-commercial, promotional purposes of the work of UICC and its member organisations.

The Congress website worldcancercongress.org will be kept up-to-date with the latest news and photos during the event. Be sure to also keep an eye on social media for live updates. More information on page 105.

If any participant or speaker has any issue being photographed or filmed during the Congress, or his/ her likeness being used, he or she is kindly requested to inform the UICC Communications team, by leaving a message with their name, email and phone number at the UICC Office in Room 215, Level 2.

ORANGE LOUNGE

PRESS / MEDIA

UICC is pleased to introduce the new Orange Lounge at the World Cancer Congress, located in Room 206 on Level 2.

The Press Lounge will be the on-site hub for Press/ Media and can be found in Room 205, on Level 2.

The Orange lounge welcomes: • UICC Partners and WCC Sponsors during the scheduled ‘VIP Lounge’ slots • All delegates during the following scheduled events: -- Two daily UICC Members Regional Meetings -- Childhood Cancer Lunchtime Workshop; Organised by UICC

Only accredited press/media will be granted access to this room and the facilities. Eligible press and media are entitled to accreditation which can be organised in advance of the Congress or on-site. Press/Media should proceed directly to the Press Lounge for badge collection and onsite registrations. Please visit worldcancercongress.org/press for more information or contact uiccpress@rdcomms.com for any questions. Please note that all material produced during the Congress for press/media purposes will also be available online from worldcancercongress.org.

REGISTRATION

SMOKING POLICY

The Congress registration desk, located in the Foyer, Level 2, will be open at the following times:

The World Cancer Congress is a strictly non-smoking event. It is therefore forbidden to smoke in the Melbourne Convention and Exhibition Centre, and all associated event venues. This policy also includes set-up and dismantling periods, and will be strictly enforced.

Days

Hours

Wednesday 3 December

Exhibitors: 10:00 - 19:00

Thursday 4 December

08:00 - 18:00

Friday 5th December

08:00 - 18:00

Saturday 6th December

08:00 - 17:00

Delegates: 15:00 - 19:00

On-site Registration Fees Standard Rate

$980

UICC Members and/or UICC Vanguard Partners

$690

Students/Trainees

$490

Participants from Low-and middle-income countries* (UICC Members Only)

$490

Accepted Abstract Presenters (non-UICC Member)

$690

Accompanying person

$210

Consumers - Saturday only

$50

All speakers who have not submitted their PowerPoint presentation or audio-visuals through the dedicated online system should visit the Speakers service centre in Room 112, Level 2, at least 90 minutes before the start of their session. There will also be computers available to use at the service centre if you wish to make changes to your presentations while at the MCEC. Speakersâ&#x20AC;&#x2122; Service Centre Hours Wednesday 3rd December

15:00 - 19:00

Thursday 4 December

07:30 - 18:00

Friday 5 December

07:30 - 18:00

Saturday 6th December

07:30 - 15:30

Joint WCC & COSA registration available. Please see registration desk for details. *Following the World Bank classification.

SPEAKERSâ&#x20AC;&#x2122; SERVICE CENTRE

SURF STATION Catch up with your emails, browse through the abstracts e-library and more in the dedicated Surf Station (Global Village stand 36-38, Melbourne room, Level 2). This free area provides a working space as well as an internet station with laptops for the Congress delegates.

SURVEYS AND FEEDBACK

By Train

After the Congress, delegates will receive by email an online survey. UICC would appreciate all delegates’ feedback, so we can try to improve everyone’s Congress experience in the future.

Take any train that goes to Southern Cross Station. Get off at Southern Cross Station and catch tram number 96,109 or 112 as above.

Everyone who completes a survey will go into the draw to win an economy return flight to Paris, to attend the 2016 World Cancer Congress, thanks to Qatar Airways.

By Bus The SkyBus transports visitors directly from Melbourne Airport to Southern Cross train station. Bus route 238 operates to and from Southern Cross Station to Convention Place between the hours of 10:00 and 15:00, Monday to Friday. The coach pick up/drop off point is in ‘Bay 1’, Convention Centre Place (closest to DFO South Wharf).

TRANSPORT

For further tram, train and bus timetable information and trip planning, visit http://ptv.vic.gov.au.

PUBLIC TRANSPORT

By Taxi

By Tram

Ask the taxi driver to drop you off at Convention Centre Place, next to the Hilton Melbourne South Wharf and DFO South Wharf.

Catch any of the following trams and get off at the stop ‘Casino/MCEC’ opposite the Clarendon Street entrance of MCEC: • Route 96 – St Kilda to East Brunswick • Route 109 – Port Melbourne to Box Hill

PARKING There are five car parks available for visitors to MCEC:

• Route 112 – West Preston to St Kilda

1. MEC basement car park – enter via Normanby Road

Alternatively catch tram number 48 or 70 and get off at the Flinders Street stop. Then take a short walk towards the Yarra River, across the Seafarers Bridge.

2. Siddeley Street car park – enter via Siddeley Street 3. Freeway car park – enter via Munro Street or Normanby Road 4. South Wharf retail car park – enter via Normanby Road 5. Corner of Montague and Munro Streets car park – enter via Munro Street

For further details and for parking rates, please refer to http://mcec.com.au/visiting-melbourne/getting-there/.

Chief Operating Officer Maria Barbara Leon Advocacy and Capacity Building Projects Riccardo Lampariello Rebecca Morton Doherty Melissa Rendler-Garcia Communications, Marketing and Web Vanessa Von der Muhll  Penny Moodie Caroline Perréard Charles Andrew Revkin Congress and Events Jessica Mathieu Yani Amar

UICC TEAM The UICC Team can be found onsite in Room 215, Level 2 at the MCEC. UICC Team Office Hours Wednesday 3rd December

12:00 - 19:00

Thursday 4 December

08:00 - 18:00

Friday 5 December

08:00 - 18:00

Saturday 6 December

08:00 - 14:30

The following UICC Team Members will be onsite during the World Cancer Congress: Chief Executive Officer Cary Adams

Memberships and Partnerships Ana Maria Angarita Correa Natacha Debbané Mina Djordjic Marion Gilodi Karine Hentsch Finance and Administration Marion Ovide Philomène Taylor McCabe Centre for Law and Cancer Jonathan Liberman NCD Alliance Katie Dain Alena Matzke Ariella Rojhani

Deputy CEO and Advocacy and Programmes Director Julie Torode 33

TRAVEL GRANTS UICC recognises the importance of providing assistance to Congress participants from low- and middle-income countries (following the World Bank classification). With this objective in mind, a number of Travel Grants were awarded to invited speakers or abstract submitters who will be presenting at the 2014 World Cancer Congress, in oral sessions, rapid fire poster presentations, e-Posters or the Big sCreen sessions. All Congress participants are highly encouraged to attend these dynamic and not-to-be missed presentations. UICC Travel Grant funds have generously been supported by Canadian Cancer Society, Canadian Partnership Against Cancer, Elekta, GlaxoSmithKline, Livestrong Foundation, the National Breast Cancer Foundation of Australia, the Norwegian Cancer Society, Novartis, Prostate Cancer Foundation of Australia, Roche and US National Cancer Institute. A dedicated â&#x20AC;&#x153;Travel Grantâ&#x20AC;? counter at the World Cancer Congress Registration Desk will be operational during the following opening hours: Opening hours Thursday 4th December

15:00 - 17:00

Friday 5 December

13:00 - 15:00

Saturday 6 December

13:00 - 15:00

UNION FOR INTERNATIONAL CANCER CONTROL (UICC) 62 route de Frontenex CH 1207 Geneva Switzerland T : + 41 22 809 1811 F : + 41 22 809 1810

VOLUNTEERS UICC would like to thank all the wonderful volunteers, including those from Cancer Council Victoria and the Breast Cancer Network of Australia for giving their time to help out at the Congress.

YOGA CLASSES The 2014 World Cancer Congress does not only lead the way in cancer and NCD prevention and control, it is also breaking ground by providing a truly healthy and NCD friendly Congress environment. Every morning delegates are invited to get moving with a gentle morning yoga flow to prepare body and mind for a packed day of sessions, meetings and networking. Whether you have never done yoga or are an experienced practitioner - come out to walk the talk of cancer and NCD prevention, soak up sun and leave behind stiffness and fatigue to discover the diverse health benefits of yoga. Register at the General Enquiries counter, located at the Registration desk, in front of the Global Village. Limited to 25 participants daily. Meeting point at 07:00am at the Registration desk, in front of the Global Village, level 2. Instructor: Alena Matzke, NCD Alliance (Switzerland) and Yoga instructor

UICC MEMBER BENEFITS

If you choose to join the largest global cancer-fighting organisation today, you will: Be part of the Global Health Community

• Network, collaborate, and share knowledge with other UICC members at key events such as the World Cancer Congress and World Cancer Leaders’ Summit.

• Engage with over 800 organisations across 155 countries that feature the world’s major cancer societies; research institutes; treatment centres, hospitals, scientific and professional societies; ministries of health, public health agencies; and patient support groups.

• Enjoy up to 60% discount at the World Cancer Congress and special discounts on publications such as the TNM, Manual of Clinical Oncology, and the International Journal of Cancer.

Support the Global Health Agenda

Complete the online application at www.uicc.org/apply-membership

• Contribute to our advocacy efforts, sharing your expertise with UICC members at both global and country levels. • Connect with the broader Non-communicable diseases (NCDs) community to help position cancer and other NCDs in the post-2015 development agenda. Increase your visibility across the global health community  • Regularly showcase your events and success stories on UICC communications platforms. • Apply to use the UICC logo on your promotional materials and have your events endorsed by UICC. The UICC logo is the embodiment of the organisation’s values and reputation and gives more visibility and recognition to your events. • Use and customise the World Cancer Day campaign materials to support your work and share it with the world in our interactive map of events. 36

Expand your network and get your message across at UICC’s convening events

APPLY FOR MEMBERSHIP TODAY

UICC MEMBERS’ MEETING ROOM @ WCC UICC Members will have access to an exclusive Members’ Room throughout the Congress, which is located in the Global Village and available for ad-hoc or scheduled meetings. Bookings can be made onsite by using the form located on the Members’ Room door. With thanks to our UICC Member for their support of this space.

SPONSORS, PARTNERS AND COLLABORATORS

DESTINATION SPONSORS

PLATINUM SPONSORS

GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSORS

SPONSOR PROFILES DESTINATION SPONSORS

PLATINUM SPONSORS

DEPARTMENT OF HEALTH VICTORIA

AMERICAN CANCER SOCIETY

The Department of Health is committed to achieving the best health and well-being for all Victorians.

The American Cancer Society is a global grassroots force of more than three million volunteers saving lives and fighting for every birthday threatened by every cancer in every community. As the largest voluntary health organization, the Society’s efforts have contributed to a 20 percent decline in cancer death rates in the U.S. since 1991, and a 50 percent drop in smoking rates. Thanks in part to our progress nearly 14 million Americans who have had cancer and countless more who have avoided it will celebrate more birthdays this year. As we celebrate 100 years of service, we’re determined to finish the fight against cancer. We’re finding cures as the nation’s largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings, clean air, and more. For more information, to get help, or to join the fight, call us anytime, day or night, at 1-800-227-2345 or visit cancer.org.

The department is one of nine state government departments in Victoria, and is the lead portfolio agency overseeing all health services, mental health, ageing and aged care, and preventative health. It is also responsible for planning, policy development, funding and regulation of health service providers and activities that promote and protect Victoria’s health. These include public health services, public hospitals and external organisations that deliver health, mental health and aged care services in metropolitan, rural and regional Victoria. Website: www.health.vic.gov.au Twitter: @VicGovHealth Facebook: facebook.com/VicGovHealth

Website: www.cancer.org Twitter: @AmericanCancer Facebook: www.facebook.com/ AmericanCancerSociety

BUPA

CANCER COUNCIL AUSTRALIA

Bupa’s purpose is longer, healthier, happier lives. As a leading international healthcare group, we offer health insurance and medical subscription products, run care homes, retirement villages, hospitals, primary care centres and dental clinics. We also provide workplace health services, home healthcare, health assessments and long-term condition management services.

Cancer Council Australia is the nation’s peak nongovernment cancer control organisation.

We have over 22m customers in 190 countries. With no shareholders, we invest our profits to provide more and better healthcare and fulfil our purpose. We employ more than 70,000 people, principally in the UK, Australia, Spain, Poland, New Zealand and Chile, as well as Saudi Arabia, Hong Kong, India, Thailand, and the USA. Website: www.bupa.com Twitter: @Bupa Facebook: www.facebook.com/BupaAustralia www.facebook.com/BupaUK linkedin.com/company/bupa

We represent the national interests of our member bodies, Australia’s state and territory Cancer Councils. Collectively, Cancer Council is Australia’s largest health charity and biggest independent funder of cancer research. Our mission is to minimise the threat of cancer to Australians, through successful prevention, best treatment and support. We advise best practice policy in cancer control and coordinate national health promotion and fundraising activity. Website: www.cancer.org.au Twitter: @CancerCouncilOz Facebook: www.facebook.com/ cancercouncilaustralia

SPONSOR PROFILES

NATIONAL CANCER INSTITUTE, US

ROCHE

The National Cancer Institute (NCI) of the National Institutes of Health, U.S.A., supports and conducts groundbreaking research in cancer biology, causation, prevention, detection, treatment, and survivorship in its effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families. In 2011, NCI established the Center for Global Health as the Institute’s principal team in coordinating and prioritizing NCI’s global activities to advance global cancer research, build expertise, and leverage resources across nations to address the challenges of cancer and reduce cancer deaths worldwide.

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century.

Website: www.cancer.gov Twitter: @NCI Facebook: www.facebook.com/cancer.gov YouTube: www.youtube.com/user/NCIgov

Website: www.roche.com

GOLD SPONSORS

BAYER

BRISTOL-MYERS SQUIBB

Bayer HealthCare, a subgroup of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry. Bayer is committed to delivering science for a better life by advancing a portfolio of innovative treatments.

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines help millions of patients around the world in their fight against cancer, cardiovascular disease, hepatitis B, HIV/ AIDS and rheumatoid arthritis. Bristol-Myers Squibb Foundation’s philanthropic programs seek to promote health equity and improve health outcomes among populations disproportionately affected by serious diseases, giving new hope to some of the world’s most vulnerable people.

The oncology franchise at Bayer now includes three oncology products and several other compounds in various stages of clinical development. Together, these products reflect the company’s approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated. Website: www.bayerpharma.com

Website: www.bms.com Twitter: @bmsnews

SPONSOR PROFILES

CANCER COUNCIL VICTORIA

GLAXOSMITHKLINE (GSK)

Cancer Council Victoria is a non-profit organisation thatâ&#x20AC;&#x2122;s been leading the fight against all cancers for more than 78 years. Our prevention programs Quit and SunSmart are world renowned. We also teamed up with the Union for International Cancer Control to launch the McCabe Centre for Law and Cancer in 2012. It is the only centre of its kind in the world designed to build global capacity for the effective use of law in cancer control. Thanks to the continuing generosity of donors, we are also able to keep working across cancer research, patient support and advocacy.

GSK is dedicated to patients, physicians and communities with a strong focus in countries where resources are limited. We understand that providing access to quality GSK medicines and vaccines should translate into a greater health impact, which in turn should affect social and economic growth over time in these countries. Access to quality medicines could not be achieved without lasting partnerships with key non-governmental organisations (NGOs). As such, we at GSK are proud to support some of the Worldâ&#x20AC;&#x2122;s leading NGOs, including: AMREF, CARE, Save the Children and the UICC.

Website: www.cancervic.org.au Twitter: @cancervic Facebook: www.facebook.com/cancervic

Website: www.gsk.com Twitter: @GSK Facebook: www.facebook.com/GSK

ELI LILLY / PACE

NOVARTIS

Created by Lilly Oncology as a global collaboration spanning diverse sectors, PACE (Patient Access to Cancer care Excellence) exists to encourage public policies and healthcare decisions that speed the development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines. PACE is engaging key oncology stakeholders: patients, advocacy, payers, policymakers, providers, the public, researchers and politicians. To learn more about PACE globally, please visit www.pacenetwork.com

Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology â&#x20AC;&#x201C; understanding how cancer develops on a genomic level and developing drugs that hone in on those targets Website: www.novartisoncology.com Twitter: @Novartis Facebook: https://www.facebook.com/novartis

Website: www.lilly.com Twitter: @EliLillyCo Facebook: www.facebook.com/PaceNetworkUSA

SPONSOR PROFILES SILVER SPONSORS

VICTORIAN CANCER AGENCY The Victorian Government established the Victorian Cancer Agency in 2006 to fund translational cancer research in order to accelerate the translation of research findings into improved cancer patient outcomes across Victoria. The priority areas of the Victorian Cancer Agency are to build cancer research capacity and capability, and to sustain and enhance Victoriaâ&#x20AC;&#x2122;s excellent track record in cancer research.

CANADIAN PARTNERSHIP AGAINST CANCER The Canadian Partnership Against Cancer works with Canadaâ&#x20AC;&#x2122;s cancer community to reduce the burden of cancer on Canadians. Grounded in and informed by the experiences of those affected by cancer, the organization works with partners to support multi-jurisdictional uptake of evidence that will help to optimize cancer control planning and drive improvements in quality of practice across the country. Through sustained effort and a focus on the cancer continuum, the Partnership supports the work of the collective cancer community in achieving long-term population outcomes: reduced incidence of cancer, less likelihood of Canadians dying from cancer, and an enhanced quality of life of those affected by cancer. Website: www.partnershipagainstcancer.ca Twitter: @Cancer_Strategy Facebook: www.facebook.com/ CanadianPartnershipAgainstCancer

CANCER AUSTRALIA

LIVESTRONG FOUNDATION

Cancer Australia is the Australian Government’s national agency providing leadership in cancer control to improve outcomes for those affected by cancer, their families and carers. Cancer Australia builds the evidence base, analyses, interprets and translates the latest scientific cancer research and data to inform policy and practice, and to provide information and expert advice on cancer control to governments, health professionals and the community.

The LIVESTRONG Foundation fights to improve the lives of people affected by cancer now. Created in 1997, the Foundation is known for providing free cancer support services and advocating for policies that improve access to care and quality of life. Known for its powerful brand – LIVESTRONG – the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has served 2.5 million people affected by the disease and raised more than $500 million to support cancer survivors. One of America’s top non-profit organizations, the Foundation has been recognized by industry leaders including Charity Navigator, the National Health Council and the Better Business Bureau for its excellent governance, high standards and transparency.

Website: www.canceraustralia.gov.au Twitter: @CancerAustralia YouTube.com/canceraustralia

Website: LIVESTRONG.org Twitter: @LIVESTRONG Facebook: www.facebook.com/livestrong

SPONSOR PROFILES

PFIZER Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time. Website: www.Pfizer.com Twitter: @pfizer Facebook: www.facebook.com/Pfizer

THE PRINCESS MARGARET CANCER FOUNDATION The Princess Margaret Cancer Foundation raises funds to support Princess Margaret Cancer Centre at University Health Network located in Toronto, Canada. As a social enterprise we pride ourselves in having one of the most diverse portfolios of fundraising programs in the world and exceling at building fundraising brands and engaging our community. Our vision is to conquer cancer in our lifetime by raising funds to support one of the top 5 cancer research centres in the world. Our success is built from a culture of belief we call our â&#x20AC;&#x153;Creedâ&#x20AC;?. Website: http://thepmcf.ca/ Twitter: @thePMCF Facebook: www.facebook.com/thePMCF

BRONZE SPONSORS

VARIAN MEDICAL SYSTEMS

CANADIAN CANCER SOCIETY

Varian Medical Systems focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the worldâ&#x20AC;&#x2122;s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.

The Canadian Cancer Society is a national, community-based organization of volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. Thanks to our donors and volunteers, the society has the most impact, against the most cancers, in the most communities in Canada. Website: www.cancer.ca Twitter: @cancersociety Facebook: www.facebook.com/ CanadianCancerSociety

Website: www.Varian.Com Twitter: @varianmedsys

SPONSOR PROFILES

ELEKTA

FORMOSA CANCER FOUNDATION

Elekta is a medical technology provider for cancer care dedicated to improving, prolonging and saving patients’ lives. Collaborating with clinicians, the company develops treatment options for cancer and other serious diseases throughout the brain and body. From Gamma Knife® radiosurgery and advanced radiotherapy techniques, to software that manages the entire patient handling process, Elekta provides complete solutions. Since 1972, Elekta has equipped physicians with tools to help patients. Today, we continue to recognize the importance of educating and training customers to confidently treat patients, and are committed to remaining a pioneer in the creation of life-changing products.

The Formosa Cancer Foundation(FCF) was founded in 1997. The FCF works to reduce cancer incidence and mortality through public education that focuses on promoting healthy life style, early detection and raising the quality of cancer care and treatment. The Foundation also provides comprehensive services and support for cancer survivors free of charge to facilitate their optimal recovery and enhance quality of life. FCF’s “Survivor Care & Education Center” in Northern and Southern Taiwan have evolved into a center for survivors’ empowerment and a “second home” for survivors and their families.

Website: www.elekta.com Twitter: @Elekta

Website: www.canceraway.org.tw

HOPE FOUNDATION FOR CANCER CARE

NORWEGIAN CANCER SOCIETY

The Hope Foundation for Cancer Care (HOPE) was established in 2002, consisting of healthcare professionals, cancer survivors and caregivers dedicated to cancer care. The foundation aims to offer comprehensive support services, cancer information and education, advocacy programs for patients’ better survivorship. With 3 service centers in Taiwan, the foundation hopes that via the accessibility of services, cancer patients and their family members can easily find support and resources through the journey to recovery.

NCS contributes to targeted efforts in cancer information, prevention, advocacy, research, care, and international cooperation. Our activities are funded by our members, bequests, and allocations from the national lottery funds.

Website: www.ecancer.org.tw Facebook: https://www.facebook.com/ehopetw

Main objectives: • Contribute to ensure that fewer people develop cancer • Contribute to more people surviving cancer • Ensure the best quality of life for people affected by cancer NCS has an annual budget of 75 million (2013); about 180 employees at its head office in Oslo and district offices; 113 000 subscribing members and 20 000 volunteers working for the cancer cause. Website: www.kreftforeningen.no Twitter: @kreftforeningen Facebook: facebook.com/Kreftforeningen Instagram: instagram.com/kreftforeningen

SPONSOR PROFILES

PANACEA GLOBAL Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. Panacea’s novel product is a blood test that can detect the presence of cancer in humans using a novel cancer biomarker named Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH), an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology. Website: http://panaceaglobalinc.com/ Twitter: @PanaceaGlobalIn Facebook: www.facebook.com/Panaceaglobalinc

PROSTATE CANCER FOUNDATION OF AUSTRALIA Prostate Cancer Foundation of Australia (PCFA) is a broad-based community organisation and the peak national body for prostate cancer in Australia. We are dedicated to reducing the impact of prostate cancer on Australian men, their partners, families and the wider community. We do this by: • Promoting and funding world leading, innovative research into prostate cancer • Implementing awareness campaigns and education programs for the Australian community, health professionals and government • Supporting men and their families affected by prostate cancer through evidence-based information and resources, support groups and prostate cancer specialist nurses PCFA receives government funding for specific projects and relies on the generosity of individuals, the community and partnerships, such as those with the Movember Foundation and Commonwealth Bank, to carry out our essential work. Website: www.prostate.org.au Facebook: www.facebook.com/pcfa1 Twitter: @PCFA You tube: www.youtube.com/user/pcfaweb

TURKISH ASSOCIATION FOR CANCER RESEARCH AND CONTROL (TACRC) Founded in 1947, TACRC is the first nongovernmental cancer organization in Turkey. Many of the earliest works in cancer control started by TACRC are: the First Cancer Hospital (1962), Turkish Journal of Cancer (1973), National Cancer Congress (1975), Cancer Mortality Statistics (1983) and others. TACRC was awarded as the best cancer society by UICC (2008). It focuses on Cancer Control, Prevention, Research, Tobacco Control, Advocacy, Patient Groups, Public and Professional Education, Awareness Campaigns, Meetings, Patient Conferences and International Relations.

UICC-ARO UICC Asia Regional Office (UICC-ARO) was established in 2006 as the first regional office of UICC with the support of the UICC President at the time, Dr. Franco Cavalli, and following the approval of the UICC Board of Directors. Our aims are to define a clear vision for UICC activities aimed at tackling cancer in Asia. Also, to ensure that this vision can be crystallized, to plan and implement information gathering and activities (support) for academic meetings and gatherings, and present the evidence gained from such efforts to UICC headquarters. Website: www.jfcr.or.jp/UICC/uicc_eng/asian_ branch.html

Website: www.turkcancer.org

Dear Delegates, As you join together at the UICC’s 2014 World Cancer Congress, The Princess Margaret Cancer Foundation located in Toronto, Canada would like to pass on words of support and encouragement for a stimulating and productive event. This is a fantastic opportunity to discuss, learn and challenge each other. Cancer will touch all of us personally, and we all know the looming numbers on the horizon. While we have made great strides in controlling some forms of cancer, there are many cancers that are still very lethal, and there is great inequity in treatments and access to treatments around the world. We applaud the UICC and its membership for all of the important work you do. We would personally like to thank Dr. Mary Gospodarowicz, for her leadership of the UICC over the last two years as President, and Cary Adams, for his passionate direction as CEO. At The Princess Margaret Cancer Foundation, our vision and our mission is to CONQUER CANCER IN OUR LIFETIME. We view ourselves as a social enterprise as opposed to a not-for-profit. We have built brands such as The Ride To Conquer Cancer, which has emerged as the world’s largest cycling fundraising brand, benefiting many cancer organizations. Conquering cancer will take money, raising awareness and harnessing the best minds with a clear focus. We would like to invite you to two important events we are sponsoring at this year’s Congress that could facilitate awareness building and fundraising: 1. First is the UICC Premiere of a must-see powerful new documentary: A DAY WITHOUT CANCER. Please join us on Thursday, December 4th from 17:30 to 19:00 in Plenary #2. A cocktail reception will follow. You will recognize many familiar faces in this documentary – leaders in the worldwide cancer control movement. Narrated by Bryan Adams, one of the world’s most acclaimed musicians, this is an event you won’t want to miss. 2. Second is a new digital brand presentation. We are excited to preview this at a lunchtime session on December 5th and offer it to other cancer organizations to raise money for their specific needs. Christine Lasky, who created The Ride to Conquer Cancer and other brands, will update you on our BILLION DOLLAR CHALLENGE and unveil this new digital brand. The session is Friday, December 5th from 13:15 to 14:45 in Room 207, Level 2. Lunch will be provided. Have a great congress!

Sincerely,

Paul Alofs President & CEO

NETWORKING EVENTS

TUESDAY 2ND DECEMBER From 18:00 – 19:00

WEDNESDAY 3RD DECEMBER From 17:00 – 18:00

UICC President’s Reception, following the UICC General Assembly

Cancer Council Victoria’s ‘Welcome to Melbourne VIP Reception’ Supporting the McCabe Centre for Law and Cancer

UICC Member Organisations and UICC Partners only Crown Towers Hotel, River Room

Invitation only

Melbourne Convention and Exhibition Centre (MCEC), Clarendon room, Level 5

2014 World Cancer Congress Welcome Reception All delegates Melbourne Convention and Exhibition Centre (MCEC), Global Village, Level 2

From 18:00 – 19:00 2014 World Cancer Congress Opening Ceremony All delegates

Melbourne Convention and Exhibition Centre, Plenary Hall 2, Ground Level

THURSDAY 4TH DECEMBER FROM 17:30 – 19:00 UICC Premiere of A DAY WITHOUT CANCER…a must see powerful new documentary. An exclusive documentary screening event sponsored by The Princess Margaret Cancer Foundation

FROM 19:00 – 22:00 American Cancer Society Dinner Programme ‘Celebrating and Accelerating Global Leadership’ With special recognition of John R. Seffrin, PhD Invitation only

Crown Towers Hotel, Palladium Ballroom

All Delegates

Melbourne Convention and Exhibition Centre, Plenary Hall 2, Ground level A day without cancer is a 75-minute exploration of cancer’s history and poses the provocative question: “Can we conquer cancer in our lifetime?” Leading cancer experts from around the world discuss cancer and their views on the progress of controlling this disease. First-person stories of survival and inspiration are woven throughout the film. The documentary is directed by Canadian film-maker Joseph Nanni, and has been narrated by Bryan Adams, one of the world’s most acclaimed musicians. Cocktail reception and lively discussion to follow hosted by The Princess Margaret Cancer Foundation.

FRIDAY 5TH DECEMBER FROM 18:00 – 19:00 Australian Performance Showcase Organised by Cancer Council Australia All delegates Melbourne Convention and Exhibition Centre, Plenary Hall 2, Ground Level Cancer Council Australia invites you to a concert spectacular featuring some of the nation’s most extraordinary performers. The incredible line-up of home-grown talent includes performances by: • Australian Girls Choir – Australia’s leading performing arts organisation for girls • Kage – A stunning and imaginative dance group • CircaNICA – Inspiring contemporary circus acts Don’t miss out and join us!

FROM 19:00 – 20:00 2016 World Cancer Congress launch Hosted by The French League Against Cancer and ALIAM Invitation only

Melbourne Convention and Exhibition Centre, Foyer in front of the Global Village, Level 2

SATURDAY 6TH DECEMBER FROM 16:00 – 17:00 2014 World Cancer Congress Closing Reception Invitation only

Melbourne Convention and Exhibition Centre (MCEC), Global Village, Level 2

FROM 19:15 – 20:45 contre le cancer www.aliam.org

FROM 19:15 – 20:45 LITTLE STARS OFFICIAL LAUNCH All delegates and non-registered guests of delegates Melbourne Convention and Exhibition Centre, Plenary Hall 2, Ground level Whatever you do this Congress - don’t let yourself miss this social event! An acclaimed panel of international speakers will present a series of breathtaking films from around the world on the big screen to launch the Little Stars global advocacy project about children’s palliative care. Brace yourself for an evening of inspiration, insight and very good company in this celebration of life.

Closing concert : ‘Inspiring Lives; Inspiring Music’ Organised by Love Hope Strength Foundation All delegates

Melbourne Convention and Exhibition Centre, Plenary Hall 2, Ground Level Organised by Mike Peters, Lead singer of The Alarm, co-founder of Love Hope Strength Foundation, and cancer survivor and, joined by a number of friends from the international music scene this event will bring the 2014 World Cancer Congress to a peak by taking delegates and Melburnians on a compelling journey, mixed with storytelling and rock music.

ABOUT AUSTRALIA

AUSTRALIA The world’s largest island, but the smallest continent, Australia is remarkably diverse. A mix of desert, beaches, mountains, bustling cities and reefs – this country does not fail to amaze. In distance, the continent stretches about 3700 kilometres from north to south and 4000 kilometres from east to west, making it the sixth-largest nation after Russia, Canada, China, the United States and Brazil. Australia has three levels of government – the Federal Australian Government, the governments of the six states and two territories, and around 700 local government authorities. Australia has been a nation with a single national government since 1 January 1901. Australia is a constitutional monarchy with Queen Elizabeth II of the United Kingdom as its head of state, which is why Australia’s national flag comprises the Union Jack. The flag also features the Commonwealth Star and the Southern Cross. Australian society is made up of people from a rich variety of cultural, ethnic, linguistic and religious backgrounds. Aboriginal and Torres Strait Islander people have inhabited Australia for tens of thousands of years. Most Australians are immigrants or the descendants of immigrants who arrived during the past 200 years from more than 200 countries. It has a population of approximately 23.1 million and Australia has one of the largest economies in the world. 60

BANKS, CURRENCY AND TAX

GETTING AROUND AUSTRALIA

The local currency is the Australian Dollar (AUD$). In September 2014 the exchange rate was approximately:

By Plane

USD$ 1 = AUD$ 1.10632 Euro 1 = AUD$ 1.43421 Currency exchange is available at banks, hotels and international airports. Australian banks offer the same range of services typical in other western nations. The easiest way to get cash away from home is from an ATM (automated teller machine) with an international network such as Cirrus (Mastercard) or PLUS (Visa). Australian ATMs use a four-digit code, so check with your bank and make sure you change yours before you leave home. EFTPOS is also widely available in most Australian shops. Fees may be charged on transactions, particularly if withdrawing from an international account. Australia has a Goods and Services Tax (GST) of 10 per cent. You may be able to claim a refund of the GST paid on goods bought here if you have spent AUD$300 or more in one store, no more than 30 days before departing Australia. Tourist Refund Scheme facilities are located in the departure area of international terminals.

Qantas is the country’s chief domestic airline. Other key carriers are Jetstar (a Qantas owned budget airline) and Virgin Australia. By Bus Australia’s extensive bus network is a relatively cheap and reliable way to get around, though it can be a tedious means of travel and requires planning if you intend to do more than straightforward city-to-city trips. Most buses are equipped with air-con, toilets and videos, and all are smoke-free zones. Greyhound Australia is Australia’s national coach service. By Car Australia has a vast network of well-maintained roads and some of the most beautiful touring routes in the world. You’ll find car rental companies at major airports, central city locations, suburbs and resorts. Please note that Australians drive on the left-hand side of the road, with the steering wheel on the right-hand side of the car.

ELECTRICITY Electricity in Australia is 230V/50Hz. The plugs in Australia have two flat metal pins shaped live a â&#x20AC;&#x153;Vâ&#x20AC;? and some may contain a third flat pin in the centre.

INTERNET AND EMAIL Most Australian cities have coffee shops or fast food outlets which offer wireless internet to their customers. Hotels will often have an internet terminal or wireless internet available for guests. Wifi is available at The Melbourne Convention and Exhibition Centre, please refer to the General Information section in this booklet.

TELEPHONE To make international calls from Australia, first dial 0011 and then the country code (e.g. Switzerland: 41). Then dial the area code and number. Eg 0011 41 22 809 1811

AUSTRALIA LINKS www.australia.com www.lonelyplanet.com www.tripadvisor.com www.wififreespot.com/aus.php

ABOUT MELBOURNE

NICHOLS

RATHDOWN E ST

DRUMMO ND ST ING ST

FANN

STUR T ST

DODD S ST

ST NICHOLSON

K LIN WADEY ST

S ST WELL

ORIA VICTRACKS BAR

ST KILDA RD

S AY

FER

G TA

DDS ST

ST MOO RE

MELBOU RN RECITALE CENTRE SOUTHB AN THEATR K E

ER KN FA W

ST H

N ORIA VICT LLEGE CO ARTS E OF TH

KA VA N

MIL

CLO

SOUTHBANK PEDESTRIAN BRIDGE

BR IDG E

RID

QUEENS BRIDGE

T BRID GE S ENS QUE

LEVA

HA IG

NS T

MA ITE

LYGON ST

CARDIGA

N ST

SWANSTON ST

ER ST

BOUVERIE ST

CAPEL ST

PEEL ST

COBDEN ST

QUEEN ST

HA W

PEEL ST

ND ST CHETWY

ST FO RD AB BO TS RA WA Y MY PA L

LEICEST

LEVESON ST

CURZON

ST DRYBUR GH PL ION

ERROL ST

ST LOTHIAN

STAWELL ST

TCE

LAUREN

S ST

MUNSTER

MA RM

HOWARD

RAL

FORD ST

FLO

NGV IONAL RNAT

CARGO LA

INTE

SON ST

LIT LIN

R MO

JOHN

EIGHTEEN PENCE LA

DRA

DA KIL

AN LA

XAN

FERRYM

NSIO

RN THE D R

WHITE

EXTE

SW BASIINGIN N LA G

L ST

FLIN

ER RALIA POTT ST IAN GV AU THE TRE: N CEN

ALE

SOU

RKE

GITTUS

SEL

SOUTH WHARF DV

RUS

MEWS

NST

LAN

R R TOU DAYDEPARTU CH

COA

HARTL EY ST

DOW

LN USE PL THO MAL OARD KB DUC C LA ACD

R OLIVE

GE BRID

CANAL

ENT

CES

MILLS

IAM

GE PD

LL SSE RU

ION

IBIT EXH

GEOR

PRIN

ERS

L PAR

MEY

ED PL

ALFR

LA RS DE IVE FLINFORTYFAIRS

BOATHOUSE DRIVE

E STAT E, TR THEA UDIO ST SE FAX HOU FAIR& PLAY

MALTH OUSE THEATRE

MILES

INS COLLACE PL

ER HAMLL HA

BOU

LLIN

RIVERSID

N VA KA

LLIN

TLE

LIT

ION RMAT RIA INFO VICTO

CLA

RS O N

L ST

SLEY

RPOO

LIVE

CROS

N HER SOUT OSS CR LA

EDGE RUTL

ER LA HOSI

RD WK FA

CH LA

HE LA

NE PL

BOUR

ARTPLAY

TRE CEN NE ARTSELBOUR M

E AT HG UT SO

IWAK AUDITI ORIUM (ABC CE NTRE)

CESS PRINEATRE TH

FEDERATION WHARF RIVER BOAT DEPARTURE POINTS

E AV

ATE

PUN

SMYT

MEL

TIO ERA FED QUARE S

POLI

THG

ST LA KET MAR AL T CROF ES PL PAYN

TRE CENAGE IAN RAL NG IM AUST MOVI THE R THE FO N

AID

S ST

RANT STAU CT E RE PRECIN HGAT AV SOUTSHOPPINGGATE & UTH

EKA EUR ECK 88 SKYD

N PL

RS’

DER

A HB UT

AY W

COHE

ELLE

UL'S TRE ST PA EDRAL THEA UM CATH FOR

T RIVER BOA POINTS DEPARTURE

SOU

RIV

ING

ION

UAY

SPR

IBIT EXH S LA PL SON WAT

AVES

DEGR

ADE

ID ERS

LAN

CE POLI

ACCA

BAL

PL ELL

R ESTE

WAY TRE TRE PL CEN

Southbank

AR SQU STO RAL CITY AN CATHCAEDDE SW AR LIP PHIL T AL SCOT PORT CADE AR

CH MAN

CEN

ET AB

D ST

ST OMEN

TLE

LIT

ET K PR

ES HOLM EGES COLL

EY PL

HOW

ELIZ

H PL

BLIG

FLIN

HBAN

EDY COM TRE THEA

BEAN LN

ENT REG TRE THEA

S NE

S’ LER

RUSS

BOW

OINT

E PL BON

EEN QU

SOUT

LON

KINO

CITYRARY LIB

TRAV

LEY

ION IGRAT ES IMMH OFFIC LT T

A SD

RAIN

TREP

TABL

K PL

BAN

CAE

COLE

& HEA

THEOUNT AM PAR

L LERY GAL N HAL CITY F-TIX NE TOW AEUM HAL BOUR ATHENTRE MEL THEA

E GRAVPL

PRES

DE ARCA

F TY O ERSI GY UNIVCHNOLO TE

WN ATO

TRAV AID

CEN

EQUI

BLOC

GET TAR TRE CEN

N TOW MID AZA PL

ALE

LON

HER ESTY'S MAJ TRE THEA

CORR

S LA

MAL

E N LA CADE DAM PL UNIO K AR EDNA WAL EWAY THE K PL CAUS BLOC THE CADE L AR ROYA

T PL ERSE SOM LA KINS ON LA RAN BURT WAR

RE LA DWA CT HAR RECIN P

T NA AL

BA BO YD

ENS BULL PL ATAH NE WAR N LA ERNA E L AV HEFF STIA

CHIN

SALL

IAN DON

RA LA

IE PL

GOLD

E WAR

HARD

NIAGA

ID DAV ES JON

TLE

LIT

ESE CHINSEUM MU

CELE

ER TATT

CALE

T NS

RIUM

MYE

To Station Pier (cruise ship/ Spirit of Tasmania terminal)

TS LA

LL SSE RU

STO AN SW

LA GPO S RNE’ ND BOU STRA THE DE ER LA MEL DRIV GPO ARCA

MS LIA

ST PIC

T HI

N DO

IA ON

MS AL N E P OW TH T CR A

WIL

R CLA

RMCOL

WAY

LA ERY

T HS

E WAR

CERY CHAN LA

BRID

RDAR Y AM C NB TR

AL ES COAT LN

ID DAV ES JON

R ALLE

NEW

ER ST

C SPEN

South Wharf

REE

N N OW ME CR TAIN LEX R TE MP EN CO

VIL

THE EELER WH TRE CEN

S LL LN RTH LWO JANE BE UEEN IA Q OR NE VICTMENS RED T OUR WO TRE INC ELB CAPE REC CEN QV M KP LN GREE BERT

W DRE

ET AB

ERS

SNID

NS QUEEIDGE BR RE SQUA

KINGS BRIDGE

T AS

WTC WHARF

R UN

ARY

WOO

HARD

Y AL FINLA

T RS CE

R H UT SO ST ED SH LAGE IL

LD WORADE TR TRE CEN

LES

LIBR

SIGN

LIFE RNE SEA LBOU M ME UARIU AQ

ALK AW

MELBOURNE CONVENTION AND EXHIBITION CENTRE

TGA TE F

WES

RNE BOU PL MEL NTRAL WERY CE DRE LA

BANA

T ORIA E YS VICT CENTR ELE CE POLI IDD

POLLY WOODSIDE

RNE

RA ENT

ION IGRAT IMM USEUM M

LAN

HIC GOT DING ANZ K BUIL BAN

FLIN

CITYLI CUSTO NK SERVIC MER E CENTRE

S DER

Yarra River

DFO HILTON SOUTH WHARF MELBOURNE CON SOUTH WHARF VEN TION CEN TRE PLAC E

Y OF ISTR THS REG S, DEAGES IA BIRTH ARR &M

G AY ILW IAN

RA G OR

LORIMER

INS

LL CO

IAN GE RAL CHAN AUSTCK EX STO TRE CEN

DUKES WALK RIVER ESPLANADE

YARRA'S EDGE

N SPE

H RT

CRO

Y AR

PTVB HU S ORTH

E STAT

EMPO

ST CIS

D FLIN

ORIA VICT LICE PO UM MUSE

SEAFARERS BRIDGE

MARINA YE

To Ballarat, via Western Ring Rd

U BO

S DER

FLIN

CHARLES GRIMES BRIDGE

LLIN

'S MAN BAT HILL

ES CR RK

T IN

WOO

AY INS IW COLLUARE TAN N SQ RE

HIL

WEBB BRIDGE

BRADY

D PL

TO SION S MIS ARER SEAF

POIN TP A

FRAN

ATO S CE OFFI

UHE LA

FIEL

AUSTRALIAN WHARF

MILLS

NEL

MAY

DS LA

SIC CLAS TION FOXCOLLEC CAR GAN KAN ITUTE INST

INC

THE

CHAN

PTV HUB

S INS

LL CO

TLE

LIT

WAY

CCA

REBE

A TM BA

KARLSR

KEERA

THE DS LAN DOCKORTSS SP URT CO

TER ENCOUN WAY

TION DR NAVIGA

ARER SEAF

L WA

ORIA VICT EEN GR

HUB

RT LA

T ST

IEW

IMPO

CHAN

RTH

MER

LINS

MARIN

LWO

PHE GEOGRA LEY BUCKALK W

ST AND

COL

WOO

E RK

TE WA

VICTORIA HARBOUR

AY ZE W

UCK

HUBB

T CHAN

BERL

CUM

NO.

DE ERSI WAT

BERTH

K WAL

MER

RPRI

TOR

VIC

T BER

PRO

L O GO RA AY ILW

AR IA H

HAL

TRO

SOU

.6 NO

PLA

GE LA

TER WA

VIL

K UR

ORIA VICT INT PO

LIT

AY ALKW N W R'S AID ATIO S ST AVELLE

CROS

HERN

BATMANS HILL DVE

RIN

TH BER

TLE

SOUT

AINS CAPT

ENTE

D'A

ORA

RIN

MAP OF MELBOURNE

H COACINAL M TER US AL SKYB MIN TER

RO AU

Docklands

ERS

BOU

D NS

REY STO

S ALE

CER SPENTLET OU TRE CEN

ETIHAD STADIUM

ADE LAN

RIV E URN T LBO CH ME PER YAINA SU MAR

F RY O HISTO SPORT TRANURAL M

ESP

arb

IER LP TRA OON CENPONT

NEL CHAN7

r ou

SHE

RIN

ITY

URN

LBO

HAR

SHE

REC

MEL HOY

AY IW ER

YM QUA

LIT

Y WA

AY LW

KWAY WAL

EPE

NEW

INA

TRO

AY LKW WA

ROM

YP QUA

NEW

AL P

DE ENA

LEG

DIG I

UN UR

WA Y

LE DA

ON EL

NEW

LISS ANG TAFE LIAM OF WIL ITUTE RIE KOO AGE INST IT HERTRUST ST

RD LA

DFO

GUIL

DV TAL

L AVE

CAR

ANG TM

SAIN

DIGITAL HARBOUR

GSTA

M LIA WIL

UIT AN

CK DOAQ

FLA

E RIV

IC LEN HEL SEUM MU

Y QUA

TS SAIN NGO TH MA NOR LA

NEW

G KIN

LITT

FCO

JEF

AD NDS

LA OCK

M BAT

TRO

AL ROY TORICAL HIS CIETY RIA SO VICTO OF

E QU

AL TIV FESHALL

ELIZ

RE RATU

B RO LAT

OLDE RN BOU L MEL GAO

KET

LITE

RMIT

West Melbourne

VICTORIA ZIE

MA RMIT

TRADES HALL

KLIN

BUILDING

RRY ST

N FRA

FRANKLIN

ALD

ROYAL EXHIBIT ION

QUEENSBE

MELBOURN CITY BATHSE

A'B

YN SL

RMIT DESIGN HUB

AN ST

MELBOURNE MUSEUM

NET BEN

LS WA

T Y S RR

To F Ra M

Carlton

YS RR

PELHAM

IMAX

THE

QUEEN VICTORIA MARKET

PIAZZA ITALIA

TON MIL

VICTORIA

IAM

L WIL

AIL WA Y

T LS

ES P

IRE

G N KI

AY ILW RA

N EL

EAD

AY W IL RA

To Airport, Bendigo, Daylesford via Calder Fwy

MILLER ST

To Melbourne Zoo

RRY ST

North Melbourne

EY KEL

QUEENSBE

THE COMIC’S LOUNGE

PELHAM

ETH

BER

ELM ST

ARTS HOUS E, NORTH MELBOURN TOWN HALLE NORTH MELBOURN LIBRARY E

O'C

VICTORIA ANDERSO N ST

RT N

RRY ST

LIZ

QUEENSBE

RI SK

A UNIQUE CITY

GETTING AROUND MELBOURNE

Victoria’s capital, Melbourne, sits on the Yarra River and around the shores of Port Phillip Bay. Acclaimed for its sense of style and elegance, Melbourne boasts glamorous festivals and events, Australia’s best shopping, a passion for good food, and a flourishing interest in the arts. Since 2011, Melbourne has been named as the world’s most liveable city. This year it was also crowned the world’s friendliest city. Often referred to as Australia’s cultural capital, Melbourne is the second most populous city in Australia.

Public transport

THE STATE OF VICTORIA Everything in Victoria is close, including idyllic escapes to the country. Some of Australia’s most spectacular coastlines, largest habitats of native animals and historic townships are just an hour’s drive from the city. Experience a taste of regional Victoria on a day tour from Melbourne or take your time over a number of days and explore the diversity of the regions such as the Mornington Peninsula, Yarra Valley, Daylesford and Macedon Ranges, Phillip Island, Gippsland, Great Ocean Road, Murray Region, Victoria’s High Country.

GEOGRAPHY Melbourne is situated on the south-eastern fringe of Australia and in the southern central part of the state. Melbourne covers an area of approximately 8,694 km². The city and metropolitan areas of Melbourne span along the lower stretches of the Yarra River. Towards eastern Melbourne is the low-lying mountain ranges known as the Dandenong Ranges, 35 km east of the city.

Melbourne has a good public transport system with a metro train line and an underground city loop, trams and buses. Free City Circle Tram Operating every 12 minutes, the City Circle Tram travels the perimeter of Melbourne’s city centre, taking in many of Melbourne’s landmarks. Delegates can catch the tram at any of the specially marked stops on Flinders Street, Harbour Esplanade, Docklands Drive or Spring Street. The City Circle route uses iconic W-Class trams, offering passengers an historical experience and commentary along the way. Myki Visitor Pass Myki is Melbourne’s ticket to travel on the city’s trains, trams and buses. It’s a plastic smartcard with stored value, which can be topped up and re-used again. The Visitor Myki has been developed for visitors and is available at Public Transport Victoria (PTV) hubs, the Melbourne Visitor Information Centre and many hotels, motels and backpacker accommodation providers. The Visitor Myki costs AU$14 and is pre-loaded with Myki money for one day’s travel in Zone 1. You can also purchase your Myki online at www.myki.com.au, premium train stations, retail outlets displaying the Myki sign (including 7-Elevens), or by calling 1800 800 007 (free from a land line) in Australia. Visit ptv.vic.gov.au for more information.

Bike

FOOD AND RECREATION

Melbourne’s Bike Share Scheme allows users to hire one of 600 bikes at the 50 docking stations around the city centre. You can take a bike out for a maximum of 24 hours; however Melbourne Bike Share is designed for short trips, which is why the first 45 mins are free to subscribers and 30 mins free to casual users. Trips longer than two hours can be expensive on Melbourne Bike Share, therefore we recommend utilising the services of one of the many bike hire and tour companies throughout Melbourne.

Experience Melbourne’s mix of cultures with its myriad restaurants, cafes, bars and bistros. Whether you’re after modern, traditional, exotic or local dishes – Melbourne’s eclectic dining scene offers an amazing array of the world’s great cuisines.

Foot The easiest way to get around the centre of Melbourne is to walk. The city centre is fairly compact and it is straightforward to navigate because the streets are organised in a grid formation. Melbourne Visitor Shuttle Bus On the Melbourne Visitors Shuttle Bus, delegates can hop on and off at any of the 13 key city locations including the Melbourne Museum, Queen Victoria Market, Royal Botanic Gardens and Chinatown. Visit thatsmelbourne.com.au for more information. River cruises With the Yarra River running through it, Melbourne is a great city to make your way around by boat. Jump on a Melbourne Water Taxi or take a scenic cruise departing from Southbank. Visit melbournewatertaxis.com.au for more information.

Share a drink while snacking on high end tapas in a laneway eatery, enjoy a Szechuan chilli dish in Chinatown, or head out of the CBD and discover the city’s specialist eating destinations – Richmond for Vietnamese, Carlton’s ‘Little Italy’, Fitzroy for Spanish and Brunswick for Lebanese.

HEALTH AND SAFETY Delegates are highly recommended to purchase travel insurance whilst travelling. Melbourne is generally a very safe city, however usual precautions should be taken to avoid petty crime.

TOURIST ATTRACTIONS Melbourne is packed with attractions, from grand museums and arty laneways to lush gardens and cutting edge architecture. Melburnians are known for their love of sport, food, art and music, and there is always something to see or do in this bustling city. Places worth visiting are the Royal Botanic Gardens for an inner city oasis, Australia’s oldest art gallery, the National Gallery of Victoria and the Eureka Skydeck to take in the highest vantage point in the Southern Hemisphere. If you want to get out of the city and experience one of the world’s most scenic coastal drives, head to the Great Ocean Road.

R AU OR A LA

GE LA VIL ST

GIA OR

GE NN AS

V EC LIC PO

O NT SIO ERS MISAFAR SE

LEY

SID

N E OWINM CR TA PLE R TE OM EN C

RLD WOADEE TR NTR CE

Yarra River

MARINA YE

SOUTH

M U AQ

www.melbourne.vic.gov.au www.visitmelbourne.com www.thatsmelbourne.com.au www.tripadvisor.com

T S S ICTOREIANTRE

ER IND

T RS

2 E

Free Melbourne Tourist App E LAN A free app is available for download in the iTunes RS DE N I App Store and on Google Play. Search for ‘Melbourne FL Visitor Guide’ ST ERS D N NE UR FLI BO UM Links EL ARI CE

AN NT

AY IW

NO. 8 B E RT H

N SPE

VIL

AL W

RIA EN

LLI CO

T MS

H LA A SS OR OD GO T AY ES ILW LAG

IEW RV

E AT W

Melbourne enjoys a temperate climate with warm to hot summers; spring and autumn are balmy and mild, the winters cool. The city is in the Southern Hemisphere, E so seasons are opposite to those in the TH B U Northern HHemisphere. In December the average high ST is around 25°C and theSaverage low around 14°C. LIN L O C

G KIN

MORE INFO

R AU

E BATMANS HILL DV

WEATHER

NCIS

FRA

LIA

E RK

LIT

DE NA

T N EN OWINM X CR TA PLE R TE OM EN C

EM A

WES TGA T

E FR

EEW AY

Y NB

ST NT AG UE MO

S G

T NS

ABOVE GROUND CAR PARK

E NN UR IO O T I B B RE EL I T M XH EN E C

O ND

MELBOURNE CONVENTION CENTRE

HILTON HOTEL

N KI

RE CLA

DFO

S EDGE

WHARF

W H

CIL

South Melb

MELBOURNE WELCOMES YOU TO THE 23RD UICC WORLD CANCER CONGRESS Once your conference is done for the day, cosmopolitan Melbourne awaits you. Explore this intriguing city where getting lost in a laneway is a highlight; hidden treasures are around each corner. If you have more time on your hands, a visit to regional Victoria unlocks a memory card full of spectacular coastlines, wildlife reserves, awardwinning wineries, premier golf courses and natural mineral springs. For more information on Melbourneâ&#x20AC;&#x2122;s attractions, see

visitmelbourne.com

melb_180x90_ad.indd 1

11/11/2014 11:46 am

The Victorian Government directly supports translational cancer research in Victoria through the work of the Victorian Cancer Agency Supported by

www.victoriancanceragency.org.au

contre le cancer www.aliam.org

2016

HOSTED BY

WORLD CANCER CONGRESS

31 OCTOBER - 3 NOVEMBER

PARIS, FRANCE PALAIS DES CONGRÈS DE PARIS

GLOBAL VILLAGE

The Global Village is the heart of the World Cancer Congress. It provides a central and dynamic environment where delegates can network, exchange ideas, and participate in a range of activities scheduled throughout the Congress. The Global Village is located in the heart of the Congress area, in the Melbourne Room on Level 2. In the Global Village you will have the opportunity to: • Engage with international organisations who will be showcasing their activities in the international exhibition • Listen to, and interact with, e-Poster presenters who will be presenting their work in one of the six e-Poster pods • Mingle and network in the lounge and catering area • Organise a meeting to connect with other UICC members in the UICC Members Meeting Room • Participate in one of the several daily activities taking place at the UICC stand • Relax at the Bupa Health Lounge • Connect at the Surf Station or join the social media buzz at the WCC Photo Booth.

CATERING OUTLET + BUPA HEALTHY BREAKS

E-POSTER POD

15a

MEDIA BUBBLE

CATERING OUTLET + BUPA HEALTHY BREAKS

PHOTO BOOTH

45 44 43

14 17 13 12 11

UICC Stand

E-POSTER POD

UICC MEMBERS MEETING ROOM

10 9

GV MAP

DAILY PROGRAMME BOARD

SURF STATION

6c 24

6b 6

26 E-POSTER POD

E-POSTER POD

REGISTRATION

GLOBAL VILLAGE BOOTHS ALLOCATION Booth Number 1

Cancer Council Australia

Elekta

The Livestrong Foundation

Peer Support Lounge

Cancer Council Queensland

Prostate Cancer Foundation of Australia

Breast Cancer Network Australia

Roche

Canadian Partnership Against Cancer

Cancer Institute NSW

Cancer Australia

Peter MacCallum Cancer Centre

Chinese Anti-Cancer Association

National Cancer Society Malaysia (NCSM)

Varian

15A

Organisation

Friends of Cancer Patients

Cancer Society of New Zealand

American Cancer Society

Norwegian Cancer Society

Turkish Association for Cancer Research and Control

UNICANCER

ALIAM and The French League Against Cancer

Victorian Integrated Cancer Services

African Organisation for Research and Training in Cancer (AORTIC)

Booth Number

Organisation

Breast Without Spot (BWS)

Leukaemia Foundation

Wiley

The NCD Alliance

The McCabe Centre for Law and Cancer

Multinational Association of Supportive Care in Cancer, MASCC

The International Agency for Research on Cancer (IARC)

Pink Drive

The Department of Health, Victoria

Surf Station

Cancer Control in Latin America

Clinical Genomics

Australian Prostate Cancer Research and Kidney Health Australia

Love Hope Strength

Techna

WCC Photo Booth

World Cancer Research Fund International

The Opal National Collection

Zahra Breast Cancer Association

National Cancer Institute , US

Bupa Health Lounge

IF1

Sun Yat-Sen University Cancer Center

IF2

The Australasian Leukemia and Lymphoma Group (ALLG)

IF3

Cicely Saunders Institute, At Kingâ&#x20AC;&#x2122;s College London

IF4

The Max Foundation

IF5

Health Technology Assessment International (HTAI)

IF6

Women's Taskforce on NCDs & CCA

Joining Forces... Accelerating

Progress

For more than 100 years, the American Cancer Society has been leading the way to transform cancer from deadly to preventable. Together with our millions of supporters worldwide, we save lives and create more birthdays by helping people stay well and get well, by finding cures, and by fighting back against cancer.

global.cancer.org

THURSDAY, DECEMBER 4 1030-1200

Joining Forces through Social Media Rooms 203-204 | Kevin Babb

1205-1305

Mobilizing Local Action For Global Change: Empowering National Networks to Make Cancer a Global Priority Room 218 | Richard Wender, MD; Ann McMikel (Society-hosted Lunch & Learn Session)

1430-1530

Developed and Developing Lung Cancer Screening Strategies Rooms 203-204 | Otis Brawley, MD

1430-1530

Collaboration to Prevent and Control Cervical Cancer in the Americas Room 217 | Sally Cowal

FRIDAY, DECEMBER 5 1015-1115

What is next? Empowering Cancer Survivors and Families for Improved Medical Follow-up and Self-care Room 211 | Rebecca Cowens-Alvarado, MPH

1015-1115

The Cancer Atlas, Second Edition Press Conference Room 209

1145-1315

The Cancer Atlas, Second Edition Rooms 212-213 | John Seffrin, PhD; Ahmedin Jemal, DMV, PhD

Visit us in the Global Village, Stand 17, for more information, and join us to finish the fight!

EXHIBITORS PROFILES ALIAM AND THE FRENCH LEAGUE AGAINST CANCER ALIAM and the French League Against Cancer 14 Rue Corvisart, 75013 Paris, France Founded in October 2009, ALIAM is comprised of 72 associations from 27 francophone countries. It aims to promote and develop the fight against cancer by encouraging South-South and North-South solidarity between members. Close to 700,000 members and 13,000 volunteers strong, the League is an independent NGO that federates 103 departmental communities. Together, they fight in three complementary directions: research, prevention and accompaniment. By breaking taboos and fears, the League contributes to changing the image of cancer and of those struggling with it. Website: www.aliam.org www.ligue-cancer.net Twitter: @ALIAMcc @laliguecancer Facebook: facebook.com/ALIAMcc facebook.com/laliguecontrelecancer

contre le cancer www.aliam.org

AMERICAN CANCER SOCIETY American Cancer Society 250 Williams Street NW Atlanta, Georgia 30303 United States The American Cancer Society is a global grassroots force of more than three million volunteers saving lives and fighting for every birthday threatened by every cancer in every community. As the largest voluntary health organisation, the Societyâ&#x20AC;&#x2122;s efforts have contributed to a 20 per cent decline in cancer death rates in the U.S. since 1991, and a 50 per cent drop in smoking rates. Thanks in part to their progress nearly 14 million Americans who have had cancer and countless more who have avoided it will celebrate more birthdays this year. As ACS celebrates 100 years of service, they are determined to finish the fight against cancer. They are finding cures as the nationâ&#x20AC;&#x2122;s largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings, clean air, and more. Tel: 1-800-227-2345 Website: www.cancer.org Twitter: @AmericanCancer Facebook: facebook.com/AmericanCancerSociety

AFRICAN ORGANISATION FOR RESEARCH AND TRAINING IN CANCER (AORTIC) AORTIC P O Box 186 Rondebosch 7500, South Africa AORTIC is a pan-African, bilingual, multi-disciplinary organisation dedicated to the promotion of cancer care and control in Africa. Their key objectives are to further research relating to cancers prevalent in Africa and to facilitate and support training initiatives in oncology for health care workers. AORTICâ&#x20AC;&#x2122;s research and training cover a diverse array of issues related to cancer control in Africa such as national cancer control programmes, establishing, advocating and training for cancer registration across the continent and strengthening health care delivery systems, in line with African Union Policy. Website: www.aorticconference.org Email: info@aorticconference.org Twitter: @AORTIC_AFRICA Facebook: facebook.com/Aortic.Africa

AUSTRALIAN PROSTATE CANCER RESEARCH Australian Prostate Cancer Research Locked Bag, LB10 East Melbourne, VIC 8002 Australia Australian Prostate Cancer Research is a national research organisation that partners with leading institutions to develop, fund and deliver national research programs. They are committed and driven to discover the killer cause in prostate cancer, improve patient outcomes and educate people on all aspects of diagnosis, treatment and patient care, thereby empowering men and their families. Website: www.prostatecancerresearch.org.au Email: info@apcr.org.au Twitter: @AustProstate Facebook: facebook.com/ AustralianProstateCancerResearch

EXHIBITORS PROFILES THE AUSTRALASIAN LEUKEMIA & LYMPHOMA GROUP (ALLG) The Australasian Leukaemia & Lymphoma Group Ground Floor, 35 Elizabeth Street Richmond VIC, 3121 Australia The Australasian Leukaemia & Lymphoma Group (ALLG) is the only not-for-profit, collaborative clinical research group in Australia and New Zealand dedicated to finding new ways to treat blood cancers. Since 1973 the ALLG has been pioneering life changing blood cancer clinical trials, delivering innovative treatment options that transform lives. Website: www.allg.org.au

BREAST CANCER NETWORK AUSTRALIA Breast Cancer Network Australia 293 Camberwell Road, Camberwell, Victoria, 3124 Australia Breast Cancer Network Australia (BCNA) works to ensure that Australians affected by breast cancer receive the very best support, information, treatment and care appropriate to their individual needs. BCNA supports, informs, represents and connects people affected by breast cancer, and consists of a network of more than 95,000 individual members and 300 support groups across Australia. BCNA is represented by the Pink Lady silhouette, symbolic of its focus on women rather than the disease. Tel: 1800 500 258 Email: www.bcna.org.au Website: beacon@bcna.org.au Twitter: @BCNAPinkLady Facebook: facebook.com/ BreastCancerNetworkAustralia

BREAST WITHOUT SPOT (BWS)

BUPA

Centre for Continuing Education in Radiology University of Nigeria Teaching Hospital Ituku-Ozalla 40000 Enugu, Nigeria

Bupa House, 15-19 Bloomsbury Way London, United Kingdom

Breast without Spot (BWS) is an NGO creating sustained awareness of prevention and early detection of cancers and other NCDs in Nigeria, through programs such as: • Re-training of Health-Care Providers to deliver cancer-NCD screening/management services • Advocacy programs to Influence political will of Government • Annual International Cancer Week with other NGOs, anchored by Federal Ministry of Health. • ‘World Cancer Day Youth Jamboree’ every February 4. •

‘School Based Cervical Cancer Vaccination Awareness Initiative’ to increase awareness and uptake of the cervical cancer vaccines

Facebook: facebook.com/pages/BreastWithout-Spot/468211420194

Bupa’s purpose is longer, healthier, happier lives. As a leading international healthcare group, Bupa offers health insurance and medical subscription products, runs care homes, retirement villages, hospitals, primary care centres and dental clinics. They also provide workplace health services, home healthcare, health assessments and long-term condition management services. Bupa has over 22m customers in 190 countries. With no shareholders, they invest their profits to provide more and better healthcare and fulfil their purpose. Bupa employs more than 70,000 people, principally in the UK, Australia, Spain, Poland, New Zealand and Chile, as well as Saudi Arabia, Hong Kong, India, Thailand, and the USA. Website: www.bupa.com Twitter: @Bupa LinkedIn: linkedin.com/company/bupa

EXHIBITORS PROFILES CANADIAN PARTNERSHIP AGAINST CANCER Canadian Partnership Against Cancer 1, University Avenue, Suite 300 Toronto, ON M5J 2P1 Canada The Canadian Partnership Against Cancer works with Canadaâ&#x20AC;&#x2122;s cancer community to reduce the burden of cancer on Canadians. Grounded in and informed by the experiences of those affected by cancer, the organisation works with partners to support multi-jurisdictional uptake of evidence that will help to optimize cancer control planning and drive improvements in quality of practice across the country. Through sustained effort and a focus on the cancer continuum, the Partnership supports the work of the collective cancer community in achieving long-term population outcomes: reduced incidence of cancer, less likelihood of Canadians dying from cancer, and an enhanced quality of life of those affected by cancer. Website: www.partnershipagainstcancer.ca Twitter: @Cancer_Strategy Facebook: facebook.com/ CanadianPartnershipAgainstCancer

CANCER AUSTRALIA Cancer Australia, Level 14, 300 Elizabeth Street Surry Hills, NSW 2010 Australia Cancer Australia is the Australian Governmentâ&#x20AC;&#x2122;s national agency providing leadership in cancer control to improve outcomes for those affected by cancer, their families and carers. Cancer Australia builds the evidence base, analyses, interprets and translates the latest scientific cancer research and data to inform policy and practice, and to provide information and expert advice on cancer control to governments, health professionals and the community. Tel: +61 2 9357 9400 Website: www.canceraustralia.gov.au Twitter: @CancerAustralia

CANCER COUNCIL AUSTRALIA

CANCER INSTITUTE NSW

Cancer Council Australia Level 14/477 Pitt St Sydney NSW 2000 Australia

Cancer Institute NSW PO Box 41 Alexandria, NSW 1435 Australia

Cancer Council Australia is the nation’s peak non-government cancer control organisation.

The Cancer Institute NSW is Australia’s only statewide, government-funded cancer control agency. Established in 2003, our main activities aim to lessen the burden of cancer on the people of NSW by:

They represent the national interests of our members, Australia’s state and territory Cancer Councils. Collectively, Cancer Council is Australia’s largest health charity and biggest independent funder of cancer research. Cancer Council’s stand at the Global Village will showcase their resources, campaigns and information, including their highly successful sun protection product range. Since 2008, sales of Cancer Council merchandise have raised $13 million. CCA would love to talk to delegates about how they can partner to replicate this success overseas, so visit them on stand one. Website: www.cancer.org.au Twitter: @CancerCouncilOz Facebook: facebook.com/cancercouncilaustralia

• Providing advice and information about cancer prevention; producing media campaigns targeting tobacco smoking, sun exposure, breast and cervical screening. • Managing BreastScreen NSW and the NSW Cervical Screening Program. • Developing programs to improve the quality of cancer care including eviQ Cancer Treatments Online. • Strategic research investment to improve cancer outcomes and set new agendas for research priorities. Website: www.cancerinstitute.org.au Twitter: @cancerNSW

EXHIBITORS PROFILES CANCER COUNCIL QUEENSLAND

CANCER SOCIETY OF NEW ZEALAND

Cancer Council Queensland PO Box 41, Alexandria NSW 1435 Australia

PO Box 12700 Wellington 6144 New Zealand

Cancer Council Queensland (CCQ) is Queensland’s leading independent community-based organisation in cancer control. A member organisation of Cancer Council Australia and the Union for International Cancer Control, CCQ’s vision is for a cancer free future. CCQ is dedicated to eliminating cancer as a life-threatening disease for future generations and to diminishing the burden of cancer through research, treatment, patient care, prevention and early detection. Website: www.cancerqld.org.au Email: info@cancerqld.org.au Twitter: @CCQLD Facebook: facebook.com/cancercouncilqueensland

The Cancer Society of New Zealand is dedicated to reducing the incidence of cancer and ensuring the best cancer care for all New Zealanders. As a leading cancer patient advocate they provide a voice on many issues, including detection and treatment. They provide a range of support services for cancer patients and their family/caregivers, fund research and produce the country’s largest source of cancer information. Through education, advocacy and communication their health promotion teams encourage people to live a healthy lifestyle. None of their work would be possible without our volunteers. Website: www.cancernz.org.nz Twitter: @NZCancerSo Facebook: facebook.com/cancersocietyofnewzealand

CHINESE ANTI-CANCER ASSOCIATION Chinese Anti-Cancer Association A-10fl, No.5 Lanyuan Rd New Technology Industrial Park Zone, Tianjin, China The Chinese Anti-Cancer Association (CACA) was founded in 1984. It is a non-government and non-profit organisation dedicated to improveing cancer control in China. It has 41 professional committees, 31 local associations with 47,000 members. The main tasks of CACA include organising scientific exchanges and conferences; promoting cooperation with international NGOs; conducting training courses and seminars; compiling and publishing academic periodicals; and mobilising all social forces to work together to disseminate the knowledge of cancer control.

CICELY SAUNDERS INSTITUTE, AT KING’S COLLEGE LONDON Cicely Saunders Institute is the world’s first purpose-built institute dedicated to palliative care. It opened in 2010, the result of a partnership between King’s College London and the charity Cicely Saunders International. The Institute integrates clinical palliative care services with excellent research, education and rehabilitation, and acts as the hub for a network of international research. Website: www.csi.kcl.ac.uk/ Twitter: @CSI_KCL Facebook: facebook.com/CicelySaundersInstitute

Website: www.caca.org.cn Email: xutt@caca.org.cn

EXHIBITORS PROFILES CLINICAL GENOMICS

DEPARTMENT OF HEALTH VICTORIA

Unit 15–16/ 2 Eden Park Drive North Ryde NSW 2113 Australia

The Department of Health, Victoria 50 Lonsdale Street Melbourne, 3000 Victoria, Australia

Clinical Genomics harness breakthrough science to create new, innovative and more accessible ways to prevent disease and enhance lives. Clinical Genomics believes that effective healthcare solutions require partnerships. They succeed by collaborating with the top research and industrial institutions around the world. They also believe that good science makes good business. The best way to translate technology innovation into improved healthcare is to make technology and products widely available to researchers and clinicians. Only by comprehensive experiments and clinical trials, published in peer review journals, can new medicine be trusted. They actively encourage researchers and clinicians to trial their products that they have worked hard to discover, develop and validate. Website: www.clinicalgenomics.com Email: larry@clinicalgenomics.com

‘Sharing The Journey’ The Victorian Aboriginal Community Controlled Health Organisation, the Department of Health Victoria and partner agencies invite delegates of the World Cancer Congress to visit the Aboriginal cultural space ‘Sharing The Journey’ for shared conversations and information about innovative approaches aimed at improving Aboriginal and other First Nation people’s cancer outcomes. Website: www.health.vic.gov.au/ Twitter: @VicGovHealth Facebook: facebook.com/VicGovHealth

ELEKTA

FRIENDS OF CANCER PATIENTS

Elekta AB, Box 7593 10393 Stockholm, Sweden

Friends of Cancer Patients PO Box 61161 Sharjah United Arab Emirates

Friends of Cancer Patients, the leading cancer-specific charity in the UAE, has delivered moral, financial and clinical support to over a thousand patients and their families since its establishment in 1999. Under the motto ‘We’re with you’, it provides a broad spectrum of cancer treatment services to people of all nationalities, genders, ages and religions. Its primary focus is to promote awareness around six cancers detectable in their early stages: breast cancer, cervical cancer, prostate cancer, testicular cancer, colorectal cancer and skin cancer. It is assisted by a dynamic team of more than 300 volunteers of both women and men.

Website: www.elekta.com Twitter: @Elekta

Tel: 0097165065542 Website: www.focp.ae Email: Info@focp.ae Twitter: @focpuae Facebook: facebook.com/FOCPUAE

EXHIBITORS PROFILES HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL (HTAI) Health Technology Assessment International (HTAi) 1200, 10405 Jasper Avenue Edmonton AB T5J 3N4 Canada HTAI is the global scientific and professional society for those who produce, use, or encounter HTA, embracing all stakeholders, including researchers, agencies, policymakers, industry, academia, health service providers, and patients/consumers. It provides a forum for collaboration and sharing of information and expertise, having members from 59 countries and six continents. The Interest Sub-Group for Patient and Citizen Involvement in HTA aims to promote and develop robust methodologies to incorporate patientsâ&#x20AC;&#x2122; perspectives, and share best practice; strengthen HTA by systematic incorporation of patient perspectives; and support countries with limited experience. Tel: +1 780 421 5492 Website: www.htai.org/ Email: csargent@htai.org

KIDNEY HEALTH AUSTRALIA Kidney Health Australia L9, 9 Young Street, Sydney NSW 2000 Australia Kidney Health Australia works to save and improve the lives of Australians affected by kidney disease and kidney cancer, by promoting good kidney health through education, advocacy, research and support. Webaite: www.kidney.org.au www.kidneycancer.org.au

THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC) The International Agency for Research on Cancer 150 Cours Albert Thomas 69372 Lyon CEDEX 08 France The International Agency for Research on Cancer (IARC) is an autonomous agency of the World Health Organization that promotes international collaboration in cancer research. Its mission is to coordinate international studies on the causes of human cancer, the mechanisms of carcinogenesis, and strategies for cancer prevention, with a focus on promoting research in regions of the world where it is lacking. Based on independence and research excellence over five decades, IARC has established itself as a unique gateway into a global network of researchers and institutions, encouraging collaboration worldwide. Tel: +33 (0)4 72 73 84 85 Website: www.iarc.fr Email: com@iarc.fr

THE LIVESTRONG FOUNDATION The LIVESTRONG Foundation 2201 E. Sixth Street Austin, Texas 78702 USA The LIVESTRONG Foundation fights to improve the lives of people affected by cancer now. Created in 1997, the Foundation is known for providing free cancer support services and advocating for policies that improve access to care and quality of life. Known for its powerful brand – LIVESTRONG – the Foundation has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has served 2.5 million people affected by the disease and raised more than $500 million to support cancer survivors. One of America’s top non-profit organizations, the Foundation has been recognized by industry leaders including Charity Navigator, the National Health Council and the Better Business Bureau for its excellent governance, high standards and transparency. Website: LIVESTRONG.org Twitter: @livestrong Facebook: facebook.com/livestrong

EXHIBITORS PROFILES LEUKEMIA FOUNDATION

LOVE HOPE STRENGTH

Leukaemia & Blood Cancer New Zealand and the Leukaemia Foundation of Australia are the only national not-for-profit organizations in their countries dedicated solely to supporting patients and families living with leukaemia, lymphoma, myeloma and related blood conditions. Both organisations also funds research, advocates on behalf of patients, provides information and education and raises awareness.

Love Hope Strength 4956 Colfax Ave Denver CO 80220 USA Mike Peters found his passion in music, and his purpose in fighting cancer. Front man for the internationally acclaimed band, The Alarm, Peters is living proof that life goes on with cancer. Together with James Chippendale, Peters founded Love Hope Strength Foundation to save lives, one concert at a time. LHS offers hope to cancer patients worldwide by leveraging the power of music to raise funds for quality cancer care and expand the international bone marrow database through the GET ON THE LIST campaign. Website: www.lovehopestrength.org Email: laney@lovehopestrength.org Twitter: @LHSF Facebook: facebook.com/lovehopestrength

THE MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE (MASCC) Multinational Association of Supportive Care in Cancer Herredsvejen 2 DK-3400, HillerĂ¸d Denmark The Multinational Association of Supportive Care in Cancer (MASCC) is an international, multidisciplinary Organization. MASCC is dedicated to research and education in all areas of supportive care for patients with cancer. Because supportive care encompasses all aspects of care, it involves a variety of disciplines and specialists. Thus membership is open to oncology medical, surgical, and radiology physicians, nurses, dentists, dental hygienists, pharmacists, social workers, dieticians, outcomes specialists, psychologists, statisticians, infectious disease specialists, educators, representatives from industry and non-profit sectors, and others interested in supportive care.

THE MAX FOUNDATION The Max Foundation 110 W. Dayton Street Suite 205 Edmonds, WA. 98020 United States The Max Foundation is a global health organisation that believes that all people living with cancer have the right to access the best treatment and support. Through personalidsed access services, quality training and education, and global advocacy efforts, they aim to help people face cancer with dignity and hope. Tel: +1 (425) 778 - 8660 Website: www.themaxfoundation.org Email: info@themaxfoundation.org Twitter: @stompoutcancer Facebook: facebook.com/themaxfoundation

Tel: +45 4820 7022 Website: www.mascc.org Email: aschultz@mascc.org Twitter: @CancerCareMASCC Facebook: facebook.com/MASCC.Cancer

EXHIBITORS PROFILES THE MCCABE CENTRE FOR LAW AND CANCER The McCabe Centre for Law and Cancer 615 St Kilda Road Melbourne Vic 3004 Australia The McCabe Centre for Law and Cancer is a joint initiative of Cancer Council Victoria and the Union for International Cancer Control. Its mission is to contribute to the effective use of the law for cancer prevention, treatment, supportive care and research. Tel: +61 3 9514 6100 Website: www.mccabecentre.org Email: info@mccabecentre.org Twitter: @McCabe_Centre

NATIONAL CANCER INSTITUTE, US National Cancer Institute, US 9609 Medical Center Drive, #2-E-562 Bethesda, Maryland 20892 United States The National Cancer Institute (NCI) of the National Institutes of Health, U.S.A., supports and conducts groundbreaking research in cancer biology, causation, prevention, detection, treatment, and survivorship in its effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families. In 2011, NCI established the Center for Global Health as the Instituteâ&#x20AC;&#x2122;s principal team in coordinating and prioritising NCIâ&#x20AC;&#x2122;s global activities to advance global cancer research, build expertise, and leverage resources across nations to address the challenges of cancer and reduce cancer deaths worldwide. Website: www.cancer.gov Email: aalameddine@vigilant-services.com Twitter: @GroupeUNICANCER Facebook: facebook.com/unicancer

NATIONAL CANCER SOCIETY MALAYSIA (NCSM) National Cancer Society Malaysia (NCSM) Bangunan Persatuan Kebangsaan Kanser Malaysia 66 Jalan Raja Muda Abdul Aziz 50300 Kuala Lumpur Malaysia NCSM is a registered medical charity body providing training & education as well as care and support services for people affected by cancer. NCSM’s mission & objective is, ‘To ensure that no Malaysian fears cancer by creating an understanding of cancer that leads to its prevention and early detection and by providing the best possible care and support for those affected by cancer’. Tel: 603-2698 7300 Website: www.cancer.org.my Email: contact@cancer.org.my Twitter: @cancermalaysia Facebook: facebook.com/ nationalcancersocietymalaysia

THE NCD ALLIANCE NCD Alliance 62, Route de Frontenex 1207 Geneva Switzerland The NCD Alliance is leading the way to a world free from preventable suffering, disability and death caused by Non-communicable diseases (NCDs). Founded in 2009, their unique civil society network unites 2,000 organisations in more than 170 countries, including global and national NGOs, scientific and professional associations, academic institutions, private sector entities and dedicated individuals. Together with strategic partners, including the World Health Organization, the United Nations, and governments, the NCD Alliance is transforming the fight against NCDs. Website: www.ncdalliance.org Email: info@ncdalliance.org Twitter: @ncdalliance

EXHIBITORS PROFILES NORWEGIAN CANCER SOCIETY

THE OPAL NATIONAL COLLECTION

Norwegian Cancer Society Tullinsgate 2, Pb. 4 Sentrum. NO-0101 Oslo Norway

The National Opal Collection 119 Swanston St, Melbourne Victoria 3000 Australia

NCS contributes to targeted efforts in cancer information, prevention, advocacy, research, care, and international cooperation. Their activities are funded by their members, bequests, and allocations from the national lottery funds. Main objectives: • Contribute to ensure that fewer people develop cancer • Contribute to more people surviving cancer • Ensure the best quality of life for people affected by cancer NCS has an annual budget of 75 million (2013); about 180 employees at its head office in Oslo and district offices; 113 000 subscribing members and 20 000 volunteers working for the cancer cause. Website: www.kreftforeningen.no Email: servicetorget@kreftforeningen.no Twitter: @kreftforeningen Facebook: facebook.com/Kreftforeningen Instagram: instagram.com/kreftforeningen

The National Opal Collection is Australia’s leading supplier of Australian opal and opal jewellery. Whether it be a romantic gift, a treasured heirloom, an investment stone, a fashion statement or a souvenir of the trip of a lifetime, the National Opal Collection will have just the piece for you. You will be purchasing beautiful pieces direct from the opal mines to you and overseas visitors will be enjoying tax-free prices. Tel: +61 9662 3524 Website: www.nationalopal.com Email: enquiries@nationalopal.com Twitter: @NationalOpal Facebook: facebook.com/Nationalopalcollection

PEER SUPPORT LOUNGE

PETER MACCALLUM CANCER CENTRE

Sponsored by three leading Australian non-profit organisations (Cancer Council Queensland, Breast Cancer Network Australia and Prostate Cancer Foundation of Australia), the Peer Support Lounge is the venue to learn about the exciting developments in provision of support and education for people living with cancer. The Peer Support Lounge is also the place to meet others interested in this important and unique style of supportive intervention – the professionals, volunteers and consumers - to engage in discussion and share stories about the remarkable contribution of peer support to the quality of life of so many people affected by cancer.

Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett Street Melbourne Victoria 8001 Australia The Peter MacCallum Cancer Centre is Australia’s only public hospital solely dedicated to cancer and one of an elite group of cancer hospitals worldwide with embedded research laboratories, which are uniquely integrated with extensive clinical and cancer experiences research programs. As the largest cancer research site in Australia, Peter Mac is a major contributor to advances in cancer prevention, diagnosis and treatment. The organisation is committed to working in partnership to stem the rising incidence of cancer globally and improve the lives of people with cancer, wherever they may live. Website: www.petermac.org Email: zoe.wainer@petermac.org Twitter: @PeterMac_News

EXHIBITORS PROFILES PINK DRIVE PinkDrive 21 Bond street Randburg Johannesburg South Africa PinkDrive is a well established breast cancer awareness and breast health initiative of Public Benefit Organisation (PBO), Cause Marketing Fundraisers. Established in 2007, PinkDrive has expanded its reach into many communities. This initiative powers Southern Africa’s first Mobile Mammography Unit as well as Mobile education Unit and three educational vehicles. Initially, working in Gauteng and the Western Cape, the initiative has now spread its Breast Health Programme to almost all of the nine provinces. Tel: +27 119988022 Website: www.pinkdrive.co.za Email: noelene@pinkdrive.co.za Twitter: @ThePinkDrive Facebook: facebook.com/ThePinkDrive

PROSTATE CANCER FOUNDATION OF AUSTRALIA Prostate Cancer Foundation of Australia PO Box 499, St Leonards, NSW 1590, Australia Prostate Cancer Foundation of Australia (PCFA) is a broad-based community organisation and the peak national body for prostate cancer in Australia. PCFA are dedicated to reducing the impact of prostate cancer on Australian men, their partners, families and the wider community. They do this by: • Promoting and funding world leading, innovative research into prostate cancer • Implementing awareness campaigns and education programs for the Australian community, health professionals and government • Supporting men and their families affected by prostate cancer through evidence-based information and resources, support groups and prostate cancer specialist nurses PCFA receives government funding for specific projects and relies on the generosity of individuals, the community and partnerships, such as those with the Movember Foundation and Commonwealth Bank, to carry out thir essential work. Website: www.prostate.org.au Twitter: @PCFA Facebook: facebook.com/pcfa1

ROCHE

TECHNA

Roche F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH - 4070 Basel Switzerland

Techna 124-‐100 College Street Toronto, Ontario M5G 1P5 Canada

Based in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Website: www.roche.com Email: kelly.butterworth@roche.com Twitter: @Roche Facebook: facebook.com/RocheCareers

The Techna Institute is a reformulation of the conventional research institute to become the ‘technology innovation house’. It helps innovators shorten the time interval from discovery and development of medical technology to application for the benefit of patients and the health care system. Techna focuses on medical technology – hardware, software, and functionalized materials. Techna accelerates the translation of medical technology by: i) engaging healthcare professionals during the development phase; ii) addressing design, human factors, and usability testing considerations; iii) establishing processes and training requirements for adopting innovation in the clinical environment; and, iv) providing professional consultation on regulatory, reimbursement and marketing issues. Website: www.technainstitute.com Twitter: @technainstitute

EXHIBITORS PROFILES TURKISH ASSOCIATION FOR CANCER RESEARCH AND CONTROL (TACRC) Turkish Association for Cancer Research and Control (TACRC) Tuna Caddesi Atac-1 Sokak, No: 21/1 06410 Yenisehir-Ankara Turkey Founded in 1947, TACRC is the first non-governmental cancer organisation in Turkey. Many of the earliest works in cancer control started by TACRC are: the first cancer hospital (1962), Turkish Journal of Cancer (1973), National Cancer Congress (1975), cancer mortality statistics (1983) and others. TACRC was awarded the best cancer society by UICC (2008). It focuses on cancer control, prevention, research, tobacco control, advocacy, patient groups, public and professional education, awareness campaigns, meetings, patient conferences and international relations. Website: www.turkcancer.org

UNICANCER UNICANCER 101, rue de Tolbiac 75654 Paris Cedex 13 France UNICANCER brings together the 20 French Comprehensive Cancer Centers (FCCC), promotes the cancer research organisation and pools resources and competencies to give a new dynamic to patient care. FCCC have held a special place in the French health care system. These private, non-profit establishments are entirely devoted to fighting cancer. They have a threefold mission: patient care, research and teaching. The cancer care and research organisation model of the FCCC has been built around multidisciplinary practice, individualised treatment and a research-healthcare continuum. Twitter: @GroupeUNICANCER Facebook: facebook.com/unicancer Website: www.unicancer.fr Email: unicancer@unicancer.fr

VARIAN Varian Medical Systems focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the worldâ&#x20AC;&#x2122;s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing. Website: www.varian.com. Twitter: @VarianMedSys

VICTORIAN INTEGRATED CANCER SERVICES A major theme of the Cancer Services Framework for Victoria is an integrated approach to service delivery and treatment, which focuses on delivering the right treatment and support to patients as early as possible in their cancer journey as close to home as appropriate. This provides access to the full range of services from prevention, screening, diagnosis, treatment, rehabilitation, supportive care and palliative care. The integrated service model is promoted through eight geographically based and one speciality based (Paediatrics) Integrated Care Services (ICS). Website: http://health.vic.gov.au/cancer/ integrated.htm

EXHIBITORS PROFILES WORLD CANCER RESEARCH FUND INTERNATIONAL World Cancer Research Fund International Second Floor, 22 Bedford Square London, WC1B 3HH United Kingdom World Cancer Research Fund (WCRF) International leads and unifies a network of cancer prevention charities with a global reach. They champion the latest and most authoritative scientific research from around the world on cancer prevention and survival through diet, weight and physical activity, so that they can help people make informed lifestyle choices to reduce their cancer risk. WCRF provide essential advice and guidance to help policymakers develop effective policies to reduce the cases of preventable cancer and other Non-communicable diseases.

ZAHRA BREAST CANCER ASSOCIATION Zahra Breast Cancer Association was established in 2007 and is based in Riyadh, Kingdom of Saudi Arabia. The organisation aims to raise awareness of breast cancer and prevention methods and to clarify the extent of the disease in the Kingdom. Their main objectives include implementing awareness programs, directing patients to the concerned authorities to receive services dedicated for them and developing the Saudi capabilities in the research related to Breast Cancer aligned with training, and educational programs. Website: www.zahra.org.sa Email: te@zahra.org.sa Twitter: @zahra_KSA Facebook: www.facebook.com/zahra.KSA Instagram: zahra_KSA

Tel: +44 (0) 20 7343 4200 Website: www.wcrf.org Email: international@wcrf.org Twitter: @wcrfint Facebook: www.facebook.com/wcrfint Íb��« ÊU�d�� …d�“ WOFL� ZAHRA BREAST CANCER ASSOCIATION

100

WILEY Wiley 33 Windorah Street Stafford Queensland 4053 Australia Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners. With strengths in every major academic, scientific and professional field, and strong brands including Wiley Blackwell and Wiley VCH, Wiley proudly partners with over 800 prestigious societies representing two million members. Contact Person: John Wiley & Sons Australia Tel: +61 (7) 3354 8444 / 1800 777 474 Fax: 1800 802 258 Website: www.wiley.com Email: aus-custservice@wiley.com

101

WORKING FOR A HEALTHIER FUTURE

19. Insert advertisement <WCC2014_ FinalProgramme_advert_Bupa_WorkingForHealthierFuture.pdf>

At Bupa, our purpose is to help people live longer, healthier, happier lives. Serving more than 22 million people in over 190 countries, Bupa focuses on providing sustainable healthcare solutions and the promotion of preventive health and wellness. We offer health insurance, run hospitals, provide workplace health services, long-term condition management services and are a major provider of aged care.

Cancer and non-communicable diseases pose a fundamental challenge to the quality and length of human life. Tackling these challenges and Home creating sustainable Call us Make a claim health systems, with the capacity to meet the demands of the future, requires innovative ways of thinking about and Parking Request ahealthcare. call back File/save/stored ite delivering We know achieving our ambitious goals requires Valet parking Email us Search commitment, passion and action. Weâ&#x20AC;&#x2122;re glad you can join us at the congress as we work together to reduce the globalWeb impact of cancer. Vaccination centre chat Refresh/update Disabledin access Visit us/pop Visit theby Bupa Health Lounge the Global Village. Membership/card

Write to us

Hospital

Renew membership

MEDIA BUBBLE

A dedicated media room will be set up in the foyer area outside the Global Village on Level 2. This mini-studio will be used for television and radio interviews. Members and partners will also have the opportunity to use the media bubble. If you wish to book the media bubble please email uiccpress@rdcomms.com or visit the Press Lounge in Room 205. Thank you to our Media Bubble Sponsor, the American Cancer Society.

103

CAN CANCER PROGRESS BE MEASURED? HOW CAN VALUE BE DEFINED? Due to increasing economic pressures and cost-containment policies, there is an increasing emphasis on providing patient access to only those new products and services deemed innovative, and the bar for innovation is rising. This approach can fail to take into account the true nature of innovation and overlook the value of stepwise advancements, or continuous innovation. Continuous innovation has led to major progress in cancer care. Survival times for many cancers are expanding, and some previously fatal cancers can now be controlled or even cured. For example, the five year survival rate has increased 21% for breast cancer; 36% for colon cancer; and 54% for lung cancer since 1975.1 Failing to recognize and reward the value of continuous innovation will stifle future innovation, threatening progress against cancer to the detriment of all, most notably the patient. That is why Lilly Oncology created PACE (Patient Access to Cancer care Excellence), a global network to encourage public policies and healthcare decisions that accelerate continuous innovation, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines.

During the 2014 World Cancer Congress, Lilly Oncology will provide a first look at the PACE Continuous Innovation Indicators™, an evidencebased tool that visually depicts treatment progress over time against 12 tumor types, the value of cancer treatments, and objective comparisons across tumor types. The PACE Continuous Innovation Indicators™ provides insights into the: step-wise nature of cancer innovation; unmet needs in cancer research; and evidence needed to create effective cancer policies that ensure patient access to cancer care excellence. The PACE Continuous Innovation Indicators™ will be introduced during a panel session entitled “Can Cancer Innovation Be Measured?” and moderated by Professor Gordon McVie of the European Institute of Oncology. The session will take place on Thursday, 4 December, 12:00 – 13:00, Room 207. Lunch will be provided. To learn more about PACE globally, please visit www.pacenetwork.com.

National Cancer Institute: Surveillance Epidemiology and End Results. Available at http://seer.cancer.gov/faststats/index.php. Accessed 13 May 2014.

Eli Lilly Australia Pty Limited, ACN 000 233 992, 112 Wharf Road West Ryde, NSW 2114, Ph +61 2 9325 4444 AUONC00149 | 08/2014

SOCIAL MEDIA

105

Join the conversation before, during and after the Congress and ensure that the whole world is talking about cancer and NCDs on social media. We have put together a short social media guide to help you spread the word and amplify the Congress messages. TWITTER Use Twitter during and after the Congress to initiate and spread the Congress messages. Hashtags to use: #25by25 #BreastCancer #breastcancerawareness #BigDebate #TheBigsCreenâ&#x20AC;¨#Cancer #Cancers #CancerAtlas #CancerCongress #CancerControl #CancerDivide #CancerInformation #CancerPatients #CancerPrevention #CancerTreatment #CervicalCancer #Care #eCigarettes #EarlyDetection #EssentialMedicines #GlobalVillage #Health #HealthyLives #HealthSystems #HBV #HPV #LiverCancer #LungCancer #MDG #NCDs #NCDmomentum #NotBeyondUs #Nutrition #Obesity #Oncology #PalliativeCare #PlainPackaging #Prevention #Post2015 #PublicHealth #QualityOfLife #Radiotherapy #Screening #Smoking #Stigma #SocialJustice #Tobaccoâ&#x20AC;¨#TIL #TreatmentForAll #Truth #UHC #Vaccines #WomensCancers #WorldCancerDay 106

Twitter handle: @2014WCC Event hashtag: #CancerCongress

EIGHT TIPS FOR USING TWITTER FOR YOUR EVENTS The use and popularity of social media have thrown open the doors of health-related events. Now a statement made during a conference plenary, a new health policy set by a government, or an exciting fundraising event, can all be read about, watched or heard by thousands of interested onlookers all over the globe. In an instant.

1.4.

Remember, they’re following YOU

Be original

Quote of the day...

If you have 100 followers or a million, they track you because of what you say and who you are. Try to relate what you hear during an event to your own knowledge and experience. ‘Speak your world’ by sharing your reactions and opinions openly. That is what your followers want to hear.

Your tweets will be valued most by your followers if they include something they could not easily obtain or find out elsewhere: Your opinion; a useful link to an interesting site or article; a relevant hashtag (other than the event hashtag); another user’s username. Don’t hit the retweet button without including your own view or added value, and avoid posting overused rhetoric about an issue. Stay fresh.

If you must tweet direct quotes, listen out for particularly incisive or original comments, and quote them for what they say, not who said them. Find the speaker’s username if you have time. Avoid repeating what the high profile speakers say, they will be tweeted and reported by everyone.

Be their ears and eyes too For every person physically present during an event, there are probably hundreds (if not thousands) of ‘remote participants’ watching from afar, many wishing they could have had the same opportunity. Try to stay conscious of what your followers and other remote participants might be most interested to read, see or find out – and not only what you want to tell them. 3.

Use the event #hashtag The more people who use the same hashtag, the more likely they are to connect with one another and share thoughts/ ideas. Find out the #hashtag the organisers have chosen for the event and use it – consistently.

No time like the present Tweet as soon as something grabs your attention or evokes a reaction in you. Share your impression or mood as well as the information content. If someone posts something you agree/disagree with, say so and why, or ask a follow-up question of your own. It is hard to find the time when you are taking part in an event, but commenting and responding in real time to others’ posts adds real depth and value to discussion.

A picture, a thousand words, etc. Use the same rules for photos/ videos as you do for text content: Add value for your followers and give them something they cannot get elsewhere, such as photos of presentations, conclusion slides, new data or the cover of a publication you have seen for the first time at an event. Avoid photos of meeting rooms and high-profile speakers. 8.

Be a Twitter advocate Remind other delegates that they can also Tweet from the event. If someone tells you something interesting/ important, encourage them to Tweet about it. If they are not Twitter users, take a few minutes to tell them why they would benefit if they were. Encourage them to sign up and follow you!

107

ANATOMY OF A TWEET

User’s Profile Photo

User’s real name

Twitter username (handle)

Subject-related hashtag

WorldCancerCongress

Event hashtag

27 Jan

@2014WCC

Be part of the #cancer and #NCDs conversation this week at the #cancerCongress bit.ly/2014wcc @CancerAustralia @EliLillyCo reply

Retweet

Favourite

Link Mentioning other users

TWITTER GLOSSARY Twitter

Information network made up of 140-character messages

A message posted via Twitter

The @ sign is used to mention other users

Handle

(or Username) Your identity on Twitter (eg@UICC or @NCDA)

#Hashtag

The #symbol is used to highlight keywords or topics (eg #WorldCancerDay)

Link

Hyperlink to a useful website or online article

To follow someone on Twitter is to subscribe to their Tweets

Follower

A follower is another Twitter is to subscribe to Their Tweets

A Tweet posted in reply to another user’s message

Retweet (or RT) A Tweet by another user forwarded to you/by you.Often used to spread news or share valuable information on Twitter

Thanks @InisCom and @CNS_health for tips

108

FACEBOOK & INSTAGRAM

FOLLOW UICC ON FACEBOOK AT facebook.com/uicc.org

FOLLOW US ON INSTAGRAM AND TAG US IN YOUR OWN CONGRESS PHOTOS @GlobalCancer A big thank you to our social media supporters @CancerAustralia @EliLillyCo

109

CONGRESS PROGRAMME

110

CONGRESS PROGRAMME OVERVIEW The 2014 World Cancer Congress programme will provide many innovative features including education and training opportunities with the Master Courses, enthralling plenary sessions with the chance to meet the experts, audience interactions in the sessions, symposia, discussion panels, Big Debates, and rapid-fire poster presentations, a media track entitled the ‘Big sCreen’, and much more.

A theme calling for action UICC is pleased this year to continue building on the World Cancer Congress’s growth as the leading international conference for cancer control experts, practitioners, and advocates to share the latest information on global advances in cancer control. This year’s conference theme - ‘Joining Forces: Accelerating Progress’ - will emphasise the impact that can be realised by consistently and energetically applying what we know, rather than waiting for possible future “breakthroughs” to change the landscape. This will be discussed across a variety of economic and cultural contexts, and participants will leave with an increased understanding of successful interventions in prevention, diagnosis and care, and supportive and palliative care. They will also have the opportunity to meet with others who have similar issues to their own, and to understand how system organisation can provide the optimum conditions for success in reducing the burden of cancer. The Congress programme has been built with UICC’s members and partners contributions that have been made through the online call for sessions. The Congress Programme Committee then reviewed and adjusted all submitted proposals, so they are of global interest and are aligned with UICC’s purpose and the four programme tracks. A number of threads will also be running throughout the four tracks, including a large emphasis on advocacy.

111

DESCRIPTION OF CONGRESS TRACKS

TRACK 1

TRACK 2

Track 1: Cancer Prevention and Screening

Track 2: Cancer Diagnosis and Treatment

The standard definition of primary and secondary prevention sets the scope for this track. Methods targeting behavioural risk factors as well as underlying factors such as social and economic disadvantage will be explored in these sessions. Tobacco control is a vital and specialised aspect of cancer control, and is an established field with knowledge and experience that can be transferred to other risk factors. Including tobacco control in a broader sense will facilitate an important exchange between participants with the goal of improving prevention outcomes for all risk factors.

This track includes proven medical treatment of the disease in the context of a desire to provide active treatment and comprehensive care for those affected by cancer, including measures to improve side-effects of treatment, psychosocial assessment and support and rehabilitation. There are also unprecedented scientific and clinical advances in the understanding of the diagnosis and treatment of cancer. In high-resource context, careful consideration needs to be given to how to prioritise new diagnostic tests and treatments.

Who should attend? Professionals in cancer control, research and programme implementation who wish to expand their knowledge on new prevention and early detection strategies.

112

Who should attend? Individuals engaged in cancer care including researchers, healthcare professionals, volunteers, patient support teams, advocacy groups, cancer networks and survivors.

TRACK 3

TRACK 4

Track 3: Cancer Survivorship and Palliative Care

Track 4: Cancer Control Systems

This track will explore in depth what ‘survivorship’ means to people affected by cancer, what they want and need, how the health system can meet those needs, and what survivors themselves can contribute. As over one third of patients die within five years of a diagnosis (even in the most advanced health systems), dying, and humane methods to ease the psychological and physical burden of impending death will be explored, as will the challenges (and benefits) of an early introduction of palliative care into the patient’s journey. In terms of equity, giving palliation and pain control importance helps address the inequity arising in resource-constrained countries where end of life interventions are often all that can be offered.

Emphasising systems solutions builds upon the theme of the 2010 Congress -‘Systems to make it happen’ - and is a priority for those who wish to make an impact at a community level to improve the access to care. A broad definition of the term ‘system’ will be used to allow for the discussion of issues, and solutions for improving national, regional and local health systems. Surveillance systems, including cancer registries, and population risk factor monitoring will be a key focus, as will how to advocate for the cancer cause, creating an infrastructure around fundraising and the distribution of resources.

Who should attend? Professionals and volunteers engaged in palliative care, symptom and pain control.

Who should attend? Cancer control researchers and programme implementers. Professionals and volunteers engaged in programme monitoring and evaluation, fundraising, advocacy, policy work or governance will also find value in attending.

MEDIA TRACK This new track highlights sessions that use television, film or social media videos as a means to achieve public health objectives. The Big sCreen sessions showcase successful campaigns that have either the potential to be, or have already been adapted internationally.

113

NCD PROGRAMME Non-communicable diseases (NCDs) will play an important part of the programme at this Congress, with a suite of plenaries, sessions and side events that are of relevance to the wider NCD community beyond cancer. This is not surprising given the many synergies between the different NCDs which: share common risk factors, require outstanding primary care services, struggle from the same myths and misconceptions which hinder the education of the general public and, certainly in low- and middle-income countries, lack the political priority to prepare for the unprecedented disease levels anticipated in future years. This event provides us with the opportunity to share best practice and discuss topics pertinent to all NCDs in a vibrant meeting, which is primed to help network experts from around the world. Whilst the Congress covers the full spectrum of cancer control, NCDs are embedded throughout, with sessions relating to risk factors, advocacy, fundraising for a cause, patient rights, palliative care and political engagement being of immense relevance to the whole NCD movement.

Look for this icon in the programme for NCD-related sessions.

114

NCD Alliance The NCD Alliance will have a large presence at the Global Village with a dedicated stand and the NCD Café. The NCD Alliance unites over 2,000 civil society organisations from 170 countries by a vision of a future free from preventable suffering and death caused by NCDs. The NCD Alliance is widely recognised as a convenor of the NCD civil society community, providing thought leadership on global policy, setting priorities for the global NCD response, and mobilising civil society action at national and regional levels. More information about the NCD Alliance can be found at ncdalliance.org. NCD Café Foyer, Ground Level An interactive space where moderated discussions and debates will be held, the NCD Café will showcase regular presentations given by world-renowned global health experts. With the high and increasing importance of NCDs worldwide, you would not want to miss the latest perspectives from frontline health professionals, policymakers, technologists, philosophers and business people on how to address chronic disease challenges. The NCD Café is the place for you to be!

The NCD Café

– Have a break...Learn more about NCDs

DAY 1 Thursday 4 December

DAY 2 Friday 5 December

DAY 3 Saturday 6 December

12:00 - 13:00 15:30 -16:00 17:30 - 18:30

11:45 - 13:15 13:15 -14:45 16:00 - 16:30

11:45 - 13:15 13:15 -14:45

With the increasing importance given to Non Communicable Diseases (NCDs) worldwide, you would not want to miss the latest fresh perspective from frontline health professionals, policymakers, technologists, philosophers and businesspeople on how to address chronic disease challenges.

The NCD Café is the place to be! The NCD Café welcomes you for a coﬀee or healthy snack whilst providing a unique space for interactive sessions on NCDs, with a focus on integration, partnerships and multidisciplinary experiences in lowand middle-income countries.

LOCATION: Melbourne Convention and Exhibition Centre, Ground Floor, opposite to the Plenary Organised by NCD Alliance Supporters: Co�fees, healthy drinks and snacks provided

SESSION TYPE DESCRIPTIONS Plenary sessions (PL)

Big sCreen sessions (BSC)

Each Congress day is opened by a 90-minute session delivered by distinguished experts in the field of cancer and/or global health. Presentation content is devoted to the main subjects of the Congress. There are no other sessions running in parallel.

Split into three focused sessions, one each day, showcasing best practice examples of video based awareness campaigns and their outcomes. The sessions will not only screen the actual campaign videos, but also feature speakers who were involved in the campaignsâ&#x20AC;&#x2122; development and implementation, presenting the background, learning points and outcomes of each campaign.

Sub - plenary sessions (SBS) After the plenary sessions, the four tracks will be covered by four different presentations of one hour and featuring high profile speakers. These sessions will all be running at the same time. Concurrent track sessions (CTS) These sessions present key questions of relevance to each track of the Congress and will run in parallel every morning after the sub-plenary sessions. Parallel sessions (PS) These standard sessions are dedicated to invited speakers with different perspectives addressing questions of interest in the various tracks.

Big Debate (BD) This session type is meant to generate interactions and debate between an expert panel and the audience around specific topics aligned with the four programme tracks. Workshop (ws) Highly interactive session aimed at addressing a given issue through a variety of approaches. For delegates who are seeking instructions on a particular topic or skill. This session style may be used for specific demonstration and skill learning. Focus on sharing and interacting with the audience, and providing educational tools and new skills. Satellite sessions (SAT) These sessions are based on the same format as the parallel sessions but have been sponsored.

116

ABSTRACT SESSIONS

e-Posters (EP)

Other sessions have been built from the open abstract submission procedure. Papers will be presented either orally or as e-Posters. Abstract presentation formats include:

There will be six dedicated e-Poster pods. e-Posters will be available for viewing on rotation on large screens on-demand, however there will also be dedicated sessions where each presenter will screen 3 slides and speak for 3 minutes.

Abstract oral sessions (AOS) Abstracts submitted by participants have been reviewed and scheduled for oral communication sessions. These presentations on specific aspects of cancer control from around the world are organised according to the four Congress tracks. Speakers will talk for 8 minutes each with up to 2 minutes allowed for one or two questions at the conclusion.

Master Courses Master Courses have been conducted through a selection of focussed courses of six-months distance learning that are culminating in Melbourne with a one-day workshop from the distinguished faculty followed by attendance at the Congress. Networking

Rapid Fire Sessions (RF) These sessions are designed to provide maximum visibility for selected high quality abstracts. Rapid Fire sessions will be organised by Congress track and will be scheduled in large-capacity rooms, with a stage and two lecterns. Each presenter will screen 3 slides and speak for 3 minutes, after which time the next speaker will commence from the other lectern. Presenters will use their time to introduce delegates to their material. There will be a procedure in place that subsequently connects presenters with other delegates interested to explore the work in more detail. We believe the RFS sessions will be stimulating and are a good way to maximise cross-fertilisation of ideas and expertise.

One of the objectives of the Congress is to give attendees, the opportunity to grow their network and exchange experiences and ideas with other experts or professionals from around the world. All attendees will have access to an app designed for the Congress. Delegates will have the chance create their own agenda to set up meetings with other participants sharing the same interest. Publication Presented abstracts from the 2014 World Cancer Congress are published with Wiley, these are freely accessible and citable worldwide on http://onlinelibrary.wiley.com/

117

WORLD-CLASS SPEAKERS Each Congress day will start with a plenary lecture that will gather all Congress participants in the auditorium to hear keynote addresses from world-class speakers. Find out who they are. This select-group of highly influential and prominent experts will cover advances in, and fresh perspectives on, prevention and screening, diagnosis and treatment, care and survivorship and innovative cancer control systems. They will discuss progress and share insights into future directions, as well as draw on their own experiences. Each keynote will end with a Q&A period, enabling participants to take the discussion further.

118

OPENING CEREMONY Ian Frazer CEO and Director of Research Translational Research Institute Pty Ltd Professor Ian Frazer, a Scottish-born Australian scientist developed and patented the basic technology behind the HPV vaccine against cervical cancer; the second cancer-preventing vaccine, and the first designed to prevent a cancer. Giving what will no doubt be an inspirational keynote speech at the official opening of the 2014 World Cancer Congress, Professor Frazerâ&#x20AC;&#x2122;s address will focus on strategies to accelerate progress in cancer, which will call delegates to action and motivate them to innovate and affect positive change. He will draw on his experience with the development of the HPV vaccine, using this as an example of finding solutions to problems that are barriers to progress.

Jacinta Elston Associate Dean, Indigenous Health Division of Tropical Health and Medicine James Cook University An Aboriginal woman from Townsville in North Queensland, Jacinta Elston is an Associate Professor in the Faculty of Medicine, Health and Molecular Sciences, James Cook University providing Indigenous leadership and strategic advice in health. She has worked for over two decades in higher education on Aboriginal and Torres Strait Islander health.

119

PLENARIES

DAY 1 - SUSTAINABLE HEALTH SYSTEMS Shared with 41st COSA Annual Scientific Meeting

Throughout the world governments are challenged to meet the health care needs of their populations. The rising incidence of cancer has been identified by the World Bank as a significant economic threat. In this session some of the big picture issues facing the delivery of sustainable cancer services – over diagnosis and over treatment will be addressed. Plenary co-chaired by Sanchia Aranda (UICC Board Member and WCC Programme Co-Chair) and Mei Krishnasamy (Convenor COSA 2014 Annual Scientific Meeting)

Peter C. Doherty Department of Microbiology and Immunology, the University of Melbourne, and, Department of Immunology, St Jude Children’s Research Hospital, Memphis 1996 Nobel Prize in Medicine Topic: Sustainable development – Lessons from Immunity Professor Doherty will present a review of our understanding of immunity with a particular focus on cell mediated immunity and the management of pandemics. The talk will consider the question of ensuring that our research efforts lead to discoveries that change not only our understanding of human disease but also lead to affordable interventions that change the course of disease management.

120

Irene Higginson Director of the Cicely Saunders Institute, King’s College London National Institute for Health Research Senior Investigator (UK) 2013 Fellowship Award of the Academy of Medical Sciences Topic: Sustainable models of palliative care in cancer: is integration the answer? In her presentation, Professor Higginson will consider the levels of evidence for the different models of palliative care and suggest a possible way forward to achieve sustainability.

Laura Levit Associate Director, Research Policy at the American Society of Clinical Oncology (ASCO) Study Director at the Institute of Medicine for the report High-Quality Cancer Care: Charting a New Course for a System in Crisis (USA) Topic: Institute of medicine recommendations for addressing the cancer care crisis in the United States report’s recommendations and conceptual framework. In the recently published Institute of Medicine Report on delivering high-quality cancer care, it states that “The cancer care delivery systems is in crisis...cost of cancer also is rising faster than many sectors of medicine.” Based on ASCO’s efforts to implement the report’s recommendations, Laura Levit will focus her presentation on the conceptual framework and recommended strategies for narrowing disparities in patient’s access to high-quality cancer care. The argument that a sustainable system can be equitable and high quality will also be presented.

121

PLENARIES

DAY 2 - NATIONAL AND INTERNATIONAL APPROACHES Efforts to integrate cancer control and address equity. Plenary chaired by Heather Bryant (UICC Board member and WCC Programme Co-Chair)

Stephen Lewis Distinguished Visiting Professor at Ryerson University Former UN Secretary-General’s Special Envoy for HIV/AIDS in Africa Keynote address supported by

Photo credit ©Farhang Ghajar, CBC

Topic: International initiatives in global health challenges: First HIV, then cancer/NCD’s We sit on the threshold of the next set of Millennium Development Goals. The greatest challenge for those goals lies in the field of global health. How do we move from infectious diseases to non-communicable diseases without prejudicing the former and finally bringing justice to the latter? How do we increase the funding so that NCDs are not reduced to fighting for a slice of the existing financial pie? Do we need a new international convention on global public health in order to guarantee fair treatment for cancer and other NCDs?

122

Nicola Roxon Former Australian Attorney-General Former Australian Minister of Health - introducing the world’s first plain packaging regime in the world Topic: How researchers, clinicians and advocates can help governments make effective policy? In a crowded political agenda, having a worthy cause isn’t always enough to capture the imagination of government. Governments are almost universally criticized for not taking action. This Plenary presentation will challenge advocates and clinicians to assess whether they have done all they can to create a fertile environment to encourage government leadership. The question will be asked: Is simply waiting for government to act too often used as an excuse? Delivered from the perspective of a former Health Minister and Attorney-General, this presentation will use Australia’s introduction of plain packaging for tobacco products as a case study for a more general discussion on ways to bring about change.

123

PLENARIES

DAY 3 - USING DATA TO DRIVE DECISIONS Plenary chaired by Robert Thomas (Victorian Department of Health)

Atul Butte Chief of Division of Systems Medicine at Stanford University School of Medicine and Lucile Packard Children’s Hospital Researcher in biomedical informatics and biotechnology entrepreneur in Silicon Valley (United States) Topic: Translating a trillion points of data into therapies, diagnostics, and new insights into disease There is an urgent need to translate genome-era discoveries into clinical utility, but the difficulties in making bench-to-bedside translations have been well described. The nascent field of translational bioinformatics may help. Dr Butte’s lab at Stanford builds and applies tools that convert more than a trillion points of molecular, clinical, and epidemiological data - measured by researchers and clinicians over the past decade and now commonly called ‘big data’- into diagnostics, therapeutics, and new insights into disease. Several of these methods or findings are spun out into new biotechnology companies. Dr Butte, a bioinformatician and paediatric endocrinologist, will highlight his lab’s work on using publicly-available molecular measurements to find new uses for drugs including drug repositioning for cancer, discovering new targetable receptors for cancer and metabolic disease, and new work on integrating and reusing the clinical and genomic data that result from clinical trials. Dr Butte will especially cover big data in biomedicine as a platform for innovation and entrepreneurship.

Keynote address followed by discussion panel

Mary Gospodarowicz, President Union for International Cancer Control (UICC) Cary Adams, Chief Executive Office for Union for International Cancer Control (UICC) Atul Butte, Chief of Division of Systems Medicine at Stanford University School of Medicine and Lucile Packard Children’s Hospital (United States) David Currow, Chief Cancer Officer and Chief Executive Officer, Cancer Institute NSW (Australia)

124

UICC SESSIONS If you would like to learn more about the Union for International Cancer Control (UICC), our work and vision, you are invited to attend one of the UICC sessions listed below.

Thursday 4th December 10:30 - 11:30 Room 214

UICC Members’ Regional Meeting - Convening the cancer community from the Commonwealth of Independent States (Russia and the Balkans) Limited space. Visit the UICC stand in the Global Village to check availabilities for this event

10:30 - 11:30 Room 206 Orange Lounge

UICC Members’ Regional Meeting – Convening the cancer community from Eastern Mediterranean Defining cancer priorities in Eastern Mediterranean countries Limited space. Visit the UICC stand in the Global Village to check availabilities for this event

125

13:15 - 14:15 Room 209

Health systems levers to reduce lives lost to breast cancer â&#x20AC;&#x201C; tools to shape policy and prwe for impact on the global 25x2025 goal Chaired by: Benjamin O. Anderson (United States), Julie Torode (Switzerland) Session proposed by: Union for International Cancer Control (UICC), Switzerland To achieve the overarching global NCD target of reducing premature deaths to NCDs by 25% by the year 2025, there is a pressing need for countries to recognise that it is a stage shift from advanced to early stage diagnosis, coupled with robust early multidisciplinary treatment which is going to make an immediate contribution to save lives. The Breast Cancer Knowledge Summaries to be launched at the WCC 2014 provide national stakeholders with a simple tool to facilitate the dialogue between clinicians and policy makers across the care continuum from promotion of breast health and increased awareness in the community, through screening and early detection to treatment and palliative care. This interactive session will discuss the role of this tool in stimulating a more forceful multi-stakeholder response to the impact on breast cancer outcomes, with panellists showcasing country experiences in building a health systems response for breast cancer management.

13:15 - 14:15 Room 219

Making cancer staging globally relevant Chaired by: Brian Oâ&#x20AC;&#x2122;Sullivan (Canada) Cancer staging is a vital component of cancer control, in assessing cancer burden, evaluating screening, treatments used, guidance concordance and outcomes. However its application and the collection of data is very limited in countries with low HDI. The symposium will describe ways in which the UICC Prognostic Factors Group, in conjunction with other organisations are trying to ensure that TNM stage is both globally relevant and is used in cancer control activities across the world.

126

14:30 â&#x20AC;&#x201C; 15:30 Room 219

Reducing inequalities in childhood cancer treatment and outcomes Chaired by: Tezer Kutluk (Turkey) and Jenny Proimus (Australia) Unlike many adult malignancies, most paediatric cancers are not associated with modifiable risk factors and are not amenable to population based screening and prevention programmes. Rather, decreasing deaths related to childhood cancer requires accurate and timely diagnosis followed by effective treatment. Fortunately, treatment for childhood cancer does exist and survival rates for childhood cancer in high-income countries are 80% and higher. However, unfortunately, survival rates for children with cancer in many low- and middle-income countries are dramatically lower ranging from under 10% in some settings to 60% in others. This inequality in outcomes is unacceptable and a matter of the right to health and social justice for children. The session will therefore discuss how the cancer and child health communities can address several challenges related to diagnosis, treatment and care for children with cancer in LMICs with reference to country level examples and approaches.

16:00 - 17:30

Room 220

Producing and using evidence for cancer control: the Global Initiative for Cancer Registry Development in LMIC Chaired by: Brenda Edwards (United States) and Freddie Bray (France) Session proposed by: International Agency for Research on Cancer (IARC), France

127

Friday 5th December

10:15 - 11:15 Room 212-213

Behind the scenes of the NCD global health and development debate Chaired by: Cary Adams (Switzerland) Discussion panel proposed by: Union for International Cancer Control (UICC), Switzerland Voted by attendees as one of the top 5 sessions at 2012 WCC, this interactive session will draw on the expertise and insights of star panellists to provide global, regional and national perspectives on the commitments to action to reduce the burden of Non communicable Diseases by 25% by 2025 as well as the backroom story on how the post-2015 debate works and progress to date. The session specifically invites you to address key questions: What role can your organisation play to secure national action on NCDs? How can the cancer community work with health and development partners to secure strong health goals in the post-2015 agenda?

11:45 - 12:45 Room 206 Orange Lounge

UICC Membersâ&#x20AC;&#x2122; Regional Meeting - Convening the cancer community from Africa Implementation Strategies for Cancer Control in Africa Limited space. Visit the UICC stand in the Global Village to check availabilities for this event

128

13:15 - 14:45 Room 214

How people affected by cancer are impacted by laws relating to patient rights, protection from discrimination, and decision-making at end of life Session proposed by: McCabe Centre for Law and Cancer, Australia The McCabe Centre is hosting a lunchtime panel session to hear international and Australian experts discuss the laws that impact on the treatment of and supportive care provided to people diagnosed with cancer, in relation to: • Capacity to make informed decisions about treatment (both during and in advance of treatment) and to have these decisions respected • The application of discrimination law to those who work during treatment, or return to work after treatment and while managing side effects of treatment • Access to social security benefits, insurance (especially travel and life insurance) and support for those who have to travel for treatment. The session will also include the release of a new report on informed consent, and regulation of complementary and alternative therapies, as part of a McCabe Centre/Cancer Council Victoria project ‘Making the law work better for people affected by cancer’

129

13:15 - 14:45 Room 206 Orange lounge

Lunch workshop - Children have cancer too! Raising awareness and strengthening advocacy on childhood cancer around the world Chaired by: Julie Torode (Switzerland) and Kenneth Dollman (South Africa) Discussion panel proposed by: Union for International Cancer Control (UICC), Switzerland and the International Confederation of Childhood Cancer Parent Organizations (ICCCPO) This interactive lunch time workshop organised by UICC and the International Confederation of Childhood Cancer Parent Organizations will discuss various awareness and advocacy campaigns to raise awareness of childhood cancer as a public health priority in childrenâ&#x20AC;&#x2122;s health and to develop national policies and programmes. The session will begin with brief presentations on conducting awareness initiatives on childhood cancer in countries and scaling up these and other efforts to bolster advocacy. From a speakerâ&#x20AC;&#x2122;s corner set up in the room, speakers will introduce and moderate discussion on questions such as how can the childhood cancer community learn from and better integrate into global health initiatives such as maternal and child health and NCDs, defining and strengthening the role of parent and survivor groups for advocacy, and what are some tools and approaches that childhood cancer health providers can use to impact policy and garner greater political and health sector support. Come and participate in what will be a dynamic discussion on how we can impact national policy and programmes to improve survival rates and quality of life for children and adolescents living with cancer!

130

15:00 - 16:00 Room 212 - 213

GTFRCC - An investment framework to close the global disparity in access to radiotherapy by 2035 Chaired by: Mary Gospodarowicz (Canada) The Board of UICC has charged the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) to answer the question, ‘What will it cost to close the gap in access to radiotherapy by 2035?’. This session will present the first outputs of the GTFRCC response - an investment framework for scaling up radiation therapy in low- and middle-income countries. The framework will be used to estimate the cost of scale up as well as the health, economic and broader societal benefits that will arise from deployment of adequate levels of radiotherapy. The framework will be used as an organising principle for a clear set of actions with a well-defined time horizon.

15:00 - 16:00 Room 206 Orange Lounge

UICC Members’ Regional Meeting - Convening the cancer community from the Americas Civil Society/NGO Engagement in Cancer Control: Integrating National Strategies, Models and Best Practices to Inform and Advance Collaborative Regional Action in the Americas. Limited space. Visit the UICC stand in the Global Village to check availabilities for this event

131

Saturday 6th December

11:45 - 13:15 Room 208

Building capacity to support civil society action on NCDs Chaired by: Katie Dain (United Kingdom), Julie Torode (Switzerland) Cancer organisations play a crucial role in leading, supporting and monitoring cancer control and non-communicable disease (NCD) responses at the country level in order to improve government accountability and accelerate action. This interactive session will highlight lessons learnt from the NCD Alliance “Strengthening Health Systems, Supporting NCD Action” programme which supports civil society groups to assess national progress, identify gaps, and advocate for improved policies. A suite of complementary NCD Alliance and UICC resources to support advocates will be presented, as well as examples of how progress can be achieved effectively by working in partnership.

13:15 - 14:45 Room 218

Using World Cancer Day as a platform for... What value World Cancer Day can bring to your organisation and how to make the most of it Chaired by: Jeff Dunn (Australia) Featuring best practice examples of collaboration and networking, this session will demonstrate how World Cancer Day represents an ideal engagement opportunity for NGOs and corporates alike, and will highlight World Cancer Day as: • Mass media engagement platform • Advocacy opportunity • Collaborative opportunity between a cancer organisation and a corporation. Attendees will leave inspired and equipped with ideas and tools for organising their own activities and initiatives, with a view to increasing global engagement.

132

13:15 - 14:45 Room 219

Building stronger networks to increase exchanges of skills and knowledge Chaired by: Jamal Khader (Jordan), Riccardo Lampariello (Switzerland) Collaborative cancer networks establish the infrastructure of processes, information, people, and relationships needed to create synergies across multiple organisations remotely. These networks may serve to improve service delivery, knowledge exchange, research collaboration, or community capacity. In times of resource constraint, existing and new networks can be effective tools for achieving sustainable change, providing a platform from which innovative responses to changing challenges emerge. However flexible and vibrant they are, cancer networks require committed resources and appropriate competencies for network action, communication, leadership, management, participation, and evaluation. The spill-over and flow of knowledge is not at all automatic, and this session will identify answers and good practices that strengthen networks and improve knowledge transfer at local, regional and global levels.

13:15 - 14:15 Room 206 Orange Lounge

UICC Membersâ&#x20AC;&#x2122; Regional Meeting - Convening the cancer community from Western Pacific Prioritising Cancer in the Western Pacific Limited space. Visit the UICC stand in the Global Village to check availabilities for this event

15:00 - 16:00 Room 206 Orange Lounge

UICC Membersâ&#x20AC;&#x2122; Regional Meeting - Convening the cancer community from South-East Asia Limited space. Visit the UICC stand in the Global Village to check availabilities for this event

133

THE BIG DEBATES This edition of the Congress will see the introduction of the new programme highlight of ‘Big Debates’ each featuring experts of different backgrounds/school of thoughts on specific topics in cancer control and public health, with a focus on global issues that create controversy and different opinions.

Day 1 - Thursday The cost of treatment is worth the benefits Moderator: Adam Spencer (Australian radio presenter, comedian, and media personality) Debaters: Prof. Robyn Ward, Prince of Wales Clinical School (Australia) Ms Donna Milne, Peter MacCallum Cancer Institute in Melbourne (Australia) A/Prof. Georgina Long, Melanoma Institute Australia, University of Sydney (Australia) The Honourable Nicola Roxon, Former Australian Minister of Health (Australia) Rather than a formal debating structure this debate on “The cost of cancer treatment is worth the benefits” will form more of a hot topic with various perspective on the issue being drawn out by the facilitator. Issues to be discussed include affordability, government decision-making, the lost opportunities of spending money on high cost drugs rather than other priorities and the consequences successful high cost drugs have on the delivery of services. The debate will be held as part of the day shared with the Clinical Oncological Society of Australia on December 4th.

134

Day 2 - Friday E-cigarettes are a helpful tool in tobacco control and cessation and should be promoted for that purpose Moderator: Norman Swan (Australian multi-award winning producer – ABC’s Health report - broadcaster and investigative journalist) Debaters: Prof. Ron Borland, Cancer Council Victoria (Australia) Prof. Simon Chapman, University of Sydney (Australia) To encourage the growing debate about the advent of electronic cigarettes and the war on smoking, the Congress will host a debate on how ‘E-cigarettes are a helpful tool in tobacco control and cessation and should be promoted for that purpose’. E-cigarettes, a nicotine-delivery system has grown into a multibillion-dollar business resulting in a massive and growing international issue. To date, there is no definitive evidence on their potential harms or potential benefits, as research in this area is in its infancy. As such, this will fuel the debate with remarkable ranges of views being expressed. The debaters will partake in a discussion focussing on e-cigarette regulation and whether or not they are a healthier alternative to tobacco cigarettes. A supporter of e-cigarettes will argue for seeing their promise as a cancer control tool and that they should be promoted for that purpose, arguing that they may be useful in the “end-game”. The opponent will argue that promoting e-cigarettes as a cessation tool will “re-normalise” smoking and undermine much of the effort gained through WHO’s Framework Convention on Tobacco Control. This debate has broad implications for public health officials, policymakers, regulation agencies, the tobacco industry and other key stakeholders in tobacco control.

135

Day 3 - Saturday Cancer Screening: Individual Decisions or Population Approaches? Moderator: Ross Stevenson (Broadcaster at 3AW Radio in Australia) Debaters: Professor Julietta Patnick, Public Health England (United Kingdom) Dr Rengaswamy Sankaranarayanan, International Agency for Research on Cancer (IARC) (France) The emphasis on over-diagnosis and other risks of screening has led many to conclude that undertaking cancer screening should be a highly individualised decision, with varying degrees of medical intervention and/or risk-benefit information provided to each person considering this. However, much of the population-based gains in screening have come from public campaigns and/or social marketing. Raising public awareness generally is going to be critical to seeing gains in the benefits of cancer screening in low and middle income countries, and among underserved populations in high-income countries. The Congress will showcase a debate on ‘Cancer screening: individual decisions or population approaches?’ where one will explore the individualised risk benefit approach and debate on the importance of including the use of decision aids and discussions with General Practitioners to help individuals make informed screening decisions. To counter this argument, a debater will defend the “pro-population marketing” approach and make a public case for the benefits of cancer screening as one important tool in cancer control. This would include a discussion of appropriate parameters of such campaigns, but also to address how they may be critical to overcoming barriers in population acceptance of cancer screening.

136

THE BIG SCREEN As part of the exciting new Media Track, the Big sCreen programme will showcase best practice examples of videobased awareness campaigns during three focused sessions. The audience will have the opportunity to see cinema-sized screenings of the campaign clips as well hear about the background, learning points and outcomes from those who contributed to their development. Attendees can expect to leave with â&#x20AC;&#x2DC;take awayâ&#x20AC;&#x2122; learning points and inspiration from successfully implemented campaigns that have either the potential to be or have already been adapted internationally.

137

THURSDAY 4th DECEMBER 16:00 TO 17:30 Plenary 2 Social media: Changing the face of awareness-raising campaigns The development of social media has fundamentally changed the way that we interact with others on a day-to-day basis in society. As it is now such a powerful communication medium, it is no wonder that organisations are leveraging social media to promote their messages. Social media platforms such as YouTube, Facebook and Twitter, allow organisations broader parameters in terms of the time, length, target audience and content of their campaigns. Removing many of the restrictions imposed by traditional media, organisations now have new and exciting ways to communicate with their audience. This session will demonstrate how social media has altered the way we can amplify health messages, by using best practice examples of public health-driven video-based social media campaigns.

FRIDAY 5TH DECEMBER 13:15 TO 14:45 Plenary 2 90-seconds or less: Communicating health messaging to the masses Using traditional mass media to broadcast campaigns remains a powerful way to raise awareness, reach a wide audience and influence behaviour change. Public service video campaigns made for television have shown to be an effective tool, particularly in the area of lifestyle-based health risks. We will showcase a selection of awareness-raising campaigns on the topic of cancer and non-communicable diseases that demonstrate the potential to be adapted beyond their original intended audience - either via translations in their current form or adaptations of the concept.

138

SATURDAY 6TH DECEMBER 11:45 TO 13:15 Plenary 2 Campaigns without borders: How to successfully adapt a public health campaign for your audience Showcasing impactful campaigns, which have been successfully adapted in multiple countries, this session will provide practical evidence that a great public health campaign doesnâ&#x20AC;&#x2122;t have to be built from scratch. Participants will be shown campaigns that were adapted to fit various local, linguistic and cultural contexts, and in so doing, were able to reach a much larger audience than originally intended. Presentations will be made by those who developed and implemented the original campaign concept as well as those who have adapted the campaign to suit their own organisationâ&#x20AC;&#x2122;s goals in an effort to raise awareness amongst, and change the behaviours of their target audience.

139

MASTER COURSES All registered Congress participants (before 31st May) had the opportunity to sign up to one of the 11 Master Courses running in conjunction with the 2014 World Cancer Congress â&#x20AC;&#x201C; a unique opportunity to acquire specialised knowledge and skills in different areas of cancer control. Master Courses have been conducted through a selection of focussed courses of six-months distance learning that is culminating here in Melbourne with a one-day workshop from the distinguished faculty followed by attendance at the Congress. The curriculum of each Master Course has been purpose-built by internationally-recognised cancer control professionals to meet specific needs for continuing education of those engaged in cancer control from various disciplines and at different levels.

140

1. SYSTEM PERFORMANCE MEASUREMENT AND REPORTING

3. BEST PRACTICES IN PUBLISHING BIOMEDICAL AND PUBLIC HEALTH RESEARCH

Rami Rahal, Director, System Performance & Surveillance, Canadian Partnership Against Cancer

Eduardo L. Franco, James McGill Professor, Departments of Oncology and of Epidemiology; Chair, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal, Canada

Heather Bryant, Vice-President Cancer Control, Canadian Partnership Against Cancer Organised and sponsored by

4. USING SOCIAL MEDIA FOR PUBLIC EDUCATION AND ADVOCACY Becky Freeman, School of Public Health, University of Sydney

2. SCREENING FOR DISTRESS IN CLINICAL CANCER CARE

5. BEST PRACTICE IN THE DELIVERY OF CANCER PREVENTION CAMPAIGNS

Jeff Dunn, CEO, Cancer Council Queensland

Todd Harper, Chief Executive Officer, Cancer Council Victoria

Mark Lazenby, Assistant Professor at Yale University School of Nursing (YSN) Luigi Grassi, Professor and Chair of Psychiatry and Chair of the Department of Biomedical and Specialty Surgical Sciences of the University of Ferrara, Italy

Craig Sinclair, Head of the Prevention Division at the Cancer Council Victoria and Director of the World Health Organizationâ&#x20AC;&#x2122;s (WHO) Collaborative Centre for UV Radiation

Suzanne Chambers, Professor at Griffith University 6. EFFECTIVE FINANCIAL MANAGEMENT OF NGOs H. Fred Mickelson, President, Corral Creek Consultants Maria Barbara Leon, COO, Union for International Cancer Control (UICC)

141

7. ESSENTIAL SKILLS FOR DEVELOPING SUCCESSFUL CANCER CONSUMER ADVOCACY STRATEGIES Maxine Morand, Chief Executive Officer, Breast Cancer Network Australia

10. PEER SUPPORT Jeff Dunn, CEO, Cancer Council Queensland Cathy Hirsch, President, Reach to Recovery International Daina Jones, Online Engagement Coordinator, Breast Cancer Network of Australia

8. IMPLEMENTATION SCIENCE - PRINCIPLES AND PRACTICE

Marie-Claire Cheron-Sauer, Director Support Network, Prostate Cancer Foundation of Australia

Cynthia Vinson, Division of Cancer Control and Population Sciences, Implementation Science Team National Cancer Institute

Suzanne Chambers, Professor of Preventative Health, Griffith University

Sudha Sivaram, Program Director for South Asia region, Center for Global Health, National Cancer Institute at the NIH

Supported by

Organised and sponsored by 11. SEXUALITY ISSUES IN CANCER CARE Doreen Akkerman, Director of Strategic Health Communications International Woet Gianotten, Psychotherapist and member of the Education Committee of the European Society of Sexual Medicine 9. BEST PRACTICE IN FUNDRAISING AND GRANTING Carole Renouf, CEO, National Breast Cancer Foundation, Australia

Anne Katz, AASECT certified sexuality counsellor at Cancer Care Manitoba Karl Lorenz, Medical College of Georgia Dr Susan Carr, Head of Psychosexual Service, RWH, Melbourne Amanda Hordern, Founder of Bayside Healthy Living

142

OPENING DAY WEDNESDAY 3RD DECEMBER

143

WEDNESDAY 3RD DECEMBER

8:00 - 15:00 The Palladium, Crown Towers

World Cancer Leaders’ Summit ‘The Economic Case for Cancer Control’ This year’s Summit is entitled The Economic Case for Cancer Control - a topic which is increasingly relevant to us all as we face a growing burden of cancer across much of the developing world. Too often, cancer is perceived to be a significant cost, whilst the economic and social benefits of addressing the disease are poorly understood and recognised. To complement the Summit, UICC will be launching a new publication on the topic. Invitation only

9:00 - 16:00 Various

UICC Master Courses In conjunction with the 2014 World Cancer Congress, UICC was pleased to offer all registered Congress participants a unique education and training opportunity, allowing them to acquire specialised knowledge and skills in different areas of cancer control. Pre-registration only

144

13:00 - 16:00 Melbourne Convention and Exhibition Centre Room 211

TRACK 1

What’s Your Story? The Power of Entertainment Education & Storytelling to Achieve Public Health Objectives Chaired by: Mona Saraiya, Centers for Disease Control and Prevention (CDC) (United States) WORKSHOP PANELLISTS: Kate Bradley, Associate Script Producer / Writer / Editor for Australian television drama series’ including ‘Home and Away’ and ‘Neighbours’ (Australia) Jennifer Cecil, Executive Producer for Hollywood television drama series’ including ‘Private Practice’ and ‘Hostages’ (United States) Chris Dzialo, Hollywood, Health and Society (United States) Kate Folb, Hollywood, Health and Society (United States) Vinta Nanda, Producer / Writer / Director for Bollywood film and television including ‘White Noise’ and ‘Tara’ (India) Demetrius Parker, Centers for Disease Control and Prevention (CDC) (United States)

Workshop WS.1.1

Whether your focus is presenting data, advocating policy or promoting health guidelines and recommendations, the art and science of storytelling can enhance the effectiveness of your communication. Learn from an international panel of master storytellers featuring television and film writers and producers from Hollywood (United States), Bollywood (India) and Australia. They will facilitate a three-hour workshop that allows participants to: - Hone their storytelling skills to make presentations more effective - Learn how to select the important aspects of a particular cancer subject matter for a variety of communication efforts, and how to convey the critical information in a compelling and meaningful way that keeps audiences engaged. Gain experience by telling their stories and receive feedback from the professionals. Worshop proposed by: Centers for Disease Control and Prevention (CDC) and Hollywood Health & Society, United States

145

15:00 - 19:00 Ground Level Foyer

The NCD CafĂŠ - Have a break...Have an NCD perspective

15:00 - 19:00 Global village

Opening of the Global Village and the Registration All participants

17:00 - 18:00 Global village

Welcome Reception All participants

17:00 - 18:00 Clarendon Room, Level 5

McCabe Centre for Law and Cancer & Cancer Council Victoria VIP Reception Invite only

146

The NCD CafĂŠ welcomes you for a coffee or healthy snack whilst providing a unique space for interactive sessions on NCDs, with a focus on integration, partnerships and multi-disciplinary experiences in low-and middle income countries.

18:00 - 19:00 Melbourne Convention and Exhibition Centre, Plenary #2

2014 World Cancer Congress Opening Ceremony All participants Welcome to Country Jacinta Elston Associate Dean, Indigenous Health Division of Tropical Health and Medicine James Cook University Australian Federal Government Representative Ian Olver Chief Executive Officer Cancer Council Australia Oleg Chestnov Assistant Director-General for Non-communicable Diseases and Mental Health World Health Organization Ian Frazer Chief Executive Officer and Director of Research Translational Research Institute Pty Ltd Mary Gospodarowicz President Union for International Cancer Control Mike Peters Co-Founder Love Hope Strength Foundation Master of Ceremonies Cary Adams Chief Executive Officer Union for International Cancer Control

147

DAY DAY11 THURSDAY 4TH DECEMBER THURSDAY 4TH DECEMBER SHARED WITH 41ST COSA ANNUAL SCIENTIFIC MEETING

SHARED WITH 41ST COSA ANNUAL SCIENTIFIC MEETING

148

DAY 1

THURSDAY 4TH DECEMBER SHARED WITH 41ST COSA ANNUAL SCIENTIFIC MEETING

7:00 - 7:45 Meeting point Registration desk

MORNING YOGA CLASS The 2014 World Cancer Congress does not only lead the way in cancer and NCD prevention and control, it is also breaking ground by providing a truly health and NCD friendly congress environment. Every morning delegates are invited to get moving with a gentle morning yoga flow to prepare body and mind for a packed day of sessions, meetings and networking. Whether you have never done yoga or are an experienced practitioner - come out to walk the talk of cancer and NCD prevention, soak up sun and leave behind stiffness and fatigue to discover the diverse health benefits of yoga.

Meeting point at 7 am in front of the Registration desk Instructor:Â Alena Matzke Register at the General Enquiries counter, located at the Registration desk, in front of the Global Village. Limited to 25 participants daily.

149

7:15 - 8:15 Clarendon Room, Level 5

PROSTATE CANCER FOUNDATION OF AUSTRALIA - BREAKFAST - RESOLVING THE PSA TESTING CONTROVERSY The lack of consensus and widely agreed clinical guidelines on PSA testing confuses and concerns men and their health advisers. Following consultation with key stakeholders in cancer control and clinical care, Prostate Cancer Foundation of Australia, in partnership with Cancer Council Australia, brought together a broadly based group of relevant experts to develop evidence-based national clinical guidelines for PSA testing and the early management of test-detected prostate cancer. This initiative breaks new ground in Australia and internationally. The guidelines are being developed in accordance with the Australian National Health and Medical Research Council’s (NHMRC’s) approved external guideline development processes. Following these processes and obtaining NHMRC approval of the final product are critical to ensuring the guidelines are soundly based in evidence and of high quality, and to their acceptance and adoption in practice in Australia. We will launch required public consultation on the draft guidelines. Members of the expert advisory panel will describe the development process; key challenges faced by the team; the main recommendations in the draft guidelines; and answer questions. The draft guidelines will be available on Cancer Council Australia’s wiki platform from the day of the meeting; we welcome comment and advice on them.

Invitation only Speakers: Villis Marshall, AC (Australia) Bruce Armstrong, AM (Australia) Mark Frydenberg, Urological Society of Australia and New Zealand (Australia)

151

8:30 - 10:00 Room 209

WORLD CANCER CONGRESS PRESS CONFERENCE

8:30 - 10:00 Plenary #2

PLENARY DAY 1 - SUSTAINABLE HEALTH SYSTEMS Chaired by: Sanchia Aranda, Cancer Institute of NSW (Australia), Mei Krishnasamy, Clinical Oncology Society of Australia (Australia)

Plenary PL.0.1

1. Institute of medicine recommendations for addressing the cancer care crisis in the United States Laura Levit, American Society of Clinical Oncology (ASCO) (United States) 2. Sustainable models of palliative care in cancer: is integration the answer? Irene Higginson, Cicely Saunders Institute (United Kingdom) 3. Sustainable Development â&#x20AC;&#x201C; Lessons from immunity Peter. C Doherty, University of Melbourne (Australia)

Session proposed by: Union for International Cancer Control (UICC), Switzerland and Clinical Oncology Society of Australia (COSA), Australia

10:00 - 10:30 Global Village

ePOSTER PRESENTATIONS Full schedule page 201 - 205

ePoster Presentations

10:00 - 10:30 Foyer/Global Village

152

BUPA HEALTHY BREAK

10:30 - 11:30 Room 214

UICC MEMBERS REGIONAL MEETING - CONVENING THE CANCER COMMUNITY FROM THE COMMONWEALTH OF INDEPENDENT STATES (RUSSIA AND THE BALKANS)

UICC Session RM.1

10:30 - 11:30 Room 206

UICC MEMBERS REGIONAL MEETING – CONVENING THE CANCER COMMUNITY FROM EASTERN MEDITERRANEAN

UICC Session RM.2

Defining cancer priorities in Eastern Mediterranean countries Sawsan Al Madhi, Friends of Cancer Patients (United Arab Emirates) Jamal Khader, King Hussein Cancer Center (Jordan)

153

10:30 - 12:00 Room 210 - 211

TRACK 1

CONNECTING RISK FACTORS TO THE BURDEN OF CANCER: GLOBAL CANCER PREVENTABILITY IN THE 21ST CENTURY Chaired by: Rachel Thompson, World Cancer Research Fund International (United Kingdom), Isabelle Soerjomataram, International Agency for Research On Cancer (IARC) (France) 1. Measuring the impact of major risk factors on the global burden of cancer and the potential for prevention Freddie Bray, International Agency for Research On Cancer (IARC) (France)

Concurrent Track Session CTS.1.56

2. Global cancer incidence attributable to excess body mass index: the state of the art Isabelle Soerjomataram, International Agency for Research On Cancer (IARC) (France) 3. The hazards of smoking and the benefits of cessation on cancer mortality worldwide Prabhat Jha, Centre for Global Health Research, St. Michaelâ&#x20AC;&#x2122;s Hospital (Canada) 4. Case study: Estimating the burden of cancer in Australia due to modifiable exposures David Whiteman, QIMR Berghofer Medical Research Institute (Australia) 5. The future of cancer prevention: setting realistic goals and time frame Christopher Wild, International Agency for Research On Cancer (IARC) (France)

Session proposed by: International Agency for Research on Cancer (IARC), France and World Cancer Research Fund International, UK

154

Immuno-Oncology: Transforming cancer outcomes Bristol-Myers Squibb is proud to partner with the Union for International Cancer Control (UICC) in its efforts to tackle the growing cancer crisis and to support the 2014 World Cancer Congress as a sponsor. Joining Forces, Accelerating Progress exemplifies our aspiration to work with the international cancer control community, governments, payers, healthcare providers and advocates to develop workable and sustainable solutions for patients.

About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Immuno-Oncology Targeting tumours through surgery, radiation and cytotoxic or targeted therapies has represented the mainstay of treatment over several decades.1 However, long-term survival and a positive quality of life remain elusive for many patients with advanced disease. To address this unmet medical need, Bristol-Myers Squibb is leading advances in a rapidly evolving field of cancer research and treatment known as Immuno-Oncology, in a wide range of cancers. Immuno-Oncology represents an innovative approach based on understanding how cancer

evades the immune system.2,3 We hope to find new ways to stop cancer from evading the immune system, thereby restoring the body’s natural ability to promote tumour destruction.2,3 We are committed to advancing the science of Immuno-Oncology, with the goal of changing survival expectations and the way patients live with cancer.

We invite you to a symposium on Thursday, 4th December, from 10.30am–12.00pm (Room 207) to learn more about how Immuno-Oncology can transform cancer outcomes.

References: 1. Devita VT Jr, Rosenberg SA. N Engl J Med 2012;366:2207–2214. 2. Borghaei H et al. Eur J Pharmacol 2009;625 (1–3):41–54. doi:10.1016/j.ejphar.2009.09.067. 3. Finn OJ. Ann Oncol 2012;23 (suppl 8):viii6–viii9. Bristol-Myers Squibb Australia, ABN 33 004 333 322, Mulgrave, Vic 3170. ONC/0019/08–14. Date of preparation: August 2014. BYV0217.

10:30 - 12:00 Room 207

TRACK 2

IMMUNO-ONCOLOGY: TRANSFORMING CANCER OUTCOMES Chaired by: Jonathan Cebon, Ludwig Institute for Cancer Research (Australia) 1. The power of the immune system in treating cancer Jonathan Cebon, Ludwig Institute for Cancer Research (Australia) 2. A patient advocacy perspective Tilly Ryan, Melanoma Patients Australia (Australia)

Satellite Session SAT.2.313

3. What is the place of biomarkers in immuno-oncology? Danny Liew, University of Melbourne (Australia) 4. Challenges for health technology assessment Greg Cook, Bristol-Meyers Squibb (Australia)

Session proposed by: Bristol-Myers Squibb (BMS), United States

10:30 - 12:00 Room 203-204

TRACK 2

JOINING FORCES THROUGH SOCIAL MEDIA Chaired by: Monika Preszly, Deutsches Krebsforschungszentrum (DKFZ) (Germany), Anna Boltong, Cancer Council Victoria (Australia) 1. The role of social media in cancer information provision Chris Donkin, Danish Cancer Society (Denmark) 2. Cancer content strategy and information provision through multiple channels Martin Ledwick, Cancer Research UK (United Kingdom)

Concurrent Track Session CTS.2.225

3. Audience & Channels Kevin Babb, American Cancer Society (United States) 4. Patient access and support Jenny Ritchie-Campbell, Macmillan Cancer Support (United Kingdom) 5. Sources of Health and Cancer Information Patterns Lilnabeth Somera, University of Guam (Guam)

Session proposed by: International Cancer Information Services Group (ICISG), United States

156

10:30 - 12:00 Plenary #2

TRACK 3

Concurrent Track Session CTS.3.250 Shared with COSA

THE FINANCIAL MORBIDITY OF CANCER CARE Chaired by: Todd Harper, Cancer Council Victoria (Australia) 1. Ethics of access to cancer care Mary McCabe, Memorial Sloan-Kettering Cancer Center (United States) 2.

Informed financial consent to cancer treatment Fran Boyle, Mater Hospital Sydney (Australia)

Advocacy perspective Maxine Morand, Breast Cancer Network Australia (Australia)

4. Patient and carer perspective Anna Ugalde, Centre for Palliative Care (Australia) 5. Early access to superannuation for cancer patients Sarah Penman, Cancer Council NSW (Australia)

Session proposed by: Cancer Council Victoria, Australia

10:30 - 12:00 Room 212-213

TRACK 4

WHAT CAN WE LEARN FROM INTERNATIONAL HEALTHCARE SYSTEMS TO IMPROVE EARLY CANCER DIAGNOSIS IN PRIMARY CARE? Chaired by: Jon Emery, University of Melbourne (Australia) 1. Health service initiatives in the United Kingdom David Weller, University of Edinburgh (United Kingdom) 2. Health service initiatives in Denmark Peter Vedsted, Aarhus University (Denmark) 3. Community symptom awareness campaigns Jon Emery, University of Melbourne (Australia)

Concurrent Track Session CTS.4.32

4. Symptom risk assessment tools for primary care Lyndal Trevena, University of Sydney (Australia) 5. How applicable are these system initiatives to low and middle income countries? Surendra Shastri, Tata Memorial Hospital (India)

Session proposed by: University of Melbourne and the Victorian Comprehensive Cancer Centre, Australia 157

10:30 - 12:00 Room 208

TRACK 4

Satellite Session SAT.4.312

TECHNOLOGIES: AN ESSSENTIAL ELEMENT OF A CANCER PLAN THE HEALTH MINISTRY PERSPECTIVE Cancer is the leading cause of death worldwide and rates are increasing. Cancer is having a particularly devastating impact on nations, in which citizens are living longer and efforts to curb communicable diseases are meeting with success. Ministries of Health across the globe recognise the need for national action and are developing national cancer control plans (NCCPs) to address this growing epidemic. Radiotherapy is a key component of the multidisciplinary treatment of cancer and as such should form an essential part of the cancer planning process both due to its cost effectiveness and impact on saving lives. Join Ministers of Health currently at different stages in the cancer control planning process as they discuss their respective nation’s unique circumstances and their thoughts on incorporating radiotherapy into their cancer control strategies.

Session proposed by: Varian Medical Systems

12:00 - 13:00 Ground Level Foyer

THE NCD CAFÉ - HAVE A BREAK...HAVE AN NCD PERSPECTIVE The NCD Café welcomes you for a coffee or healthy snack whilst providing a unique space for interactive sessions on NCDs, with a focus on integration, partnerships and multi-disciplinary experiences in low-and middle income countries.

NCDC.2

12:00 - 13:15 Global Village

ePOSTER PRESENTATIONS Full schedule page 205 - 214

ePoster Presentations

159

12:00 - 13:00 Room 104

TRACK 2

CANCER TREATMENT AND TRANSLATIONAL RESEARCH IN CHINA Chaired by: Xishan Hao, Chinese Anti-Cancer Association (CACA) (China), Jiafu Ji, Chinese Anti-Cancer Association (CACA) (China) 1. New monoclonal antibody targeting on basic fibroblast growth factor (bFGF) against melanoma, lung cancer and breast cancer in vitro and in vivo Meng Xu, The First Affiliated Hospital Jinan University (China) 2. Phase II trial of isolated limb infusion with cisplatin in treatment of locally advanced extremity malignancies: Report of the first 2 cases Yong Chen, Fudan University Shanghai Cancer Center (China) 3. Low frequency microsatellite instability in genomic dinucleotide sequences correlate with lymphatic invasion and a poor prognosis in gastric cancer Yan Zhao, Liaoning Cancer Hospital (China)

Satellite Session SAT.2.20

A preliminary evaluation of HPV DNA tests for cervical cancer screening in rural Jiangxi Province of China Ling Li, Maternity and Child Health Hospital Jiangxi Province (China)

5. ITGBL1 transcriptionally regulated by runx2 facilitates bone metastasis of breast cancer Li Xiaoqing, Tianjin Medical University Cancer Institute & Hospital (China)

Session proposed by: Chinese Anti-Cancer Association (CACA), China

160

12:00 - 13:00 Room 208

TRACK 4

SUSTAINABLE ACCESS TO INNOVATIVE CANCER MEDICINE; WHAT ARE THE INGREDIENTS FOR SUCCESS? Opening: Mary Gospodarowicz, Princess Margaret Cancer Centre (Canada) 1. Provide overview of future of oncology using precision oncology (and immune-oncology) & Novartis Pipeline as examples highlight implications on patient access in high, middle & low resource countries. 2. Highlight need for governments /regulatory authorities, physicians, patient advocacy organisations and industry to collaborate and look for solutions to address access to cancer care in low to middle income countries.Â

Satellite Session SAT.4.300

3. Showcase Novartis Oncology collaborative partnerships to improve patient access and healthcare infrastructure globally. 4. Call for greater collaboration and dialogue between all stakeholders to meet needs of patients with cancer.

Session proposed by: Novartis Oncology

162

Mobilizing Local Action for Global Change: Empowering National Networks to Make Cancer a Global Priority

Thursday, December 4 12:05-1:05 p.m. | Room 218 Join the American Cancer Society â&#x20AC;&#x201C; and its partners from around the world â&#x20AC;&#x201C; to discuss how strategic, regional advocacy campaigns to fight cancer and other noncommunicable diseases are building the political will to make these diseases a global health and development priority.

global.cancer.org

12:00 - 13:00 Room 218

TRACK 4

MOBILISING LOCAL ACTION FOR GLOBAL CHANGE: EMPOWERING NATIONAL NETWORKS TO MAKE CANCER A GLOBAL PRIORITY Chaired by: Richard Wender, American Cancer Society (United States) 1. Chair’s welcome and Introduction of Global Potential of Partnerships Richard Wender, American Cancer Society (United States) 2. 10,000 Women raise their voices in the fight against NCDs Nalini Saligram, Arogya World (United States) 3. Creating a civil society led cervical cancer advocacy movement – The Caribbean Cervical Cancer Electronic Petition Laura Tucker-Longsworth, Healthy Caribbean Coalition Inc. (Barbados)

Satellite Session SAT.3.306

4. Riding the development wave to prevent and control NCDs: What do India’s development programmes tell us? John Shoba, Healthbridge (Canada) 5. Strengthening national tobacco control: the experience of Jordan Feras Hawari, King Hussein Cancer Center (Jordan) 6. Release of the final report of the American Cancer Society’s “Meet The Targets” grants programme Ann McMikel, American Cancer Society (United States)

Session proposed by: American Cancer Society, USA

164

CAN CANCER INNOVATION BE MEASURED? Panel discussion on the value of continuous innovation in cancer care and a first look at the PACE Continuous Innovation Indicators™. Moderated by Professor Gordon McVie, European Institute of Oncology.

THURSDAY 4 DECEMBER 2014 12:00 – 13:00

To learn more about PACE (Patient Access to Cancer care Excellence) globally, please visit www.pacenetwork.com.

Melbourne Convention and Exhibition Centre Room 207 Lunch will be provided

The featured artwork was selected from the Lilly Oncology On Canvas: Expressions of a Cancer Journey Art Competition and Exhibition. Eli Lilly Australia Pty Limited, ACN 000 233 992, 112 Wharf Road West Ryde, NSW 2114, Ph +61 2 9325 4444 AUONC00151 | 08/2014

12:00 - 13:00 Room 207

TRACK 4

CAN CANCER INNOVATION BE MEASURED? Chaired by: Gordon McVie, European Institute of Oncology (Italy) 1. Welcome and introductory remarks Gordon McVie, European Institute of Oncology (Italy) 2. Questions for panelists Gordon McVie, European Institute of Oncology (Italy) Geipel Gary, Eli Lilly (United States) Silvia Paddock, Rose Li & Associates (United States) Richard Vines, Rare Cancers Australia (Australia) 3. Audience questions 4. Closing

Session proposed by: Eli Lilly / PACE Satellite Session SAT.4.311

12:00 - 13:00 Room 103

TRACK 4

Satellite Session SAT.4.380

166

RESOLVING THE PSA TESTING CONTROVERSY Prostate Cancer Foundation of Australia - Panel Villis Marshall, AC (Australia) Bruce Armstrong, AM (Australia) Mark Frydenberg (Australia) The lack of consensus and widely agreed clinical guidelines on PSA testing confuses and concer ns men and their health advisers. Following consultation with key stakeholders in cancer control and clinical care, Prostate Cancer Foundation of Australia, in partnership with Cancer Council Australia, brought together a broadly based group of relevant experts to develop evidence-based national clinical guidelines for PSA testing and the early management of testdetected prostate cancer. This initiative breaks new ground in Australia and internationally.

13:15 - 14:15 Room 207

ABSTRACT ORAL SESSION 1 - ADVOCACY REPORTS Chaired by: Loyce Pace, LIVESTRONG Foundation (United States)

AOS.1

1. Virtual Health Library Prevention and Cancer Control: providing reliable information Rodrigo Feijo, National Cancer Institute of Brazil, (Brazil) 2. Partnering with school-based immunisation providers to improve HPV immunisation uptake in Victoria, Australia Heather O’Donnell, Cancer Council Victoria, (Australia) 3. Project-infection control Jyoti Patil, V Care Foundation, (India) 4. NIH tobacco or health research and capacity building grant program review Kalina Duncan, National Cancer Institute, (United States) 5. Lessons learnt from an implementation research study on HPV detection based cervical cancer screening program in low resource setting Srabani Mittal, Child In Need Institute (CINI) (India)

13:15 - 14:15 Room 208 AOS.2

ABSTRACT ORAL SESSION 2 – SCIENTIFIC STUDIES ON CERVICAL AND COLORECTAL CANCER Chaired by: David Hill, Cancer Council Victoria (Australia) 1. Knowledge, attitudinal disposition and willingness of men to support spouses’ cervical cancer screening in a sub-urban area in Nigeria Awele Chukwuedo, University of Ibadan, (Nigeria) 2. Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid (VIA) for cervical cancer screening in a low income setting Joël Bertrand Fokom Domgue, Department of Obstetrics and Gynaecology, Faculty of Medicine and biomedical Sciences, University of Yaoundé, Cameroon, (Cameroon) 3. Efficacy of HPV DNA detection test to triage VIA positive women for cervical cancer screening in low resource setting Partha Basu, Chittaranjan National Cancer Institute, (India) 4. Comparative evaluation of Colposcopy verses Conventional Cytology and HPV DNA testing as a diagnostic triage for Single visit Screen and Treat strategy in VIA based cervical cancer screening programs in low resource settings in India. Sharmila Pimple, Tata Memorial Centre, (India)

168

5. Aspirin, Ibuprofen and risk of colorectal cancer for carriers of germline mutations in DNA mismatch repair genes Driss Ouakrim, The University of Melbourne, (Australia)

VACCINATING AGAINST CANCER Hepatitis B and HPV vaccines protect our future

www.gavi.org Reach every child

13:15 - 14:15 Room 210-211

TRACK 1

Symposium PS.1.234

PREVENTION AND CONTROL OF CERVICAL AND LIVER CANCER Chaired by: Andreas Ullrich, World Health Organization (WHO) (Switzerland) Benjamin Cowie, World Health Organization (WHO) (Switzerland) 1. Research findings from Australia’s national HPV vaccination programme Ian Frazer, Translational Research Institute (Australia) 2. Liver cancer prevention: HBV vaccination and aflatoxin control Chris Wild, International Agency for Research on Cancer (IARC) (France) 3. Bridging the equity gap: reaching girls with HPV vaccines against cervical cancer Helen Evans, GAVI, the Vaccine Alliance (Switzerland) 4. Treatment as a form of liver cancer prevention: the clinical efficacy and cost effectiveness of treatment across Asia Henry Chan, Centre for Hepatitis Research (Hong Kong)

Session proposed by: GAVI the Vaccine Alliance, Switzerland - World Health Organization - Cancer Council Victoria, Australia

13:15 - 14:15 Room 212-213

TRACK 1

TOBACCO RETAIL REFORM – THE NEXT STEP FOR TOBACCO CONTROL Chaired by: Kelly Williams, Cancer Council NSW (Australia) 1. Supply and demand: How the number and type of tobacco retail outlets influences smoker behaviour Suzan Burton, University of Western Sydney (Australia) 2. The Characteristics of tobacco retailers in New Zealand Louise Marsh, University of Otago (New Zealand)

Discussion panel PS.1.165

3. Results of an evaluation of the tobacco retail regulatory system in New South Wales Kelly Williams, Cancer Council NSW (Australia) 4. Licensing models from the USA Kelly Williams, Cancer Council NSW (Australia) 5. Perceptions of tobacco retail interventions in New Zealand Lindsay Robertson, University of Otago (New Zealand)

170

Session proposed by: Cancer Council NSW, Australia

13:15 - 14:15 Room 104

TRACK 1

Symposium PS.1.83

MAMMOGRAPHIC SCREENING - ARE WE DOING MORE HARM THAN GOOD? Chaired by: Craig Sinclair, Cancer Council Victoria (Australia) 1. Overview of the evidence of breast cancer screening Heather Bryant, Canadian Partnership Against Cancer (Canada) 2. Communicating the benefits and risks of breast cancer screening in light of the evidence Sara Hiom, Cancer Research UK (United Kingdom) 3. Challenges for breast screening in low resource countries Vivien Davis Tsu, PATH (United States)

Session proposed by: Cancer Council Victoria, Australia

13:15 - 14:15 Room 103

TRACK 2

Symposium PS.2.44

MODELS OF CARE IN TELEONCOLOGY: INNOVATION IN RURAL CANCER SERVICE DELIVERY Chaired by: Sabe Sabesan, Townsville Cancer Centre (Australia) 1. Overview of teleoncology service at Townsville Cancer Centre Sabe Sabesan, Townsville Cancer Centre (Australia) 2. The teleoncology nursing: bridging gaps in rural/regional cancer service delivery Maree Bransdon, Central Integrated Regional Cancer Service (Australia) 3. Using technology to enhance allied health models of care for patients with head and neck cancer Liz Ward, University of Queensland Centre for Clinical Research (Australia) 4. Multidisciplinary care using teleoncology model Ian Olver, Cancer Council Australia (Australia)

Session proposed by: Townsville Cancer Center, Australia

171

13:15 - 14:15 Room 218

TRACK 3

Symposium PS.3.24

ADDRESSING SEXUALITY ISSUES AS PART OF INTRODUCING SEXUAL HEALTH INTO CANCER Chaired by: Doreen Akkerman, Strategic Health Communications International Pty (Australia) 1. Why is sexuality & intimacy important for people and their partners affected by cancer Woet Gianotten, International Society for Sexuality and Cancer (France) 2. Not an on-off switch, male sexuality after cancer Anne Katz, CancerCare Manitoba (Canada) 3. Intimacy and sexuality-an essential part of quality at end of life Karl Lorenz, University of California (United States) 4. Communication Issues-Challenges and Practical Solutions, Joint presentation Susan Carr, Royal Womenâ&#x20AC;&#x2122;s Hospital (Australia) Amanda Hordern, Cancer Council Victoria (Australia)

Session proposed by: Strategic Health Communications International, Australia

172

1 in 9 women will get breast cancer

If you are between 50 and 74, a breast screen every two years could save your life. It takes only 10 minutes, it’s with a woman and it’s free.

BreastScreen Victoria acknowledges the support of the Victorian Government.

For interpreter assistance call 13 14 50

TTY 13 36 77

If you’re 50 to 74 book your breast screen today Visit breastscreen.org.au Or call 13 20 50

13:15 - 14:15 Room 209

TRACK 4

UICC Session UICC.4.1

HEALTH SYSTEMS LEVERS TO REDUCE LIVES LOST TO BREAST CANCER – TOOLS TO SHAPE POLICY AND PRACTICE FOR IMPACT ON THE GLOBAL 25X2025 GOAL Chaired by: Benjamin O. Anderson, Fred Hutchinson Cancer Research Center (United States) Julie Torode, Union for International Cancer Control (UICC) (Switzerland) To achieve the overarching global NCD target of reducing premature deaths to NCDs by 25% by the year 2025, there is a pressing need for countries to recognise that it is a stage shift from advanced to early stage diagnosis, coupled with robust early multidisciplinary treatment which is going to make an immediate contribution to save lives. The Breast Cancer Knowledge Summaries to be launched at the WCC 2014, provides national stakeholders with a simple tool to facilitate the dialogue between clinicians and policy makers across the care continuum from promotion of breast health and increased awareness in the community, through screening and early detection to treatment and palliative care. This interactive session will discuss the role of this tool in stimulating a more forceful multi-stakeholder response to the impact on breast cancer outcomes, with panelists showcasing country experiences in building a health systems response for breast cancer management.

Session proposed by: Union for International Cancer Control (UICC), Switzerland

174

13:15 - 14:15 Room 203-204

TRACK 4

Symposium PS.4.248

CANCER PREVENTION AND CONTROL IN AFRICA Chaired by: Makeda Williams, National Cancer Institute - USA (United States) Martin Damali, National Cancer Institute - USA (United States) 1. Introduction Makeda Williams, National Cancer Institute - USA (United States) 2. Research and health infrastructure Isaac Adewole, African Organisation for Research & Training in Cancer (AORTIC) (South Africa) 3. Resources and investments Miriam Schneidman, World Bank (United States) 4. Cancer control planning Lisa Stevens, National Cancer Institute - USA (United States) 5. Ethics Christopher Sola Olopade, University of Chicago (United States)

Session proposed by: National Cancer Institute - USA, United States

13:15 - 14:15 Room 219

TRACK 4

UICC Session UICC.4.9

MAKING CANCER STAGING GLOBALLY RELEVANT Chaired by: Brian Oâ&#x20AC;&#x2122;Sullivan, Princess Margaret Hospital (Canada) 1. Needs of cancer registries in relation to stage of disease Max Parkin, African Cancer Registry Network (United Kingdom) 2. The need for simplified stage language for all James Brierley, Princess Margaret Hospital (Canada) 3. Developing a simple TNM stage tool Giulio Napolitano, Northern Ireland Cancer Registry (United Kingdom) 4. Promoting TNM stage use/ensuring stage is globally relevant Anne Lee, The Hong Kong Anti-Cancer Society (Hong Kong)

Session proposed by: UICC TNM project Geneva (Switzerland)

175

13:15 - 14:15 Room 220

TRACK 4

Symposium PS.4.46

RESEARCH EFFORTS TO OVERCOME INEQUALITIES IN CANCER CARE FOR INDIGENOUS PEOPLES IN DEVELOPED COUNTRIES Chaired by: Gail Garvey, Menzies School of Health Research (Australia) Baxi Siddartha, Genesis Cancer Care (Australia) 1. Improving cancer outcomes for Indigenous Australians Joan Cunningham, Menzies School of Health Research (Australia) 2. From patterns to pathways to respect: Advancing the right to respectful cancer care for First Nations in Manitoba, Canada Brenda Elias, University of Manitoba (Canada) 3. From research to translational science: taking action to improve cancer outcomes for indigenous Māori in Aotearoa/New Zealand Lis Ellison-Loschmann, CPHR, Massey University (New Zealand) 4. Native Americans with cancer: Inequities, access to care, quality of life and survival Linda Burhansstipanov, Native American Cancer Research Corporation (United States) 5. International efforts to assess cancer burden and care among Indigenous peoples globally Suzanne Moore, International Agency for Research On Cancer (IARC) (France)

Session proposed by: Menzies School of Health Research, Australia

14:15 - 14:30 Foyer/Global Village

176

NETWORKING BREAK

14:30 - 15:30 Room 206

UICC MEMBERS’ REGIONAL MEETING - CONVENING THE CANCER COMMUNITY FROM EUROPE

UICC Session RM.3

Legal expertise as an effective tool in European cancer control Tryggve Kielland, Norwegian Cancer Society (Norway) Marc Keller, French League against Cancer (France)

14:30 - 15:30 Plenary #2

THE COST OF CANCER TREATMENT IS WORTH THE BENEFITS Moderator: Adam Spencer (Australia)

Big Debate BD.0.1 Shared with COSA

Robyn Ward, Prince of Wales Clinical School (Australia) Nicola Roxon, Former Australian Minister of Health (Australia) Donna Milne, University of Melbourne (Australia) Georgina Long, University of Sydney (Australia) David Grainger, Eli Lilly (Australia) TBA Patient representative Rather than a formal debating structure this debate on “The cost of cancer treatment is worth the benefits” will form more of a hot topic with various perspectives on the issue being drawn out by the facilitator. Issues to be discussed include affordability, government decision making, the lost opportunities of spending money on high cost drugs rather than other priorities and the consequences successful high cost drugs have on the delivery of services.

177

14:30 - 15:30 Room 207

ABSTRACT ORAL SESSION 3 - ADVOCACY REPORTS Chaired by: Chris Hanser, American Cancer Society (United States)

AOS.3

1. Harnessing the community to accelerate cancer research outcomes Alison Butt, National Breast Cancer Foundation, (Australia) 2. Making Radiotherapy a Global Health Priority Through Social Media Mobilisation: The Case of GlobalRT Danielle Rodin, University of Toronto (Canada) 3. Cancer control – current trends in data protection legislation may impede data driven progress in Europe - counter acted by data driven advocacy. Hans Storm, Danish Cancer Society, (Denmark) 4. Accelerating Decision-Making with Microsimulation: The Adoption of Evidence in Cervical Cancer Screening Natalie Fitzgerald, Canadian Partnership Against Cancer, (Canada) 5. Women’s Empowerment Cancer Advocacy Network (WE CAN) 2014 East Africa WE CAN Breast and Cervical Cancer Advocacy, Education and Outreach Summit September 11-13, Dar es Salaam, Tanzania Seattle Cancer Care Alliance/University of Washington (SCCA/UW) National Cancer Institute Center for Global Health (NCI CGH) Allison Dvaladze, Seattle Cancer Care Alliance/University of Washington, (United States)

178

14:30 - 15:30 Room 208 AOS.4

ABSTRACT ORAL SESSION 4 - SCIENTIFIC STUDIES ON TOBACCO CONTROL Chaired by: Edouard Tursan D’Espaignet (WHO – Switzerland) 1. Promoting tobacco without the tobacco - Continuing use of price boards to promote tobacco post- point-of-sale display bans Megan Bayly, Cancer Council Victoria, (Australia) 2. Impact of electronic cigarette use on smoking cessation among U.S. adults: A longitudinal study Lois Biener, University of Massachusetts Boston, (United States) 3. Short-term impact of Australia’s new tobacco plain packs on adult smokers’ pack-related perceptions and responses: Results from a continuous tracking survey Sally Dunlop, Cancer Institute NSW, (Australia) 4. Smoking before first childbirth and risk of breast cancer Inger Gram, UiT the Arctic University of Norway, (Norway) 5. Smoking cessation after a cancer diagnosis Marianne Weber, Cancer Council NSW, (Australia) 6. Association between smoking and primary malignant brain tumors: a national population-based case-control study in China Jingmei Jiang, Institute of cancer research, Chinese, (China)

179

14:30 - 15:30 Room 209

TRACK 1

OUT OF YOUR FACEBOOK: ALCOHOL MARKETING IN A DIGITAL AGE Chaired by: Gerard Hastings, Institute for Social Marketing, University of Stirling/ Open University (United Kingdom) Sally Caswell, Massey University (New Zealand) 1. Introduction and welcome Terry Slevin, Cancer Council Western Australia (Australia) 2. Alcohol and Cancer Sally Caswell, Massey University (New Zealand)

Discussion panel PS.1.55

3. The nature of marketing Gerard Hastings, Institute for Social Marketing, University of Stirling/Open University (United Kingdom) 4. An Audit of Alcohol Marketing on Facebook Sandra Jones, University of Wollongong (Australia) 5. Digital Alcohol Marketing in the UK Richard Purves, Institute for Social Marketing University of Stirling (United Kingdom) 6. Digital Alcohol Marketing in Thailand Thaksaphon Thamarangsi, International Health Policy Program (IHPP) (Thailand)

Session proposed by: Institute for Social Marketing, University of Stirling/Open University, United Kingdom

180

14:30 - 15:30 Room 104

COLLABORATION TO PREVENT AND CONTROL CERVICAL CANCER IN THE AMERICAS Chaired by: Mona Saraiya, Centers for Disease Control and Prevention (CDC) (United States)

TRACK 1

Symposium PS.1.105

1. Cervical cancer situation in Latin America and the Caribbean Mona Saraiya, Centers for Disease Control and Prevention (CDC) (United States) 2. The network of National Cancer Institutions of Latin America (RINC): A regional model for capacity building and knowledge share Luiz Antonio Santini Rodrigues da Silva, INCA Instituto Nacional de Cãncer (Brazil) 3. Increasing civil society’s role in cancer prevention and control Sally Cowal, American Cancer Society (United States)

Session proposed by: Centers for Disease Control and Prevention (CDC), United States

181

14:30 - 15:30 Room 203-204

TRACK 1

Symposium PS.1.189

DEVELOPED AND DEVELOPING LUNG CANCER SCREENING STRATEGIES Chaired by: Shelly Jamieson, Canadian Partnership Against Cancer (Canada) 1. Lung cancer screening framework in Canada and overview of international guidelines Heather Bryant, Canadian Partnership Against Cancer (Canada) 2. A review of key lung cancer screening guidelines in the US Otis Brawley, American Cancer Society (United States)

Session proposed by: Canadian Partnership Against Cancer, Canada

14:30 - 15:30 Room 103

TRACK 2

Symposium PS.2.41

CREATING THE BEST PATIENT EXPERIENCE POSSIBLE FOR ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH CANCER Chaired by: Janine MacDonald, CanTeen Australia (Australia) 1. The establishment and management of a dedicated AYA cancer service in Australia Michael Osborn, Women’s and Children’s Hospital/ Royal Adelaide Hospital (Australia) 2. The use of the modified Distress Thermometer in identifying and managing distress amongst AYA cancer patients Pandora Patterson, CanTeen Australia (Australia) 3. The Canadian Task Force on Adolescents and Young Adults with Cancer: Moving forward to optimize outcomes for AYA survivors of cancer Norma D’Agostino, Princess Margaret Cancer Centre (Canada) 4. Core competencies for AYA professionals Maria Cable, Coventry University (United Kingdom) 5. Optimising fertility preservation for AYAs with cancer Rebecca Johnson, Seattle Children’s (United States)

Session proposed by: CanTeen Australia, Australia

182

14:30 - 15:30 Room 212-213

TRACK 2

Symposium PS.2.39

SUPPORTIVE CARE IN ELDERLY AND NOT SO ELDERLY: IMPORTANT ISSUES FOR PATIENT QUALITY OF LIFE AND SURVIVAL Chaired by: Dorothy Keefe, Multinational Association of Supportive Care in Cancer MASCC (Australia) Gilbert Zulian, Hopitaux Universitaires de GenĂ¨ve (HUG) (Switzerland) 1. Bone health: a key factor in elderly and not so elderly patients with cancer Matti Aapro, International Society for Geriatric Oncology (SIOG) (Switzerland) 2. Mucositis and new drugs: to prevent or to treat? Dorothy Keefe, Multinational Association of Supportive Care in Cancer MASCC (Australia) 3. Depression: an issue in survivorship for elderly cancer patients Lodovico Balducci, H. Lee Moffitt Cancer Center & Research Institute (United States) 4. Ovarian cancer: issues in the long term for elderly patients Christopher Steer, Border Medical Oncology (Australia)

Session proposed by: Multinational Association of Supportive Care in Cancer (MASCC), Denmark and International Society of Geriatric Oncology (SIOG), Switzerland

183

14:30 - 15:30 Room 218

TRACK 3

Symposium PS.3.112

ROLE OF YOGA AND YYURVEDA IN CANCER CONTROL Chaired by: Swami Ramdev, Patanjali Yogpeeth (India) Sukdev Nayak, All India Institute of Medical Sciences (AIIMS), India 1. Physiology of yogic practices Pranati Nanda, All India Institute of Medical Sciences (India) 2. Yogic and ayurvedic principles in cancer control Swami Ramdev, Patanjali Yogpeeth (India) 3. Meditation & cancer control Manjula Bala Nayak, Cancer Care Every Where (India) 4. Yoga in integrative oncology Raghavendra Rao, Health Care Global Hospital (India) 5. Palliative care and yoga Sukdev Nayak, All India Institute of Medical Sciences (AIIMS) (India)

Session proposed by: All India Institute of Medical Sciences (AIIMS), India

14:30 - 15:30 Room 219

TRACK 4

Symposium UICC.4.226

REDUCING INEQUALITIES IN CHILDHOOD CANCER TREATMENT AND OUTCOME Chaired by: M. Tezer Kutluk, Turkish Association for Cancer Research & Control (Turkey), Jenny Proimos, University of Melbourne (Australia) 1. The need for national childhood cancer strategies in low- and middleincome countries Sumit Gupta, The Hospital for Sick Childrens (Canada) 2. Reducing inequalities in childhood cancer: Experience from Asia Akira Nakagawahara, Chiba Cancer Center (Japan) 3. Diagnosis and treatment of childhood cancer in Iran Saba Kamkar, MAHAK “Society to Support Children Suffering from Cancer” (Islamic Republic of Iran)

Session proposed by: Union for International Cancer Control (UICC), Switzerland, Turkish Association for Cancer Research, Turkey

184

14:30 - 15:30 Room 220

TRACK 4

Symposium PS.4.43

INTERNATIONAL COLLABORATION ENHANCES DEVELOPMENT AND DISSEMINATION OF INNOVATIVE DIGITAL CANCER GUIDELINES Chaired by: Jutta von Dincklage, Cancer Council Australia (Australia) 1. Integration and coordination of guidelines Amir Qaseem, American College of Physicians (United States) 2. (Inter)National collaboration on guidelines Sonja Kersten, IKNL Integraal Kankercentrum Nederland (The Netherlands) 3. Linking of guidelines with educational tools and other resources Ian Olver, Cancer Council Australia (Australia) 4. Implementation and translation of guidelines Mary Haines, Cancer Institute NSW (Australia)

Session proposed by: Cancer Council Australia, (Australia)

15:30 - 16:00 Global Village

ePOSTER PRESENTATIONS Full schedule page 214 to 218

ePoster Presentations

15:30 - 16:00 Foyer/Global Village

NETWORKING BREAK The NCD CafĂŠ welcomes you for a coffee or healthy snack whilst providing a unique space for interactive sessions on NCDs, with a focus on integration, partnerships and multi-disciplinary experiences in low-and middle income countries.

185

16:00 - 17:30 Plenary #2

BIG SCREEN - SOCIAL MEDIA: CHANGING THE FACE OF AWARENESS-RAISING CAMPAIGNS Chaired by: Kristen Boschma, Whizz Bang Communications (Australia) 1. Smoking Kid Supatnuj Sorndamrih, Thai Health promotion Foundation (Thailand) 2. The Answer is Plain Donnal Buggy, Irish Cancer Society (Ireland) Alison Cox, Cancer Research UK (United Kingdom)

Big sCreen BSC.0.1

3. Dear 16-year-old Me DanielleÂ Paterson, David Cornfield Melanoma Fund (Canada) 4. Nutiquette Joelle Walker, Canadian Cancer Society (Canada) The development of social media has fundamentally changed the way that we interact with others on a day-to-day basis in society. As it is now such a powerful communication medium, it is no wonder that organisations are leveraging social media to promote their messages. Social media platforms such as YouTube, Facebook and Twitter, allow organisations broader parameters in terms of the time, length, target audience and content of their campaigns. Removing many of the restrictions imposed by traditional media, organisations now have new and exciting ways to communicate with their audience. This session will demonstrate how social media has altered the way we can amplify health messages, by using best practice examples of public health-driven video-based social media campaigns.

186

16:00 - 17:30 Room 203-204 Rapid-Fire Abstract Presentations RF.1

RAPID FIRE 1 - TOBACCO CONTROL; CERVICAL CANCER PREVENTION AND EARLY DETECTION; BREAST CANCER PREVENTION, AWARENESS AND EARLY DETECTION Chaired by: Terry Slevin, Cancer Council Western Australia (Australia) 1. Impact of plain packaging in Australia: Lessons for India Monika Arora, Public Health Foundation of India, (India) 2. Advancing tobacco dependence treatment services through training: King Hussein Cancer Center and global bridges spearheading change in the region Rasha Bader, King Hussein Cancer Center, (Jordan) 3. The Case for banning slims and superslims cigarettes Rob Cunningham, Canadian Cancer Society, (Canada) 4. Experience implementing WHO’s trade and tobacco control capacity building module at regional and country-levels Katherine DeLand, DeLand Associates, LLC, (United States) 5. The Tobacco-Free Investment Initiative Bronwyn King, Peter MacCallum Cancer Centre, (Australia) 6. Translation of a global best practice in tobacco control: Exploring plain packaging for India applying the Australian experience Nathan Grills, EHA, (India) 7. More comprehensive tobacco control policies associated with reduced socio-economic and age group disparities in smoking prevalence: evidence from Victoria, Australia Linda Hayes, Cancer Council Victoria, (Australia) 8. Association of oral precancer with non tobacco areca nut consumption. Divya Mehrotra, King George’s Medical University, Lucknow, (India) 9. Impact of a post-discharge smoking cessation intervention for smokers admitted to a smoke-free psychiatric hospital: A randomised controlled trial Jenny Bowman, University of Newcastle, (Australia) 10. Longer term impact of cigarette package warnings in Australia compared to the United Kingdom and Canada Lin Li, Cancer Council Victoria, (Australia)

187

Rapid-Fire Abstract Presentations

11. Narghile, water pipe smoking associated with earlier development of oral cancer OMAR NIMRI, Ministry of Health, (Jordan)

RF.1

12. The effect of a voice-site on informed choice for women considering cervical cancer screening in rural India: A phase II controlled trial Rita Isaac, Christian Medical College, (India) 13. Impact of HPV vaccination in the general and indigenous Australian population: Analysis of genital warts diagnoses in national hospital data Megan Smith, UNSW Australia, (Australia) 14. Preventing cervical cancer in Karen women - A peer education project Lucy Forwood, Cancer Council Victoria, (Australia) 15. For a future without cervical cancer in El Salvador Lisseth Ruiz de Campos, Salvadoran Association for Cancer Prevention, (El Salvador) 16. Naivety and language, not culture! New approaches for cancer prevention through HPV vaccination among culturally and linguistically diverse population groups. Margaret Heffernan,O.A.M., RMIT University, (Australia) 17. A mobile phone-based survey on knowledge of cervical cancer and HPV vaccination in Kenya Mellany Murgor, Young Professionals Chronic Disease Network, (Kenya) 18. Renewal of the national cervical screening program - from evidence-based recommendations to policy and practice Tracey Bessell, Australian Government Department of Health, (Australia) 19. Exercise training and inflammatory blood biomarkers in breast cancer patients: a metaanalysis of randomized-controlled trials Jose F Meneses-Echavez, Universidad Santo Tomรกs, (Colombia) 20. Be frank and help beat cancer: Empowering hairdressers to raise breast cancer awareness Amyza Saleh, Cancer Research Initiatives Foundation (CARIF), (Malaysia) 21. Development of a service model for a breast cancer screening program and evaluation of its effectiveness Memnun Seven, Koรง University School of Nursing, (Turkey) 22. Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada Yoon-Jung Kang, UNSW, (Australia)

188

16:00 - 17:30 Room 212-213 Rapid-Fire Abstract Presentations RF.2

RAPID FIRE 2 - CANCER CONTROL, SYSTEMS AND GUIDELINES; DATA / POPULATION Chaired by: Julie Torode, Union for International Cancer Control (UICC) (Switzerland) 1. Forum for improving cancer control in Latin America Eduardo Cazap, SLACOM, (Argentina) 2. The power of empathy in advocating for cancer control policy: Combining evidence and a personal cancer story to motivate stakeholders to advocate for the first asbestos registry in Canada Donna Pasiechnik, Canadian Cancer Society, (Canada) 3. Updating clinical guidelines: A stream education program for research translation in ovarian cancer Tim Shaw, University of Sydney, (Australia) 4. Integrating universal consent for biobanking and health data collection within clinical pathways in NSW - the BSN consent project Nicola Meagher, University of New South Wales, (Australia) 5. Optimal care pathways: Achievements and future directions Alexandra Philpott, Cancer Council Victoria, (Australia) 6. Establishing a translational cancer research program by developing research infrastructure and influencing system changes Lena Caruso, Translational Cancer Research Network, (Australia) 7. Grass roots advocacy to influence healthy public policy Jackie MvIver, Cancer Council NSW, (Australia) 8. Update of the European code against cancer Carolina Espina, Agency for International Research on Cancer (IARC), (France) 9. Access to cancer treatments in the face of intellectual property and international trade laws Elizabeth Holzer, Cancer Council Victoria, (Australia) 10. The creation of a stakeholder workshop process whereby a four-levelled ‘call to action’ advocacy framework is applied to the analysis of photovoice narratives of cancer challenges collected in South African Linda Greeff, People Living With Cancer, (South Africa) 189

A critical factor for defining the value of cancer care Join the discussion: #cancercongress

Platinum sponsor, Roche, embraces the UICC World Cancer Congress (WCC) as an important opportunity to address current and future needs with those at the forefront of cancer care and control worldwide. Roche believes that multidisciplinary collaboration is vital to address global needs in cancer care and control and WCC represents an important platform to make such connections and collaborations a reality. Roche will be providing WCC delegates with opportunities to hear and share perspectives on the importance, impact and practicalities of including patient wellbeing as a factor in defining the value of cancer care. This will take the form of: ď Ž An ancillary event entitled: Patient well-being: A critical factor for defining the value of cancer care

ď Ž A host of information and activities at the Roche booth in the Global Village (space 8) Roche looks forward to hearing your perspectives on this important topic via the activities mentioned above and encourages you to use the official WCC twitter hashtag: #cancercongress, to continue the conversation at WCC and beyond.

Issued by F Hoffmann-La Roche AG, Basel, Switzerland NP/ONCO/1408/0011

Rapid-Fire Abstract Presentations RF.2

11. Reducing time to cancer diagnosis in rural Western Australia (WA): Results of a cluster randomised controlled trial of community and primary care interventions Jon Emery, University of Melbourne, (Australia) 12. A novel approach to improve recruitment of cancer patients: Experience from the Improving Rural Cancer Outcomes Trial Victoria Gray, University of Western Australia and Cancer Council WA, (Australia) 13. A national strategy for quality and safety in radiotherapy: A policy approach for global consideration Gunita Mitera, Canadian Partnership Against Cancer, (Canada) 14. Online hub for the learning and development of health professionals in cancer care Rob Sutherland, Cancer Australia, (Australia) 15. Continuous innovation indicators: Measuring progress in cancer treatments Silvia Paddock, Rose Li and Associates, Inc., (United States) 16. eviQ Cancer treatments online (www.eviQ.org.au) - An international perspective Julia Shingleton, Cancer Institute NSW, (Australia) 17. Community Cancer Programs Network - Bringing cancer care closer to home Jodi Hyman, Cancer Care Manitoba, (Canada) 18. Promoting equity in cancer survivorship care Tracy Truant, University of British Columbia, (Canada) 19. National breast cancer quality register as a powerful tool to improve treatment Kerstin Sandelin, Karolinska Institutet, (Sweden) 20. A chemoinformatics approach for identifying priority agents for cancer hazard evaluation: The IARC monographs and pesticides Dinesh Barupal, International Agency for Research on Cancer, (France) 21. The New South Wales Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): A resource for cancer research. Usha Salagame, Cancer council NSW, (Australia) 22. Joining forces in cancer information and support: Collaboration adds value Monika Preszly, German Cancer Research Center, (Germany) 23. The International Collaboration on Cancer Reporting (ICCR) – from clinical need to international partnerships and global goals John Srigley, Canadian Partnership Against Cancer, (Canada)

192

16:00 - 17:30 Clarendon room Level 5

Workshop WS.2.2

PATIENT WELLBEING: A CRITICAL FACTOR FOR DEFINING THE VALUE OF CANCER CARE - MULTIDISCIPLINARY PERSPECTIVES ON IMPORTANCE, IMPACT AND PRACTICALITIES 1. 2. 3. 4. 5. 6. 7.

Welcome Wellbeing: The patient perspective Speed-networking session: Patient wellbeing Speed-networking session: Economics Wellbeing: The practicalities of measurement Speed-networking session: Measurement Wrap-up

Ancillary event organised by: Roche Issued by F. Hoffmann - La Roche AG, Basel, Switzerland NP/ONCO/1408/0011a

193

16:00 - 17:30 Room 210-211

TRACK 1

REDUCING THE GLOBAL CANCER BURDEN THROUGH POLICY ACTION ON DIET, PHYSICAL INACTIVITY AND ALCOHOL: WHAT POLICIES ARE NEEDED FOR HIGH IMPACT AND HOW TO ADVOCATE THEIR WIDER IMPLEMENTATION Chaired by: Tim Armstrong, World Health Organization (WHO) (Switzerland) Kathryn Allen, World Cancer Research Fund International (United Kingdom) Panel 1 - Overview and scene setting Tim Armstrong, World Health Organization (WHO) (Switzerland) 1. What are the high-impact policies to improve prevention outcomes? (Diet) Corinna Hawkes, World Cancer Research Fund International (WCRF) (United Kingdom)

Discussion Panel PS.1.223

2. What are the high-impact policies to improve prevention outcomes? (Alcohol) Thaksaphon Thamarangsi, International Health Policy Program (IHPP) (Thailand) 3. What are the high-impact policies to improve prevention outcomes? (Physical Activity) Fiona Bull, University of Western Australia (Australia) Panel 2 Kathryn Allen, World Cancer Research Fund International (WCRF) (United Kingdom) 1. A united policy front: lessons learnt by coalitions for cancer prevention Jane Martin, Cancer Council Victoria (Australia) 2. Youth leadership in creating a global social movement around NCDs Alessandro Demaio, University of Copenhagen/University of Harvard Global Health Equity Initiative (Denmark)

Session proposed by: World Cancer Research Fund International, United Kingdom and Cancer Council Victoria, Australia

194

16:00 - 17:30 Room 207

TRACK 1

Symposium PS.1.90

PRIORITIES TO REDUCE ENVIRONMENTAL CANCERS Chaired by: Bernard Stewart, SE Sydney Public Health Unit (Australia) 1. Implications from occupational carcinogenesis Kurt Straif, International Agency for Research on Cancer (IARC) (France) 2. Mechanisms of carcinogenesis to identify priority carcinogens Bernard Stewart, SE Sydney Public Health Unit (Australia) 3. Diesel emissions affecting the wider community Christopher Portier, Center for Disease Control and Prevention (CDC) (United States) 4. Benzene exposure and cancer Deborah Glass, Monash University (Australia) 5. Evidence-based advocacy for regulatory actions Paul Grogan, Cancer Council Australia, Australia

Session proposed by: International Agency for Research on Cancer (IARC), France

16:00 - 17:30 Room 209

SCREENING FOR COLORECTAL CANCER – A PRACTICE GUIDE FROM AN INTERNATIONAL PERSPECTIVE Chaired by: Stephen Halloran, WEO Colorectal Cancer Screening Committee (United Kingdom), Graeme Young, Flinders University (Australia)

TRACK 1

Symposium PS.1.235

1. Colorectal Cancer – The case for screening Ernst Kuipers, WEO Colorectal Cancer Screening Committee (The Netherlands) Gary Ginsberg, Ministry of Health (Israel) 2. Colorectal Cancer Screening – Setting it up and making it work Julietta Patnick, Public Health England (United Kingdom) Robert Steele, University of Dundee (United Kingdom) 3. Colorectal Cancer Screening – Reaching the population – an international perspectives Graeme Young, Flinders University (Australia) Linda Rabeneck, Cancer Care Ontario (Canada)

Session proposed by: RTI International, USA, Canadian Partnership Against Cancer, Canada and WEO Colorectal Cancer Screening Committee, UK 195

16:00 - 17:30 Room 208

TRACK 2

AN NGO MODEL FOR CANCER CARE IN TAIWAN - A NICHE TO MEET PATIENT NEEDS Chaired by: Cheng-Hsu Wang, Hope Foundation for Cancer Care 1. The Current Status of Cancer Care in Taiwan Chien-Yuan Wu, Health Promotion Administration, R.O.C. Taiwan 2. Bridging the Gap in Cancer Care: Cancer Resource Center and HOPE Station as Examples Shiu-Yu Chiou Lee, Hope Foundation for Cancer Care 3. Advocacy and Campaigns to Promote Cancer Care Li-Ying Chiu, Hope Foundation for Cancer Care

Satellite Session SAT.2.307

16:00 - 17:30 Room 218

TRACK 3

Symposium PS.3.241

Moderator: June Chan, Hope Foundation for Cancer Care Session proposed by: Hope Foundation for Cancer Care

INTERNATIONAL PERSPECTIVES ON POST-TREATMENT SURVIVORS Chaired by: Felicia Knaul, Harvard Global Equity Initiative (United States) 1. Cancer Survivorship in the Developed World: A Work in Progress Mary McCabe, Memorial Sloan-Kettering Cancer Center (United States) 2. Multidisciplinary Survivorship Care: The Australian Experience Michael Jefford, Cancer Council Victoria (Australia) 3. Long Term Cancer Survivorship Needs: The Qualitative Case of Mexico Felicia Knaul, UICC; Harvard Global Equity Initiative (United States) 4. Meeting the Unmet Survivorship Needs: The Case of Brazil Luiz Antonio Santini Rodrigues da Silva, INCA Instituto Nacional de C達ncer (Brazil) 5. Beating the Odds: Surviving Breast Cancer in India Suneeta Krishnan, Research Triangle Institute (India)

Session proposed by: Harvard Global Equity Initiative, USA

197

16:00 - 17:30 Room 220

TRACK 4

Symposium PS.4.57

PRODUCING AND USING EVIDENCE FOR CANCER CONTROL: THE GLOBAL INITIATIVE FOR CANCER REGISTRY DEVELOPMENT (GICR) IN LMICS Chaired by: Brenda Edwards, National Cancer Institute - USA (United States) Freddie Bray, International Agency for Research On Cancer (IARC) (France) 1. The Global Cancer Burden Freddie Bray, International Agency for Research on Cancer (IARC) (France) 2. Implementing the GICR: an overview of Regional Hubs development and future direction Les Mery, International Agency for Research on Cancer (IARC) (France) 3. Cancer registries and control planning: How do they fit together? David Roder, Cancer Council South Australia (Australia) 4. Building cancer surveillance capacity in low and middle income countries Lisa Stevens, National Cancer Institute - USA (United States) 5. The African Regional Cancer Network: An IARC Regional Hub in practice Max Parkin, African Network of Cancer Registries (United Kingdom)

Session proposed by: International Agency for Research on Cancer (IARC), France

16:00 - 17:30 Room 219

TRACK 4

Discussion panel PS.4.390

CHANGING CANCER CARE – THE ROLE OF PATIENT PERSPECTIVES Chaired by: Dale Fisher, Peter MacCallum Cancer Centre (Australia) 1. Listening and Responding Requires a Culture Change Deb Dudgeon, Canadian Partnership Against Cancer (Canada) 2. System Responses to Patient Experience Surveys – the NHS experience Jane Maher, Macmillan Cancer Support (United Kingdom) 3. Canadian Cancer Action Network - Canadian health technology assessment system for cancer drugs improving cancer patient outcomes: How patient engagement systematically informs a uniquely Canadian HTA system James Gowling, Canadian Cancer Action Network (Canada) 4. Consumer involvement in developing supportive care research Sanchia Aranda, Cancer Institute of NSW (Australia) 5. Discussion panel

198

17:30 - 19:00 Plenary #2

TRACK 3

DOCUMENTARY SCREENING: A DAY WITHOUT CANCER An exclusive documentary screening event proposed by The Princess Margaret Cancer Foundation, Canada UICC Premiere of A DAY WITHOUT CANCER…a must see powerful new documentary.

All Delegates

SAT.3.305

A day without cancer is a 75-minute exploration of cancer’s history and poses the provocative question: “Can we conquer cancer in our lifetime?” Leading cancer experts from around the world discuss cancer and their views on the progress of controlling this disease. First-person stories of survival and inspiration are woven throughout the film. The documentary is directed by Canadian film-maker Joseph Nanni, and has been narrated by Bryan Adams, one of the world’s most acclaimed musicians. Cocktail reception and lively discussion to follow hosted by: The Princess Margaret Cancer Foundation

17:45 - 18:15 Foyer

200

ePOSTER SESSION TIMES THURSDAY 4TH DECEMBER

10:00 - 10:30

ePoster Pod 1 - EP1.1 1.1 ADVOCACY & AWARENESS; CANCER PREVENTION 1. Social marketing campaigns for tobacco control in Thailand, 2005 - 2013 Nipapun Kungskulniti, Mahidol University, (Thailand) Abstract No: 541

5. How do you solve a problem like Angelina? Carole Arbuckle, Cancer Council Victoria, (Australia) Abstract No: 545 6. Enhancing legislation as a tool for the control of tobacco usesÂ Elizabeth Ayoo, Tobacco Alcohol Free Initiative(TAFI), MASENO University, (Kenya) Abstract No: 546

2. Nationwide cancer awareness program Neha Tripathi, Cancer Aid Society, (India) Abstract No: 542

7. Jordan Tobacco Dependence Treatment (TDT) Guidelines: Rationale and development. Hiba Ayub, King Hussein Cancer Center, (Jordan) Abstract No: 547

3. Tobacco control in prevention of oral cancer Dilip Acharya, Cancer Society of Madhya Pradesh, (India) Abstract No: 543

8. Breast cancer challenges in South Africa Gerda Strauss, Cancer Association of South Africa (CANSA), (South Africa) Abstract No: 548

4. Successful strategies of education and communication to prevent the occurrence of oral cancer among rural Indian population Mira Aghi, (India) Abstract No: 544

201

10:00 - 10:30

ePoster Pod 2 - EP2.1 2.1 ADVOCACY AND AWARENESS - TREATMENT 1. Quality indicators for radiation treatment: A global perspective Michael Milosevic, Princess Margaret Cancer Centre, (Canada) Abstract No: 549

7. Report on best practices, conventions and communications on cancer of describing innovative programmes in the field of detection of care, support for prevention Martial Tiburce Zannou, Association FrancoBéninoise de Lutte contre le Cancer, (Benin) Abstract No: 555

2. The views of oncology professionals regarding the Victorian Cancer Trials Link (VCTL), an online clinical trials portal Cat Parker, Cancer Council Victoria, (Australia) Abstract No: 550

10:00 - 10:30

3. Study: Decreasing cancer mortality rates in Serbia Ljiljana Stonic-Pejin, Economics Insitute, Belgrade, (Serbia and Montenegro) Abstract No: 551

1. Changes of tobacco use and cancer incidence: comparisons between different birth cohorts of men in Sweden Lars Ramström, Institute for Tobacco Studies, (Sweden) Abstract No: 557

4. Using the National Cancer Patient Experience Survey to drive improvements in staff and patient experience Jenny Ritchie-Campbell, Macmillan Cancer Support, (United Kingdom) Abstract No: 552 5. Integrated marketing/influencing campaign to improve support for hidden cancer carers Jenny Ritchie-Campbell, Macmillan Cancer Support, (United Kingdom) Abstract No: 553 6. Joining forces across a cancer NGO and cancer hospitals to the advantage of cancer patients Laila Walther, Danish Cancer Society, (Denmark) Abstract No: 554 202

ePoster Pod 3 - EP3.1 3.1 SCIENTIFIC STUDIES - SCREENING

2. Risk prediction models for melanoma: a systematic review Fiona Walter, University of Cambridge, (United Kingdom) Abstract No: 558 3. Evaluation of community based cervical screening in Ogun State, Nigeria Olumide Abiodun, Babcock University, (Nigeria) Abstract No: 559 4. Epidemiological characteristics of carcinoma of the cervix in Federal Teaching Hospital, Abakaliki, Nigeria Joseph Agboeze, Federal Teaching Hospital Abakaliki,Nigeria, (Nigeria) Abstract No: 560

5. Diagnostic value of rectal bleeding in predicting CRC in developing country – pilot study Olusegun Alatise, Obafemi Awolowo University, (Nigeria) Abstract No: 561

2. The association between body mass index (BMI), morphologic type and survival in patients with renal cell carcinoma (RCC) in Latvia Dace Baltina, Riga East University Hospital, (Latvia) Abstract No: 566

6. Variations in serum androgens and estradiol in prostate disorders in Calabar Gloria Archibong, Nigerian Cancer Society, (Australia) Abstract No: 562

3. Early versus late onset breast cancer in Pakistani women undergoing breast conservative therapy: Are the outcomes different? Abu Bakar Bhatti, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, (Pakistan) Abstract No: 567

7. Demographic variation of Cancer incidence in Jordan 2000 -2009 (age and sex as example) Kamal Arqoub, MOH, (Jordan) Abstract No: 563 8. An analysis of the relationship between cancer patients and their quality of life in Trinidad and Tobago Kimlim Ashing, City of Hope Medical Center, (United States) Abstract No: 564

10:00 - 10:30

ePoster Pod 4 - EP4.1 4.1 SCIENTIFIC STUDIES - SURVIVORSHIP 1. A population-based study of adverse physical effects following prostate cancer treatment: Results from the PiCTure (Prostate Cancer Treatment – your Experience) study Anna Gavin, Queen’s University Belfast, (United Kingdom) Abstract No: 565

4. The relationship between viral load measurements of HPV-16 and prognostic of cervical cancer Hongbing Cai, Zhongnan Hospital, Wuhan University, (China) Abstract No: 568 5. Attitudes to cancer follow-up care in general practice Margaret Crowley, TCRN, (Australia) Abstract No: 570 6. A cross-sectional study assessing the association of unmet supportive care needs and comorbidity among Indigenous cancer patients in Queensland, Australia Abbey Diaz, Menzies School of Health Research, (Australia) Abstract No: 571 7. Chinese women living with cervical cancer in the first three months following diagnosis: A qualitative study Yan Ding, Obstetrics and Gynecology Hospital, Fudan University, (China) Abstract No: 572 203

10:00 - 10:30

ePoster Pod 5 - EP5.1 5.1 SCIENTIFIC STUDIES - DIAGNOSIS 1. CIN2 regression for young patients who were conservatively managed Rhys Powell, Curtin University, (Australia) Abstract No: 574

2. Characteristics of Chronic Lymphocytic Leukemia (CLL) in Senegal. Clinical features, cytology, immunophenotype, cytogentic abnormalities and altered expression of microRNA Martine Raphaël, Alliance mondiale Contre le Cancer (AMCC), ALIAM, (France) Abstract No: 575 3. Telepathology in hematopathology : experience in francophone Africa Martine Raphaël, Alliance mondiale Contre le Cancer (AMCC), ALIAM, (France) Abstract No: 576 4. Treatment for older women with breast cancer – challenges and opportunities –an experience from Toronto Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada Ewa Szumacher, Sunnybrook Health Sciences Centre , University of Toronto, (Canada) Abstract No: 577 5. Breast and cervical cancer screening behaviors among University of Calabar women, Cross River State, Nigeria Chinyere Adanna Opara Usoro, Nigerian Cancer Society, (Nigeria) Abstract No: 578

204

6. Cancer epidemiology in low income country: A case study of Aden Cancer Registry, Yemen, 15 years period Amen Bawazir, College of Public Health and Health Informatics, (Saudi Arabia) Abstract No: 579 7. Contribution of DNA mismatch repair (MMR) defects and inflammation towards outcome from colorectal cancer in American Blacks John Carethers, University of Michigan, (United States) Abstract No: 580

10:00 - 10:30

ePoster Pod 6 - EP6.1 6.1 SCIENTIFIC STUDIES - PALLIATIVE CARE 1. Symptom clusters in cancer patients receiving palliative care Neşe Uysal, Gazi University, (Turkey) Abstract No: 581

2. “They see the place in a different way” Māori cancer patients, families, community and hospice views of hospice care Tania Slater, Massey University, (New Zealand) Abstract No: 582 3. Knowledge, attitudes and practices of oncology healthcare providers towards complementary and alternative medicine for cancer care in Qatar Ayman Allam, National Center for Cancer Care & Research, Hamad Medical Corporation, (Qatar) Abstract No: 583

4. Knowledge and attitudes of Chinese oncology nurses to palliative care Airong Lu, Cancer Hospital of Chinese Academy of Medical Sciencese, (China) Abstract No: 584 5. Prospective audit for pain control. Sanghamitra Bora, B.P.Poddar Hospital & Medical Research Ltd., (India) Abstract No: 585 6. Analysis of bacterial infections and antibiotic use in Chinese advanced cancer patients Menglei Chen, Fudan University Shanghai Cancer Center, (China) Abstract No: 586 7. Addressing the knowledge gap in palliative care among the Indigenous workforce: The role of the program of Experience in Palliative Approach (PEPA) Shaouli Shahid, Combined Universities Centre for Rural Health, (Australia) Abstract No: 587 8. Availability of palliative care services for children with cancer in Turkey Tezer Kutluk,Turkish Association for Cancer Research and Control (TACR), Turkey Abstract No: 588

12:00 - 13:15

ePoster Pod 1 - EP1.2 1.2 ADVOCACY & AWARENESS; SYSTEMS; SURVIVORSHIP 1. Cervical cancer awareness and prevention cervical cancer prevention: Educating young adults on the importance of cervical cancer awareness and the importance of HPV Vaccination S.Nair1 Early Prevention 1, HPV Vaccination2, National Cancer Society Malaysia (NCSM) 3, Malaysia4 Sangeetha Nair, National Cancer Society Malaysia, (Malaysia) Abstract No: 589

2. Role of private enterprise in cancer control in Low to Middle Income Countries Chukwumere Nwogu, Roswell Park Cancer Institute, (United States) Abstract No: 590 3. Shifting U.S. global health policy to provide international development assistance for cancer control in low- and middle-income countries Loyce Pace, LIVESTRONG Foundation, (United States) Abstract No: 591 4. An exploration of the relationship between funding and patient accrual to oncology clinical trials: Additional Funding Intervention Trial (AFIT) Cat Parker, Cancer Council Victoria, (Australia) Abstract No: 592

205

5. Challenges in times of austerity Nicolas Philippou, The Cyprus Association of Cancer Patients and Friends (PASYKAF), (Cyprus) Abstract No: 593

11. Enhancing cancer control in primary health care: A system response Megan Varlow, Cancer Institute NSW, (Australia) Abstract 599

6. The Experience of Gharbiah Population-Based Cancer Registry (GPBCR) in Egypt Mohamed Ramadan, Gharbia Cancer Society, (Egypt) Abstract No: 594

12. Adherence to surveillance guidelines for early breast cancer in Croatia Damir Vrbanec, University Hospital Zagreb, (Croatia) Abstract No: 600

7. Challenges to attend patients with gynecologic cancer after the implantation of the Regulatory System at the Cancer Hospital II, National Cancer Institute, Brazil Marcos Renni, Hospital of Cancer II/INCa, (Brazil) Abstract No: 595

13. Developing a service capability framework: a guide for health services providing care to children and adolescents with cancer Jane Williamson, Paediatric Integrated Cancer Service, (Australia) Abstract No: 601

8. Sustainable cancer care in Africa: present status of policies and funding? Daniela Cristina Stefan, Stellenbosch University/Tygerberg Hospital, (South Africa) Abstract No: 596 9. Building a pan-regional network to foster best practice exchange and a bottom-up approach to advocating quality measures in cancer care Julie Torode, UICC, (Switzerland), UICC, (Switzerland) Abstract No: 597 10. Strategies for indepth involvement of national accrediatialing programs in cancer care the Turkish experience Nazim Serdar Turhal, Marmara University, (Turkey) Abstract No: 598

206

14. Structuring cancer research in Morocco Ahmed ZIDOUH, Lalla Salma Foundation, (Morocco) Abstract No: 602 15. Working through cancer programme Jenny Ritchie-Campbell, Macmillan Cancer Support, (United Kingdom) Abstract No: 604 16. MaxSmiles: Blood cancer and rare cancer patient support group Wirat Sae-Kuai, The Max Foundation, (Thailand) Abstract No: 605

12:00 - 13:15

ePoster Pod 2 - EP2.2 2.2 ADVOCACY & AWARENESS - SURVIVORSHIP 1. Patient empowerment workshop Bertha Aguilar, president, (Mexico) Abstract No: 607

2. Psycho-education intervention for Saudi breast cancer survivors to improve quality of life Haifa Alshamsi, ZAHRA Breast Cancer Organization, (Saudi Arabia) Abstract No: 608

6. The Knowledge in the Room: evidencegathering and partnership-building through community sharing circles to address concerns about cancer in First Nation (aboriginal) communities in the Northwest Territories, Canada Sabrina Broadhead, Government of the Northwest Territories, (Canada) Abstract No: 612 7. Developing a rehabilitation framework for cancer survivorship Trish Calder, Epworth Healthcare, (Australia) Abstract No: 613

3. Involving carers, partners and family members in health programs for cancer survivors Gabrielle Asprey, Cancer Council NSW, (Australia) Abstract No: 609

8. The Establishment of PCFA Affiliated Gay/ Bi-sexual Prostate Cancer Support Groups in Australia Marie-Claire Cheron-Sauer, Prostate Cancer Foundation of Australia, (Australia) Abstract No: 614

4. Improving cancer care in Uganda through the development of a national palliative care policy Zipporah Ali, African Palliative Care Association, (Uganda) Abstract No: 610

9. HAMAARI PATHSHALA – A Platform for informal education for children under treatment Amishi Choksi, V Care Foundation, (India) Abstract No: 615

5. Piloting an education program for cancer survivors, their friends and family: lessons learned Anna Boltong, Cancer Council Victoria, (Australia) Abstract No: 611

10. +Cancer Care Package Program- Delivering free requested products right to the doorstep for cancer patients across The United States Jula Connatser, American Association for Cancer Support, Inc., (United States) Abstract No: 616 11. The Healthy Living after Cancer Partnership Project Elizabeth Eakin, The University of Queensland, (Australia) Abstract No: 617

207

12. Using photovoice to collect feedback about challenges of sexuality in advanced breast cancer patients in South Africa Lynn Edwards, PLWC, (South Africa) Abstract No: 618

12:00 - 13:15

13. Support group leader training: development and implementation Evan Kallipolitis, Prostate Cancer Foundation of Australia, (Australia) Abstract No: 619

1. Partnering for success: Lessons from breast and cervical cancer screening in rural Honduras Suyapa Bejarano, Liga Contra el Cancer Honduras, (Honduras) Abstract No: 625

14. Online cancer forum usersâ&#x20AC;&#x2122; voice in France: Insights for services reorientation towards cancer-related community capacity building Marc Keller, French League Against Cancer, (France) Abstract No: 620 15. The Roles of data systems in developing a robust evidence base along the cancer journey David Roder, University of South Australia, (Australia) Abstract No: 621 16. A model for improving breast cancer care through the HOPE Peer-Nurse Navigation in Ghana Beatrice Addai, Breast Care International, (Ghana) Abstract No: 622 17. Establishing paediatric long term follow-up transition clinics in the tertiary adult health care sector Jane Williamson, Paediatric Integrated Cancer Service, (Australia) Abstract No: 623

208

ePoster Pod 3 - EP3.2 3.2 ADVOCACY & AWARENESS - SCREENING

2. Cervical cancer secondary prevention: POC STI Screening AND Treatment on the ZDFMS Integrated Mobile HCT/Cervical Cancer screening program Paul Chilwesa, Defense Forces Medical Services, (Zambia) Abstract No: 626 3. Pink Caravan national breast cancer screening and awareness campaign 2011 - 2014, United Arab Emirates, an initiative by Friends of Cancer Patients Sawsan Al Madhi, Friends of Cancer Patinets Society UAE, (United Arab Emirates) Abstract No: 627 4. The role of mHealth in cancer care: Designing with the user in mind Jay Evans, Medic Mobile, (United States) Abstract No: 628 5. Using cancer registry data to evaluate Israeli national screening programs for breast and colorectal cancer Lital Keinan-Boker, Ministry of Health, (Israel) Abstract No: 629

6. Screening of rural female population for breast cancer by mobile mammography unit of Nimra, Jamshoro Pakistan Naeem Ahmed Laghari, Pakistan Atomic Energy Commission (PAEC), (Pakistan) Abstract No: 630

12. A single community-wide, low-literacy and culturally appropriate education resource – is it possible? Kathleen O’Connor, WA Department of Health, (Australia) Abstract No: 636

7. Optimising the expansion of the National Bowel Cancer Screening Program – Influencing the national policy agenda Melissa Ledger, Cancer Council Western Australia, (Australia) Abstract No: 631

13. The potential for early diagnosis of oral cancer by oral health professionals in limited resource settings Ravikiran Ongole, Manipal College of Dental Sciences, Mangalore, Manipal University, (India) Abstract No: 637

8. Sisters Hand in Hand: A community outreach project targeting rural African American women Tonya Linthacum, SSM Audrain Medical Center, (United States) Abstract No: 632

14. Breast cancer awareness survey in Lagos mainland local government area of Lagos State, Nigeria Omolola Salako, Sebeccly Cancer Care and Support Center, (Nigeria) Abstract No: 638

9. Tobacco free Bangladesh: A dream need to become reality Sheikh Mostofa, National Institute of Cancer Research & Hospital, Dhaka, Bangladesh., (Bangladesh) Abstract No: 633

15. Bowel Cancer Screening Programme: The impact of local education sessions by health care professionals in South London, United Kingdom Cheh Kuan Tai, NHS UK, (United Kingdom) Abstract No: 639

10. Evaluation of see and treat program implementation in East Java Province, Indonesia three years experience Sjahjenny Mustokoweni, Airlangga University, (Indonesia) Abstract No: 634

16. Train elementary school student as the “Health Promotion Messanger” - An innovative approach for diet education Jane Tsai, Formosa Cancer Foundation Abstract No: 640

11. Advancing multidisciplinary care and collaboration through the establishment of a dysphagia service at the Kuwait Cancer Control Center (KCCC) Veronica Nickerson, Princess Margaret Cancer Centre, (Canada) Abstract No: 635

17. Unproven breast imaging and the law: A win Emma Croager, Cancer Council WA, (Australia) Abstract No: 641

209

12:00 - 13:15

ePoster Pod 4 - EP4.2 4.2 SCIENTIFIC STUDIES - DIAGNOSIS 1. How patients with cholangiocarcinoma experiences attendance at the specialised gastroenterology or oncology unit, and the transition between these specialities: A qualitative interview study Kristine Dengsoe, Rigshospitalet, (Denmark) Abstract No: 643

2. Providing coordinated cancer care: Who should we be targeting? Ivana Durcinoska, University of Sydney, Surgical Outcomes Research Centre (SOuRCe), (Australia) Abstract No: 644 3. Clinicopathological features of gastric cancer in Ibadan, 2000-2011 Henry Elibi, Olabisi Onabanjo University/ Olabisi Onabanjo University Teaching Hospital, (Nigeria) Abstract No: 645 4. Immunoexpression of K-RAS, p53, PTEN, and MLH1 genes among Saudi patients with colorectal cancer Abdelbaset Elasbali, University of Hail, (Saudi Arabia) Abstract No: 646 5. Routes to Diagnosis, a novel English methodology Lucy Elliss-Brookes, Public Health England, (United Kingdom) Abstract No: 647

210

6. Variation in cancer incidence (1996-2010) and mortality (1997-2011) by deprivation quintile, in England Lucy Elliss-Brookes, Public Health England, (United Kingdom) Abstract No: 648 7. Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal and gall bladder carcinomas Rajesh K. Grover, Delhi State Cancer Institute, (India) Abstract No: 649 8. Cyclin D1 and p53 in urinary bladder carcinoma and precursor epithelial lesions Vinita Agrawal, SGPGIMS, (India) Abstract No: 650 9. Challenges in treating solid tumors in low income countries: Children Hospital Lahore Pakistan experience Alia Ahmad, The Children’s Hospital Lahore, (Pakistan) Abstract No: 651 10. Incidence of K-RAS mutation in metastatic colorectal carcinoma and further to find any associated correlation between K-RAS mutation and various demographic and clinical factors. A Hospital based study Altaf Ali, Hospital, (India) Abstract No: 652 11. Histological pattern of malignant colon tumors in Almadinah Almnoura, KSA Ibraheem Ashankyty, University of Hail, (Saudi Arabia) Abstract No: 653

12. The association of HR-HPV and EGFR, p53 and CD5 Markers in Head and Neck cancer Ibraheem Ashankyty, University of Hail, (Saudi Arabia) Abstract No: 654 13. Sensitivity of APTIMA E6/E7 mRNA test in detection of Cervical Cancer& its Concordance with Hybrid Capture 2 HPV DNA test Dipanwita Banerjee, Chittaranjan National Cancer Institute, (India) Abstract No: 655 14. Curative radiotherapy timeline milestones in management of gynaecological cancer at the Alan Walker Cancer Care Centre, Darwin: Effective multi-disciplinary care in remote Australia Ryan Coad, Genesis Cancer Care WA, (Australia) Abstract No: 656 15. Improving access to psychological services for people with cancer: A randomised controlled trial of an interactive web-based intervention Kate Blackler, Cancer Council Queensland, (Australia) Abstract No: 657 16. Clinical significance of serum HMGB1 test in esophageal squamous cell carcinoma Chuangui Chen, Chinese Anti-Cancer Association, (China) Abstract No: 658 17. Routes to Diagnosis: Does it matter when or how a cancer is diagnosed? Lucy Elliss-Brookes, Public Health England, (United Kingdom) Abstract No: 659

18. Metabolic syndrome in Korean adult cancer survivors, family members and non-cancer subjects Jinyoung Shin, Samsung Medical Center, Seoul, (South Korea) Abstract No: 660

12:00 - 13:15

ePoster Pod 5 - EP5.2 5.2 SCIENTIFIC STUDIES - PREVENTION 1. Constructing and pretesting a questionnaire to assess the treatment of smokers in Brazilian public health care facilities Leticia Casado, National Cancer Institute from Brazil, (Brazil) Abstract No: 661

2. Nicotinamide for skin cancer chemoprevention in renal transplant recipients Andrew Chen, Royal Prince Alfred Hospital, (Australia) Abstract No: 662 3. Implementing QCancer into general practitioner (GP) consultations: exploratory study using simulated consultations with Australian GPs Peggy Chiang, University of Melbourne, (Australia) Abstract No: 663 4. Underlying themes in habitual sun-related behaviours in adolescents and the role of appearance-based motivations Nadia Corsini, Cancer Council SA (Australia) Abstract No: 664 211

5. Monitoring approval of new legislation banning smoking in children’s playgrounds and public transport stops in South Australia Joanne Dono, SAHMRI, (Australia) Abstract No: 665 6. Public campaign against waterpipe / Hookah Smoking in Turkey Tuba Durgut, Turkish Green Crescent, (Turkey) Abstract No: 666 7. Oral epithelium atypia associated with cigarette smoking among medical students in KSA Abdelbaset Elasbali, University of Hail, (Saudi Arabia) Abstract No: 667 8. Effects of peer education on the knowledge of breast cancer and practice of breast selfexamination among Mansoura University Female Students, Egypt Karima Elshamy, Faculty of Nursing, Mansoura University, Egypt, (Egypt) Abstract No: 668 9. Effect of breast cancer and early detection measures ‘awareness program on women’ knowledge, attitude and practicing breast self examination at Talkha cement factory, Egypt Karima Elshamy, Faculty of Nursing, Mansoura University, Egypt, (Egypt) Abstract No: 669 10. Associations between risk attributes, “Control” and “Dread”, with perceptions of importance of cancer risk factors Kerry Ettridge, SAHMRI, (Australia) Abstract No:670

212

11. Good or bad? Children’s social representations of smokers through a photovoice project in Petrópolis, Rio de Janeiro, Brazil Rodrigo Feijo, National Cancer Institute of Brazil, (Brazil) Abstract No: 671 12. Rising cancer incidence and reductions in mortality in Australia from 1987-2007 Eleonora Feletto, Cancer Council NSW, (Australia) Abstract No:672 13. Should threat messages be avoided for Aboriginal Australian smokers? Findings from a cross-sectional survey in regional NSW to validate the Risk Behaviour Diagnosis scales Gillian Gould, James Cook University, (Australia) Abstract No:673 14. Smoking before first childbirth and risk of breast cancer risk is independent from alcohol use and does not seem to differ across ethnic groups: The Multiethnic Cohort study Inger Gram, UiT the Arctic University of Norway, (Norway) Abstract No:674 15. Alcohol: a population study of predictors of consumption and awareness of the link with cancer Jacqueline Bowden, South Australian Health and Medical Research Institute, (Australia) Abstract No: 675 16. Community mental health services and smoking cessation care: an unrealised potential Jenny Bowman, University of Newcastle, (Australia) Abstract No: 676

17. Anti tobacco campaigns in India and its impact on adolescents and young adults -A population based study Nidhin Raj, Madras Medical College,Chennai, (India) Abstract No: 677 18. Global Adult Tobacco Survey (GATS) data as a tool to improve smoking cessation strategies in Brazil Andre Szklo, Brazilian National Cancer Institute, (Brazil) Abstract No: 678

12:00 - 13:15

ePoster Pod 6 - EP6.2 6.2 FUNDRAISING REPORTS 1. Betel-nut chewing a time bomb for oral cancer in Papua New Guinea Rose Andrew, PNG Cancer Centre, National Department of Health, (Papua New Guinea) Abstract No: 679

2. Together we can beat cancer! A community engagement strategy to drive emotional connection with Cancer Council and our mission Karen Armstrong, Cancer Council Australia, (Australia) Abstract No: 680 3. Purpose driven fundraising Lee Cooper, Cancer Council NSW, (Australia) Abstract No: 681

4. Breast cancer organized screening program in Rio de Janeiro, Brazil Sandra Gioia, Andarai Federal Hospital, (Brazil) Abstract No: 682 5. Fundraising report Ken Phinéas Tchiteya, Fondation Calissa Ikama, (Congo) Abstract No: 683 6. The billion dollar challenge Christine Lasky, The Princess Margaret Cancer Foundation, (Canada) Abstract No: 684 7. Raising research money through an innovative event - Ride to conquer cancer Christine Lasky, The Princess Margaret Cancer Foundation, (Canada) Abstract No: 685 8. Road hockey to conquer cancer - A unique team fundraising program appealing to a distinct new segment Christine Lasky, The Princess Margaret Cancer Foundation, (Canada) Abstract No: 686 9. Joe’s Team - An innovative triathlon/duathlon sprint event to raise money for head and neck cancer research Christine Lasky, The Princess Margaret Cancer Foundation, (Canada) Abstract No: 687 10. A pilot study of out of pocket expenditure in treating children with cancer in Indian government hospitals Alexandra Martiniuk, University of Sydney, University of Toronto, and the George Institute for Global Health, (Australia) Abstract No: 688 213

11. Fundraising strategy for cancer control in Nigeria Benjamin Ogbalor, Partnership for Eradication of Cancer in Africa, (Nigeria) Abstract No: 689

15:30 - 16:00

12. Fundraising strategies for cancer (NGOS) Anita Peter, Cancer Patients Aid Association, (India) Abstract No: 690

1. Lobby Day Project: Breast cancer survivors take action in the Brazilian National Congress Maira Caleffi, FEMAMA - Brazilian Federation of Philanthropic Breast Health Institutions, (Brazil) Abstract No: 695

13. With supporter numbers declining, how Cancer Council Queensland took the F2F step Karen Shields, Cancer Council Queensland, (Australia) Abstract No: 691 14. Insights driven product development - Daffodil Day Alan Sicolo, Cancer Council SA, (Australia) Abstract No: 692 15. Web site and donations – success through serving peoples needs Eric Vigander, Norwegian Cancer Society, (Norway) Abstract No: 693

ePoster Pod 1 - EP1.3 1.3 ADVOCACY & AWARENESS; DIAGNOSIS

2. Joining Forces to overcome cancer: the kenya cancer research and control stakeholder meeting experience Kalina Duncan, National Cancer Institute, (United States) Abstract No: 696 3. The development of a communal tumour board in South West Nigeria Suleiman Giwa, Lagos State University Teaching Hospital, Ikeja, (Nigeria) Abstract No: 697 4. Educational resources of the National society of pediatric hematologists and oncologists for improvement of early diagnosing of pediatric oncological diseases Kirill Kirgizov, Dmitriy Rogachev Federal Research Centre of Pediatric Hematology, Oncology and Immunology, (Russia) Abstract No: 698 5. Cancer crusades: student-inspired, studentdirected Ritu Lakhtakia, College of Medicine & Health Sciences Sultan Qaboos University, (Oman) Abstract No: 699

214

6. Electronic cancer referral for family doctors (GPs) Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 700 7. What drives the cost of cancer treatment? Insights from an analysis of a longitudinal cohort (Cancer 2015) linked to administrative reimbursement data Paula Lorgelly, Monash University, (Australia) Abstract No: 701

15:30 - 16:00

ePoster Pod 2 - EP2.3 2.3 ADVOCACY & AWARENESS - PALLIATIVE CARE 1. Development of palliative care in Kazakhstan Gulnara Kunirova, Together Against Cancer, (Kazakhstan) Abstract No: 703

2. Motivational interviewing and cognitive behavioral therapies. New roads to the final destinations Joel Marcus, Ochsner Cancer Institute, (United States) Abstract No: 704

4. Building a network of pediatric palliative care in Thailand through cancer children’s activity and education Issarang Nuchprayoon, Wishing well foundation, (Thailand) Abstract No: 706 5. The role of a physician in palliative care of cancer patients admitted in a western Kenya county hospital Sarah Obuya, Moi Teaching &Referral Hospital, (Kenya) Abstract No: 707 6. Management of children with end stage disease in a burkkitt lymphoma treatment program in Western Kenya Pamela Were, Moi Teaching & Referral Hospital, (Kenya) Abstract No: 708 7. Recognition of palliative care as a nursing specialty in Israel: A big step forward Aliza Yaffe, Israeli Association of Palliative Care, (Israel) Abstract No: 709 8. Determining the symptoms of the patients with head and neck cancers receiving radiotherapy Sevinç Kutlutürkan, Gazi University, (Turkey) Abstract No: 710

3. Illness trajectories: evidence for improving palliative care in Botswana Esther Ntsayagae, University of Botswana, (Botswana) Abstract No: 705

215

15:30 - 16:00

ePoster Pod 3 - EP3.3 3.3 SCIENTIFIC STUDIES - SYSTEMS; PREVENTION

6. Developing standards tool and evaluation of population based cancer registry in Iran Kazem Zendehdel, Cancer Institute of Iran, (Iran) Abstract No: 716

1. An investigation of quality of life in patients with gastric cancer after total gastrectomy Huiying Wang, Department of Gastrointestinal Oncological Surgery, (China) Abstract No: 711

7. Cancer care nurses’ competencies in Malaysia: The work environment Nor Aida Maskor, Universiti Putra Malaysia, (Malaysia) Abstract No: 717

2. Association between ambient concentrations of fine particulate matter and the incidence and mortality of cancer XiaoJian Qin, Fudan University Shanghai Cancer Center, (China) Abstract No: 712

8. The National Cancer Registry of Uruguay: a model for sustainable cancer registration in LATIN-AMERICA Maria Munoz, Comisión Honoraria de Lucha contra el Cáncer, (Uruguay) Abstract No: 718

3. The potential to use an existing criterion to underpin food marketing to children regulation in Australia Wendy Watson, Cancer Council NSW, (Australia) Abstract No: 713 4. Can front-of-pack labelling schemes guide healthier food choices? Consumer research into shoppers’ responses Wendy Watson, Cancer Council NSW, (Australia) Abstract No: 714 5. Advanced stage presentation of cancer in Eastern India- how is the alternative medicine responsible? Soma Mukhopadhyay, Netaji Subhas Chandra Bose Cancer Research Institute, (India) Abstract No: 715

216

15:30 - 16:00

ePoster Pod 4 - EP4.3 4.3 SCIENTIFIC STUDIES - PREVENTION 1. Barriers to follow-up of abnormal Pap smears among female sex workers in Lima, Peru Devora Aharon, Icahn School of Medicine at Mount Sinai, (United States) Abstract No: 719

2. Role of sustainable cancer awareness programs in decreasing morbidity and mortality with cancer: A Sudanese experience Hussain Ahmed, Universityof Hail, Sudanese Cancer Foundation, (Saudi Arabia) Abstract No: 720

3. Burden of oral cancer in Sudan and the possible risk factors Hussain Ahmed, Universityof Hail, Sudanese Cancer Foundation, (Saudi Arabia) Abstract No: 721

15:30 - 16:00

4. Breast cancer knowledge, perception and screening practices among Yemeni women: An application of the health belief model Khaled Al-Sakkaf, Aden Cancer Registry and Research Center, Faculty of Medicine and Health Sciences, Aden University, (Yemen) Abstract No: 722

1. C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation Ewa Kurzejamska, Karolinska Institute, (Sweden) Abstract No: 727

5. Frequency of locally advanced breast cancer and its determinant factors in North Pakistan Muhammad Aleem Khan, Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), Islamabad, Pakistan, (Pakistan) Abstract No: 723

2. UK cancer survivorship: What the data tells us about the number of children, teenagers and young adults living with and beyond cancer Elizabeth Jane Maher, Macmillan Cancer Support, (United Kingdom) Abstract No: 728

6. Knowledge of breast cancer among newly diagnosed female clients at Komfo Anokye Teaching Hospital, Kumasi, Ghana Comfort Asoogo, Komfo Anokye Teaching Hospital, (Ghana) Abstract No:724

3. Psychological distress among caregivers of longterm survivors of primary malignant glioma – a mixed methods study Jennifer Philip, St Vincent’s Hospital, (Australia) Abstract No: 729

7. The provision of smoking cessation care for people with mental illness: Expectations and experiences of ‘carers’ Jacqueline Bailey, University of Newcastle, Australia, (Australia) Abstract No:726

ePoster Pod 5 - EP5.3 5.3 SCIENTIFIC STUDIES - SURVIVORSHIP

4. Modifying body image related affect and cognitions in breast cancer survivors using a self-compassion based writing activity Astrid Przezdziecki, Liverpool Cancer Therapy Centre, (Australia) Abstract No: 730 5. Living well after breast cancer: Feasibility, acceptability and efficacy of a weight loss intervention for women following breast cancer treatment Marina Reeves, Cancer Prevention Research Centre, SPH, University of Queensland, (Australia) Abstract No: 731 217

6. Attitude and insight of husbands of mastectomized patients in a resource limited setting Rakesh Roy, Saroj Gupta Cancer Centre & Research Institute, (India) Abstract No: 732 7. Making sense and moving on: Understanding the impact of cancer on the life narratives and adjustment of adolescent and young adult cancer survivors, compared to healthy controls Ursula Sansom-Daly, University of New South Wales, (Australia) Abstract No: 733 8. Lets talk about sex baby: Exploring the barriers and facilitators to effective sexual communication in male cancer survivors and strategies to improve psychosexual Interventions Zac Seidler, University of Sydney, (Australia) Abstract No: 734

15:30 - 16:00

ePoster Pod 6 - EP6.3 6.3 SCIENTIFIC STUDIES - TREATMENT 1. Ginger as an adjuvant for chemotherapyinduced nausea and vomiting: where does the evidence stand? Wolfgang Marx, Bond University, (Australia) Abstract No: 735 2. Awareness about breast-self examination and behavioral-related risk factors for breast cancer among young Colombian women: A cross-sectional analysis Jose Meneses- Echavez, Universidad Santo Tomás, (Colombia) Abstract No: 736 218

3. A single institution experience of 701 Juvenile Nasopharyngeal Angiofibromas (JNA): Changing epidemiology in past 6 decades and Clinical/ Molecular behaviour in Indian population Anupam Mishra, CSMMU (KGMC), (India) Abstract No: 737 4. Hopes and hypes with image based brachytherapy: An Indian experience with 53 patients. Can it be the standard yet? Swarupa Mitra, Rajiv gandhi Cancer institute and Research centre. Delhi India, (India) Abstract No: 738 5. Analysis of surgical treatment for 72 patients with brain metastases Yonggao Mou, Chinese Anti Cancer Association, (China) Abstract No: 739 6. High incidence of gall bladder cancer in Gangetic West Bengal: A study from a hospital based cancer registry Ashis Mukhopadhyay, Netaji Subhas Chandra Bose Cancer Research Institute, (India) Abstract No: 740 7. Utilisation of cotesting (human papillomavirus DNA and cervical cytology) after treatment of CIN: A survey of GPs awareness and knowledge Aime Munro, Women’s Health Clinical Care Unit, (Australia) Abstract No: 741 8. Metaplastic carcinoma of breast: The Basilisk among breast cancer Shravan Nadkarni, Sawai Mansingh Medical College and Hospitals, Jaipur, (India) Abstract No: 742

DAY 2

FRIDAY 5TH DECEMBER

219

DAY 2

FRIDAY 5TH DECEMBER

7:00 - 7:45 Meeting point Registration desk

Meeting point at 7 am in front of theÂ Registration desk Instructor:Â Alena Matzke Register at the General Enquiries counter, at the Registration desk, in front of the Global Village, on level 2.

220

7:00 - 8:00 Room 214

TRACK 4

APPLYING BEST PRACTICE GLOBAL CANCER CONTROL STRATEGIES IN TURKEY: RESPONSIBILITIES OF DIFFERENT ORGANIZATIONS Chaired by: M. Tezer Kutluk, Turkish Association for Cancer Research & Control (Turkey), Suayib Yalcin, Turkish Association for Cancer Research & Control (Turkey) 1. National Cancer Control plan: future applications Murat Gültekin, Turkish Ministry of Health, Department of Cancer Control (Turkey) 2. Medical Oncologist perspectives on cancer control Pınar Saip & Faruk Aykan, İstanbul University Institute of Oncology & Turkish Medical Oncology Society (Turkey)

Workshop

3. Radiation Oncologist perspectives on cancer control Ferah Yıldız & Yavuz Anacak, Hacettepe University Cancer Institute Department of Radiation Oncology & Ege University Faculty of Medicine Department of Radiation Oncology & Turkish Radiation Oncology Society (Turkey) 4. The role of academic organizations on cancer control Ahmet Demirkazık & Serdar Turhal, Ankara University Medical School, Department of Medical Oncology & Anadolu Medical Center, Department of Medical Oncology (Turkey) 5. Lessons learnt from Urooncology societies’ experience Bülent Akdoğan & Talha Müezzinoğlu, Turkish Urooncology Society (Turkey) 6. Palliative care for cancer patients: are we on the right direction? Özgür Özyılkan & Sadık Muallaoğlu, Çukurova University Medical School Department of Medical Oncology (Turkey) 7. Nursing Care and the role of oncology nurses in cancer control Sevgisun Kapucu & Sevinç Kutlutürkan, Oncology Nursing Society (Turkey) 8. Measurement & evaluation of programmes Mutlu Hayran & Mustafa Erman , Hacettepe University Cancer Institute Department of Preventive Oncology (Turkey) 9. Group Discussion All participants

Workshop organised by: Turkish Association for Cancer Research Control (TACRC), Turkey

221

07:00 - 08:00 Room 102 Breakfast

THANK-YOU FOR DIVESTING Chaired by: Bronwyn King, Free Investment Initiative (Australia) This breakfast session will showcase the world leading decision of many of Australiaâ&#x20AC;&#x2122;s largest superannuation funds, in implementing completely tobaccofree investment mandates. Since 2011, seventeen funds have divested a total of more than $1.2 billion of tobacco stocks. The Tobacco-Free Investment Initiative is working towards creating a tobacco-free investment universe.

This event will be by invitation only

8:30 - 10:00 Plenary #2

PLENARY DAY 2 - NATIONAL AND INTERNATIONAL APPROACHES Chaired by: Heather Bryant, Canadian Partnership Against Cancer (Canada)

Mr Stephen Lewis' keynote address is supported by

1. International initiatives in global health challenges: First HIV, then cancer/NCDâ&#x20AC;&#x2122;s Stephen Lewis, AIDS-Free World (Canada) 2. How researchers, clinicians and advocates can help governments make effective policy Nicola Roxon, Former Australian Minister of Health (Australia)

Session proposed by: Union for International Cancer Control (UICC), Switzerland Plenary PL.0.2

222

SAVE THE DATE 13 –16 APRIL 2016 BRISBANE, AUSTRALIA

APOCP8

8th General Assembly and International Conference of the Asian Pacific Organisation for Cancer Prevention Foundations of Cancer Control in the Asian Pacific: • Research • Program Development • Practical Interventions APOCP8 will be an exciting international meeting, providing a platform for building networks, sharing knowledge and information, and an opportunity to meaningfully contribute to the future direction and priorities of cancer control in the Asia-Pacific region. Program topics will include: • Regional priorities • Cancer registration • Epidemiology • Prevention • Screening • Survivorship • Molecular diagnostics

We look forward to welcoming you to Brisbane, Australia in April 2016! Visit www.apocp8.org for further details.

10:00 - 10:15 Foyer/Global Village

10:15 - 11:15 Room 209

MORNING NETWORKING BREAK

AMERICAN CANCER SOCIETY - PRESS CONFERENCE Join us for a press conference to launch the all-new Cancer Atlas, Second Edition. A vital tool for the cancer community, this compelling volume aims to increase knowledge, provide a reliable basis for evidence-based decision making, and inspire united action and partnerships against the cancer epidemic. Â Since the publication of the first Cancer Atlas in 2006, the cancer epidemic has shifted. Developing countries are showing increases in diagnosed breast and lung cancers while deaths due to some cancers are decreasing; new treatments and other interventions such as HPV vaccines have been brought to bear; tobacco use has accelerated globally; some governments are facing the cancer epidemic head-on while others are unable to do so. In 2014, continuing and escalating the global fight against cancer will demand new tools and the latest information. The Cancer Atlas illustrates the latest available data and trends on the cancer epidemic, showing the prevalence of major risk factors, stages of development, and rates of different types of cancers by gender, income group, and region. Accessible for the layman but detailed enough for the expert, it examines the costs of the disease, both in terms of health care and commercial interests, and highlights the steps being taken to curb the epidemic, from research and screening to cancer control programs and health education. Full-color graphics present fully sourced data in a clear, accessible format.

224

What’s Your Story?

The Power of Storytelling and Entertainment Education to Achieve Public Health Objectives A Sub-plenary session on Entertainment Education Whether your focus is presenting data, advocating policy or promoting health guidelines and recommendations, the art and science of storytelling can enhance the effectiveness of your communication. Featuring an international panel of writers/producers/filmmakers from Hollywood, Bollywood and Australia, the session will demonstrate the power of entertainment education in successfully raising awareness and affecting behavior change for health related topics. Joining them are Entertainment Education experts from the University of Southern California, Annenberg School, Hollywood Health & Society; and the Centers for Disease Control and Prevention. Panellists will speak about their own writing experiences, showcase best practice TV and film examples and discuss the creative process as it relates to health messages in their stories as well as the public health and audience impact stemming from these collaborations. Moderator Dr Mona Saraiya, Associate Director, International Cancer in the CDC Division of Cancer (United States) Speakers Kate Bradley Associate Script Producer / Writer / Editor for Australian television drama series’ including ‘Home and Away’ and ‘Neighbours’ (Australia) Jennifer Cecil Former Executive Producer for Hollywood television drama series’ including ‘Private Practice’ and ‘Hostages’ (United States) Chris Dzialo Program Administrator, Hollywood Health & Society (United States) Image: © Frederick Dennstedt ShareAlike 2.0 Generic (CC BY-SA 2.0)

Kate Folb Director, Hollywood Health & Society (United States) Vinta Nanda Producer / Writer / Director for Bollywood film and television including ‘White Noise’ and ‘Tara’ (India) Demetrius M. Parker Entertainment Education and Health Marketing Strategist, Centers for Disease Control and Prevention (United States)

Friday 5th December 2014 | 10:15 - 11:15 | Level 2, Room 203-205

10:15 - 11:15 Room 203-204

TRACK 1

WHAT’S YOUR STORY? THE POWER OF STORYTELLING AND ENTERTAINMENT EDUCATION TO ACHIEVE PUBLIC HEALTH OBJECTIVES Chaired by: Mona Saraiya, Centers for Disease Control and Prevention (CDC) (United States) 1. Overview of the elements of effective storytelling: The importance of crafting effective stories to best communicate key health Kate Folb, Hollywood, Health and Society (United States) 2. The Components of the narrative writing process: The tools and techniques for creating a compelling story Chris Dzialo, Hollywood, Health and Society (United States)

Sub-Plenary SBP.1.103

3. Entertainment education: An overview on how the art and science of storytelling can enhance the effectiveness of your communications Demetrius Parker, Centers for Disease Control and Prevention (CDC) (United States) 4. Entertainment education in Australia: Insights and case studies Kate Bradley, Associate Script Producer / Writer / Editor for Australian television drama series’ including ‘Home and Away’ and ‘Neighbours’ (Australia) 5. Entertainment Education in Hollywood: Insights and case studies Jennifer Cecil, Executive Producer for Hollywood television drama series’ including ‘Private Practice’ and ‘Hostages’ (United States) 6. Entertainment Education in Bollywood: Insights and case studies Vinta Nanda, Producer / Writer / Director for Bollywood film and television including ‘White Noise’ and ‘Tara’ (India)

Session proposed by: Centers for Disease Control and Prevention (CDC); Hollywood, Health Society and supported by Livestrong Foundation, United States

226

10:15 - 11:15 Room 210-211

TRACK 2

Sub-Plenary SBP.2.253

10:15 - 11:15 Room 219-220

TRACK 3

Sub-Plenary SBP.3.187

THE ETHICS OF CLINICAL RESEARCH: DO THEY DIFFER BETWEEN HIGH-, MIDDLE-, AND LOW-INCOME COUNTRIES? Chaired by: Isaac Adewole, African Organisation for Research & Training in Cancer (AORTIC) (South Africa) Edward Trimble, National Cancer Institute - USA (United States)

Session proposed by: Session proposed by National Cancer Institute USA, United States

WHAT IS THE NEXT? EMPOWERING CANCER SURVIVORS AND FAMILIES FOR IMPROVED MEDICAL FOLLOW-UP AND SELF CARE Chaired by: Amy Zhang, Case Western Reserve University (United States) Kimlin Tam Ashing, City of Hope National Medical Center (United States) 1. Implementation Science for Survivorship Care: From Institute to Community Application Kimlin Ashing, City of Hope National Medical Center (United States) 2. Utilisation of online self-management resources and guideline Rebecca Cowens-Alvarado, The George Washington University Cancer Institute (United States) 3. A patient-centered approach to persistent urinary incontinence in prostate cancer patients Amy Zhang, Case Western Reserve University (United States) 4. Incorporating a self-management approach to cancer survivorship, lessons from chronic disease management and their application in the Australian setting Malcolm Battersby, Flinders University (Australia)

Session proposed by: Case Western Reserve University, United States

227

10:15 - 11:15 Room 212-213 TRACK 4

BEHIND THE SCENES OF THE NCD GLOBAL HEALTH AND DEVELOPMENT DEBATE Chaired by: Cary Adams, Union for International Cancer Control (UICC) (Switzerland) Discussion panel George Alleyne, Pan American Health Organization/World Health Organization (PAHO/WHO) (United States) HRH Princess Dina Mired, King Hussein Cancer Foundation (Jordan) Ariella Rojhani, NCD Alliance (Switzerland)

Session proposed by: Union for International Cancer Control (UICC), Switzerland

Sub-Plenary SBP.4.238

11:15 - 11:45 Global Village

ePOSTER PRESENTATIONS See full schedule on page 275 - 279

ePoster Presentations

11:15 - 11:45 Foyer/Global Village

BUPA HEALTHY BREAK

11:15 - 13:15 Ground Level Foyer

THE NCD CAFÉ - HAVE A BREAK... HAVE AN NCD PERSPECTIVE •

NCD Presentations

See full programme on-site

228

Pfizer invites you to attend our symposium on improving early detection in breast cancer:

The role of early detection in improving treatment outcomes for breast cancer patients in LMICs Symposium at the 2014 UICC World Cancer Congress FRIDAY, 5 DECEMBER 2014 11:45-13:15 ROOM 208 MELBOURNE CONVENTION AND EXHIBITION CENTRE MELBOURNE, AUSTRALIA

While significant progress has been made in treating breast cancer and increasing survival rates in high-income countries, late diagnosis remains a challenge to care in both low- and middle-income countries. Join a panel of breast cancer experts as they explore early detection strategies, using regional examples to discuss successful interventions and help to understand opportunities for replication. The panel will consider the role that registries, guidelines, awareness campaigns, clinical evaluation and diagnosis training, advocacy and other elements can play, supporting early detection in improving treatment outcomes for breast cancer patients in limited resource settings.

ÂŠ 2014 Pfizer Inc.

October 2014

11:45 - 13:15 Room 208 TRACK 1

Satellite Session SAT.1.351

11:45 - 13:15 Room 203-204

TRACK 1

THE ROLE OF EARLY DETECTION IN IMPROVING TREATMENT OUTCOMES FOR BREAST CANCER PATIENTS IN LMICS While significant progress has been made in treating breast cancer and increasing survival rates in high income countries, late diagnosis remains a challenge to care in both low and middle income countries. This panel will explore early detection strategies, using regional examples to discuss successful interventions and understand opportunities for replication. The panel will consider the role that registries, guidelines, awareness campaigns, clinical evaluation and diagnosis training, advocacy and other elements can play supporting early detection in improving treatment outcomes for breast cancer patients in limited resource settings.

Session proposed by: Pfizer

TOBACCO PLAIN PACKAGING AND GRAPHIC HEALTH WARNINGS Chaired by: Kylie Lindorff, Cancer Council Victoria (Australia) Rob Cunningham, Canadian Cancer Society (Canada) 1. Impact of Australiaâ&#x20AC;&#x2122;s new tobacco plain packs on adult smokersâ&#x20AC;&#x2122; packrelated perceptions and responses: Results from a continuous tracking survey Sally Dunlop, Cancer Institute NSW (Australia) 2. Plain packaging: did it result in a flood of cheap tobacco in Australia? Michelle Scollo, Cancer Council Victoria (Australia)

Concurrent Track Session CTS.1.233

3. Progress towards plain packaging in Ireland Donal Buggy, Irish Cancer Society (Ireland) 4. Adoption of graphic health warnings in Thailand: successes and challenges Prakit Vathesatogkit, Action on Smoking and Health Foundation - ASH (Thailand) 5. Progress on packaging regulation in Africa

Session proposed by: Cancer Council Victoria, Australia

230

11:45 - 13:15 Room 207

TRACK 2

USING TECHNOLOGY TO DELIVER SUSTAINABLE MODELS OF CARE 1. 2. 3. 4. 5. 6.

Better screening, better detections Can skin cancer be prevented? Treatment that takes care into consideration Quality of life after early treatment care All for healthy future Join Bupa for an important discussion

Session proposed by: Bupa

Satellite Session SAT.4.350

11:45 - 13:15 Room 210 TRACK 2

Concurrent Track Session CTS.2.143

CARING FOR CANCER PATIENTS WITH COMORBIDITY Chaired by: Diana Sarfati, Cancer Control and Screening Research Group (New Zealand) 1. How does cancer interact with other chronic conditions? Diana Sarfati, Cancer Control and Screening Research Group (New Zealand) 2. Comorbidity among Indigenous Australian cancer patients Patricia Valery, Menzies School of Health Research (Australia) 3. Comorbidity in clinical decision-making Louise Signal, Womens Health research Centre, University of Otago (New Zealand) 4. Methods to improve the dosing of therapeutic agents in cancer for patients with comorbidities Jennifer Martin, University of Queensland (Australia) 5. Interventions to improve cancer outcomes for people with comorbidity Inga Oâ&#x20AC;&#x2122;Brien, University of Otago (New Zealand)

Session proposed by: University of Otago, New Zealand

231

PREVENTION DETECTION TREATMENT AND BEYOND Call us

Home

Make a claim

With innovative thinking and improvements in prevention Parking a cancer diagnosis are Request a call back survival rates after File/save/stored item and treatment, at 66%1. Valet parking Email us In partnership with leading organisations and by investing in Bupa Health Foundation, Bupa is focused on addressing some of todayâ&#x20AC;&#x2122;s key health challenges, Web chat including cancer, at all stages Vaccination of the centre journey.

Refresh/update

Disabledin access Visit us/pop Visit theby Bupa Health Lounge the Global Village.Membership/card

Write to us

Hospital

Renew membership

1 Australian Institute of Health and Welfare and Australasian Association of Cancer Registries 2012. Cancer in Australia: an overview, 2012 (page 35). In 2006â&#x20AC;&#x201C;2010 in Visit websiterelative survival was 66% Medical Favourites Australia, five-year for allbranch/medical cancers combined. 2 Australian Institute of Health and Welfare and Australasian Association of Cancer Registries facility/medical centre

Better screening, better detection We are supporting the CSIRO to determine the usefulness of a simple, non-invasive, blood-based test for Colorectal Cancer that will enable broader penetration of screening and early diagnosis for more people. Colorectal Cancer is the second most common internal cancer in Australia, and for those at risk, only 30% take part in preventative measures due to the invasive nature of testing. The CSIRO team hopes its patented blood test will significantly improve screening rates and early detection, when the chance of cure is greater than 80 per cent. Early detection will also significantly reduce the health burden of this disease, which is estimated to cost Australia over $2 billion a year in direct health costs.2 Can skin cancer be prevented? Our partners, Professor Ian Frazer and his team at the Diamantina Institute, UQ, are applying an approach that relates to Professor Frazer’s work in developing the HPV vaccine. The study is exploring whether viruses are similarly implicated in skin cancer, in conjunction with risky exposure to sunlight, and if so, whether a vaccine can be developed. This work may also provide insights into how the body gets rid of cancers, providing other potential opportunities to develop successful interventions, treatments or even cure. Treatment that takes care into consideration In the UK, Bupa and Macmillan Cancer Support are finding ways to better assist customers throughout their cancer treatment. The Bupa Oncology Support Team is led by specialist nurses and is available to all members who are diagnosed with cancer. They help people to navigate their cancer treatment and discuss all the choices available to them, appreciating that each person’s circumstances are unique.

Quality of life after early treatment and care With constantly improving survival rates following cancer diagnosis and treatment, there is an increasing number of cancer survivors in our community. There are now growing concerns about their ongoing quality of life, and the interplay between their ongoing physical and psychological needs and survival. In response, Bupa Health Foundation is supporting a series of initiatives focused on improving the quality of life for cancer survivors. We are collaborating with the Cancer Institute of NSW to develop an integrated on-line portal to support survivors. They’ll be able to access online tools, resources and evidence-based information, all with the aim of achieving better health, wellbeing and outcomes. Through another important partnership with the Monash University Women’s Health Research Group, the ‘Bupa Health Foundation Life After Breast Cancer’ study is a longitudinal study of consecutive registrants in the Victorian Breast Cancer Registry, following women who have had breast cancer, who are sharing their experiences for future survivors. The study looks at which factors impacted their outcomes and what activity or support approaches worked best in aiding their recovery. All for a healthy future For the foreseeable future, cancer still remains a threat to the Bupa goal of longer, healthier, happier lives. But as Dr Paul Bates from Bupa Health Foundation states us ‘We are Call excited by the possibility Home of finding better ways of screening for cancer and improving the quality of life of cancer survivors.’ Parking Request a call back Join Bupa for an important discussion Valet parking Email us to join Bupa and their You’re invited partner organisations for a discussion on how we are supporting patients and health outcomes. Web chat

Vaccination centre

Make

File/

Searc

Refre

Disabled Visit us/pop Join theby ‘Using technology to access deliver sustainable models of care’ session.

Mem

Hospital Write to us 5th December – 11.45am, Friday Room 207.

Rene

Visit website

Medical branch/medical facility/medical centre

2010. Cancer in Australia: an overview, 2010. Cancer series no. 60. Cat. No. CAN 56. Canberra: AIHW 3 UK Department of Health 2012 National Cancer Survivorship Initiative – Quality Health Quality of Life of Cancer Survivors in England: Report on a Pilot SurveyDownload Using Patient Reported Outcome Measures (PROMS). Location/address map

Favou

Join B

11:45 - 13:15 Room 211

TRACK 3

Concurrent Track Session CTS.3.229

THE ROLE OF PHYSICAL ACTIVITY AND EXERCISE FOR CANCER PATIENTS AND CANCER SURVIVORS Chaired by: John Keyserlingk, Ville Marie Breast and Oncology Center (Canada) Christobel Saunders, University of Western Australia (Australia) 1. Historical role of exercise and activity with the cancer population Kerry Courneya, University of Alberta (Canada) 2. The known benefits of exercise and activity with the oncology patients(risks assessment) Kristin Campbell, University of British Columbia (Canada) 3. Targeted exercise prescription for specific cancers and treatment side effects. Rob Newton, Edith Cowan University Health and Wellness Institute (Australia) 4. Building a successful program to address the patient needs and measuring success MarlĂ¨ne Elisabeth Spielmann, Danish Cancer Society (Denmark) 5. Establishing partnerships disseminating information- program development at a macro level Jenny Ritchie-Campbell, Macmillan Cancer Support (United Kingdom)

Session proposed by: Concordia University, Canada, Macmillan Cancer Support, United Kindgom and Edith Cowan University, Australia

234

The Cancer Atlas, Second Edition Friday, December 5

11:45 a.m. - 1:15 p.m. | Room 212-213 The all-new Cancer Atlas, Second Edition provides a vital tool for the cancer community. This compelling volume aims to increase knowledge, provide a reliable basis for evidence-based decision making, and inspire united action and partnerships against the cancer epidemic. The Cancer Atlas contains the latest available data and trends on the cancer epidemic and prevalence of major risk factors, stages of development, and rates of different types of cancers by gender, income group, and region. Participate in the special Cancer Atlas session, where we will highlight key findings from the authors, as well as advocacy opportunities for making cancer a global health and development priority.

11:15 - 13:15 Room 212-213

TRACK 4

Concurrent Track Session CTS.4.230

THE CANCER ATLAS, SECOND EDITION Chaired by: John Seffrin, American Cancer Society (United States) Mary Gospodarowicz, Princess Margaret Cancer Center (Canada) 1. Overview of The Cancer Atlas, Second Edition John Seffrin, American Cancer Society (United States) 2. Major risk factors for cancer Paolo Vineis, Imperial College London (United Kingdom) 3. The cancer burden Freddie Bray, International Agency for Research on Cancer (IARC) (France) 4. Cancer interventions and potential for impact Jemal Ahmedin, American Cancer Society (United States) 5. Presentation of cancer data for public engagement Mary Gospodarowicz, Princess Margaret Cancer Center (Canada)

Session proposed by: American Cancer Society, United States, International Agency for Research on Cancer (IARC), France and Union for International Cancer Control, Switzerland

11:45 - 12:45 Room 206

UICC MEMBERS REGIONAL MEETING - CONVENING THE CANCER COMMUNITY FROM AFRICA Implementation strategies for cancer control in Africa Belmira Rodrigues, African Organisation for Research & Training in Cancer (AORTIC) (South Africa) Wondu Bekele, Mathiwos Wondu Ye-Ethiopia Cancer Society (Ethiopia) Beatrice Wiafe Addai, Breast Care International (BCI) (Ghana)

UICC Session RM.4

236

13:15 - 14:45 Ground Level Foyer

THE NCD CAFÉ - HAVE A BREAK... HAVE A NCD PERSPECTIVE •

NCD Presentations

See full programme on-site

13:15 - 14:45 Global Village

ePOSTER PRESENTATIONS See full schedule on page 279 - 293

ePoster Presentations

13:15 - 14:45 Plenary #2

90-SECONDS OR LESS: COMMUNICATING HEALTH MESSAGING TO THE MASSES Chaired by: Vanessa Von der Muhll, Union for International Cancer Control (UICC) (Switzerland) 1. Zita’s Story Cassandra Clayforth, Cancer Council Western Australia (Australia) 2. NCDs, The Disease You Made Yourself Supatnuj Sorndamrih, Thai Health Promotion Foundation (Thailand)

Big sCreen BSC.0.2

3. Not Alone Jane Maher, Macmillan Cancer Support (United Kingdom) 4. The Real Cost April Brubach, US Food and Drug Administration (United States) Using traditional mass media to broadcast campaigns remains a powerful way to raise awareness, reach a wide audience and influence behaviour change. Public service video campaigns made for television have shown to be an effective tool, particularly in the area of lifestyle-based health risks. We will showcase a selection of awareness-raising campaigns on the topic of cancer and noncommunicable diseases that demonstrate the potential to be adapted beyond their original intended audience - either via translations in their current form or adaptations of the concept. 237

13:15 - 14:45 Room 206

TRACK 4

Workshop UICC.4.2

CHILDREN HAVE CANCER TOO! RAISING AWARENESS AND STRENGTHENING ADVOCACY ON CHILDHOOD CANCER AROUND THE WORLD Chaired by: Julie Torode, Union for International Cancer Control (UICC) (Switzerland) Kenneth Dollman, ICCCPO – International Confederation of Children Cancer Parent Organizations (South Africa) CHICA Discussion panel Julie Torode, Union for International Cancer Control (UICC) (Switzerland) Kenneth Dollman, International Confederation of Childhood Cancer Parent Organisations - (ICCCPO) (South Africa) Carmen Auste, Cancer Warriors Foundation, Inc (Philippines) Sumit Gupta, The Hospital for Sick Childrens (Canada) Sawsan Al-Mahdi, Friends of Cancer Patients (United Arab Emirates) This interactive lunch time workshop organised by UICC and the International Confederation of Childhood Cancer Parent Organizations will discuss various awareness and advocacy campaigns to raise awareness of childhood cancer as a public health priority in children’s health and to develop national policies and programmes.

Workshop proposed by: Union for International Cancer Control, Switzerland and the International Confederation of Childhood Cancer Parent Organizations (ICCCPO)

238

13:15 - 14:45 Room 103

TRACK 1

EVIDENCE-BASED IMPLEMENTATION ON CANCER PREVENTION & SCREENING IN TAIWAN - SCREENING PROGRAM, DIET EDUCATION, COMPLEMENTARY CHEMOPREVENTION Chaired by: Jacqueline Whang-Peng, Formosa Cancer Foundation 1. Evidence-based cancer screening policy and implementation in Taiwan Chien-Yuan, Wu, Health Promotion Administration, Minister of Health and Welfare of Taiwan 2. Dietary education on cancer prevention - School & community initiative Jane Tsai Lai, Formosa Cancer Foundation

Satellite Session SAT.1.340

3. Fighting against obesity in Taiwan - An innovative approach Chien-Yuan, Wu, Health Promotion Administration, Minister of Health and Welfare of Taiwan 4. Complementary Chinese herbs as cancer chemopreventive agents â&#x20AC;&#x201D; from bench to clinic Lai Gi-Ming, Formosa Cancer Foundation

Session proposed by: Formosa Cancer Foundation

13:15 - 14:45 Room 209

TRACK 1

UNIVERSAL HEALTH COVERAGE ON CANCER/NCDS Chaired by: Hideyuki Akaza, Japan Society of Clinical Oncology (Japan) Jae Kyung Roh, Yonsei University (Japan) Xishan Hao, Chinese Anti-Cancer Association (CACA) (China) 1. Research trends on UHC Shinjiro Nozaki, World Health Organization (Switzerland) 2. Profiling case models in Asia Shigeto Sonoda, University of Tokyo (Japan)

SAT.1.380

240

Session proposed by: UICC-ARO and UICC Japan

Friday

5th December from 13:15 – 14:45

Melbourne Convention and Exhibition Center, Room 211 Agenda • Introduction • Supporting research and patient education: the role of patient advocacy groups • Example of unifying patients and HCPs, and building strong advocacy networks • Patient advocacy groups in developing countries: views from the MAX Foundation • Roundtable discussion • Close This is a GSK-sponsored event. GSK has been involved in selecting the faculty and in the creation of the agenda and the content.

GlaxoSmithKline Australia Pty Ltd. ABN 47 100 162 481. Melbourne, VIC.OF/COM/0005/14a. Date of Approval: September 2014

Why collaboration is key to support patient advocacy

13:15 - 14:45 Room 211

WHY COLLABORATION IS KEY TO SUPPORT PATIENT ADVOCACY 1. Topicâ&#x20AC;&#x2122;s Introduction

TRACK 1

2. Supporting research and patient education - The role of patient advocacy groups 3. Patient advocacy groups in developing countries: views from the Max Foundation 4. Roundtable discussion; Initiating an advocacy group - Capabilities building Network building - Financial support 5. Close

Satellite Session SAT.1.308

242

Session proposed by: GlaxoSmithKline

SATELLITE SYMPOSIUM Friday, 5th December 2014 | 13:15-14:45 | Melbourne Convention and Exhibition Center, Room 218

ENSURING PATIENT ACCESS TO OPTIMAL TREATMENT: Why does access to evidence-based innovative treatment remain a challenge? Panel discussion with representatives of different stakeholders with an interest in improving patient access, followed by open discussion. This interactive workshop will build on the topic of access to best treatment. The session will begin with brief presentations from a range of perspectives, including experts from science, health authorities, health technology assessment, advocates and industry, followed by open discussion. Patient organisations are increasingly demanding a seat at the table when decisions are made about access to treatment and the patient perspective will be a key theme of this discussion. Come and add your voice to the global discussion on how we can improve access to treatments that can improve survival rates and quality of life for people living with cancer, wherever they are in the world. The session is open to everyone.

13:15 - 14:45 Room 218

TRACK 2

Satellite Session SAT.2.353

ENSURING PATIENT ACCESS TO OPTIMAL TREATMENT: WHY DOES ACCESS TO EVIDENCE-BASED INNOVATIVE TREATMENT REMAIN A CHALLENGE?

A Bayer sponsored symposium with a panel of different stakeholders with an interest in improving patient access to treatment Cancer remains a major healthcare challenge, with increasing numbers of people being diagnosed. The incidence of cancer may double by 2030 and, with increasingly effective treatment approaches, more and more patients are surviving longer with their illness. This has major implications for healthcare systems, as more treatments become available and more people live with the long term consequences of cancer diagnosis and treatment. The recent advances in understanding the biological basis of cancer have allowed the development of novel treatment approaches to the disease but this, too, brings issues. The cost of cancer medicines is often used as a reason that patients are unable to access these new treatments and processes such as health technology assessment have been implemented to provide a systematic way to assess the benefit they bring. It is unthinkable that patients are being denied access to treatments that can prolong or improve the quality of their life, based on a cost-effectiveness calculation that ignores many of the benefits these treatments bring. We need to find new solutions to the challenge of introducing new treatments that allow patients – young or old, rich or poor, wherever they are in the world – to benefit from these advances. This panel will bring together stakeholders from a range of different backgrounds to discuss the challenges and explore what can be done to overcome them. We cannot continue to deny patients access to effective treatment, as the numbers of patients increases with an ever greater impact on society.

Session proposed by: Bayer

244

Cancer Australia Workshop

Involving consumers leads to better cancer care Be involved today

Friday 5th December World Cancer Congress Join us and learn how Cancer Australia’s online practical tools and resources can assist you to engage people affected by cancer in treatment decisions, service development, policy development and research. Room 208, Level 2 1.15pm - 2.45pm Lunch time workshop Friday 5th December 2014 Hosted by Professor Helen Zorbas, CEO Cancer Australia, this workshop will include a facilitated hypothetical case study by an expert panel including consumers. For more information visit the Cancer Australia stand in the Global Village.

Do you want to: improve outcomes and experiences of people affected by cancer create health services that are more responsive to consumer needs and issues improve quality and safety of heath care organisations improve cancer research.

Involving consumers leads to better cancer care Evidence shows that working with consumers – people affected by cancer – results in better outcomes and improves the quality and safety of our health care organisations and research. Get involved today.

@CancerAustralia

‘Getting involved leads to better cancer care, and it’s a rewarding experience for all.’ Ms Kerry Russo, Consumer © Cancer Australia 2014

consumerinvolvement.canceraustralia.gov.au

13:15 - 14:45 Room 208

TRACK 2

INVOLVING CONSUMERS LEADS TO BETTER CANCER CARE

A practical workshop based on the principles of the National Framework for Consumer Involvement in Cancer Control utilising online internationally applicable resources to promote consumer engagement in cancer control. Hosted by Professor Helen Zorbas, CEO Cancer Australia, this workshop will include a facilitated hypothetical case study by an expert panel including consumers. Session proposed by: Cancer Australia, Australia

Satellite Session SAT.2.341

13:15 - 14:45 Room 214 TRACK 4

UICC Session UICC.4.4

HOW PEOPLE AFFECTED BY CANCER ARE IMPACTED BY LAWS RELATING TO PATIENT RIGHTS, PROTECTION FROM DISCRIMINATION, AND DECISIONMAKING AT END OF LIFE The McCabe Centre is hosting a lunchtime panel session to hear international and Australian experts discuss the laws that impact on the treatment of and supportive care provided to people diagnosed with cancer, in relation to: •

capacity to make informed decisions about treatment (both during and in advance of treatment) and to have these decisions respected

•

the application of discrimination law to those who work during treatment, or return to work after treatment and while managing side effects of treatment

•

access to social security benefits, insurance (especially travel and life insurance) and support for those who have to travel for treatment.

The session will also include the release of a new report on informed consent, and regulation of complementary and alternative therapies, as part of a McCabe Centre/Cancer Council Victoria project ‘Making the law work better for people affected by cancer’

Session proposed by: McCabe Centre for Law and Cancer, Australia 246

13:15 - 14:45 Room 207

TRACK 4

Satellite Session SAT.4.302

THE BILLION DOLLAR CHALLENGE FOR PERSONALIZED CANCER MEDICINE – KEEPING A CAMPAIGN VITAL FOR 5 YEARS Chaired by: Christine Lasky, Princess Margaret Cancer Foundation (Canada) The session will describe and showcase key elements of The Princess Margaret Cancer Foundation’s BILLION DOLLAR CHALLENGE from its inception to midpoint as it tracked through time. A new great digital fundraising program, part of the campaign, will also be unveiled at this session and offered to other cancer organisations around the world. The UICC is proud to be a collaborating partner of this new digital initiative. The session hopes to share some best practices and engage others to be one of the first to take this new digital fundraising brand to their organisation.

Session proposed by: The Princess Margaret Cancer Foundation, Canada

13:15 - 14:45 Room 220

TRACK 4

HEALTHY PLANET, HEALTHY PEOPLE – ADDRESSING NCDS IN THE POST-2015 DEVELOPMENT AGENDA Chaired by: George Alleyne, Pan American Health Organization/World Health Organization (PAHO/WHO) (United States) 1. Implications of the Post-2015 Development Agenda on NCD prevention and control and bilateral aid Helen McFarlane, Department of Foreign Affairs and Trade (Australia) 2. NCD Alliance vision for health and NCDs in post-2015 Katie Dain, NCD Alliance (Switzerland)

Discussion panel UICC.4.3

3. Palliative care in the post-2015 development agenda – challenges and opportunities Jim Cleary, Pain Policy Research Group, University of Wisconsin-Madison (United States) 4. East Africa Regional perspectives on post-2015 Constance Kekihembo, Uganda NCD Alliance and East Africa NCD Alliance Initiative (Uganda) 5. The private sector’s role in integrating NCDs into existing services, health systems strengthening, and patient empowerment Jacob Gayle, Medtronic Philantropies (United States)

Session proposed by: The NCD Alliance, Switzerland 248

13:15 - 14:45 Room 210

HOW INTERNATIONAL ONCOLOGY NURSES ARE WORKING TOGETHER TO ACCELERATE PROGRESS Chaired by: Janice Stewart, International Society of Nurses in Cancer Care (ISNCC) (Canada)

TRACK 4

1. How International Oncology Nurses are working together to accelerate progress - International Janice Stewart, International Society of Nurses in Cancer Care (ISNCC) (Canada)

Satellite Session SAT.4.256

2. How International Oncology Nurses are working Together to accelerate progress - Europe Birgitte Grube, European Oncology Nursing Society - EONS (United Kingdom) Erik van Muilekom, European Oncology Nursing Society - EONS (United Kingdom) 3. How International Oncology Nurses are working together to accelerate progress - Australia Sandy McKiernan, Cancer Nurses Society of Australia (CNSA) (Australia) 4. How International Oncology Nurses are working together to accelerate progress â&#x20AC;&#x201C; North America Margaret Barton-Burke, Oncology Nursing Society (United States) 5. How International Oncology Nurses are working together to accelerate progress - Asia Kazuko Onishi, Asian Oncology Nursing Society (AONS) (Japan)

Session proposed by: International Society of Nurses in Cancer Care - ISNCC, Canada

250

15:00 - 16:00 Room 206

UICC MEMBERS’ REGIONAL MEETING - CONVENING THE CANCER COMMUNITY FROM THE AMERICAS Civil Society/NGO Engagement in Cancer Control: Integrating National Strategies, Models and Best Practices to Inform and Advance Collaborative Regional Action in the Americas.

RM.4

15:00 - 16:00 Room 207 AOS.5

Marjorie Morrison, Canadian Cancer Action Network (Canada) Maira Caleffi, FEMAMA - Brazilian Federation of Philanthropic Breast Health Institutions (Brazil)

ABSTRACT ORAL SESSION 5 - ADVOCACY REPORTS Chaired by: Todd Harper, Cancer Council Victoria (Australia) 1. Tools for catalyzing a shift to new cervical cancer screening strategies in Central America Vivien Tsu, PATH, (United States) 2. An international partnership to align cancer control planning efforts with global noncommunicable disease (ncd) control targets Cynthia Vinson, National Cancer Institute, (United States) 3. Engaging policy makers, civil society and youth for prevention and control of cancer and other NCDs in India Abhinav Bassi, HRIDAY, (India) 4. “Meet the Targets” Project on the Implementation of United Nation Political Declaration on Non-Communicable Diseases. Wondu Bekele, Mathiwos Wondu-YeEthiopia Cancer Society, (Ethiopia) 5. Global surveillance of cancer survival (CONCORD) Claudia Allemani, London School of Hygiene and Tropical Medicine, (United Kingdom) 6. Building capacity for oncology nursing education and training in low- and middle-income countries: A call to action Makeda Williams, National Cancer Institute, (United States)

251

15:00 - 16:00 Room 208 AOS.6

ABSTRACT ORAL SESSION 6 - SCIENTIFIC STUDIES IN PREVENTION AND MISCELLENEAOUS Chaired by: Anil D’Cruz, Tata Memorial Hospital (India) 1. Finding the keys to successful public health campaigns promoting healthy weight and lifestyle to adults: quantitative and qualitative audience testing research. Helen Dixon, Cancer Council Victoria, (Australia) 2. Green Tea Consumption Is Associated with a Reduced Risk of Adult Leukemia Ping Liu, The University of Western Australia, (Australia) 3. Adherence to dietary and lifestyle recommendations and prostate cancer risk in the Prostate Testing for Cancer and Treatment (ProtecT) trial. Vanessa Er, University of Bristol/NIHR Bristol Nutrition Biomedical Research Unit, (United Kingdom) 4. Long-term follow-up of breast cancer mortality in Turku, Helsinki and the rest of Finland with employment of different screening policies Pirjo Immonen-Räihä, Turku University Hospital, (Finland) 5. An impactful e-learning course for palliative care in cancer for African healthcare professionals. Gordon McVie, IEO Istituto Europeo di Oncologia, (Italy)

252

15:00 - 16:00 Plenary #2

Big Debate BD.0.2

E-CIGARETTES ARE A HELPFUL TOOL IN TOBACCO CONTROL AND CESSATION AND SHOULD BE PROMOTED FOR THAT PURPOSE Moderator: Norman Swan, Producer, broadcaster and investigative journalist (Australia) E-cigarettes are a helpful tool in tobacco control and cessation and should be promoted for that purpose Simon Chapman, University of Sydney (Australia) Ron Borland, Cancer Council Victoria (Australia) To encourage the growing debate about the advent of electronic cigarettes and the war on smoking, the Congress will host a debate on how ‘E-cigarettes are a helpful tool in tobacco control and cessation and should be promoted for that purpose’. E-cigarettes, a nicotine-delivery system has grown into a multibilliondollar business resulting in a massive and growing international issue. To date, there is no definitive evidence on their potential harms or potential benefits, as research in this area is in its infancy. As such, this will fuel the debate with remarkable ranges of views being expressed. The debaters will partake in a discussion focussing on e-cigarette regulation and whether or not they are a healthier alternative to tobacco cigarettes. A supporter of e-cigarettes will argue for seeing their promise as a cancer control tool and that they should be promoted for that purpose, arguing that they may be useful in the “end-game”. The opponent will argue that promoting e-cigarettes as a cessation tool will “renormalize” smoking and undermine much of the effort gained through WHO’s Framework Convention on Tobacco Control. This debate has broad implications for public health officials, policymakers, regulation agencies, the tobacco industry and other key stakeholders in tobacco control.

Session proposed by: Union for International Cancer Control (UICC)

253

15:00 - 16:00 Room 211

TRACK 1

CAMPAIGNS FOR CANCER PREVENTION: USING TV, FACEBOOK AND OTHER MEDIA TO CHANGE POLICY AND BEHAVIOR Chaired by: Rebecca Perl, World Lung Foundation (United States) Stephen Hamill, World Lung Foundation (United States) 1. Harnessing mass media for cancer prevention in Africa Rebecca Perl, World Lung Foundation (United States) 2. Small dollar, big results: online advertising for tobacco control advocacy in Senegal, Vietnam and India Stephen Hamill, World Lung Foundation (United States)

Symposium PS.1.228

3. Attracting likes, shares and comments â&#x20AC;&#x201C; What works to grow and engage a Facebook community Becky Freeman, University of Sydney (Australia) 4. Putting tobacco control to work: applying best practice to obesity and beyond Trish Cotter, Victorian Comprehensive Cancer Centre (Australia)

Session proposed by: World Lung Foundation, United States

254

15:00 - 16:00 Room 210

TRACK 1

Symposium PS.1.49

VIBRANT CESSATION TECHNIQUES RESPONSIVE TO WOMEN’S NEEDS Chaired by: Patricia Lambert, Campaign for Tobacco-Free Kids (United States) 1. A women-centered, trauma-informed harm reduction oriented approach to encouraging cessation Lorraine Greaves, BC Centre of Excellence for Women’s Health (Canada) 2. Disadvantaged women’s perceptions and use of smokeless tobacco and the women needs’ driven cessation strategies that can help... Mira B Aghi, Advocacy Forum for Tobacco Control (India) 3. Smoking cessation for women in Hong Kong: Challenges and Opportunities Sophia Chan, Ministry of Food and Health (Hong Kong) 4. Lack of cessation services for women in selected African Countries Mary Okioma, African Women’s Alliance for Tobacco Control (AWATC) (Kenya)

Session proposed by: International Network of Women against Tobacco (INWAT) and Adocacay Forum for Tobacco Control (AFTC), India

15:00 - 16:00 Room 220

TRACK 2

Discussion panel PS.2.101

SHARE YOUR STORY: CHANGING HOW THE WORLD VIEWS CANCER Chaired by: Loyce Pace, LIVESTRONG Foundation (United States) 1. Global Perceptions of Cancer Devon McGoldrick, LIVESTRONG Foundation (United States) 2. Mobilising through Social Media Fernando Rodriguez Hernandez, Comparte Tu Historia (Mexico) 3. Elevating the voices of people affected by cancer Lauren Pretorius, Campaigning for Cancer (South Africa)

Session proposed by: LIVESTRONG Foundation, United States

255

15:00 - 16:00 Room 219

TRACK 2

Symposium PS.2.47

EARLY DIAGNOSIS AND OPTIMISING TREATMENT: HOW CONSUMERS CAN JOIN FORCES AND ACCELERATE PROGRESS Chaired by: Helen Zorbas, Cancer Australia (Australia) 1. Critical success factors in cancer control Christine Giles, Cancer Australia (Australia) 2. Consumer engagement in Breast cancer control in Australia Maxine Morand, Breast Cancer Network Australia (Australia) 3. Consumer engagement in cancer control inÂ Argentina Eduardo Cazap, Latin American & Caribbean Society of Medical Oncology (SLACOM) (Argentina) 4. Consumer engagement in cancer control in Sweden Kerstin Sandelin, Cancer Center Karolinska, Karolinska Institutet (Sweden) 5. Early diagnosis and optimising treatment: How consumers can join forces and accelerate progress Claudine Lyons, Centre for Population Health NSW Ministry of Health (Australia)

Session proposed by: Cancer Australia, Australia

256

15:00 - 16:00 Room 218

TRACK 2

Discussion panel PS.2.205

IMPLEMENTING THE NCD ACTION PLAN: CATALYZING CHANGES IN ACCESS TO AFFORDABLE CANCER TREATMENT? Chaired by: Franco Cavalli, Oncology Institute of Southern Switzerland (IOSI) (Switzerland) Andreas Ullrich, World Health Organization (WHO) (Switzerland) 1. What do we know and what we do need to know about affordable cancer treatment? Richard Sullivan, Cancer Research UK (United Kingdom) 2. New strategies to reduce health inequalities in cancer, a proposal from the European Commission- funded EUROCHIP study Franco Cavalli, International Extranodal Lymphoma Study Group (IELSG) (Switzerland) 3. How will the NCD agenda boost cancer treatment: The perspective of Senegal Serigne Magueye Gueye, African Organisation for Research & Training in Cancer (AORTIC) (Senegal) 4. How can the pharmaceutical industry facilitate increased access to chemotherapy and medicines? Martin Cross, Medicines Australia (Australia)

Session proposed by: World Health Organization, Switzerland

257

15:00 - 16:00 Room 212-213

GTFRCC - AN INVESTMENT FRAMEWORK TO CLOSE THE GLOBAL DISPARITY IN ACCESS TO RADIOTHERAPY BY 2035 Chaired by: Mary Gospodarowicz, Princess Margaret Cancer Center (Canada)

TRACK 4

Radiotherapy is an essential component of cancer care, being used in high income countries in 48% of cancer cases. It is used as a curative modality in early stage and locally advanced disease and is a very effective modality for palliation. It is particularly effective in the treatment of locally advanced cancers, which are often more common at first presentation in low-to-middle income countries. However, the availability of radiotherapy is limited or non-existent in these settings. For example, 29 out of 52 African countries do not have any radiation facilities. This disparity in access to radiotherapy persists, despite an increasing evidence base for the cost-effectiveness of radiation treatment.

UICC Session UICC.4.5

The Board of the UICC has charged the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) to answer the question, â&#x20AC;&#x2DC;what will it cost to close the gap in access to radiotherapy by 2035?â&#x20AC;&#x2122;. This session will present the first outputs of the GTFRCC response - an investment framework for scaling up radiation therapy in low- and middle-income countries. The framework will be used to estimate the cost of scale up as well as the health, economic and broader societal benefits that will arise from deployment of adequate levels of radiotherapy. The framework will be used as an organizing principle for a clear set of actions with a well-defined time horizon.

Session proposed by: Union for International Cancer Control (UICC), Switzerland

258

15:00 - 16:00 Room 103

TRACK 4

Symposium PS.4.227

STRATEGIES TO IMPROVE QUALITY AND MEANINGFUL ENGAGEMENT OF INDIGENOUS PEOPLES IN ACHIEVING CULTURALLY RESPONSIVE CANCER CARE SERVICES Chaired by: Kelly Atkinson, Cancer Society of New Zealand Inc. (New Zealand) 1. First Nations, Inuit & Metis Cancer Control Strategy in Canada Pam Tobin, Canadian Partnership Against Cancer (Canada) 2. The journey towards implementing a strategy within the cancer control system Kali Leary, Cancer Care Manitoba (Canada) 3. An overview of the cancer control partnership between the Samoa Cancer Society and the Cancer Society of New Zealand Dalton Kelly, Cancer Society of New Zealand Inc. (New Zealand) 4. Pacific partnerships for cancer control Daryl Clarke, Samoa Cancer Society Inc. (Samoa)

Session proposed by: Canadian Partnership Against Cancer, Canada and Cancer Society of New Zealand, New Zealand

15:00 - 16:00 Room 104

TRACK 4

Symposium PS.4.99

USING CANCER POPULATION EVIDENCE TO IMPROVE/INFORM SYSTEM REDESIGN AT A LOCAL AND NATIONAL LEVEL Chaired by: Jenny Ritchie-Campbell, Macmillan Cancer Support (United Kingdom) 1. Using population evidence to support system redesign Jenny Ritchie-Campbell, Macmillan Cancer Support (United Kingdom) 2. Sharing insights from across the world Mary McBride, British Columbia Cancer Agency (Canada) 3. Data systems and their role in developing a robust evidence base about the cancer journey David Roder, Cancer Council South Australia (Australia) 4. Commissioning in the real world – using data and evidence to support commissioning – innovative solution to system redesign Sinéad O’Brien, Department for Health and Ageing South Australia (Australia)

Session proposed by: Macmillan Cancer Support, United Kingdom 259

16:00 - 16:30 Global Village

ePOSTER PRESENTATIONS Refer to full schedule page 293 - 297

ePoster Presentations

16:00 - 16:30 Foyer/Global Village

AFTERNOON NETWORKING BREAK

16:00 - 16:30 Ground Level Foyer

THE NCD CAFÉ - HAVE A BREAK... HAVE A NCD PERSPECTIVE •

NCD Presentations

See full programme on-site

16:30 - 18:00 Room 203-204 Rapid-Fire Abstract Presentations RF.3

RAPID FIRE 3 - PREVENTION, EARLY DETECTION AND CANCER AWARENESS; CANCER CONTROL AMONGST INDIGENOUS POPULATIONS; PSYCHOSOCIAL ASPECT Chaired by: Jeff Dunn, Cancer Council Queensland (Australia) 1. Enhancing access to estimates of occupational and environmental carcinogen exposure: CAREX Canada’s knowledge translation programme Alison Palmer, CAREX Canada, (Canada) 2. Early detection saves lives through mobile screening units Noelene Kotschan, Pink Drive, (South Africa) 3. There is an app for that! Communicating UV via the SunSmart app Kimberley Dunstone, Cancer Council Victoria, (Australia) 4. A human rights-based approach to cancer prevention and treatment Alexandra Jones, Cancer Council Victoria, (Australia)

260

Rapid-Fire Abstract Presentations RF.3

5. The impact of alcohol outlet density on alcohol consumption among urban and regional Australian adolescents Denise Azar, Cancer Council Victoria, (Australia) 6. Alcohol advertising review board: two year summary of a national advocacy initiative Terry Slevin, Cancer Council Western Australia, (Australia) 7. “The work around”: An innovative data collection approach to support a cancer screening program Kathleen O’Connor, WA Department of Health, (Australia) 8. Ultra-processed products attenuating and reversing the impact of an effective intervention to increase household availability of fruits and vegetables Fabio Gomes, National Cancer Institute of Brazil (INCA), (Brazil) 9. Can you see what they’re saying? A content analysis of skin cancer and recreational tanning coverage in popular magazines Jennifer McWhirter, University of Waterloo, (Canada) 10. A qualitative investigation of knowledge, beliefs and attitudes regarding sugar-sweetened beverages, including responses to potential regulatory measures aimed at curbing obesity. Caroline Miller, SAHMRI, (Australia) 11. Cancer warning statements on alcoholic beverage labels Simone Pettigrew, Curtin University, (Australia) 12. An alarming association between ambient concentrations of fine particulate matter and prostate cancer XiaoJian Qin, Fudan University Shanghai Cancer Center, (China) 13. Second to fourth digit ratio (2D:4D) and prostate cancer risk: Evidence from the PROtEuS case-control study in Montreal, Canada Marie-Elise Parent, Institut national de la recherche scientifique, (Canada) 14. Cancer beliefs and behaviors survey in Turkey Tezer Kutluk, Turkish Association for Cancer Research and Control, (Turkey) 15. Structure versus flexibility: How should an Indigenous cancer support group operate? Sandra Thompson, University of Western Australia, (Australia)

261

Rapid-Fire Abstract Presentations RF.3

16. Keep calm, let’s talk about sex Lena Kurtz, Israel Cancer Association, (Israel) 17. A randomized placebo-controlled feasibility trial of dietary interventions for prostate cancer prevention: ProDiet J Athene Lane, University of Bristol, (United Kingdom) 18. Psychological distress, self-efficacy, quality of life and burden in informal cancer caregivers, and the relationship with patient outcomes Anna Ugalde, Deakin University & Cancer Council Victoria, (Australia) 19. Building international research capacity; exploring oncology nurses family assessment practices. Elisabeth Coyne, Griffith University, (Australia) 20. Adapting evidence-based psychological therapy to the computer screen for adolescent and young adult cancer survivors: Preliminary results from the ‘Recapture Life’ randomised controlled trial. Ursula Sansom-Daly, University of New South Wales, (Australia) 21. Investigating the impact of distress on wellbeing among adolescent and Young Adult (AYA) cancer patients at Princess Margaret Cancer Centre: A needs assessment analysis Hayley Panet, Princess Margaret Cancer Centre, (Canada) 22. Reducing the psychological distress of family caregivers of home based palliative care patients: A randomised controlled trial Kristina Thomas, St Vincent’s Hospital Melbourne, (Australia) 23. Development, validation and usage of measures of unmet needs for adolescent and young adults who have a sibling or parent with cancer Fiona McDonald, CanTeen Australia, (Australia) 24. “This isn’t what mine looked like”: A qualitative study of symptom appraisal and help seeking in UK patients recently diagnosed with melanoma Fiona Walter, University of Cambridge, (United Kingdom)

262

16:30 - 18:00 Room 212-213 Supported by

Rapid-Fire Abstract Presentations RF.4

RAPID FIRE 4 - CLINICAL, PALLIATIVE CARE, PATIENT EXPERIENCE, PSYCHOSOCIAL ASPECT Chaired by: Marian Gandy, Bristol-Myers Squibb Australia & New Zealand (Australia) 1. Does HER2 affect prognosis in oesophageal and gastric cancer: A systematic review Barbara-Ann Adelstein, University of NSW, (Australia) 2. The paradox of favorable outcomes and inferior survival improvement – AYA cancer survival in the United States Rebecca Johnson, Seattle Children’s Hospital, (United States) 3. A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C Wen-Zhuo He, Sun Yat-Sen university, (China) 4. Exploring the cost-effectiveness of next-generation sequencing in lung adenocarcinoma: What is the effect of a maturing evidence base? Brett Doble, Centre for Health Economics, (Australia) 5. Radiotherapy for stage I-II testicular seminoma: A prospective evaluation of body image and sexual functioning Luca Incrocci, Erasmus MC Cancer Institute, (Netherlands) 6. Palliative care in Egypt: The experience of the Gharbiah Cancer Society. Mohamed Hablas, Gharbia Cancer Society, (Egypt) 7. Integrating palliative care in cancer management: An overview of the Kenya situation Zipporah Ali, Kenya Hospices and Palliative Care Association, (Kenya) 8. Quality of pain management for end-of-life cancer patients receiving hospice and non-hospice care: Pain assessment and patient education Mei-Ling Chen, Chang Gung University 9. Family caregiver involvement in home based palliative care for cancer patients in Indonesia Erna Rochmawati, University of Adelaide, (Australia) 10. Cancer Information Needs in Germany: Lessons learned from a population-based survey Monika Preszly, German Cancer Research Center, (Germany) 263

11. Peer-to-peer support of men with advanced prostate cancer: An exercise in finding appropriate technology Jim Marshall, Prostate Cancer Foundation Australia, (Australia) 12. Involving consumers leads to better cancer care Susan Hanson, Cancer Australia, (Australia) 13. Consumer experience of a telephone based peer support intervention for women with a BRCA1/2 mutation Ashley Farrelly, Cancer Council Victoria, (Australia) 14. Creating an effective means of capturing cancer care experiences Chris Donkin, Danish Cancer Society, (Denmark) 15. Making the law work better for people affected by cancer Sondra Davoren, Cancer Council Victoria, (Australia) 16. The economic cost of cancer to patients and their families in Southeast Asia Mark Woodward, The George Institute for Global Health, (Australia) 17. Global mortality trends in hepatitis B induced liver cancer Christina Fitzmaurice, University of Washington/IHME, (United States) 18. Rates of chemotherapy adverse-events in clinical practice: Results from prospective cohort study Philip Haywood, UTS, (Australia) 19. Letâ&#x20AC;&#x2122;s talk about sex: A phone-based intervention to deliver psychosexual care for people affected by cancer Katherine Lane, Cancer Council Victoria, (Australia) 20. Radiotherapy quality of care indicators for locally advanced cervical cancer: A consensus guideline Michael Milosevic, Princess Margaret Cancer Centre, (Canada) 21. Clinical application of intelligent pain managment system to cancer-pain control Gang Ding, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chongming Branch, (China) 22. Genetic test declining and high cancer risk perception in DNA mismatch repair gene mutation families Louisa Flander, University of Melbourne, (Australia) 23. Pilot of pain indicator audit tool as part of a complex intervention to improve cancer pain outcomes. Melanie Lovell, HammondCare, (Australia)

264

PARTNERING FOR A HEALTHIER FUTURE Since 2012, we’ve been working with UICC to reduce the global impact of cancer. We know workplaces present an opportunity to address health challenges, so we are working together to deliver proven, practical solutions to help businesses support the health of their workforce through prevention and treatment. With 70,000 employees worldwide, it’s a passion close to our heart and a partnership that embodies our collaborative Home Call us Make a claim approach to global health. It’s all part of our commitment to longer, healthier, happier lives. Request a call back

Parking

File/save/stored ite

Find out how to impact cancer in the workplace Explore how UICC members can play a pivotal role in Valet parking Email us Search engaging organisations worldwide to adopt best practices in employee health and prioritise cancer prevention and Vaccination centre chat Refresh/update early Web detection in the workplace. Disabled access Visit us/pop Membership/card Join theby‘Wellness at work: Realising the opportunity to tackle cancer’ session. Hospital Write to us 5th December – 4:30pm, Friday Room 209.

Visit website

Medical branch/medical facility/medical centre

Renew membership

Favourites

16:30 - 18:00 Room 211

TRACK 1

Symposium PS.1.222

PART 1: HOW TO IMPROVE CERVICAL CANCER PREVENTION IN LOW-RESOURCE SETTINGS: LESSONS LEARNED FROM COUNTRY EXPERIENCES PART 2: USING COMPETENCY-BASED TRAINING AND SUPPORTIVE SUPERVISION FOR PROVIDER PERFORMANCE QUALITY IMPROVEMENT Chaired by: John Varallo, JHPIEGO Corporation (United States) 1. Competency-based training and supportive supervision: quality improvement processes in visual inspection with acetic acid (VIA), cryotherapy, and loop electrosurgical excision procedure (LEEP) Enriquito R. Lu, JHPIEGO Corporation (United States) Tsigue Pleah, JHPIEGO Corporation (United States) John Varallo, JHPIEGO Corporation (United States) 2. Establishing cervical cancer screening programmes in low-resource settings: experiences from Salvador, Bangladesh, and Vietnam Miriam Cremer, Basic Health International, Inc (United States) Anne kathryn Goodman, Massachusetts General Hospital (United States) Quoc Huy Nguyen Vu, Hue Univeristy of Medicine and Pharmacy (Vietnam) Linus Chang, Ichan School of Medicine at Mount Sinai (United States)

Session proposed by: Mount Sinai School of Medicine and Jhpiego, United States

16:30 - 18:00 Room 209

TRACK 1

WELLNESS AT WORK: REALISING THE OPPORTUNITY TO TACKLE CANCER With 3.28 billion workers in the world today, there is a tremendous opportunity to tackle cancer in the workplace. In this interactive session, we will explore how UICC members can play a pivotal role in engaging organisations worldwide to adopt best practices in employee health and prioritise cancer prevention and early detection in the workplace. UICC members will be invited to share their views on how they believe they can influence companyâ&#x20AC;&#x2122;s practices and the challenges that they may face in working together with local businesses to adopt workplace programmes. Bupa and UICC will also introduce member organisations to resources designed to inspire and support employers to take on employee health and well-being in the workplace.

SAT.1.352

266

Roundtable proposed by: Bupa

16:30 - 18:00 Room 218

TRACK 1

LAW AND POLICY-MAKING IN CANCER PREVENTION: USING EVIDENCE, LAW, AND POLITICAL SCIENCE TO ADVANCE CANCER PREVENTION POLICIES Chaired by: Anne Lise Ryel, Norwegian Cancer Society (Norway) 1. Advancing the use of evidence in cancer prevention policies Deb Keen, Canadian Partnership Against Cancer (Canada) 2. Evidence-based advocacy for regulatory action Mamadou Bamba Sagna, African Tobacco Control Alliance (ATCA) (Senegal) 3. The role of evidence in defending against legal challenges to cancer prevention laws Jonathan Liberman, McCabe Centre for Law and Cancer (Australia) 4. Using the law as an opportunity for non-communicable disease prevention Sondra Davoren, McCabe Centre for Law and Cancer (Australia)

Symposium PS.1.220

16:30 - 18:00 Room 207

TRACK 1

Symposium PS.1.164

5. Policy theories to advance cancer prevention policies Evelyne de Leeuw, Deakin University (Australia)

Session proposed by: Canadian Partnership Against Cancer, Canada and McCabe Centre for Law and Cancerâ&#x20AC;&#x2039;, Australia

CANCER AND LIFESTYLE: HEALTH PROMOTION IN HEALTH SERVICES AN UNDER EXPLORED AREA Chaired by: Annie Anderson, University of Dundee (United Kingdom) 1. Prevention activities in cancer screening settings Annie Anderson, University of Dundee (United Kingdom) 2. Should we offer cancer prevention interventions in colorectal cancer screening settings? Robert Steele, University of Dundee (United Kingdom) 3. Working together - Consultant referral and physical activity programme for prostate cancer survivors Trish Livingston, Deakin University (Australia) 4. Community based exercise programme for cancer survivors - opportunities for health enhancement Sandy McKiernan, Cancer Council Western Australia (Australia)

Session proposed by: University of Dundee, United Kingdom 267

16:30 - 18:00 Room 210

TRACK 1

Discussion panel PS.1.221

EXPANDING CANCER CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES: CHARTING NEW STRATEGIES FOR CANCER PREVENTION AND SCREENING Chaired by: Maria Aponte, Sociedad Anticancerosa de Venezuela (Venezuela) 1. Cancer awareness in rural village in Kenya: Challenges and experience from screening and awareness camps Kiarie Gladwell, Kenya Cancer Association (Kenya) 2. Psychosocial and cultural challenges in cancer prevention and screening in rural areas Regina Fernandez, Una Voz Contra el Cancer (Guatemala) 3. Using culturally appropriate methods for cancer prevention among indigenous populations Regina Fernandez, Una Voz Contra el Cancer (Guatemala) 4. Building initiatives for cancer early detection and awareness incorporating under screened populations Maria Aponte, Sociedad Anticancerosa de Venezuela (Venezuela)

Session proposed by: Kenyan Cancer Association, Kenya, Una Voz Contra el Cancer, Guatemala and Venezuelan Cancer Society, Venezuela

268

16:30 - 18:00 Room 219

TRACK 2

Symposium PS.2.93

THE INTERNATIONAL CANCER BENCHMARKING PARTNERSHIP GLOBAL LEARNING FROM OUR RESULTS Chaired by: Sara Hiom, Cancer Research UK (United Kingdom) Harpal Kumar, Cancer Research UK (United Kingdom) 1. International comparisons of survival, stage and treatment Heather Bryant, Canadian Partnership Against Cancer (Canada) 2. International comparisons of population awareness, attitudes and beliefs about cancer Peter Vedsted, Aarhus University (Denmark) 3. Primary care: systems and practitioners Jane Young, University of Sydney (Australia) 4. International comparison of routes to diagnosis and possible reasons for delay Victoria White, Cancer Council Victoria (Australia) David Weller, University of Edinburgh (United Kingdom) 5. What can we learn from international comparisons of data linkage? Jem Rashbass, Public Health England (United Kingdom)

Session proposed by: Cancer Research UK, United Kingdom

269

16:30 - 18:00 Room 220

TRACK 2

Symposium PS.2.145

ADDRESSING INEQUITIES IN CANCER CARE FOR INDIGENOUS PEOPLE IN AUSTRALIA, NEW ZEALAND AND NORTH AMERICA Chaired by: Patricia Valery, Menzies School of Health Research (Australia) Gail Garvey, Menzies School of Health Research (Australia) 1. Inequities in pathways of care and cancer outcomes in Australia Rajah Supramaniam, Cancer Council NSW (Australia) 2. Inequities in pathways of care and cancer outcomes in New Zealand Diana Sarfati, Cancer Control and Screening Research Group (New Zealand) 3. Patient cancer treatment consultations: do they contribute to inequities in cancer treatment and outcomes? Jeannine Stairmand, Womens Health Research Centre, University of Otago (New Zealand) 4. Indigenous Patient Navigator an intervention aimed at addressing unmet supportive care needs of Indigenous cancer patients in Australia Patricia Valery, Menzies School of Health Research (Australia) 5. Tele-oncology for Indigenous cancer patients in remote Queensland Sabe Sabesan, Townsville Cancer Centre (Australia)

Session proposed by: Menzies School of Health Research, Australia

270

16:30 - 18:00 Room 208

TRACK 3

Symposium PS.3.215

CANCER PAIN ACROSS THE WORLD: GLOBAL EFFORTS TO DEFINE AND MEET THE CHALLENGES Chaired by: Nathan Cherny, Shaare Zedek Cancer Pain and Palliative Care (Israel) James Cleary, UW Carbone Cancer Center (United States) 1. The global crisis of unrelieved cancer pain James Cleary, UW Carbone Cancer Center (United States) 2. Findings from the international collaborative project to evaluate the availability and accessibility of opioids Nathan Cherny, Shaare Zedek Cancer Pain and Palliative Care (Israel) 3. Global initiatives addressing the problem of inadequate cancer pain relief Julia Downing, International Children’s Palliative Care Network (South Africa)

Session proposed by: European Society for Medical Oncology (ESMO), Switzerland

16:30 - 18:00 Room 104

TRACK 4

Symposium PS.4.7

NATIONAL CANCER PLANS AND QUALITY OF CARE Chaired by: Peter Yu, Palo Alto Medical Foundation (United States) 1. The French National Cancer Plan 2003-2007 David Khayat, Salpetriere Hospital (France) 2. Cancer control and quality: the Australian experience Ian Olver, Cancer Council Australia (Australia) 3. Digital health, health disparities and quality improvement Peter Yu, Palo Alto Medical Foundation (United States) 4. Cancer prevention plans in the ASEAN region – the Tobacco Experience Mary Assunta, Southeast Asian Tobacco Control Alliance (Thailand)

Session proposed by: American Society of Clinical Oncology (ASCO), United States

271

Performance Showcase Cancer Council Australia invites you to a concert spectacular featuring some of the nation’s most extraordinary performers. Our incredible line-up of home-grown talent includes performances by: ·

Australian Girls Choir - Australia’s leading performing arts organisation for girls

Kage - A stunning and imaginative dance group

CircaNICA - Inspiring contemporary circus acts

Don’t miss out! Mark your diary and join us: 6-7pm, Friday 5 December Melbourne Convention and Exhibition Centre, Plenary Room #2 KAGE’s FORKLIFT, pictured: Amy Macpherson, photo: Jeff Busby

16:30 - 18:00 Room 103

TRACK 4

Symposium PS.4.115

HOW BURDEN ESTIMATES CAN MAKE AN IMPORTANT CONTRIBUTION TO CANCER SURVEILLANCE AND PREVENTION SYSTEMS Chaired by: Terry Slevin, Cancer Council Western Australia (Australia) 1. Global burden of cancer – uses and challenges Tim Driscoll, University of Sydney (Australia) 2. Importance of local exposure data for measuring burden and impacting policy Lin Fritschi, University of Western Australia (Australia) 3. Assessing burden to leverage system change Paul Demers, Occupational Cancer Research Centre (Canada) 4. Challenges of assessing the occupational cancer burden in Latin America and the Caribbean Julietta Rodriguez-Guzman, Pan-American Health Organization (Colombia) 5. Counting the cost of occupational cancer Lesley Rushton, Imperial College London (United Kingdom)

Session proposed by: Occupational Cancer Research Centre, Canada

18:00 - 19:00 Plenary #2

AUSTRALIAN PERFORMANCE SHOWCASE Cancer Council Australia invites you to a concert spectacular featuring some of the nation’s most extraordinary performers.

All Delegates

The incredible line-up of home-grown talent includes performances by: Australia Girls Choir – Australia’s leading performing arts organisation for girls Kage – A stunning and imaginative dance group CircaNICA – Inspiring contemporary circus acts

Organised by: Cancer Council Australia and the 2014 World Cancer Congress Local Host Committee

273

19:15 - 20:45 Plenary #2

TRACK 3

Big sCreen BSC.0.3

274

FILM PREMIERE: LITTLE STARS Chaired by: David Hill, Cancer Council Victoria (Australia) An acclaimed panel of international speakers will present a series of breathtaking films from around the world on the big screen to launch the Little Stars global advocacy project about childrenâ&#x20AC;&#x2122;s palliative care. Brace yourself for an evening of inspiration, insight and very good company in this celebration of life.

Event open to all delegates and non-registered guests of delegates

ePOSTER SESSION TIMES FRIDAY 5TH DECEMBER

11:15 - 11:45

ePoster Pod 1 - EP1.4 1.4 SCIENTIFIC STUDIES - DIAGNOSIS

4. Stages at diagnosis of common cancers in Ghana, Western Africa Paul Opoku, African Cancer Organisation, (Ghana) Abstract No: 746

1. Late diagnosis of female breast cancers in Cameroon: Between ignorance and negligence Marc Keller, French League Against Cancer, (France) Abstract No: 743

5. Same genetic factors of predisposition to lung cancer Sergiu Brenister, Moldavian Oncology Institute, (Moldova, Republic of) Abstract No: 747

2. Cultural beliefs about cancer influencing help-seeking and symptom appraisal: A metasynthesis of qualitative findings Sharon Licqurish, University of Melbourne, (Australia) Abstract No: 744

6. Preliminary application of contrast-enhanced cone-beam breast CT in differentiating benign and malignant breast lesions Zhaoxiang Ye, Tianjin medical university cancer institute & hospital, (China) Abstract No: 748

3. Age of Technology: Falling standard of clinical competence of new medical graduates; Oncology’s contribution to reverse this trend: improve clinical competence, care for all, including cancer patients Kamalendu Malaker, Ross University School of Medicine, (Canada) Abstract No: 745

7. The value of cone-beam breast computed tomography in breast cancer detection and diagnosis with comparison to conventional digital mammography Zhaoxiang Ye, Tianjin medical university cancer institute & hospital, (China) Abstract No: 749 8. Correlations between perfusion and intravoxel incoherent motion (IVIM) diffusion in nasopharyngeal carcinoma Xaioping Yu, Hunan Cancer Tumor (China) Abstract No: 750 275

11:15 - 11:45

2.4 ADVOCACY & AWARENESS - SCREENING

3.4 ADVOCACY & AWARENESS - DIAGNOSIS

1. Exploring options for cancer prevention in underserved populations: Experience of PESCA programme in Honduras Suyapa Bejarano, Liga Contra el Cancer Honduras, (Honduras) Abstract No: 751

1. Improving early detection and diagnosis of breast cancer in the Commonwealth of Dominica Hedda Dyer, Ross University School of Medicine, (Dominica) Abstract No: 759

2. Raising awareness of breast cancer early detection in Kingdom of Saudi Arabia Eiman Binyameen, Alfaisal Unversity, (Saudi Arabia) Abstract No: 752

2. An organized cervical cancer recommendation for regions with low rate of cervical cancer(Iran/Muslim countries) Nahid Khodakarami, Shahid beheshti University of Medical Sciences, (Iran) Abstract No: 760

ePoster Pod 2 - EP2.4

3. Shwe Yaung Hnin Si Cancer Foundationâ&#x20AC;&#x2122;s efforts to improve awareness of cancer among people of Myanmar Yin Yin Htun, Shwe Yaung Hnin Si Cancer Foundation, (Myanmar) Abstract No: 753 4. Encouraging equal access to breast cancer health services through breast health education Ana Teasdale, Susan G. Komen, (United States) Abstract No: 754 5. Cervical precancer treatment in low-resource settings: Lower prices, new technology options, and optimal scenarios for smart deployment Vivien Tsu, PATH, (United States) Abstract No: 755

276

ePoster Pod 3 - EP3.4

3. National society of pediatric hematologists and oncologists as an instrument of united professional community forming on the territory of the Russian Federation Kirill Kirgizov, Dmitriy Rogachev Federal Research Centre of Pediatric Hematology, Oncology and Immunology, (Russia) Abstract No: 761 4. Costing of a state wide population based Cancer awareness and early detection campaign in 2.7 million population of Punjab State in Northern part of India Jarnail Thakur, Post Graduate Institute of Medical Education and Research, Chandigarh, (India) Abstract No: 762 5. Signs in MR mammography: Eyes sees what mind knows Meenakshi Thakur, Tata Memorial Hospital, (India) Abstract No: 763

6. “I am Maximo. I am an advocate.” The universal story of the advocate Viji Venkatesh, The Max Foundation, (India) Abstract No: 764 7. Drama therapy workshop – Awareness through creative expression Viji Venkatesh, The Max Foundation, (India) Abstract No: 765 8. Validity and reliability study of ChemotherapyInduced Taste Alteration Scale (CITAS) Elif Sözeri, Gazi University, (Turkey) Abstract No: 766

11:15 - 11:45

ePoster Pod 4 - EP4.4 4.4 SCIENTIFIC STUDIES - PREVENTION 1. Improving information dissemination in BRCA1/2 families with a family communication tool Emma Healey, Prince of Wales Hospital, (Australia) Abstract No: 767

2. Understanding information dissemination challenges in BRCA1/2 families Emma Healey, Prince of Wales Hospital, (Australia) Abstract No: 768

3. The Relationship between passive smoking and breast cancer risk by N-Acetyltransferase 2 (NAT2) in non-smoking arab Israeli women Lital Keinan-Boker, Ministry of Health, (Israel) Abstract No: 769 4. Prevalence and socio-demographic deciding facts of tobacco use inside a group of people in Ouagadougou having HIV Marc Keller, French league against cancer, (France) Abstract No: 770 5. Survey on tobacco addiction at Senghor University in Alexandria, Egypt: Mars 2012 Marc Keller, French league against cancer, (France) Abstract No: 771 6. Application of fluorescence quantitation polymerase chain reaction(PCR) and HC2HPV-DNA for high-risk HPV detection in early screening of uterine cervical cancer Shixia Li, Tianjin Medical University Cancer Institute and Hospital, (China) Abstract No: 772 7. Environmental determinants for head & neck cancer prevention in North India Anupam Mishra, CSMMU (KGMC), (India) Abstract No: 773 8. Evaluation of the Western Australian (WA) LiveLighter “Sugary Drinks” obesity campaign Belinda Morley, Cancer Council Victoria, (Australia) Abstract No: 774

277

11:15 - 11:45

ePoster Pod 5 - EP5.4 5.4 SCIENTIFIC STUDIES - PALLIATIVE CARE 1. Burnout and meaning in life in volunteers working in palliative care Jayita Deodhar, Tata Memorial Hospital, Mumbai, India, (India) Abstract No: 775

2. Assessment of social and emotional wellbeing in cancer patients by FACT-G score and it’s correlation with FACT-G TOTAL score in Indian scenario Sanjay Dhiraaj, Sanjay Gandhi Post Graduate Institute of Medical Sciences, (India) Abstract No: 776 3. Impact of palliative care education intervention on nurses’ knowledge, attitudes and experience towards the care of the dying at oncology center -Mansoura University Karima Elshamy, Faculty of Nursing, Mansoura University, Egypt, (Egypt) Abstract No: 777 4. Social constraint amongst people with advanced cancer: A correlate with stigmatisation and anxiety Nicole Hennessy Anderson, Saint Vincent’s Hospital, (Australia) Abstract No: 778 5. Bone lesion score - a predictor of success of radionuclide therapy in skeletal metastasis Ghazal Jameel, Nuclear Medicine Oncology and Radiotherapy Institute -Islamabad -Pakistan, (Pakistan) Abstract No: 779

278

6. Decision making factors in consultations between older people and their oncologists Heather Lane, St Vincent’s Hospital, (Australia) Abstract No: 780 7. The discussion of age and geriatric assessment domains in consultations between older people and their oncologists Heather Lane, St Vincent’s Hospital, (Australia) Abstract No: 781 8. Tendency to breast reconstruction after breast mastectomy among Iranian women with breast cancer Maryam Salehi, Mashad University of medical sciences, (Iran) Abstract No: 782

11:15 - 11:45

ePoster Pod 6 - EP6.4 6.4 SCIENTIFIC STUDIES - SYSTEMS 1. Bone tumor profile in Dr. Soetomo Hospital Surabaya – Indonesia six years experience Sjahjenny Mustokoweni, Airlangga University, (Indonesia) Abstract No: 783

2. Purposes, of Jordan cancer registration cancer figures 1996-2010 Omar Nimri, Ministry of Health, (Jordan) Abstract No: 784 3. Trends of mortality from leukemia and lymphomas in children below 20 years, Brazil Débora Silva, INCA, (Brazil) Abstract No: 785

4. Racial disparities in cervical cancer (CC) survival in Brazil Luiz Thuler, Brazilian National Cancer Institute, (Brazil) Abstract No: 786

13:15 - 14:45

5. Prognostic factors in cervical cancer: a Brazilian cohort Luiz Thuler, Brazilian National Cancer Institute, (Brazil) Abstract No: 787

1. One size does not fit all: Introducing an equity framework into a tobacco reduction strategy Lorraine Greaves, BC Centre of Excellence for Womenâ&#x20AC;&#x2122;s Health, (Canada) Abstract No: 791

6. Patterns of care and outcome of elderly women diagnosed with cervical cancer (CC) in the developing world Luiz Thuler, Brazilian National Cancer Institute, (Brazil) Abstract No: 788

2. The case for banning duty-free tobacco sales and for banning/restricting duty-free personal import allowances Rob Cunningham, Canadian Cancer Society, (Canada) Abstract No: 792

7. The challenges of coding cancer of unknown primary (CUP) - a survey of current registration and reporting practices in Australia, the United Kingdom, and Republic of Ireland Claire Vajdic, University of New South Wales, (Australia) Abstract No: 789

3. Turkey Hookah awareness campaign Tuba Durgut, Turkish Green Crescent, (Turkey) Abstract No: 793

8. Incidence, mortality and survival trends of smoking-related cancers in women in Setif, Algeria, 1990-2009 Zoubida Zaidi, University Hospital of Setif, (Algeria) Abstract No: 790

ePoster Pod 1 - EP1.5 1.5 ADVOCACY & AWARENESS; PREVENTION

4. Advancing supportive cancer care and healing: evidence-based training for oncology nurses in georgia June 2014 University of Washington Allison Dvaladze, Seattle Cancer Care Alliance/ University of Washington, (United States) Abstract No: 794 5. Citizen science: Cancer Council volunteers auditing tobacco retail outlets Rae Fry, Cancer Council NSW, (Australia) Abstract No: 795 6. A peculiar African country with its peculiar challenges in cervical cancer prevention- The school-based cervical cancer vaccination awareness initiative in Nigeria James Oluwafunmilola, Breast Without Spot, (Nigeria) Abstract No: 796 279

7. A Nation with 70% Youths- Using our resources to increase cancer control advocacy in Nigeria James Oluwafunmilola, Breast Without Spot, (Nigeria) Abstract No: 797 8. Population-level relevance of risk factors for cancer: pooled study of seven Australian cohorts Maarit Laaksonen, The University of New South Wales, (Australia) Abstract No: 798 9. Testing ‘Just Say AAH’ for Smokefree Smiles: a victorian smokefree oral health project Alvin Lee, Cancer Council Victoria, (Australia) Abstract No: 799 10. Pretty Shady - engaging young Australians to stop skin cancer one summer at a time Blanche Marchant, Cancer Institute NSW, (Australia) Abstract No: 800 11. Advocacy strategies for public health policy gains -utilising the Smokefree Auckland Campaign as a case study Kristina Marcks, Cancer Society of NZ Auckland Division, (New Zealand) Abstract No: 801 12. Changing the cancer landscape by 2037: The Canadian Partnership Against Cancer (CPAC)’s approach to driving outcomes and measuring Performance Melanie Mayoh, Canadian Partnership Against Cancer, (Canada) Abstract No: 802

280

13. Establishing a protocol for intervention in hospitalized smokers. Experience in an urology department of a public Hospital, Montevideo, Uruguay Adriana Menendez, Comisión Pro Fomento Vecinal Plaza Cuauhtémoc, (Uruguay) Abstract No: 803 14. Youth against cancer in Kenya Atilla Merdin, Youth Against Cancer in Kenya, (Kenya) Abstract No: 804 15. A short introduction to cancer statistics Terence Mills, Loddon Mallee Integrated Cancer Service, (Australia) Abstract No: 805 16. Increasing awareness of alcohol as a risk factor for cancer: Approaches taken in Canada Robert Nuttall, Canadian Cancer Society, (Canada) Abstract No: 806 17. Addressing the educational needs of nurses caring for people with cancer in Ireland Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 807 18. Improving NCD prevention by comprehensive health promotion strategies the complementary roles of the public and NGO actors Eeva Ollila, Cancer Society of Finland, (Finland) Abstract No: 808 19. Establishing cancer information service center in Accra, Ghana Paul Opoku, African Cancer Organisation, (Ghana) Abstract No: 809

20. Papua New Guinea cancer policy: Developing a National Cancer Control Program George Otto, PNG National Cancer Centre, (Papua New Guinea) Abstract No: 810

13:15 - 14:45

21. E -health strategy for control and treatment of smokers from the Professional Council of Economics Sciences, City of Buenos Aires, Argentina (2013) Raul Pitarque, Argentinean Union against tobacco, (Argentina) Abstract No: 811

1. The sensory effects of licorice: The abuse liability of a flavor additive in tobacco products Pebbles Fagan, University of Hawaii Cancer Center, (United States) Abstract No: 819

22. Result and implementation of the graphic health warming in Indonesia Soeminar Siregar-Soeryakoesoema, Indonesian Cancer Foundation, (Indonesia) Abstract No: 812 23. Using mass media and online strategies to increase understanding of the UV Index Terry Slevin, Cancer Council Western Australia, (Australia) Abstract No: 813 24. Pink chain campaign in corporate offices: Cancer awareness campaign helping people to understand problems and screening modalities in cancer in high risk group Vivek Srivastava, Punarjeevan Bihar, (India) Abstract No: 814 25. Scientific technical literature - contribution to the knowledge and prevention of cancer Letecia Casado, National Cancer Institute, (Brazil) Abstract No: 815

ePoster Pod 2 - EP2.5 2.5 SCIENTIFIC STUDIES - PREVENTION

2. The development of a comprehensive exposure assessment strategy for polybrominated diphenyl ethers (PBDEs) for use in cancer epidemiology studies Shelley Harris, Cancer Care Ontario & University of Toronto, (Canada) Abstract No: 820 3. Bladder cancer risk is associated with occupational exposures to diesel but not gasoline engine emissions in a populationbased case-control study of Canadian men Shelley Harris, Cancer Care Ontario & University of Toronto, (Canada) Abstract No: 821 4. Occupational exposure to diesel and gasoline engine emissions and colon and rectal cancer risk: results from a population-based casecontrol study in Canadian men Shelley Harris, Cancer Care Ontario & University of Toronto, (Canada) Abstract No: 822 5. Results of the 2013 National Early Childhood Sun Protection Survey Kimberley Hawkins, Cancer Council SA, (Australia) Abstract No: 823

281

6. Rapidly changing causal factors of hepatocellular carcinoma (HCC) in Japan Hiroaki Kanda, Department of Pathology, the Cancer Institute of Japanese Foundation for Cancer Research(JFCR), (Japan) Abstract No: 824 7. Alcohol consumption and persistent infection of high risk-human papillomavirus Mi Kyung Kim, National Cancer Center, (South Korea) Abstract No: 825 8. Synergistic effect of secondhand smoking and alcohol drinking on risk of high risk-persistent human papillomavirus infection Ji Sook Kong, National Cancer Center, (South Korea) Abstract No: 826 9. Trends of female malignant neoplasms at Delhi State Cancer Institute (DSCI) - a tertiary level cancer care center catering to northern India Vinita Jaggi Kumar, Delhi State Cancer Institute (East), Dilshad Garden , Delhi , 110095, (India) Abstract No: 827 10. A novel and sustainable approach to educate the public on cancer awareness in Dominica: A unique Ross initiative Kamalendu Malaker, Ross University School of Medicine, (Canada) Abstract No: 828 11. Impact of a 10% excise tax increase on the retail price of tobacco in New Zealand Louise Marsh, University of Otago, (New Zealand) Abstract No: 829

282

12. Sugar-sweetened beverage (SSB) tax: Framing the message for public acceptability and support Jane Martin, Obesity Policy Coalition, (Australia) Abstract No: 830 13. Mental health patients’ receptivity to and uptake of a smoking cessation intervention, and reported changes in smoking behaviour Alexandra Metse, University of Newcastle, (Australia) Abstract No: 831 14. Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: study protocol for a randomized controlled trial Alexandra Metse, University of Newcastle, (Australia) Abstract No: 832 15. The correlation between history of breastfeeding and the incidence of childhood acute leukemia in Semarang, Indonesia Yetty Nency, Faculty of Medicine, Diponegoro Univ/ Kariadi Hospital, (Indonesia) Abstract No: 834 16. Food marketing with movie character toys: effects on young children’s preferences for healthy and unhealthy fast food meals Philippa Niven, Cancer Council Victoria, (Australia) Abstract No: 835

17. Impact of cigarette smoking on Nigerian air quality Chukwumere Nwogu, Roswell Park Cancer Institute, (United States) Abstract No: 836

23. Self-reported prevalence on cancer-related risky behaviors of junior high school students in Taiwan Anlin Peng, TTY Biopharm Company Limited Abstract No: 842

18. Cancer incidence and mortality due to alcohol in Ireland (2001-2010) Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 837

24. Prevalence and determinants of tobacco use among Restaurant employees in Mumbai, India Sharmila Pimple, Tata Memorial Centre, (India) Abstract No: 843

19. Synergistic effect of tobacco smoking and oral contraceptive on cervical intraepithelial neoplasia risk in Korea Hea Young Oh, National Cancer Center, (South Korea) Abstract No: 838

25. ‘Alcohol causes cancer in more places than you think’: Using a mass media campaign to raise awareness of the link between alcohol and cancer Helen Dixon, Cancer Council Victoria, (Australia) Abstract No: 844

20. Case-Control study of lifetime physical activity and breast cancer risk among Sri Lankan women Varuni Kumari, National Cancer Control Programme, (Sri Lanka) Abstract No: 839 21. Increasing implementation of effective smoking cessation strategies – The Quitstair Christine Paul, University of Newcastle, (Australia) Abstract No: 840 22. The preliminary report for breast cancer screening for 20000 women in China Tao Yu, Liaoning Cancer Hospital, (China) Abstract 841

26. Influence of a community-based breast health education model on early diagnosis of breast cancer in Ghanaian women Seth Wiafe, University of Southampton, (United Kingdom) Abstract No: 845 27. Making sense of quitting unassisted – exploring the reasons why smokers choose to quit on their own Andrea Smith, University of Sydney, (Australia) Abstract No: 846

283

13:15 - 14:45

ePoster Pod 3 - EP3.5 3.5 ADVOCACY & AWARENESS - SYSTEMS, PALLIATIVE CARE 1. Development of a framework of national cancer control indicators in Australia Cleola Anderiesz, Cancer Australia, (Australia) Abstract No: 847

2. Indigenous Patient Navigator: lessons learned from a pilot study in Queensland, Australia Christina Bernardes, Menzies School of Health Research, (Australia) Abstract No: 848 3. Changing the law: evidence, advocacy, and collaboration. Vanessa Rock, Cancer Council NSW, (Australia) Abstract No: 849 4. Policies Informed by evidence workshop: improving decision making processes for cancer control in Brazil Rodrigo Feijo, National Cancer Institute of Brazil, (Brazil) Abstract No: 850 5. Cancer Council NSW Healthy Lunch Box strategy: Utilising trained volunteers to achieve high reach into the community to deliver nutrition sessions Kristi Gander, Cancer Council NSW, (Australia) Abstract No: 851 6. The Nigerian National System of Cancer Registries-developing national cancer registration in developing countries Elima Jedy-Agba, Research, (Nigeria) Abstract No: 852 284

7. Consumer engagement in cancer research: Development of a consumer advisory committee for researchers in Sydney, Australia Stella Jun, TCRN, (Australia) Abstract No: 853 8. Conducting a cancer awareness campaign Subject based strategies Mohan Kumar, M.S.Ramaiah Medical College, (India) Abstract No: 854 9. The Patients’ expectations Observatory: Having a better understanding of patients’ expectations and needs in order to improve care and management Agathe Lasne, UNICANCER, (France) Abstract No: 855 10. Using network analysis in CANCON Joint Action Satu Lipponen, Cancer Society of Finland, (Finland) Abstract No: 856 11. Passing FCTC compliant tobacco control legislation amid conspicuous industry interference: the case of Senegal Mamadou Bamba Sagna, LISTAB, (Senegal) Abstract No: 857 12. Khojo cancer mitao cancer Lalit Gandhi, Global Marwari Charitable Foundation, (India) Abstract No: 858 13. The past, present and future of regulation of claims on food packages in Australia Lyndal Wellard, Cancer Council NSW, (Australia) Abstract No: 860

14. Use of mobile phone to disseminate information on the dangers of tobacco Hesborn Were, Tobacco and Alcohol Free Initiative(TAFI), (Kenya) Abstract No: 861 15. Designing and implementing a health disparities framework at Quit Victoria Bryn Williams, Cancer Council Victoria, (Australia) Abstract No: 862 16. Ethnicity as a risk in the first 10 year population study in Sikkim – A North Eastern State of India Yogesh Verma, Departmant of Health care Human services and family welfare, (India) Abstract No: 863 17. “Palliative care… Transforming Ideas to Actions”; A community outreach program Manal Al-Zadjali, Ministry of Health, (Oman) Abstract No: 864 18. Palliative care: Getting started – An online program Lyndsay Cassidy, St Vincents Hospital, Melbourne, (Australia) Abstract No: 865 19. Palliative care model in Ho Chi Minh city, Vietnam Dung Pham Xuan, Ho Chi Minh City Oncology Hospital, (Viet Nam) Abstract No: 866 20. Evidence level of integrative medicine in supportive care Afsar Imam, Akhter Husain Foundation, (Pakistan) Abstract No: 867

21. Generating evidence for strategic funding of cancer research: Cancer Australia’s audit of funding in Australia to cancer research projects and research programs 2006 – 2011 Cleola Anderiesz, Cancer Australia, (Australia) Abstract No: 868 22. Canadian health technology assessment system for cancer drugs improving cancer patient outcomes: How patient engagement systematically informs a uniquely Canadian HTA system James Gowing, Canadian Cancer Action Network, (Canada) Abstract No: 869 23. Cross-boundary Cancer Studies Norie Kawahara, Research Center for Advanced Science and Technology, The University of Tokyo, (Japan) Abstract No: 870 24. Implementing a cancer registry in a Brazilian nationwide self-administered health care plan: Strategies and initial findings Marcia Braga, Petróleo Brasileiro S.A. Petrobras, (Brazil) Abstract No: 871 25. Knowledge summaries of comprehensive breast cancer control Andre Ilbawi, MD Anderson Cancer Center, (United States) Abstract No: 872 26. Lessons learned: Establishing performance measurement for a provincial cancer control organization in Saskatchewan, Canada Riaz Alvi, Saskatchewan Cancer Agency, (Canada) Abstract No: 873 285

13:15 - 14:45

ePoster Pod 4 - EP4.5 4.5 SCIENTIFIC STUDIES - SURVIVORSHIP 1. A longitudinal pilot evaluation ofÂ supportive care intervention for colorectal cancer patients in general practice: The SATp Intervention Irene Ngune, Curtin University, (Australia) Abstract No: 875

2. Predicting attendance of post treatment cancer care patients in general practice: the role of concomitant health conditions in the theory of planned behaviour Irene Ngune, Curtin University, (Australia) Abstract No: 876 3. What causes breast cancer? A systematic review of causal attributions among breast cancer survivors and how these compare to expert endorsed risk factors Jo Anne Dumalaon, Flinders Centre for Innovation in Cancer, (Australia) Abstract No: 877 4. The ProCare Trial: A phase II randomised controlled trial of shared care for follow-up of men with prostate cancer Jon Emery, University of Melbourne, (Australia) Abstract No: 878 5. Are we talking with patients about sexuality: Challenges in ambulatory settings Margaret I. Fitch, Odette Cancer Centre, Sunnybrook Health Sciences Centre, (Canada) Abstract No: 879

286

6. Screening for symptom and emotional distress in cancer patients: Overcoming implementation challenges in an ambulatory setting Margaret I. Fitch, Odette Cancer Centre, Sunnybrook Health Sciences Centre, (Canada) Abstract No: 880 7. Telephone, print and web-based interventions for physical activity, diet and/or weight loss among cancer survivors: A systematic review Ana Goode, University of Queensland, (Australia) Abstract No: 881 8. How is post-treatment survivorship conceptualised by people from different cultural groups? Michael Jefford, Peter MacCallum Cancer Centre, (Australia) Abstract No: 883 9. Helping our support group leaders to lead Evan Kallipolitis, Prostate Cancer Foundation of Australia, (Australia) Abstract No: 884 10. Association between chronic kidney disease and cancer experiences among Korean adults: The Korean National Health and Nutrition Examination Survey V (2010-2012)Â Hee-Taik Kang, Gangnam Severance Hospital, (South Korea) Abstract No: 885

11. What can the youth internet culture offer to survivorship care in young adults with cancer? A study of blogs with an interest in gender differences Bora Kim, University of Sydney, (Australia) Abstract No: 886 12. Implementing survivorship care plans in a comprehensive cancer centre Nicole Kinnane, Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, (Australia) Abstract No: 887

17. Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: a multicentre cluster randomized controlled trial [ENGAGE] Patricia Livingston, Deakin University, (Australia) Abstract No: 892 18. Identifying variation in cancer mortality in the elderly; not as easy as it sounds Elizabeth Jane Maher, Macmillan Cancer Support, (United Kingdom) Abstract No: 893

13. Self-reported chronic disease in those with history of cancer – the influence of sex and socioeconomic status Bogda Koczwara, Flinders Centre for Innovation in Cancer, (Australia) Abstract No: 888

19. Understanding the variation in brain and central nervous system survivorship outcomes and morbidities Elizabeth Jane Maher, Macmillan Cancer Support, (United Kingdom) Abstract No: 894

14. Change in supportive care needs over the early disease trajectory for adults with primary brain tumours: a population-based study Danette Langbecker, Queensland University of Technology, (Australia) Abstract No: 889

20. Body image in adolescents and young adults with cancer: A systematic review and metaanalysis Serafino Mancuso, St Vincent’s Hospital Melbourne, (Australia) Abstract No: 895

15. Predictors of body image in overweight and obese breast cancer survivors: Living well after breast cancer Sheleigh Lawler, University of Queensland, (Australia) Abstract No: 890

21. Cancer patients motives and commitment towards Islamic healing Mazanah Muhamad, Universiti Putra Malaysia, (Malaysia) Abstract No: 896

16. The correlation between preoperative tumor markers and lymph node metastasis in gastric cancer patients underwent curative treatment Fangxuan LI, Tianjin medical university, (China) Abstract No: 891

22. Skin-sparing mastectomy with immediate breast reconstruction - When feasible, why not! Shravan Nadkarni, Sawai Mansingh Medical College & Hospitals, Jaipur, Rajasthan, (India) Abstract No: 897

287

23. Financial hardship and challenges accessing income support for AYAs and parent carers: ‘The amount of pressure Centrelink puts on you is enough to send anyone mental’ Lisa Orme, Peter MacCallum Cancer Centre, (Australia) Abstract No: 898 24. Quality of life, depression and anxiety levels and social support perceiving in caregivers of Turkish cancer patients under radiotherapy Zerrin Ozgen, MARMARA University Pendik Hospital, (Turkey) Abstract No: 899 25. Development of a population-based model of local control and survival benefit of radiotherapy for selected gastro-intestinal cancers Jesmin Shafiq, Collaboration for Cancer Outcomes Research & Evaluation (CCORE), Ingham Institute of Applied Medical Research, (Australia) Abstract No: 900 26. The changing landscape of advanced melanoma and its impact for cancer nurse specialists Christine Archer, ACT Health, (Australia) Abstract No: 901 27. The prognostic value of BAFF and APRIL serum levels in patients with follicular lymphoma Pingyong Yi, Hunan Cancer Hospital and the Affiliated Cancer Hospital Of Xiangya School Of Medicine, Central South University, (China) Abstract No: 902

288

13:15 - 14:45

ePoster Pod 5 - EP5.5 5.5 SCIENTIFIC STUDIES - TREATMENT 1. Quality of life of gynaecological cancer patients undergoing radiotherapy treatment at the Oncology Department at the Komfo Anokye Teaching Hospital, Ghana Vivian Della Atuwo-Ampoh, Komfo Anokye Teaching Hospital, (Ghana) Abstract No: 903

2. Effect of prostate cancer treatment types on cardiovascular disease risk factors in prostate cancer patients Iya Eze Bassey, Nigerian Cancer Society, (Nigeria) Abstract No: 904 3. Final Results from a phase-II randomized controlled study evaluating ADXS11-001 immunotherapy targeting HPV-E7 in women with recurrent/refractory cervical cancer Partha Basu, Chittaranjan National Cancer Institute, (India) Abstract No: 905 4. “If you were going to have bowel cancer surgery, who would you choose?” How urban and rural colorectal patients experience decision-making for referral to hospital and specialist Rebecca Bergin, Cancer Council Victoria, (Australia) Abstract No: 906

5. A Phase-II Randomized placebo controlled study on efficacy of topical application of curcumin and curcumin containing polyherbal cream to clear cervical human papillomavirus infection Jaydip Biswas, Chittaranjan National Cancer Institute, (India) Abstract No: 907 6. Need and tolerance of G-CSF in patients with targeted CD20+ diffuse large B-Cell lymphoma treated with R-CHOP regimens Chinmoy Bose, NCRI, (India) Abstract No: 908 7. Quality of implementation of a smoke-free policy in an inpatient psychiatric facility: Association with patient acceptability Jenny Bowman, University of Newcastle, (Australia) Abstract No: 909 8. Male breast cancer: Epidemiological study in patients attended in three academic hopistals in São Paulo Marcelo Calil, Instituto Brasileiro de Controle do Câncer, (Brazil) Abstract No: 910 9. Cat’s claw (Uncaria tomentosa) for the treatment of paliative care Marcelo Calil, Instituto Brasileiro de Controle do Câncer, (Brazil) Abstract No: 911 10. Chemotherapy in patients with hormone resistant prostate cancer: analysis of benefits and efficacy at a public hospital of Brazil Marcelo Calil, Instituto Brasileiro de Controle do Câncer, (Brazil) Abstract No: 912

11. Distant metastasis in squamous cell cancer of the oral cavity Arun Chaturvedi, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, (India) Abstract No: 913 12. Psychological issues and interventions in elderly cancer patients referred to a psychooncology service in a tertiary care cancer centre in a developing country Jayita Deodhar, Tata Memorial Hospital, Mumbai, India, (India) Abstract No: 914 13. The information needs of egyptian newly diagnosed breast cancer women undergoing surgery and their levels of satisfaction with the provision of information Karima Elshamy, Faculty of Nursing, Mansoura University, Egypt, (Egypt) Abstract No: 915 14. Time trends of chlinicopathological features and surgical treatment for gastric cancer - results from high-volume institutions in southern China Cheng Fang, Sun-yat sen university cancer center, (China) Abstract No: 916 15. Socioeconomic and geographic disparities: concordance with treatment guidelines and time to treatment for people with lung cancer Kalinda Griffiths, University of Sydney, (Australia) Abstract No: 917 16. The applying of NiTi cryoapplicators in the treatment of skin tumors Anton Khazov, Saint-Petersburg City Clinical Oncology Health Center, (Russia) Abstract No: 918 289

17. Treatment outcomes of incidentally detected carcinoma of gallbladder: Experiences from a tertiary care cancer centre in India Sunil Kumar, All India Institute of Medical Sciences, New Delhi, (India) Abstract No: 919 18. Predictors of breast radiotherapy plan modifications: Quality assurance rounds in a large cancer centre Fei-Fei Liu, Princess Margaret Cancer Centr, (Canada) Abstract No: 920 19. Comparison of IMRT and VMAT for stereotactic irradiation of primary prostate cancer Bo Luo, Hubei Cancer Hospital, (China) Abstract No: 921 20. Abrupt isolated central nervous system relapses after completion of palliative platinum based chemotherapy vinayak maka, M S Ramaiah Medical college, (India) Abstract No: 922 21. Combination of intraoperative radiotherapy (IORT) by using intrabeam system and oncoplastic breast surgery in Vietnam Tung Dinh Nguyen, Hue Central Hospital, (Viet Nam) Abstract No: 923 22. Nipple sparing mastectomy and immediately breast reconstruction in Vietnam Tung Dinh Nguyen, Hue Central Hospital, (Vietnam) Abstract No: 924

290

23. Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castrationresistant prostate cancer: dose-related immune boosting and suppression Masanori Noguchi, Kurume University School of Medicine, (Japan) Abstract No: 925 24. Exploring the education and information needs of patients on oral anticancer medications Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 926 25. Does neoadjuvant chemoradiation maintain a functional anal sphincter and a good quality of life in rectal cancer patients? Zerrin Ozgen, MARMARA University Pendik Hospital, (Turkey) Abstract No: 927 26. Trends in breast cancer care 2000 â&#x20AC;&#x201C; 2010; surgery (including Breast Reconstruction), radiation therapy, and chemotherapy: a joint breast cancer quality project between the Victorian Cancer Registry and the Victorian Admitted Episode Dataset Georgina Prassas, The Royal Prince Alfred Hospital, (Australia) Abstract No: 928 27. Analysis of the determinants that influence delays in the time to initiation of treatment of breast cancer in Brazil Luiz Claudio Thuler, Brazilian National Cancer Institute, (Brazil) Abstract No: 929 28. The Australian National Blood Cancer Registry Janey Stone, Australasian Leukaemia & Lymphoma Group, (Australia) Abstract No: 930

13:15 - 14:45

ePoster Pod 6 - EP6.5 6.5 SCIENTIFIC STUDIES - DIAGNOSIS, TREATMENT 1. Microsatellite instability status of gastric carcinoma from patients in the University College Hospital, Ibadan Henry Ebili, Olabisi Onabanjo University/Olabisi Onabanjo University Teaching Hospital, (Nigeria) Abstract No: 931

2. What is the best way to organise online colorectal cancer information? Ingrid Flight, Flinders Centre for Innovation in Cancer, (Australia) Abstract No: 932 3. Home care and palliative care services in Turkey Murat Gültekin, Turkish Ministry Of Health Cancer Control Department, (Turkey) Abstract No: 933 4. “I’d do anything. I’d try anything. When you’re in this position you just want to get well again” Acceptability of nutritional and physical activity interventions for men with localised prostate cancer Lucy Hackshaw-McGeagh, Bristol NIHR Biomedical Research Unit / University of Bristol, (United Kingdom) Abstract No: 934 5. Awareness and understanding of disease among hospitalized cancer patients in Pakistan Mansoor Hussain, (Pakistan) Abstract No: 935

6. Information needs and preferences: perspective of Pakistani cancer patients Mansoor Hussain, (Pakistan) Abstract No: 936 7. A central cancer registry and a physician join forces to accelerate progress in understanding thyroid cancer Jeannette Jackson-Thompson, University of Missouri School of Medicine, (United States Abstract No: 937 8. The predicted increase in cancer cases in Africa by the year 2050: Positive or negative news? Webster Kadzatsa, College of Health Sciences, University of Zimbabwe, (Zimbabwe) Abstract No: 938 9. Semi-quantitative HPV viral load estimation by Hybrid Capture2 as bio-marker for detection of Cervical Intraepithelial Neoplasia3 and cancers SRABANI MITTAL, Chittaranjan National Cancer Institute, (India) Abstract No: 939 10. Cytokine receptor expression in adult acute myeloid leukemia: high expression of interleukin-2 receptor α-chain (CD25) predicts a poor prognosis Kazunori Nakase, Mie University Hospital, (Japan) Abstract 940 11. Trends in Residual NMSC Treatment Neiraja Gnaneswaran, Waterford Medical Centre, (Australia) Abstract 1196 12. Blocking the PI3K/AKT pathway can impair metastasis of esophageal cancer Wen Wen Xu, The University of Hong Kong, (Hong Kong) Abstract 942 291

13. CanStaging: The online tool facilitating the international availability, standardisation and comparison of cancer staging Giulio Napolitano, Northern Ireland Cancer Registry, Queen’s University Belfast, (United Kingdom) Abstract No: 943 14. Annexin V expression and its relation with inflammatory mediators in colorectal cancer patients Serpil Nebioglu, Ankara University, Faculty of Pharmacy, (Turkey) Abstract No: 944 15. The malignant palm-plantar melanoma at the University Hospital in Brazzaville, Congo Judith Nsonde Malanda, Science faculty Brazzaville, (Congo) Abstract No: 945 16. Health-seeking trajectory of men with regards to symptoms of colorectal-cancer : A qualitative study Devesh Oberoi, Curtin University, (Australia) Abstract No: 946 17. A South Australian Cancer Atlas shows important variations in cancer risk and outcomes, but can better use be made of Australian data to support the work of cancer councils? Greg Sharplin, Cancer Council SA, (Australia Abstract No: 947

18. Correlation between parameters of dynamiccontrast enhanced MRI and clinical stage of nasopharyngeal carcinoma Xiaoping Xu, Hunan Cancer Tumor, (China) Abstract No: 948 19. Cancer Council Helpline 13 11 20 – how many people use this information and support service and why not? Monica Byrnes, Cancer Council SA, (Australia) Abstract No: 949 20. Tobacco related cancers in Turkey Murat Gultekin, Turkish Ministry Of Health Cancer Control Department, (Turkey) Abstract No: 950 21. Cervical cancer epidemiology in Ghana Yvonne Nartey, University of Otago, (New Zealand) Abstract No: 951 22. Facilitators and barriers to help seeking behaviour among Ghanaian women with breast cancer symptoms Seth Wiafe, University of Southampton, (United Kingdom) Abstract No: 952 23. Colposcopy as an adjunct to cytology in the diagnosis of cervical precancer and cancer in an executive health care set-up: A retrospective study in Mumbai, India Yogesh Kumar Gundakalle, J.N.Medical College, (India) Abstract No: 953 24. Using data visualization and mapping software to enhance understanding and increase use of health-related data Jeannette Jackson-Thompson, University of Missouri School of Medicine, (United States) Abstract No: 954

292

25. A palliative performance scale based prediction model for survival in patients undergoing palliative radiotherapy Fuqiang Wang, National Cancer Centre Singapore, (Singapore) Abstract No: 955 26. Survival analysis of 121 patients with spinal metastases from single center Guowen Wang, Tianjin Medical University Cancer Institute And Hospital, (China) Abstract No: 956 27. Review of cancer literacy across cultures Anna Shillabeer, RMIT University, (Viet Nam) Abstract No: 957 28. Evaluation of quality of life and anxiety and depresison levels in patients receiving chemotherapy for colorectal cancer: impact of patient education before treatment initiation Suayib Yalcin, Hacettepe University Institute of Cancer, (Turkey) Abstract No: 958

16:00 - 16:30

ePoster Pod 1 - EP1.6 1.6 ADVOCACY & AWARENESS - PREVENTION 1. Sustainable cancer prevention starts with sustainable prevention success Naowarut Charoenca, Mahidol University, (Thailand) Abstract No: 959

2. Please like me – A qualitative evaluation of the Make Smoking History Facebook Page Cassandra Clayforth, Cancer Council WA, (Australia) Abstract No: 960 3. Social marketing on a shoe string Amy Collie, Cancer Council Victoria, (Australia) Abstract No: 961 4. Prohibitions/restrictions on flavoured tobacco products: Updated overview of international developments Rob Cunningham, Canadian Cancer Society, (Canada) Abstract No: 962 5. Cancer Council NSW Healthy Lunch Box strategy: Improving acceptability and relevance for culturally and linguistically diverse (CALD) Communities? Kristi Gander, Cancer Council NSW, (Australia) Abstract No: 963 6. An example of a non-government and government program working in partnership to increase fruit and vegetable consumption Nina Tan, Cancer Council NSW, (Australia) Abstract No: 964 7. Pink Chain Campaign: Awareness regarding risk factors, symptoms and treatment facilities for cancer in different states of India Ankita Jaiswal, Punarjeevan Bihar, (India) Abstract No: 965

293

16:00 - 16:30

ePoster Pod 2 - EP2.6 2.6 ADVOCACY & AWARENESS - SURVIVORSHIP 1. To e or not to e: patient support in the digital era Corinne Hinlopen, Dutch Cancer Society, (Netherlands) Abstract No: 967

2. Key learnings from an evaluation of statewide models of post-treatment care Michael Jefford, Peter MacCallum Cancer Centre, (Australia) Abstract No: 968 3. A video advocacy campaign prepared with technology readily available on most computers: Put this drug on the Pharmaceutical Benefits Scheme (PBS) for men with advanced prostate cancer Jim Marshall, PCFA, (Australia) Abstract No: 969 4. ....Thrive to Survive: Enabling patient selfmanagement in the acute phase of treatment for head and neck cancer. Sharon McGonigle, Princess Margaret Cancer Center, (Canada) Abstract No: 970 5. Using digital technology to empower and support young adult (18-45 years) cancer survivors and their significant others. Jillian Mills, Cancer Council NSW, (Australia) Abstract No: 971 6. Irelandâ&#x20AC;&#x2122;s approach to survivorship Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 972 294

7. Challenges in the development and implementation of a national follow up policy for women with early breast cancer Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 973 8. Extending on assistant activities for breast cancer patients in Hanoi - Vietnam Huong Phung Thi, Vietnam Environment Protection Fund, (Viet Nam) Abstract No: 974

16:00 - 16:30

ePoster Pod 3 - EP3.6 3.6 SCIENTIFIC STUDIES - SYSTEMS 1. Trends in cancer incidence and mortality in Venezuela between 1990 and 2010 Maria Eugenia Aponte-Rueda, Venezuelan Cancer Society, (Venezuela) Abstract No: 975

2. Incidence and mortality of breast cancer in Venezuela: Past and current trends Maria Eugenia Aponte-Rueda, Venezuelan Cancer Society, (Venezuela) Abstract No: 976 3. National breast cancer control strategy in Yemen Huda Ba Saleem, Faculty of Medicine and Health Sciences, Aden University, (Yemen) Abstract No: 977 4. Creating a research resource for less common cancers Fiona Bruinsma, Cancer Council Victoria, (Australia) Abstract No: 978

5. Cancer Control in Mali - Local perceptions of cancer treatment and priority setting among health care providers Smita Chackungal, Western University, (Canada) Abstract No: 979 6. As time goes by: exploring cancer survival differences across small areas and time period Susanna Cramb, Cancer Council Queensland, (Australia) Abstract No: 980 7. Routes to diagnosis, a new measure for awareness and early diagnosis initiatives Lucy Elliss-Brookes, Public Health England, (United Kingdom) Abstract No: 981 8. Tackling inequalities through cancer intelligence: key metrics to enable change Lucy Elliss-Brookes, Public Health England, (United Kingdom) Abstract No: 982

16:00 - 16:30

ePoster Pod 4 - EP4.6 4.6 SCIENTIFIC STUDIES - PREVENTION 1. Knowledge, attitude and practices of cervical cancer prevention among women attending HIV treatment centre in LAUTECH Teaching Hospital, Nigeria: A qualitative study Adebola Adejimi, Ladoke Akintola University of Technology (LAUTECH)Teaching Hospital, (Nigeria) Abstract No: 983

2. The effect of scalp cooling on chemotherapyinduced hair loss on breast cancer patients Ayşe Arıkan Dönmez, Hacettepe University, (Turkey) Abstract No: 984 3. Need for action: Preventive care for chronic disease risk factors within community mental health services Jenny Bowman, University of Newcastle, (Australia) Abstract No: 985 4. Mindful weight loss: A systematic review of the efficacy of mindfulness interventions in terms of weight-related outcomes Amanda Hutchinson, University of South Australia, (Australia) Abstract No: 986 5. Disease prone behavior pattern and their interaction with smoking Aleksandra Kizior, Not for Profit, (Poland) Abstract No: 987 6. Cancer prone behavior pattern and their interaction with smoking habit Aleksandra Kizior, Not for Profit, (Poland) Abstract No: 988 7. Lifetime physical activity and breast cancer risk, a case-control study in Kelantan, Malaysia Aishah Knight Abd Shatar, Universiti Sains Malaysia, (Malaysia) Abstract No: 989 8. Alcohol consumption and Mortality in the Korean Multi-center Cancer Cohort (KMCC) Study Keun-Young Yoo, Seoul National University College of Medicine, (South Korea) Abstract No: 990 295

16:00 - 16:30

ePoster Pod 5 - EP5.6 5.6 SCIENTIFIC STUDIES - SCREENING 1. Patterns of childhood cancer incidence In Saudi Arabia (1999- 2008) Amen Bawazir, College of Public Health and Health Informatics, (Saudi Arabia) Abstract No: 991

2. Overdiagnosis due to mammography screening programs: Evidence from South Australia Kerri Beckmann, University of Adelaide, (Australia) Abstract No: 992 3. Colposcopy accuracy in a non-cytology based cervical cancer screening program Jaydip Biswas, Chittaranjan National Cancer Institute, (India) Abstract No: 993 4. Mortality profile of women recruited in a 10-years breast cancer screening cohort Maira Caleffi, FEMAMA - Brazilian Federation of Philanthropic Breast Health Institutions, (Brazil) Abstract No: 994 5. Association of history of dental extraction in patients with carcinoma of the alveolus of the maxilla and mandible- an audit Kanchan Dholam, Tata Memorial Hsopital, (India) Abstract No: 995 6. New consolidated decision principles for screening: a systematic review and synthesis of 45 years of evolving guidanceÂ Mark Dobrow, University of Toronto, (Canada) Abstract No: 996 296

7. The outcome of cervical cancer screening services integrated with primary health care: Down staging cervical cancer in a resource poor setting Rita Isaac, Christian Medical College, (India) Abstract No: 997 8. Trends in epithelial cell abnormalities observed on cervical smears (1992 â&#x20AC;&#x201C; 2012) in Mubarak Al-Kabeer Hospital, Kuwait Kusum Kapila, Kuwait University, (Kuwait) Abstract No: 998

16:00 - 16:30

ePoster Pod 6 - EP6.6 6.6 SCIENTIFIC STUDIES - TREATMENT 1. Functional Polymorphisms in cancer stem cell marker gene CD133 predict local recurrence and distant metastasis in non-small cell lung cancer patients treated with definitive radiotherapy Qiming Wang, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, (China) Abstract No: 999

2. Cyberknife radiosurgery for spinal lesions: experience in 21 cases Xiaoguang Wang, tianjin cancer hospital, (China) Abstract No: 1000

3. Outcome of supportive management in the prevention of chemotherapy induced nausea and vomiting in a resource limited set up â&#x20AC;&#x201C; nurse experience Job Wekesa Wamukaya, Moi Teaching and Referal Hospital, (Kenya) Abstract No: 1001 4. Predicting fear of cancer recurrence in gynaecological cancer survivors Hayley Whitford, Cancer Council Australia, (Australia) Abstract No: 1002 5. Quality of life (QoL) in patients with malignant dysphagia receiving radiotherapy alone versus chemoradiotherapy: An International randomized trial: TROG (03.01) NCIC CTG (ES2) Rebecca Wong, Princess Margaret Cancer Center, (Canada) Abstract No: 1003

6. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III Xufeng Wu, Hubei Maternity and Childrenâ&#x20AC;&#x2122;s Hospital, (China) Abstract No: 1004 7. Association of GSTP1 and RRM1 polymorphisms with response and toxicity to gemcitabine-cisplatin combination chemotherapy in Chinese NSCLC patients zhijun yuan, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, (China) Abstract No: 1005 8. Amplification of EGFR or FGFR1 was predominantly found in HPV negative oropharyngeal carcinoma Jiyun Yun, Pathology, (South Korea) Abstract No: 1006

297

DAY 3

SATURDAY 6TH DECEMBER

298

DAY 3

SATURDAY 6TH DECEMBER 7:00 - 7:45 Meeting point Registration desk

Meeting point at 7 am in front of the Registration desk Instructor: Alena Matzke Register at the General Enquiries counter, at the Registration desk, in front of the Global Village, on level 2. 8:30 - 10:00 Plenary #2

PLENARY DAY 3 - USING DATA TO DRIVE DECISIONS Chaired by: Robert Thomas, Victorian Department of Health (Australia) Translating a trillion points of data into therapies, diagnostics, and new insights into disease Atul Butte, Stanford University School of Medicine and Lucile Packard Children’s Hospital (United States)

Plenary PL.0.3

Panel discussion Cary Adams, Union for International Cancer Control (UICC) (Switzerland) Atul Butte, Stanford University School of Medicine and Lucile Packard Children’s Hospital (United States) Mary Gospodarowicz, Princess Margaret Cancer Center (Canada) David Currow Cancer Institute NSW (Australia)

Session proposed by: Union for International Cancer Control (UICC), Switzerland 299

10:00 - 10:15 Foyer/Global Village

10:15 - 11:15 Room 203-204

TRACK 1

Sub-Plenary SBP.1.80

BREAK

ADVANCES IN CERVICAL CANCER PREVENTION - WHATâ&#x20AC;&#x2122;S NEXT? Chaired by: Louise Galloway, Victorian Depatment of Health (Australia) 1. Australian HPV vaccination programme Julia Brotherton, National HPV Vaccination Register (Australia) 2. IPap Self Sampling Trial Dorota Gertig, Victorian Cervical Cytology Register (Australia) 3. Cervical cancer prevention - PATH projects in the developing world Scott Lamontagne, Program for Appropriate Technology in Health (PATH) (United States) 4. HPV testing pilot in the United Kingdom Julietta Patnick, Public Health England (United Kingdom)

Session proposed by: Cancer Council Victoria, Australia

10:15 - 11:15 Room 219-220

TRACK 2

THE JUSTICE OF PROVIDING APPROPRIATE CARE TO SENIOR CANCER PATIENTS: WHEN ETHICS MEETS ECONOMY Chaired by: Deb Keen, Canadian Partnership Against Cancer (Canada) Gilbert Zulian, University Hospital of Geneva (HUG) (Switzerland)

Session proposed by: Union for International Cancer Control (UICC), Switzerland Sub-Plenary SBP.2.252

300

Pap tests. A little awkward for a lot of peace of mind. Most women diagnosed with cervical cancer haven’t had regular Pap tests. It’s essential, even after the

HPV vaccine. If you’re overdue, book a Pap test with your doctor or nurse today. For more information phone 13

11 20 or visit papscreen.org.au

10:15 - 11:15 Room 210-211

TRACK 3

DEVELOPING THE EVIDENCE FOR CHILDREN’S PALLIATIVE CARE: FROM THEORY TO PRACTICE Chaired by: Julia Downing, International Children’s Palliative Care Network (South Africa) 1. The global need for children’s palliative care and the challenges for developing the evidence base Joan Marston, International Children’s Palliative Care Network (South Africa) 2. Findings from the Delphi study on prioritising global research in children’s palliative care including education and training Julia Downing, International Children’s Palliative Care Network (South Africa)

Sub-Plenary SBP.3.53

3. Developing and utilising the evidence for pain management in children Jenny Hynson, Victorian Paediatric Palliative Care Program (Australia) 4. Interventions and models of care in children’s palliative care – where are we and where are we going? Mary Ann Muckaden, Tata Memorial Centre (India)

Session proposed by: International Children’s Palliative Care Network (ICPCN), South Africa

10:15 - 11:15 Room 212-213 TRACK 4

Sub-Plenary SBP.4.91

POSITION, ROLE AND STRATEGIES OF CANCER SOCIETIES IN CANCER CONTROL Chaired by: Cora Honing, Dutch Cancer Society (The Netherlands) 1. Political and legal aspects of cancer control Anne Lise Ryel, Norwegian Cancer Society (Norway) 2. Building meaningful relationships - supporting and influencing a cancer control programme Donal Buggy, Irish Cancer Society (Ireland) 3. A challenge for a Cancer Society: Developing new strategies and defining new priorities in cancer control Stan Termeer, Dutch Cancer Society (The Netherlands)

Session proposed by: Dutch Cancer Society, The Netherlands

302

11:15 - 11:45 Global Village

ePOSTER PRESENTATIONS See full programme on page 332 - 336

ePoster Presentations

11:15 - 11:45 Foyer/Global Village

BUPA HEALTHY BREAK Morning coffee break sponsored by Bupa

11:45 - 13:15 Plenary #2

THE BIG SCREEN - CAMPAIGNS WITHOUT BORDERS: HOW TO SUCCESSFULLY ADAPT A PUBLIC HEALTH CAMPAIGN FOR YOUR AUDIENCE Chaired by: Kate Folb, Hollywood, Health and Society (United States)

TRACK 4

1. Every Cigarette is doing you damage David Hill, Cancer Council Victoria (Australia) Cameron Sugden, Tonga Health Promotion Foundation (Tonga) Stephen Hamill, World Lung Foundation (United States) 2. Pouring on the pounds / Rethink sugary drink Rebecca Perl, World Lung Foundation on behalf of NYC Department of Health (United States) Rebecca Berner, El Poder del Consumidor, (Mexico) Craig Sinclair, Cancer Council Victoria (Australia)

Big sCreen BSC.0.4

Showcasing impactful campaigns, which have been successfully adapted in multiple countries, this session will provide practical evidence that a great public health campaign doesn’t have to be built from scratch. Participants will be shown campaigns that were adapted to fit various local, linguistic and cultural contexts, and in so doing, were able to reach a much larger audience than originally intended. Presentations will be made by those who developed and implemented the original campaign concept as well as those who went through the process of adapting the campaign to suit their own organisation’s goals in an effort to raise awareness amongst, and change the behaviours of their target audience.

303

11:45 - 13:15 Ground Lever Foyer

THE NCD CAFÉ - HAVE A BREAK... HAVE AN NCD PERSPECTIVE •

NCD Presentations

See full programme on-site

NCDC.6

11:45 - 13:15 Room 203-204

TRACK 1

Concurrent Track Session CTS.1.224

THE WORLD CANCER RESEARCH FUND INTERNATIONAL CONTINUOUS UPDATE PROJECT (CUP): NOVEL ASPECTS AND LATEST RESULTS Chaired by: Kathryn Allen, World Cancer Research Fund International (United Kingdom) 1. Introduction to the World Cancer Research Fund International CUP Rachel Thompson, World Cancer Research Fund International (United Kingdom) 2. What is the epidemiological evidence linking early life events and cancer risk and what are the potential critical windows for cancer prevention? Ricardo Uauy, INTA University of Chile (Chile) 3. Ethnic differences, obesity and cancer, stages of the obesity epidemic and cancer prevention Tai Hing Lam, University of Hong Kong (Hong Kong) 4. Epidemiological evidence linking food, nutrition, physical activity and prostate cancer risk: results from the CUP Michael Leitzmann, Regensburg University Medical Center (Germany) 5. New methods for reviewing mechanistic evidence Richard Martin, University of Bristol (United Kingdom)

Session proposed by: World Cancer Research Fund International (United Kingdom)

304

11:45 - 13:15 Room 210

TRACK 2

Concurrent Track Session CTS.2.92

MEASURING THE PATIENT PERSPECTIVE IN CANCER CARE Chaired by: Janne Lehmann Knudsen, Danish Cancer Society (Denmark) 1. Measuring the patient perspective in cancer care Janne Lehmann Knudsen, Danish Cancer Society (Denmark) 2. Patient experiences of real time remote patient reported outcome assessment Sanchia Aranda, Cancer Institute of NSW (Australia) 3. Measuring the patient perspective through the whole pathway â&#x20AC;&#x201C; The experiences from establishment of a follow-up survey Cecilie Sperling, Danish Cancer Society (Denmark) 4. Cancer experience survey and patient reported outcomes - Development, use and the link between patient experiences and outcomes Jane Maher, Macmillan Cancer Support (United Kingdom) 5. Introducing patient reported outcome measures in clinical practice â&#x20AC;&#x201C; how can the tool support the patients? Janne Lehmann Knudsen, Danish Cancer Society (Denmark)

Session proposed by: Danish Cancer Society, Denmark

305

11:45 - 13:15 Room 211

TRACK 3

Concurrent Track Session CTS.3.85

HELP LIFE GET BETTER – “WHO CARES WHEN TREATMENT FINISHES?” HOW THE NFP SECTOR CAN ENGAGE THE COMMUNITY Chaired by: Haryana Dhillon, University of Sydney (Australia) 1. Integrating post treatment care – specialist centres, community, not-forprofits Michael Jefford, Cancer Council Victoria (Australia) 2. Utilising life-changing experiences of cancer survivors and caregivers to deliver community-based psychosocial workshops Annie Miller, Cancer Council NSW (Australia) 3. Cancer in the Workplace: supporting employers and employees affected by cancer Jenny Ritchie-Campbell, Macmillan Cancer Support (United Kingdom) 4. “Splashy headlines” to supportive care - Making collaborative research count - powerful examples translating research through to support services Annie Miller, Cancer Council NSW (Australia) Catalina Lawsin, University of Sydney (Australia) 5. Cancer Survivors taking a lead in steering collaborative advocacy campaigns engaging the community, policymakers and media to achieve positive outcomes in cancer policy Kelly Williams, Cancer Council NSW (Australia)

Session proposed by: Cancer Council NSW, Australia

306

TARGETING CANCER A Catalyst for Research Discovery From day one, NFCR has stood apart from larger cancer charities and government science funding institutions because we support the leading-edge research that those other groups can’t and won’t fund. NFCR is dedicated to supporting “high risk/high reward” cancer research and public education relating to prevention, early diagnosis, better treatments and, ultimately, a cure for cancer. With the help of 4.5 million individual donors over the last 40 years, NFCR has delivered more than $320 million in funding to cancer research leading to numerous breakthroughs, including prevention strategies, earlier diagnostic techniques, and new anticancer drugs and therapies.

A Facilitator for International Collaboration

A new era is dawning in the diagnosis and treatment of cancer. The black box that was the cancer cell has been opened, and with the grassroots support of millions worldwide, NFCR researchers have pioneered the redefinition of cancer as a genomic disease, transforming medicine, and bringing hope to patients around the world. NFCR research funding promotes and facilitates worldwide collaboration among scientists to accelerate the pace of discovery from laboratory bench to patient bedside. We currently support scientists in the US, UK, China, Germany, France, Italy, Poland, Mexico, Brazil, Spain, India and Canada. At NFCR, we are seeking to unite and focus the best minds on cancer. With so many dying from cancer every day, this is an urgent and essential mission, and we know you share our commitment to ending the tyranny of cancer.

1-800-321-CURE (2873) | www.NFCR.org | info@nfcr.org www.facebook.com/theNFCR | www.twitter.com/nfcr | www.youtube.com/wwwnfcrorg

11:45 - 13:15 Room 207

TRACK 4

Symposium SAT.4.347

DEVELOPMENTS IN PREVENTION AND EARLY DETECTION - SPOTLIGHT ON CERVICAL AND BOWEL CANCER PROGRAMMES Chaired by: Julie Torode, Union for International Cancer Control (UICC) (Switzerland) 1. Introducing new WHO guidelines for cervical cancer prevention Nathalie Broutet, World Health Organization (WHO) (Switzerland) Groesbeck Parham, Centre for Infectious Disease Research (Zambia) 2. Renewal of Australia’s National Cervical Screening Programme Karen Canfell, Cancer Council NSW (Australia) Louise Galloway, Victorian Department of Health (Australia) Tracey Bessell, Department of Health (Australia) 3. Progress towards a biennial bowel cancer screening program in Australia Bernie Towler, Australian Government Department of Health (Australia)

Session proposed by: Department of Health (Australia) and World Health Organization (Switzerland)

11:45 - 13:15 Room 212-213 TRACK 4

Concurrent Track Session CTS.4.196

REDUCING PREMATURE DEATHS FROM CANCER BY 50% IN 15 YEARS: GLOBAL LESSONS FROM DISEASE CONTROL PRIORITIES PROJECT Chaired by: Felicia Knaul, UICC; Harvard Global Equity Initiative (United States) Prabhat Jha, Centre for Global Health Research, St. Michael’s Hospital (Canada) 1. Panel discussion around the DCP project Prabhat Jha, Centre for Global Health Research, St. Michael’s Hospital (Canada) George Alleyne, Pan American Health Organization/World Health Organization (PAHO/WHO) (United States) Mary Gospodarowicz, Princess Margaret Cancer Center (Canada) Chris Wild, International Agency for Research On Cancer (IARC) (France) Anil D’Cruz, Tata Memorial Hospital (India)

Session proposed by: Harvard Global Equity Initiative, United States

308

11:45 - 13:15 Room 208

TRACK 4

BUILDING CAPACITY TO SUPPORT CIVIL SOCIETY ACTION ON NCDS Chaired by: Katie Dain, NCD Alliance (United Kingdom) Panel discussion Constance Kekihembo, Uganda NCD Alliance and East Africa NCD Alliance Initiative (Uganda) Anne Lise Ryel, Norwegian Cancer Society (Norway) Rebecca Morton-Doherty, Union for International Cancer Control (Switzerland)

Session proposed by: NCD Alliance and Union for International Cancer Control (UICC), Switzerland UICC Session UICC.4.6

11:45 - 12:45 Room 206

UICC MEMBERS’ REGIONAL MEETING - CONVENING THE CANCER COMMUNITY FROM WESTERN PACIFIC Prioritising Cancer in the Western Pacific Saunthari Somasundaram, National Cancer Society of Malaysia (Malaysia) Ian Olver, Cancer Council Australia (Australia)

RM.6

13:15 - 14:45 Foyer

THE NCD CAFÉ - HAVE A BREAK... HAVE AN NCD PERSPECTIVE •

NCD Presentations

See full programme on-site

309

13:15 - 14:45 Global Village

ePOSTER PRESENTATIONS See full programme on page 336 - 349

ePoster Presentations

13:15 - 14:15 Room 220

ABSTRACT ORAL SESSION 7 - SCIENTIFIC STUDIES IN PREVENTION AND MISCELLENEAOUS Chaired by: Rami Rahal, Canadian Partnership Against Cancer (Canada)

AOS.7

1. Comparison of cancer survival in New Zealand and in Australia, 2006-10 and 2000-05 Phyu Aye, The University of Auckland, (New Zealand) 2. Implementation of Ireland’s national cancer control strategy 2007 - 2013 Susan O’Reilly, Health Service Executive Ireland, (Ireland) 3. Towards an evidence-based model of palliative and supportive care for people with high-grade malignant glioma and their carers Jennifer Philip, St Vincent’s Hospital, (Australia) 4. A population study of the severity of symptoms and their correlates among 1127 men treated for prostate cancer in the Australian healthcare setting Julie Sykes, Prostate Cancer Foundation of Australia, (Australia) 5. Introducing careHPV into a public sector screening program in El Salvador Miriam Cremer, Basic Health International, (United States) 6. Pregnancy outcomes following diagnosis and treatment of adolescent and young adult cancer Fatima Haggar, The Ottawa Hospital and The University of Western Australia, (Canada)

310

Not Beyond Us

Don’t miss the World Cancer Day session to learn more about how your organisation can benefit from the Day!

Taking place under the tagline ‘Not beyond us’, World Cancer Day 2015 will take a positive and proactive approach to the fight against cancer, highlighting that solutions do exist across the continuum of cancer, and that they are within our reach.

Saturday 6th December 13:15-14:45 Room 218, Level 2 Melbourne Convention and Exhibition Center

The campaign will explore how we can implement what we already know in the areas of prevention, early detection, treatment and care, and in turn, open up to the exciting prospect that we can impact the global cancer burden – for the better.

A healthy lunch will be provided.

World Cancer Day is a unique opportunity to raise awareness that there is much that can be done at an individual, community and governmental level, to harness and mobilise these solutions and catalyse positive change. By moving forward together we have the potential to show: Cancer. It is not beyond us.

Visit worldcancerday.org to access all campaign materials! Follow us and take part in the global conversation on social media #WorldCancerDay #NotBeyondUs Facebook: World Cancer Day - Instagram: @WorldCancerDay

EARLY AND ACCURATE DIAGNOSIS OF CANCER Moving Towards a Solution. Chaired by: Dr. Mahmood Moshiri & Dr. Hossein Ghanbari LUNCH WILL BE PROVIDED

December TRACK 2

2014

13:15 14:15

ROOM

207

Early diagnisis as a solution and the current limitations of Early Diagnosis Dr. Ronald Stead of Gamma Dynacare Laboratories, Canada Serum based Cancer diagnosis, as a solution in the developing world Dr. Omid Khojasteh, Princess Margaret Hospital, Australia Early diagnosis as a solution using new bio-markers (HAAH) Dan Dumont and Kiarash Moshiri, Sunnybrook Research Institute, Canada, Poznan University of Medical Sciences, Poland Progress in diagnosis through blood testing and imaging David Andrews, Dr. Ladan Shariat, Sunnybrook Research Institute, Canada. Proteus Imaging Canada Inc.

13:15 - 14:45 Room 218

USING WORLD CANCER DAY AS A PLATFORM FOR... - WHAT VALUE CAN WORLD CANCER DAY BRING TO YOUR ORGANISATION AND HOW YOU CAN MAKE THE MOST OF IT Chaired by: Jeff Dunn, Cancer Council Queensland (Australia) 1. Using World Cancer Day as a Mass media engagement platform 2. Using World Cancer Day as an advocacy opportunity Wondu Bekele, Mathiwos Wondu Ye-Ethiopia Cancer Society (Ethiopia) 3. Using World Cancer Day as a collaborative opportunity between a cancer organisation and a corporate partner Cora Honing, Dutch Cancer Society (Netherlands) Ali McEvoy, Holland America Line (Australia)

UICC Session UICC.0.7

13:15 - 14:45 Room 207

TRACK 1

Session proposed by: Union of International Control (Switzerland)

EARLY AND ACCURATE DIAGNOSIS OF CANCER, MOVING TOWARDS A SOLUTION Chaired by: Mahmood Moshiri (Canada) and Haleh Samimi (Canada) Haleh Samimi, Panacea Global Inc. (Canada) 1. Academic-Industrial collaborations as a platform for developing novel cancer diagnostics David Andrews, Sunnybrook Research Institute (Canada) 2. Highly sensitive serum-based cancer diagnostics; a solution in the developing world Kiarash Moshiri, Poznan University of Medical Sciences (Poland) 3. Early cancer diagnosis using a new bio-maker (HAAH) reduces time to treatment, patient anxiety and health care costs Omid Khojasteh, Princess Margaret Hospital Australia (Australia)

Satellite Symposia SAT.1.395

4. Progress in cancer diagnosis through targeted imaging Ladan Shariat, Proteus Imaging Canada Inc. (Canada) 5. Correlating HAAH expression with the angiogenic and lymphangiogenic response Dan Dumont, Sunnybrook Research Institute (Canada)

313

13:15 - 14:45 Room 103

TRACK 2

QUALITY PATHOLOGY DIAGNOSIS: A KEY TO IMPROVING GLOBAL HEALTH. ADVANCING AFFORDABLE, ACCURATE, TIMELY PATHOLOGIC DIAGNOSTICS IN AFRICA 1. Introduction Edward Trimble, National Cancer Institute - USA (United States) 2. Fine needle aspiration and cytopathology: timely, accurate and affordable diagnostics in Africa Andrew Field, St. Vincentâ&#x20AC;?s Hospital, Sydney (Australia) 3. African Strategies for advancing pathology: maximizing the impact of pathology diagnosis on cancer control John Flanigan, National Cancer Institute - USA (United States)

Satellite Session SAT.2.360

4. Roundtable discussion

Session proposed by: National Cancer Institute - USA (United States)

314

13:15 - 14:45 Room 219

TRACK 4

BUILDING STRONGER NETWORKS TO INCREASE EXCHANGES OF SKILLS AND KNOWLEDGE Chaired by: Jamal Khader, King Hussein Cancer Center (Jordan) Riccardo Lampariello, Union for International Cancer Control (UICC) (Switzerland) 1. Cancer control in Africa – Sharing knowledge through networks Isaac Adewole, African Organisation for Research & Training in Cancer (AORTIC) (South Africa) 2. National Cancer Institutes join forces to accelerate cancer prevention and control in South America Luiz Antonio Santini Rodrigues da Silva, INCA Instituto Nacional de Cãncer (Brazil)

UICC Session UICC.4.12

3. The development of pediatric oncology in Turkey: Improving childhood cancer survival rate th rough professional training and education Tezer Kutluk, Turkish Association for Cancer Research & Control (Turkey) 4. Training and education in South East Asia – how knowledge is shared within the region Kailash Sharma, Tata Memorial Hospital (India) 5. Towards establishing twinning oncology programs between developing & developed countries: KHCC as an example Jamal Khader, King Hussein Cancer Center (Jordan)

Session proposed by: Union for International Cancer Control, Switzerland

315

Roundtable Discussion

Sponsored Session proposed by : UICC-ARO and UICC Japan

Friday 5th December 11:45 -- 13:45 in Room 209 Melbourne Convention and Exhibition Centre

Research trends on UHC

Lunch will be served to all attendees!

Shinjiro Nozaki, WHO

Profiling case models in Asia Shigeto Sonoda, Tokyo Univ.

Chair (moderator) Hideyuki Akaza, UICC-ARO, Tokyo Univ. Jae Kyung Roh, UICC-ARO, Yonsei Univ. Xishan Hao, UICC-ARO, CACA

The Path toward Universal Health Coverage At this roundtable we will be joined by key persons from Asian countries, who will engage in active discussions on the profiling of country case models with regard to Universal Health Coverage.

13:15 - 14:45 Room 210

TRACK 4

ECONOMIC BURDEN OF CANCER IN ASIAN COUNTRIES: HOW SHOULD WE FACE THE CURRENT SITUATION? Chaired by: Hideyuki Akaza, Japan Society of Clinical Oncology (Japan) Jae Kyung Roh, Yonsei University (Korea, Republic of) Xishan Hao, Chinese Anti-Cancer Association (CACA) (China) 1. Is Asia socially and scientifically meaningful concept?: Challenges of Asia barometer and its contribution to cancer studies Shigeto Sonoda, University of Tokyo (Japan)

Satellite Session SAT.4.231

2. Cost effectiveness in Japan Takashi Fukuda, National Institute of Public Health (Japan) 3. Cost effectiveness of cancer treatment in Korea Eun-Cheol Park, National Cancer Center - Korea (Korea, Republic of) 4. Cancer burden in China Ying Wang, Chinese Anti-Cancer Association (CACA) (China)

Session proposed by: UICC-Asia Regional Office, Japan

13:15 - 14:45 Room 208

TRACK 4

GLOBAL COUNTRY CANCER PROFILES – A TOOL TO SHAPE POLICY AND PRACTICE FOR IMPACT ON NATIONAL CANCER OUTCOMES AND THE GLOBAL 25X2025 GOAL Chaired by: Julie Torode, Union for International Cancer Control (UICC) (Switzerland) Tim Armstrong, World Health Organization (WHO) (Switzerland) In light of 2013 commitments to the global NCD targets and indicators, there is a pressing need for countries to both obtain and communicate accurate information on readiness and priority actions to respond to the growing cancer burden.

UICC Session UICC.4.11

The Global Country Cancer Profiles, to be launched at the WCC 2014, provides national stakeholders for the first time with a one-reference synthesis of the country cancer situation; cancer incidence, mortality, risk factor prevalence and status of policies and services. This interactive session will discuss the role of this tool in stimulating a more forceful multi-stakeholder response to the impact on national cancer outcomes, with panellists showcasing country experiences in using data to inform policy and practice. 317

Have you thought about product licensing? See what itâ&#x20AC;&#x2122;s all about on stand 1

HELPING YOU RAISE REVENUE TO FUND THE FIGHT AGAINST CANCER Looking for a new revenue stream? Have you considered product licensing in your country? Cancer Council Australia is a world leader in sun protection licensing, with products in more than 5000 stores across Australia and 23 countries around the globe. Our official licensing program offers the products and expertise to help reduce the risk of skin cancer while raising revenue for your cancer programs and services. Visit Cancer Council Australia on stand 1 and find out how we can help you develop an effective product licensing program.

Eyewear Sunshades Eyewear By purchasing Cancer Council sunglasses you can be confident you are getting the highest levels of eye protection, with our quality Category 3 polarised lenses.

Children’s Sunglasses The Eyewear Company A range of fun sunglasses designed for children and toddlers that have the maximum Eye Protection Factor rating of 10.

Sunscreen and Cosmetics Skin Health Pty Ltd Help protect your skin from the sun’s damaging UV rays with Cancer Council sunscreens and cosmetics ranges. With a broad range of SPF 30 – 50+ products to suit personal and lifestyle needs, there is a product for everybody.

Swimwear and Clothing Bright Bots Clothing and swimwear designed to ensure high levels of protection from the sun. Includes styles for adults and children.

Headwear Greenwich Headwear Broad brim, bucket and legionnaire style hats provide excellent sun protection. All Cancer Council hats have a UPF rating of 50+ and are available in a wide range of styles for men, women and children.

Optical Lens Coatings Essilor Crizal UV spectacle lenses cut UV radiation entering the front of the lens, as well as UV reflected off the back surface of lenses into and around the eyes of the wearer, providing maximum UV protection.

Auto Tinting Worldmark With a UPF rating of 50+, Cancer Council automotive window films deliver the highest protection available against the sun’s damaging UV rays.

13:15 - 14:45 Room 211

TRACK 4

WHAT IS THE UNIQUE ROLE OF GOVERNMENT POLICY LEADERSHIP IN CANCER CONTROL? WHAT SHOULD GOVERNMENT DO, WHAT SHOULDN’T IT DO, AND EXAMPLES OF THESE? Chaired by: Louise Galloway, Victorian Department of Health (Australia) This session will take a panel based approach and explore specific examples of policy reform, including legislation, system re-design, targeted programs, and supporting innovation in the sector, to improve outcomes and effectiveness and cost-effectiveness of cancer control.

Session proposed by: Victoria Department of Health (Australia) Satellite Session SAT.4.345

15:00 - 16:00 Room 206

UICC MEMBERS’ REGIONAL MEETING - CONVENING THE CANCER COMMUNITY FROM SOUTH-EAST ASIA Topic: TBD E. Soeminar Siregar, Indonesian Cancer Foundation (Indonesia) Anil D’Cruz, Tata Memorial Hospital (India)

RM.7

320

15:00 - 16:00 Room 212-213 Rapid-Fire Abstract Presentations RF.5

RAPID FIRE 5 - WORLD’S MOST INNOVATIVE CANCER FUNDRAISING CAMPAIGNS Chaired by: Car Adams, Union for International Cancer Control (UICC), (Switzerland) 1. Joining forces to fund national cancer research: Cancer Australia’s Prioritydriven Collaborative Cancer Research Scheme (PdCCRS) Cleola Anderiesz, Cancer Australia, (Australia) 2. Utilising social media to engage new audiences in a discussion about cancer. Virtual morning tea a new twist on a traditional fundraising event Karen Armstrong, Cancer Council Australia, (Australia) 3. Licensed products generate income, increase brand awareness and provide education opportunities Vivienne Mellish, Cancer Council Australia, (Australia) 4. Million dollar corporate partnerships Jane Hutchison, Cancer Council Australia, (Australia) 5. Fundraising for cancer patients, can it be a sustainable activity in resource constraint settings? Javaid Irfan, Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), Islamabad, Pakistan, (Pakistan) 6. Be Frank Campaign by Cancer Research Initiatives Foundation (CARIF) Jane Kweh, Cancer Research Initiatives Foundation (CARIF), (Malaysia) 7. Lotteries - A unique and sustainable source of undesignated funding for cancer research Christine Lasky, The Princess Margaret Cancer Foundation, (Canada) 8. Because Caring Counts by Colgate Palmolive Sangeetha Nair, National Cancer Society Malaysia, (Malaysia) 9. Three year 13 million USD 609 patient report of Indian Cancer Society’s AAA rated HDFC Debt Fund for Cancer Cure Purvish Parikh, Indian Cancer Society, (India)

321

Rapid-Fire Abstract Presentations RF.5

10. Macmillan Cancer Support: World’s Biggest Coffee Morning (WBCM) segmentation Jenny Ritchie-Campbell, Macmillan Cancer Support, (United Kingdom) 11. Raising funds to finance the fight against childhood cancer in Congo: The experience of the Calissa Ikama Foundation Ken Phinéas Tchiteya, Fondation Calissa Ikama, (Congo) 12. LIVESTRONG Day model for grassroots fundraising Devon McGoldrick, LIVESTRONG Foundation, (United States) 13. Christmas stars – Christmas campaign Ola Alexander Opdalshei, Norwegian Cancer Society, (Norway) 14. Changes in Australian incidence and mortality from 1987-2007: Sharing the news Eleonora Feletto, Cancer Council NSW, (Australia) 15. Leveraging formalised localism in fundraising Noelene Kotschan, Pink Drive, (South Africa) 16. Charitable funds, a ray of hope to rural poor cancer patients-an experience from Eastern India Jayasri Basak, Netaji Subhas Chandra Bose Cancer Research Institute, (India)

322

15:00 - 16:00 Room 211 Rapid-Fire Abstract Presentations RF.6

RAPID FIRE 6 - LATE BREAKING AND CANCER CONTROL, SYSTEMS AND GUIDELINES; DATA POPULATION Chaired by: Michael Jefford, Cancer Council Victoria (Australia) 1. Displaying the global burden of cancer – an international collaboration Lucy Elliss-Brookes, Public Health England, (United Kingdom) 2. Resource requirement for cancer registration in Low and Middle Income Countries: A case study in Kenya Mona Saraiya, Centers for Disease Control, (United States) 3. Racial and ethnic incidence and survival disparities among children with acute lymphoblastic leukemia in California, 1988-2011: what can be done to improve survival among the minority groups? Renata Abrahao, London School of Hygiene and Tropical Medicine, (United States) 4. Menthol cigarette smoking and obesity: Is there a link? Pebbles Fagan, University of Hawaii Cancer Center, (United States) 5. Alternative methods for primary cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of accuracy of VIA, VILI and HPV testing Joël Bertrand FOKOM DOMGUE, Department of Obstetrics and Gynaecology, Faculty of Medicine and biomedical Sciences, University of Yaoundé, Cameroon, (Cameroon) 6. The association of perceived efficacy and threat with intentions to quit smoking in Indigenous smokers aged 18-45 years in regional New South Wales: findings from a community-based survey Gillian Gould, James Cook University, (Australia) 7. International study of cancer management in general practice (New Zealand): preliminary findings Han Win Htun, University of Auckland, (New Zealand) 8. Obesity and risk of breast cancer in India Rajini Nagrani, Tata Memorial Centre, (India)

323

Rapid-Fire Abstract Presentations RF.6

9. Empowering Canadians through It’s My Life! - Stop cancer before it starts, an online interactive cancer prevention tool Robert Nuttall, Canadian Cancer Society, (Canada) 10. Smoking on the margins: An equity analysis of a municipal outdoor smokefree policy Ann Pederson, BC Women’s Hospital + Health Centre, (Canada) 11. Tobacco-specific pulmonary carcinogen higher in older smokers in the United States: National Health and Nutrition Examination Survey 2007-2012 Yang Xia, Centers for Disease Control and Prevention, (United States) 12. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer Guangyu An, Beijing Chaoyang Hospital, (China) 13. The effect of dendritic cell therapy on the overall survival of patients with locally advanced or metastatic breast cancer Jireh Ann Batac, The Medical City, (Philippines) 14. Circulating non-coding RNAs as biomarkers for the early detection of head and neck cancer Nham Tran, University of Technology, (Australia) 15. Engagement for cancer prevention: Forming partnerships with Canada’s indigenous peoples Deb Keen, Canadian Partnership Against Cancer, (Canada) 16. Brazilian inquiry of oncology nutrition Nivaldo Barroso de Pinho, National Cancer Institute, (Brazil) 17. Bone scan quantitative parameters as prognostic imaging biomarkers in Ca. prostate Shazia Fatima, Nuclear medicine, oncology & radiotherapy institute, (Pakistan) 18. Epidemiological and clinical characteristics of prostate cancer men with multiple cancers Leon Sun, National Cancer Institute, National Institutes of Health, w(United States)

324

Almost

80%

of NCD-related deaths occurres in low- and middle-income countries

Andri Tambunan/CAPA Pictures

www.sanofi.com

15:00 - 16:00 Plenary #2

CANCER SCREENING: INDIVIDUAL DECISIONS OR POPULATION APPROACHES? Moderator: Ross Stevenson, 3AW Radio (Australia)

Big Debate BD.0.3

Julietta Patnick, Public Health England (United Kingdom) Rengaswamy Sankaranarayanan, International Agency for Research On Cancer (IARC) (France) The emphasis on over-diagnosis and other risks of screening has led many to conclude that undertaking cancer screening should be a highly individualized decision, with varying degrees of medical intervention and/or risk-benefit information provided to each person considering this. However, much of the population-based gains in screening have come from public campaigns and/ or social marketing. Raising public awareness generally is going to be critical to seeing gains in the benefits of cancer screening in low and middle income countries, and among underserved populations in high income countries. The Congress will showcase a debate on ‘Cancer screening: individual decisions or population approaches?’ where one will explore the individualized risk benefit approach and debate on the importance of including the use of decision aids and discussions with General Practitioners to help individuals make informed screening decisions. To counter this argument, a debater will defend the “propopulation marketing” approach and make a public case for the benefits of cancer screening as one important tool in cancer control. This would include a discussion of appropriate parameters of such campaigns, but also to address how they may be critical to overcoming barriers in population acceptance of cancer screening.

326

15:00 - 16:00 Room 210

TRACK 1

Symposium PS.1.232

PREVENTING SKIN CANCER: ENABLING GOVERNMENT ACTION Chaired by: Sue Heward, Cancer Council Victoria (Australia) 1. Motivating evidence-based action in skin cancer prevention – the US Surgeon General Report and the Community Guide Mona Saraiya, Centers for Disease Control and Prevention (CDC) (United States) 2. Banning tanning beds – lessons from Brazil Rafael Gomes Fernandes, Brazilian Health Surveillance Agency (ANVISA) (Brazil) 3. Establishing a state-wide skin cancer prevention agenda Sally Doncovio, Victorian Government Department of Health (Australia) 4. Committing to social marketing for cancer prevention Blanche Marchant, Cancer Institute NSW (Australia)

Session proposed by: Cancer Council Victoria, Australia

15:00 - 16:00 Room 208

TRACK 1

END GAME STRATEGIES: BEGINNING OF THE END OR END OF THE BEGINNING? Chaired by: Alison Cox, Cancer Research UK (United Kingdom) 1. A global overview of End Games Strategies Ruth Malone, University of California (United States) 2. Smoking futures in Australia Wayne Hall, University of Queensland Centre for Clinical Research (Australia) Coral Gartner, University of Queensland Centre for Clinical Research (Australia)

Symposium PS.1.152

3. Smokefree New Zealand 2025 Edwards Richard, University of Otago (New Zealand) 4. South Asian perspectives on end game strategies Monika Arora, Public Health Foundation of India (India)

Session proposed by: Cancer Research UK, United Kingdom

327

15:00 - 16:00 Room 207

TRACK 1

FOOD POLICY FOR CANCER CONTROL – GLOBAL PERSPECTIVES FOR LOCAL SUCCESS Chaired by: Kathy Chapman, Cancer Council NSW (Australia) 1. Influencing food policy for cancer control - the Australian experience Clare Hughes, Cancer Council NSW (Australia) 2. Global perspectives on food policy for cancer control Corinna Hawkes, World Cancer Research Fund International (WCRF) (United Kingdom)

Discussion panel PS.1.48

Panelists Jane Landon, UK Health Forum (United Kingdom) Colleen Doyle, American Cancer Society (United States) Cliona Mhurchu, University of Auckland (New Zealand)

Session proposed by: Cancer Council New South Wales, Australia

15:00 - 16:00 Room 219

TRACK 2

Symposium PS.2.94

PATIENT SAFETY IN CANCER CARE - INITIATIVES IN THE NORDIC COUNTRIES Chaired by: Henriette Lipczak, Danish Cancer Society (Denmark) 1. Patient safety in cancer care – what’s the problem? Henriette Lipczak, Danish Cancer Society (Denmark) 2. Patient safety in cancer care – Norway Einar Hannisdal, Akershus University Hospital (Norway) 3. Patient safety in cancer care – Denmark Henriette Lipczak, Danish Cancer Society (Denmark) 4. Patient safety in cancer care - Sweden Mirjam Ekstedt, Royal Institute of Technology (Sweden)

Session proposed by: Danish Cancer Society, Denmark

328

15:00 - 16:00 Room 218

TRACK 3

Discussion panel PS.3.251

15:00 - 16:00 Room 220

TRACK 4

Symposium PS.4.69

GLOBAL AND LOCAL STEPS TO SHAPING A HEALTH SYSTEMS APPROACH TO PALLIATIVE CARE AND PAIN RELIEF AS A CORE COMPONENT OF NCCP Chaired by: George Alleyne, Pan American Health Organization/World Health Organization (PAHO/WHO) (United States) Jonathan Liberman, McCabe Centre for Law and Cancer (Australia) 1. Panel discussion Zipporah Ali, Kenya Hospices and Palliative Care Association (KEHPCA) (Kenya) Dennis Ocansey, Ministry of Health Ghana (Ghana) Jim Cleary, Pain Policy Research Group, University of Wisconsin-Madison (United States) Elizabeth Mattfeld, Pacific Institute for Research and Evaluation - PIRE (United States)

Session proposed by: Global Access to Pain Relief Initiative (GAPRI), Switzerland

ACCELERATING AND MEASURING THE APPLICATION OF CANCER EVIDENCE Chaired by: Shelly Jamieson, Canadian Partnership Against Cancer (Canada) 1. Measuring and monitoring the effectiveness of knowledge transfer and exchange in the pan-Canadian cancer control strategy Shelly Jamieson, Canadian Partnership Against Cancer (Canada) 2. Advancing the application, quality and harmonisation of implementation science measures 3. Implementing and evaluating a national knowledge translation and exchange platform for NCD prevention Tahna Pettman, CO-OPS collaboration (Australia)

Session proposed by: Canadian Partnership Against Cancer, Canada

329

15:00 - 16:00 Room 103

TRACK 4

Symposium PS.4.246

FUNDING CANCER RESEARCH: HOW TO ALLOCATE FUNDS WELL – AND HOW TO DO IT EVEN BETTER Chaired by: Terry Slevin, Cancer Council Western Australia (Australia) Ian Olver, Cancer Council Australia (Australia) 1. How to (and why) establish a cancer research funding programme: Tips for organisations new to cancer research funding Emma Croager, Cancer Council Western Australia (Australia) 2. How to measure the results of cancer research funding programmes: “Fishing for the answers” Alison Butt, National Breast Cancer Foundation (Australia) 3. How the future might look: A big picture view of cancer research funding trends internationally Harpal Kumar, Cancer Research UK (United Kingdom)

Session proposed by: Cancer Council Western Australia, Australia

16:00 - 17:00 Global village

2014 WORLD CANCER CONGRESS CLOSING RECEPTION

17:00 - 19:00 Plenary #2

CLOSING CONCERT: INSPIRING LIVES; INSPIRING MUSIC

Invite only

Mike Peters, joined by a number of friends from the international music scene will bring the 2014 World Cancer Congress to a peak by taking delegates and Melbournians on a compelling journey, mixed by storytelling and rock music.

OPEN TO ALL CONGRESS DELEGATES Closing event organised by: Mike Peters, Lead singer of The Alarm, co-founder of Love, Hope, Strength Foundation, and cancer survivor

Plenary

330

UICC AND LOVE HOPE STRENGTH FOUNDATION PRESENTS

ROCK THE CONGRESS INSPIRING LIVES INSPIRING MUSIC

JOIN MIKE PETERS OF THE ALARM & SPECIAL GUESTS MELBOURNE CONVENTION & EXHIBITION CENTER 1700-1900 SATURDAY 6th DECEMBER PLENARY #2

ePOSTER SESSION TIMES SATURDAY 6TH DECEMBER

11:15 - 11:45

ePoster Pod 1 - EP1.7 1.7 ADVOCACY & AWARENESS - TREATMENT 1. Correction of anatomic changes after surgery for breast cancer by evaluating multidisciplinary team and individualized preparation of external prosthesis Marcelo Calil, Instituto Brasileiro de Controle do CĂ˘ncer, (Brazil) Abstract No: 1007

2. Cervical cancer control program in botswana: current state and future directions Surbhi Grover, UPENN, (United States) Abstract No: 1008 3. Prostate Cancer Education Day Patricia (Trish) Husband, The Townsville Hospital, (Australia) Abstract No: 1009 4. Use of Canadian Association of nurses in oncology standards and competencies to enhance the oncology nursing curriculum for the community cancer programs in Manitoba Jodi Hyman, Cancer Care Manitoba, (Canada) Abstract No: 1010

332

5. Psychosocial issues in genetic counseling referrals in a cancer hospital in New Delhi, India Deepali Kapoor, Breast Cancer Patients Benefit Foundation, (India) Abstract No: 1011 6. A multi-site evaluation of summer camps for children with cancer and their families Alexandra Martiniuk, University of Sydney, University of Toronto, and the George Institute for Global Health, (Australia) Abstract No: 1012 7. Together weâ&#x20AC;&#x2122;re better: Establishing a community oncology nursing programme to improve cancer care through shared working Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 1013 8. Research project involved patient advocates in three regions: barriers accessing PCR testing among people living with CML Mei Ching Ong, The Max Foundation, (Malaysia) Abstract No: 1014

11:15 - 11:45

ePoster Pod 2 - EP2.7 2.7 ADVOCACY & AWARENESS - PREVENTION 1. Best bang for your buck – a quasiexperimental approach to investing public money in an anti-tobacco campaign Cassandra Clayforth, Cancer Council WA, (Australia) Abstract No: 1015

2. Successful advocacy strategies that brought about a solarium ban in Victoria Cairin Conway, Cancer Council Victoria, (Australia) Abstract No: 1016 3. Keep fresh air fresh: Mobilising supporters through digital advocacy Jessica Craven, Cancer Council Victoria, (Australia) Abstract No: 1017 4. The case for banning visible displays of tobacco products in retail stores Rob Cunningham, Canadian Cancer Society, (Canada) Abstract No: 1018 5. QUEST – making the healthy choice the easy choice Rebecca Lowe, Cancer Council Queensland, (Australia) Abstract No: 1019 6. Homeless clients benefit from smoking cessation treatment delivered by a homeless persons’ program Sarah Maddox, Cancer Council Victoria, (Australia) Abstract No: 1020

7. Lessons learned: A partnership approach for ‘Smoking Care’ in a housing crisis and homelessness services organisation Ben O’Mara, Quit, Cancer Council Victoria, (Australia) Abstract No: 1021 8. The legal barriers to plain packaging: A juridical analysis from India and Australia to assist India progress with plain pax Amit Yadav, PHFI, (India) Abstract No: 1022

11:15 - 11:45

ePoster Pod 3 - EP3.7 3.7 SCIENTIFIC STUDIES - PREVENTION 1. Relationship between obese women with breast cancer, their socioeconomic status and comorbidities Linda Nguyen, Queensland Health, (Australia) Abstract No: 1023

2. Quitting experiences and preferences of smokers admitted to Australian public hospitals participating in a randomised controlled trial Dennis Thomas, Monash University, (Australia) Abstract No: 1024 3. Cancer incidence attributable to alcohol drinking in Brazil Luiz Claudio Thuler, Brazilian National Cancer Institute, (Brazil) Abstract No: 1025

333

4. Proactive recruitment into effective interventions targeting cancer risk behaviours Flora Tzelepis, University of Newcastle, (Australia) Abstract No: 1026

11:15 - 11:45

5. Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study Claire Vajdic, University of New South Wales, (Australia) Abstract No: 1027

1. Nutritional and physical activity interventions for men with prostate cancer: A systematic review Lucy Hackshaw-McGeagh, Bristol NIHR Biomedical Research Unit / University of Bristol, (United Kingdom) Abstract No: 1031

6. Study protocol: Prospective evaluation of personalised melanoma risk information in Australian general practice Kylie Vuong, University of Sydney, (Australia) Abstract No: 1028

2. Cannabinoid botanicals in cancer treatment Sukdev Nayak, AIIMS, Bhubneshwar, (India) Abstract No: 1032

7. Trialling a colorectal cancer risk tool within general practice; NHMRC “Centre for Research Excellence for reducing the burden of colorectal cancer by optimising screening” Jon Emery, University of Melbourne, (Australia) Abstract No: 1029 8. Relationship between three major dietary patterns and risk of colorectal cancer: Results from general Newfoundland and Labrador population recruited from 1999-2003 Peizhong Wang, Memorial University of Newfoundland, (Canada) Abstract No: 1030

334

ePoster Pod 4 - EP4.7 4.7 SCIENTIFIC STUDIES - TREATMENT

3. Quality of breast cancer care following centralisation in Ireland Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 1033 4. Efficacy of centralisation of breast cancer surgery in Ireland Susan O Reilly, Health Service Executive Ireland, (Ireland) Abstract No: 1034 5. Multi-centre pre-post test trial of a complex Qstream© pain assessment intervention on cancer nurses’ pain screening and assessment practices Jane Phillips, University of Technology Sydney, (Australia) Abstract No: 1035

6. Image guided radiotherapy in prostate cancer: Early results with safety and efficacy Neeraj Rastogi, Sanjay Gandhi Postgraduate Institute of Medical Sciences, (India) Abstract No: 1036 7. Hyperthermia as adjunctive therapy in integrative cancer therapy Avni Sali, National Institute of Integrative Medicine, (Australia) Abstract No: 1037 8. What are the supportive care issues affecting the Victorian cancer population: How do we know, what does it mean and what can we do? Melissa Shand, North Eastern Melbourne Integrated Cancer Service (NEMICS), (Australia) Abstract No: 1038

11:15 - 11:45

ePoster Pod 5 - EP5.7

3. Demographic characteristics, information and psychosocial support needs of carers who accessed Australian Cancer Council helplines from January 2010 – December 2012 Leila Heckel, Deakin University, (Australia) Abstract No: 1041 4. Relay For Life…or a few years, in Queensland: Episodic volunteer retention in the cancer control context Melissa Hyde, Griffith University, (Australia) Abstract No: 1042 5. Cancer incidence in South-Eastern NigeriaFirst results from the Enugu Cancer Registry Elima Jedy-Agba, Research, (Nigeria) Abstract No: 1043 6. A novel IGF1 signalling pathway regulated by EphA4 delays cancer development induced by 4T1 murine breast cancer isografts Xuefeng Jing, Wakayama Medical University, (Japan) Abstract No: 1044

5.7 SCIENTIFIC STUDIES - SYSTEMS, PREVENTION

7. Changes in cancer care by 2020 Agathe Lan, UNICANCER, (France) Abstract No: 1045

1. Factors influencing patient delay in seeking medical care among egyptian women presenting with advanced breast cancer at Oncology Centre –Mansoura University Karima Elshamy, Faculty of Nursing, Mansoura University, Egypt, (Egypt) Abstract No: 1039

8. The role of informal caregivers in cancer care: Tasks, time spent and relationship with perceived burden Ruby Lipson-Smith, Peter MacCallum Cancer Centre, (Australia) Abstract No: 1046

2. Analysis of mortality from acute lymphoblastic leukemia in children and adolescents in Mexico, 2003-2012 Aurora Gonzalez Rivera, Instituto Nacional de Pediatria, (Mexico) Abstract No: 1040 335

11:15 - 11:45

ePoster Pod 6 - EP6.7 6.7 SCIENTIFIC STUDIES - LATE BREAKING 1. Lymph node density is a prognostic factor in patients with major salivary gland carcinoma Hidenori Suzuki, Aichi Cancer Center Hospital, (Japan) Abstract No: 1047

2. The role of Histone Methyltransferase G9a and Chemotherapeutic Susceptibility in head and neck cancer Ching-Ting Tan, National Taiwan University College of Medicine Abstract No: 1048 3. A novel literature-based approach to identify genetic and molecular predictors of survival in GBM: Analysis of 14678 patients using systematic review and meta-analytical tools Matthew Thuy, Ryde Hospital, (Australia) Abstract No: 1049 4. Development and evaluation of a potential treatment against castration resistant prostate cancer.Â Xin Wang, Sichuan Kangcheng Biomed Ltd.Co, (China) Abstract No: 1059 5. The combination of PAX1 methylation gene with oncogenic HPV typing is a new molecular pap smear for cervical cancer detection in China Yu Zhang, Xiangya Hospital, Central South University, (China) Abstract No: 1051

336

6. The preliminary analysis of the factors related to the survival of pancreatic cancer in elderly patients with minimally invasive therapy Xiaoyan Zhu, , (China) Abstract No: 1052 7. Pim-1 acts as an oncogene in human salivary adenoid cystic carcinoma Xin Zhu, Zhejiang Cancer Hospital, (China) Abstract No: 1053 8. A novel blood test for tumour resection and recurrence monitoring Susanne Pedersen, Clinical Genomics Technologies, (Australia) Abstract No: 1054

13:15 - 14:45

ePoster Pod 1 - EP1.8 1.8 ADVOCACY & AWARENESS - PREVENTION 1. Strengthening national tobacco control in Jordan: stirring up momentum and engagement through creating forums for collaboration, communication, and sharing of information Rasha Bader, King Hussein Cancer Center, (Jordan) Abstract No: 1055

2. Teaching doctors regarding various aspects of breast cancer at primary health center in rural part of India: Can drive future in breast cancer outcome in India by prevention and early detection Keshav Barnwal, Punarjeevan Bihar, (India) Abstract No: 1056

3. Entering the virtual health library prevention and cancer control in social networks - the experience on Facebook Leticia Casado, National Cancer Institute from Brazil, (Brazil) Abstract No: 1057 4. Reach and reaction – promoting World No Tobacco Day to the masses through Facebook Cassandra Clayforth, Cancer Council WA, (Australia) Abstract No: 1058 5. Making the most of the tobacco excise Amy Collie, Cancer Council Victoria, (Australia) Abstract No: 1059 6. No more hiding: capitalising on the conversation around plain packaging through viral video Jessica Craven, Cancer Council Victoria, (Australia) Abstract No: 1060 7. Development and evaluation of the Find Cancer Early community education campaign in regional Western Australia Emma Croager, Cancer Council WA, (Australia) Abstract No: 1061 8. Can the voluntary services of cancer clinicians be an alternative strategy to extend the outreach of cancer control strategies: Experience from a rural cancer initiative in eastern India Sunil Kumar, All India Institute of Medical Sciences, New Delhi, (India) Abstract No: 1065

9. Harnessing coalitions to counter food industry solutions – the Coca Cola journey Jane Martin, Obesity Policy Coalition, (Australia) Abstract No: 1066 10. Building capacity for cervical cancer prevention in Fiji Catherine McGowan, Family Planning NSW, (Australia) Abstract No: 1067 11. New technologies and new industry tactics: recent developments in industry selfregulation of food advertising to children in Australia Caroline Mills, Cancer Council Victoria, (Australia) Abstract No: 1068 12. Awareness on testicular cancer: saving lives through self examination Miryana Pérez Vela, Fundación Rebecca de Alba, A.C., (Mexico) Abstract No: 1069 13. The added value of primary prevention to the battle against cancer Tim Rombouts, KWF Kankerbestrijding / Dutch Cancer Society, (Netherlands) Abstract No: 1070

337

14. Breast cancer awareness and navigation programme Gerda Strauss, Cancer Associaiton of South Africa (CANSA), (South Africa) Abstract No: 1072 15. Pink chain campaign in Delhi University: An initiative to teach Delhi university youth about cancer prevention and early detection Sneha Upadhyaya, Punarjeevan Bihar, (India) Abstract No: 1073 16. Whose Rights? Enabling community action to implement smoking bans in multi-unit housing complexes Scott Walsberger, Cancer Council NSW, (Australia) Abstract No: 1074 17. What have been the consequences of the introduction of menu labelling in fast food outlets? Lyndal Wellard, Cancer Council NSW, (Australia) Abstract No: 1075 18. Challenging the status quo of settings-based health promotion program delivery Emma White, Cancer Council NSW, (Australia) Abstract No: 1076 19. Title: Health Empowerment for You (HEY) Cheryl Whiting, Saskatchewan Cancer Agency, (Canada) Abstract No: 1077

20. Addressing delayed breast cancer presentation in Ghana through community outreach programs Seth Wiafe, University of Southampton, (United Kingdom) Abstract No: 1078 21. Building capacities, advocating policy compliance and engaging media for effective implementation of FCTC – Experience from Project ‘STEPS’ in two states of India Amit Yadav, PHFI, (India) Abstract No: 1079

13:15 - 14:45

ePoster Pod 2 - EP2.8 2.8 ADVOCACY & AWARENESS - TREATMENT 1. Using photovoice to collect evidence-based material for cancer advocacy in South Africa Linda Greef, People Living With Cancer, (South Africa) Abstract No: 1080

2. A comparison of the caller profiles of carers/ family members and people diagnosed with cancer who called a South Australian cancer helpline: implications for practice Kate Gunn, Cancer Council SA, (Australia) Abstract No: 1081 3. Delivering the right information to the most in need Loren Imbriano, Cancer Council NT, (Australia) Abstract No: 1082

338

4. Implementing best practice approaches for the management of lung cancer: A national approach Liz King, Cancer Australia, (Australia) Abstract No: 1083

11. What can the data tell us about the supportive care needs of the Victorian cancer population? Melissa Shand, North Eastern Melbourne Integrated Cancer Service (NEMICS), (Australia) Abstract No: 1090

5. Establishing a national model for the detection and management of cancer treatment related consequences (CoT): a case study based on the collaboration between a British national charity and Department of Health in relation to consequences of treatment of pelvic cancers Elizabeth Jane Maher, Macmillan Cancer Support, (United Kingdom) Abstract No: 1084

12. Quantifying workforce ratios for paediatric oncology services. How do we plan for our future? Amy Shelly, Paediatric Integrated Cancer Service, (Australia) Abstract No: 1091

6. Dietitians and nurses working together to assess malnutrition in oncology patients Veronica Nickerson, Princess Margaret Cancer Centre, (Canada) Abstract No: 1085 7. Developing age friendly care Jenny Ritchie-Campbell, Macmillan Cancer Support, (United Kingdom) Abstract No: 1086 8. Breast cancer support for Vietnamese women; in Vietnam and in Australia Mikayla Rose, Breast Cancer Network Australia, (Australia) Abstract No: 1087 9. Making the law work better for people affected by cancer Esther Sadek, Cancer Council Victoria, (Australia) Abstract No: 1088 10. An international curriculum in oncology nursing for cancer centres Pamela Savage, Princess Margaret Cancer Centre, (Canada) Abstract No: 1089

13. The New Zealand Cancer Nurse Coordinator Initiative Saskia Booiman, Ministry of Health, (New Zealand) Abstract No: 1092 14. Implementing a 62 day cancer health target Andrew Simpson, Ministry of Health, (New Zealand) Abstract No: 1093 15. Development of New Zealand tumour standards Andrew Simpson, Ministry of Health, (New Zealand) Abstract No: 1094 16. Integrative oncology in Australia Michael Thomsen, Swinburne University, (Australia) Abstract No: 1095 17. The ‘Radiation Oncology: Targeting Cancer’ Campaign Sandra Turner, Westmead Hospital, (Australia) Abstract No: 1096 18. Prospective evaluation of implementation of 3 consecutive ICRETT programs at a low resource high volume tertiary care cancer centre Bipin Varghese, Regional Cancer Centre, (India) Abstract No: 1097 339

19. Building capacity to improve cancer outcomes for Aboriginal and Torres Strait Islander people Isabella Wallington, Cancer Australia, (Australia) Abstract No: 1098

13:15 - 14:45

20. Enabling consumers to have a seat at the table Kathryn Wells, Breast Cancer Network Australia, (Australia) Abstract No: 1099

1. Predictors of self-reported anxiety and depression in Saudi men who undergo surgery for colorectal cancer Ahmad Aboshaiqah, King Saud University, (Saudi Arabia) Abstract No: 1205

21. Strategies for increasing early detection of breast cancer Beatrice Wiafe Addai, Breast Care International, (Ghana) Abstract No: 1100 22. Joining forces with health professionals to energise the smoking conversation Stavroula Zandes, Health & Wellbeing Training Consultants, (Australia) Abstract No: 1101 23. Efficacy and safety of nitroglycerin combined with chemotherapy in the elderly patients with advanced non-small cell lung cancer complicated with coronary heart disease Zhen He, Henan Cancer Hospital, (China Abstract No: 1102 24. Palliative care in enugu, nigeria: a success story Nneka Iloanusi, Breast Without Spot, (Nigeria) Abstract No: 1103 25. Multi perspective evaluation: qualitative and quantitative, academics and management consultants - a collaborative approach to evaluating a complex palliative care service Elizabeth Jane Maher, Macmillan Cancer Support, (United Kingdom) Abstract No: 1104 340

ePoster Pod 3 - EP3.8 3.8 SCIENTIFIC STUDIES - SURVIVORSHIP, TREATMENT

2. Exploring patientsâ&#x20AC;&#x2122; perspective and expectations regarding involvement in treatment decision making Nauman Jadoon, Ittefaq Trust Hospital, Lahore, (Pakistan) Abstract No: 1206 3. Re-Admission frequency and reasons in cancer patients over 65 Years: Preliminary results Sevgisun Kapucu, Hacettepe University, (Turkey) Abstract No: 1207 4. Therapeutic touch TM in a geriatric palliative care unit - A retrospective review Helen Senderovich, Baycrest Health Sciences, (Canada) Abstract No: 1208 5. Economic assessment on a trial intervention of cancer survivorship service Sophy Shih, Deakin University, (Australia) Abstract No: 1209 6. Identification of resilience and burnout status among nurses working in the field of oncology Elif SĂśzeri, Gazi University, (Turkey) Abstract No: 1210

7. Caring for an older person with ambulatory chemotherapy: An informal caregivers’ perspective Petra Stolz-Baskett, Zurich University of Applied Sciences, (Switzerland) Abstract No: 1211

12. Development and psychometric evaluation of the quality of patient-centered cancer care measure with haematological cancer survivors Flora Tzelepis, University of Newcastle, (Australia) Abstract No: 1216

8. Integrative literature review of instruments used to assess informational and practical needs of acute leukaemia and lymphoma survivors Karen Taylor, Western Australia Cancer and Palliative Care Network, (Australia) Abstract No: 1212

13. Being an oncology nurse from the perspective of second grade nursing students Neşe Uysal, Gazi University, (Turkey) Abstract No: 1217

9. Dietary outcomes following a six-month weight loss intervention for breast cancer survivors: Living well after breast cancer Caroline Terranova, University of Queensland, (Australia) Abstract No: 1213 10. Can low cost low tech neurosurgery help neurological tumor patients? An experience with more than thousand neurological tumor surgery at BPKMCH, Nepal Balkrishna Thapa, BP Koirala memorial cancer hospital, (Nepal) Abstract No: 1214 11. Perioperative smoking and alcohol intervention in relation to radical cystectomy: effect on postoperative complications and quality of life Susanne Vahr Lauridsen, University of Copenhagen, Rigshospitalet, (Denmark) Abstract No: 1215

14. Meeting the needs of men with prostate cancer - Prostate cancer specialist nurse service activity – The Canberra Hospital, Australian Capital Territory. Vivienne Van Dissel, The Canberra Hospital, (Australia) Abstract No: 1218 15. Influence of prediagnostic cigarette smoking on colorectal cancer survival: Overall and by tumor molecular phenotype Peizhong Wang, Memorial University of Newfoundland, (Canada) Abstract No: 1219 16. Can peer support program for female BRCA1 or BRCA2 mutation carriers reduce distress? Findings from a randomized controlled trial Victoria White, Cancer Council Victoria, (Australia) Abstract No: 1220 17. The clinical and research implications of peace as part of spiritual wellbeing assessment in quality of life in cancer Hayley Whitford, Cancer Council Australia, (Australia) Abstract No: 1221

341

18. Aging and the existential: spiritual wellbeing, quality of life, and psychological morbidity in older adult cancer survivors Hayley Whitford, Cancer Council Australia, (Australia) Abstract No: 1222 19. Availability of information about lifestyle for cancer survivors in England: a review of statutory and voluntary sector organisations Kate Williams, UCL, (United Kingdom) Abstract No: 1223 20. Awareness of lifestyle guidelines for cancer patients and the provision of lifestyle advice among oncology health professionals in the UK Kate Williams, UCL, (United Kingdom) Abstract No: 1224 21. Cancer survivors’ views on diet and cancer: a qualitative study Kate Williams, UCL, (United Kingdom) Abstract No: 1225 22. Double modality treatment with neoadjuvant intra-arterial infusion chemotherapy in patients with stage IB2–IIB2 cervical cancer: a randomized controlled study Dong Ding, Hubei Maternity and Children’s Hospital, (China) Abstract No: 1227 23. The 1000 Survivor Study Leah Zajdlewicz, Cancer Council Queensland, (Australia) Abstract No: 1228 24. Cost-effectiveness of an intervention to persistent urinary incontinence in prostate cancer patients: A call for system change Amy Zhang, Case Western Reserve University, (United States) Abstract No: 1229 342

25. Depressive symptoms and its assessment in African American cancer patients Amy Zhang, Case Western Reserve University, (United States) Abstract No: 1230 26. Enzalutamide in men with chemotherapynaïve metastatic castration resistant prostate cancer (mCRPC): Primary and Australian/ Asian regional results of the phase 3 PREVAIL study Ian Davis, The Austin Hospital; Austin Health, (Australia) Abstract No: 1231 27. DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer’ Fang Wu, Hubei Maternity and Children’s Hospital, (China) Abstract 1232

13:15 - 14:45

ePoster Pod 4 - EP4.8 4.8 SCIENTIFIC STUDIES - TREATMENT 1. Obesity a risk factor for chemotherapy dose reduction in breast cancer: a multi-centered approach Matthew Cheng, Princess Alexandra Hospital (Metro South), (Australia) Abstract No: 1133

2. evidence-based modelling of optimal CT simulation appointment length Sophie Foxcroft, Princess Margaret Cancer Centre, (Canada) Abstract No: 1134 3. Long-term outcomes and risk factors of lymph node metastases in submucosal colorectal cancer Shiki Fujino, Osaka Medical Center for Cancer and Cardiovascular Disease, (Japan) Abstract No: 1135 4. Morbidity in selective neck dissection a randomized control trial Nebu George, Regional Cancer Cenrtre, (India) Abstract No: 1136 5. Prospective cohort of cervical cancer patients in Botswana treated with definitive (chemo) radiotherapyÂ Surbhi Grover, UPENN, (United States) Abstract No: 1137 6. Addition of oxaliplatin to neoadjuvant radiochemotherapy in MRI defined T3, T4 or N+ rectal cancer: A randomized clinical trial Peiman Haddad, Cancer Institute, Tehran University of Medical Sciences, (Iran) Abstract No: 1138 7. Carer burden, depression and unmet needs among carers of people newly diagnosed with cancerÂ Leila Heckel, Deakin University, (Australia) Abstract No: 1139 8. HPV infection and anemia status stratify the survival of early laryngeal squamous cell carcinoma Wei-han Hu, Sun Yat-sen University Cancer Cente, (China) Abstract No: 1140

9. Information disclosure and decision making preferences in metastatic cancer patient: a study in teaching hospital in Pakistan Nauman Jadoon, Ittefaq Trust Hospital, Lahore, (Pakistan) Abstract No: 1141 10. KRAS mutation does not influence antiproliferation effects but inhibits apoptosis of cetuximab in gastric xenografts Jun Zhang, , (China) Abstract No: 1142 11. Nursing studies on the symptom control of patients who have received chemotherapy for a cancer diagnosis in Turkey in the last 10 years: a systematic review Sevgisun Kapucu, Hacettepe University, (Turkey) Abstract No: 1143 12. Development of a cell based assay for identification of BAX activating compounds as anti-tumor agents Lakshmi Kesari, Fatima College of Health Science, (United Arab Emirates) Abstract No: 1144 13. The combined approach to the treatment of limb soft tissue sarcoma recurrences Anton Khazov, Saint-Petersburg City Clinical Oncology Health Center, (Russia) Abstract No: 1145 14. Surgical outcomes of the head and cancer patients: 20 years single surgeon experience in single institution Min Sik Kim, The Catholic University of Korea, (South Korea) Abstract No: 1146

343

15. Local advanced lung cancer: Precise prediction of 5-year survival after combined lobectomies/pneumonectomies Oleg Kshivets, Kaluga Cancer Center, (Russia) Abstract No: 1147 16. Skin reactions and treatment interruptions with concurrent weekly paclitaxel - A prospective study in ca breast patients Mohan Kumar, M.S.Ramaiah Medical College, (India) Abstract No: 1148

21. Study assessing feasibility of electrochemotherapy using bleomycin followed by pre-operative radiotherapy in locally advanced lip and buccal mucosa cancer Vishal Manik, Madras Medical College, (India) Abstract No: 1153 22. Can N-acetylcysteine or vitamin C protect human bladder urothelial cells from acrolein toxicity? Kylie Mills, Bond University, (Australia) Abstract No: 1154

17. Self-reported cancer patient experience in Australia and England Karen Lacey, VCCC, (Australia) Abstract No: 1149

23. Skin cancer’s burden and cost to the public hospital system in Victoria, Australia Sophy Shih, Deakin University, (Australia) Abstract No: 1155

18. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in patients with stage IIIc ovarian cancer Zhen Li, Zhongnan Hospital, Wuhan University, (China) Abstract No: 1150

24. Study on the role of primary systemic chemotherapy with anthracycline combination schedule in locally advanced breast cancer in Indian patients Aravindh Sivanandan Anand, Government Medical College, Thiruvananthapuram, Kerala, (India) Abstract No: 1156

19. The clinical outcomes and prognostic factors on surgical treatment of advanced medullary thyroid carcinoma patients Shihong Ma, Gansu Provical Cancer Hospital, (China) Abstract No: 1151 20. Malignant perforation peritonitis: Challenge to a general surgeon Puneet Malik, SMS Hospital, (India) Abstract No: 1152

344

25. Evolution of collaborative group AML studies in Australia Janey Stone, Australasian Leukaemia & Lymphoma Group, (Australia) Abstract No: 1157 26. MPV as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab Tolga Tuncel, Gata Haydarpasa, (Turkey) Abstract No: 1158

27. Reducing cancer health disparities in the Western Pacific through a partnership between the University of Guam and the University of Hawaii Cancer Center Neal Palafox, University of Hawaii - JABSOM, (United States) Abstract No: 1159 28. Conquering Cancer through Undergraduate Medical Education in a War-Torn Country: Initiative Experience from Iraq Layth Mula-Hussain, Kurdistan Board for Medical Specialties, (Iraq) Abstract No: 1160

13:15 - 14:45

ePoster Pod 5 - EP5.8 5.8 SCIENTIFIC STUDIES - TREATMENT, PREVENTION 1. The GSTP1 313G and MTHFR 677T Alleles increase breast cancer risk but enhance response to CEF chemotherapy in women of North China Yu-Mei Feng, Tianjin Medical University Cancer Institute and Hospital, (China) Abstract No: 1161

2. Pre-analytic time and temperature variation in detection of antibodies to cancer related infections Verity Hodgkinson, Cancer Council NSW, (Australia) Abstract No: 1162

3. Clinical validation of the AnyplexTM II HPV HR Detection for primary cervical cancer screening Sunkyung Jung, Seegene Medical Foundation, (South Korea) Abstract No: 1163 4. Cervical cancer prevention in eastern Europebarriers and challenges Aleksandra Kizior, Not for Profit, (Poland) Abstract No: 1164 5. Some features of cancer prevalence in Kyrgyzstan Zakir Kamarli, KRSU, (Kyrgyzstan) Abstract No: 1165 6. Prostate disease, cancer epidemic: Ethnic advantage in a high risk country of Dominica Kamalendu Malaker, Ross University School of Medicine, (Canada) Abstract No: 1166 7. In the wake of prostate cancer epidemic: Dominica a resource-scarce and high risk country, its effort to minimize the risk: low cost, high clinical profeciency screening effort: a revelation Kamalendu Malaker, Ross University School of Medicine, (Canada) Abstract No: 1167 8. High-grade cervical abnormality following the cytologic diagnosis of atypical endocervical cells of undetermined significance: a retrospective study of 1736 cases Aime Munro, Women’s Health Clinical Care Unit, (Australia) Abstract No: 1168

345

9. Cervical cancer knowledge and screening uptake among women in Embu county, Kenya Anne Nthiga, Amref Health Africa in Kenya, (Kenya) Abstract No: 1169 10. Development and assessment of an evidencebased prostate cancer intervention program for black men: The W.O.R.D. on prostate cancer video Folakemi Odedina, University of Florida, (United States) Abstract No: 1170 11. High rates of pelvic ultrasonography and tumor marker use suggest physician nonadherence to ovarian cancer screening guidelines Leigh Passman, Instituto Nacional de Cancer, (Brazil) Abstract No: 1171 12. Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades Maryam Salehi, Mashhad university of medical sciences, (Iran) Abstract No: 1172 13. Variation in the cost of promoting cancer screening: Real world experience from CDCâ&#x20AC;&#x2122;s colorectal cancer control program in the USA Mona Saraiya, Centers for Disease Control, (United States) Abstract No: 1173 14. Evaluation of cervical cancer screening program using VIA testing in Morocco Farida Selmouni, Health Ministry, (Morocco) Abstract No: 1174

346

15. Physician advocacy and herd signaling in bridging knowledge-behavior gap in cervical cancer screening Kaijun Tay, Singapore General Hospital, (Singapore) Abstract No: 1175 16. What do people want to know about colorectal cancer and what is the best way to organise the information they want? Carlene Wilson, Flinders University and Cancer Council South Australia, (Australia) Abstract No: 1176 17. Public support for the solarium ban in Australia Ivanka Prichard, Flinders University, (Australia) Abstract No: 1177 18. Impact of school policies on NCD risk factors â&#x20AC;&#x201C; A systematic review Tina Rawal, Public Health Foundation of India, (India) Abstract No: 1178 19. Strategies to combat arsenic calamity in West Bengal, India by Tea Madhumita Roy, Chittaranjan National Cancer Institute, (India) Abstract No: 1179 20. Level of awareness of lung cancer risk factors, signs, symptoms and safe practices among college teachers in India: Does awareness have a role in prevention and early detection along with change in practice? Shubham Roy, VMMC & Safdarjung Hospital, (India) Abstract No: 1180

21. Knowledge, attitudes and practices on Cervical cancer, the human papillomavirus (HPV) and prevention procedures in the Departments of Santa Ana and Sonsonate, Republic of El Salvador Lisseth Ruiz de Campos, Salvadoran Association for Cancer Prevention, (El Salvador) Abstract No: 1181 22. Menopausal Hormone Therapy (MHT) use and breast cancer risk in Australia: Initial findings from the NSW CLEAR study Usha Salagame, Cancer council NSW, (Australia) Abstract No: 1182 23. Systematic review of School Environment Assessment Tools (SEA) Kiran Saluja, Public Health Foundation of India, (India) Abstract No: 1183 24. Television viewing and time spent sedentary in relation to cancer risk: A meta-analysis Daniela Schmid, University of Regensburg, (Germany) Abstract No: 1184 25. Level of awareness of cervical and breast cancer among college teachers of different states in India: Do awareness campaigns have an impact on prevention and early detection by adopting safe practices? Abhishek Shankar, All India Institute of Medical Sciences, (India) Abstract No: 1185 26. Effect of lifestyle factors on risk of early-onset colorectal cancer Aung Ko Win, The University of Melbourne, (Australia) Abstract No: 1186

27. The spiritual dimensions of Islamic healing: patients’ perspectives Norhasmilia Suhami, Universiti Putra Malaysia, (Malaysia) Abstract No: 1187 28. The cancer patient’s economic burden and the feeling of burden Nobuo Koinuma, Tohoku Pharmaceutical University, (Japan) Abstract No: 1188

13:15 - 14:45

ePoster Pod 6 - EP6.8 6.8 SCIENTIFIC STUDIES - LATE BREAKING 1. Anthracycline induced cardiotoxicity in childhood cancer survivors aruna alahari dhir, Tata memorial hospital, (India) Abstract No: 1189

2. Dimensions and predictors of multiple symptoms in patients with advanced cancer in Saudi Arabia Mohammad Alhazmi, King Saud University, (Saudi Arabia) Abstract No: 1190 3. Cytogenetic effects of methidathion pesticide on rat bone marrow cells Mohammed Alshehri, King Khalid University, (Saudi Arabia) Abstract No: 1191

347

4. Cancer screening iPhone application jean-paul bahary, Centre Hospitalier de l’Université de Montréal, (Canada) Abstract No: 1192 5. Psychological responses of breast cancer patients after receiving reports of BRCA1 mutation testing: Preliminary/Pilot study in Eastern India Jayasri Basak, Netaji Subhas Chandra Bose Cancer Research Institute, (India) Abstract No: 1193 6. Using data to inform and support system improvement – overcoming challenges in a low-volume environment Nicola Creighton, Cancer Institute NSW, (Australia) Abstract No: 1194 7. Familial appendiceal tumours: A rare predisposition? Mathew Doyle, St George Hospital, (Australia) Abstract No: 1195 8. CPEB4 :A promising maker for the high grade gliomas and its overexpression predicts poor prognosis in patients with glioma Wanming Hu, Department of Pathology, Cancer Center, Sun Yat-Sen University, Guangzhou, China, (China) Abstract No: 1197 9. BARD1, an oncogenic driver and biomarker of lung cancer Irmgard Irminger-Finger, University Hospitals Geneva HUG, (Switzerland) Abstract No: 1198

348

10. Evaluation of quality of life of the patients under Ayurvedic cancer management practices Swarna Kaluthotage, Bandaranayake Memorial Ayurvedic Research Institute, (Sri Lanka) Abstract No: 1199 11. ‘Cancer Diagnosis and Culture’: Exploring patient and health system factors in timely diagnosis of cancer in CALD communities Sharon Licqurish, University of Melbourne, (Australia) Abstract No: 1200 12. Brain metastatic tumor treated with Korean medicine during chemotherapy: A case report Hara Lim, Soram Cancer and Immunotherapy Hospital, (South Korea) Abstract No: 1201 13. Human immunodeficiency virus-negative plasmablastic lymphoma: A full-scale analysis of 114 cases Min Liu, Department of Radiation Oncology, The First Hospital, Jilin University, (China) Abstract No: 1202 14. A retrospective study of pattern and outcome of metastatic breast carcinoma in rural population Puneet Malik, SMS Hospital, (India) Abstract No: 1203 15. Clinicopathological characteristics and prognosis of stage IV colorectal cancer Norikatsu Miyoshi, Osaka Medical Center for Cancer and Cardiovascular Diseases, (Japan) Abstract No: 1204

16. Estrogen and progesterone receptors in gallbladder disease: On the cusp of a discovery? Shravan Nadkarni, Sawai Mansingh Medical College and Hospitals, Jaipur, (India) Abstract No: 1232 17. Relationship between enteric fever and gallbladder cancer: A systematic review and meta-analysis Vinayak Nagaraja, Prince of Wales Hospital, University of New South Wales, (Australia) Abstract 1233 18. Retrospective single institution study of prediagnostic medical radiation exposure in children with blood cancers, 1998-2013 Robin Rohrer, Seton Hill University, (United States) Abstract No: 1234 19. Consumption of deep fried foods intake and breast cancer risk among women in Karachi, Pakistan – A matched case control study Uzma Shamsi, University of Adelaide & Aga Khan University, (Australia) Abstract No: 1235 20. Promoting physical activity among breast cancer survivors using computer-tailored online interventions: IMove More for Life RCT Ron Plotnikoff, The University of Newcastle, (Australia) Abstract No: 1236

21. Haploinsufficiency of MIIP Disables APC/ Ccdc20-Securin/Topoisomerase IIα Rheostat and induces chromosomal instability in colorectal cancer Yan Sun, Tianjin Medical University Cancer Hospital, (China) Abstract No: 1237 22. Identification of microRNA-mRNA regulatory network in gemcitabine resistant cells derived from human pancreatic cancer cells Yehua Shen, Fudan University Shanghai Cancer Center, (China) Abstract No: 1238 23. Helicobacter pylori cag-a positivity - an important determinant for esophageal squamous cell carcinoma risk: a metaanalysis Vinayak Nagaraja, Prince of Wales Hospital, University of New South Wales, (Australia) Abstract No: 1239 24. Ill-fitting dentures increase the risk of developing oral cancer: a meta-analysis Vinayak Nagaraja, Prince of Wales Hospital, University of New South Wales, (Australia) Abstract No: 1240 25. The relationship between Agent Orange and cancer: a systematic review and meta-analysis Vinayak Nagaraja, Prince of Wales Hospital, University of New South Wales, (Australia Abstract No: 1241 26. Laser Induced Fluorescence Spectroscopy tool for early diagnosis Keerthilatha M Pai, Manipal College of Dental Sciences, Manipal, (India) Abstract 1242

349

REVIEWERS

350

ABSTRACTS

Thank you to the 2014 World Cancer Congress Abstract Reviewers.

Alberto Bagnulo Ausl Reggio Emilia

Carlo Senore AOU CittĂ della Salute e della Scienza

Alison Butt National Breast Cancer Foundation

Carole Renouf National Breast Cancer Foundation

Amit Yadav PHFI

Christine Lasky The Princess Margaret Cancer Foundation

Amy Zhang Case Western Reserve University Andrew Chapman Thomas Jefferson University Anil Dâ&#x20AC;&#x2122;Cruz Tata Memorial Hospital Anna Boltong Cancer Council Victoria Anna Ugalde Deakin University and Cancer Council Victoria Anne Lee University of Hong Kong Shenzhen Hospital Annie Miller Cancer Council NSW Bernard Stewart SESI Public Health Unit Bogda Koczwara Flinders Centre for Innovation in Cancer

Elisabeth Kvaavik Norwegian Institute for Alcohol and Drug Research Elisabetta Rapiti University of Geneva Emma Croager Cancer Council WA

Claire Morris Worldwide Palliative Care Alliance

Enriquito (Ricky) Lu Jhpiego

Craig Sinclair Cancer Council Victoria

Eva Johanna Kantelhardt Martin-Luther-University Halle (Saale) Germany

Damali Martin National Cancer Institute David Hill Cancer Council Victoria David Weller University of Edinburgh David Young Cancer Council Victoria Deb Keen Canadian Partnership Against Cancer Deborah Glass Monash University Deepak Khuntia Varian Medical Systems Ednin Hamzah Hospis Malaysia

Gathari Gichuhi Jhpiego Gilberto Schwartsmann Academic Hospital, Federal University, Porto Alegre, Brazil Harald Haeske Helene Sancho-Garnier ICM Inger T. Gram UiT the Arctic University of Norway Ira Pavlovic-Ruzic University Hospital Center Rijeka, Croatia Jane Martin Obesity Policy Coalition

351

Jean King Cancer Research UK Joan Marston International Childrenâ&#x20AC;&#x2122;s Palliative Care Network

Liz Ward Queensland Health and The University of Queensland Madiajagane Ramasamy Trichy Cancer And Daycare Center

Patricia Lambert Campaign for Tobacco-Free Kids Patricia Valery Menzies School of Health Research Pongsri Srimoragot Faculty of Nursing Mahidol University

John Varallo Jhpiego

Maree Bransdon Queensland Health

Jose Jeronimo PATH

Maria Cable Coventry University

Pranati Nanda All India Institute of Medical Sciences, Bhubaneswar, Odisha

Joseph Wee National Cancer Centre Singapore

Maria Eugenia Aponte-Rueda Venezuelan Cancer Society

Rebecca Cowens-Alvarado American Cancer Society

Julie Torode UICC

Maria Stella de Sabata Fondo Anglesio Moroni

Regina Fernandez Una voz contra el cĂĄncer

Kananathan Ratnavelu Nilai Medical Centre

Marion Pineros MPineros

Rob Newton Edith Cowan University

Kawkab Shishani Washington state university

Mary Gospodarowicz Princess Margaret Cancer Centre

Robyn Mullins Cancer Council Victoria

Kevin Babb American Cancer Society

Melanie Wakefield Cancer Council Victoria

Ron Borland Cancer Council Victoria

Krassimir Metodiev Medical University

Michael Jefford Peter MacCallum Cancer Centre

Sally Doncovio Department of Health Victoria

Kristin Campbell University of British Columbia

Mira Aghi

Samson Fung Fung Consulting

Lauren Pretorius Campaigning for Cancer Lesley Rushton Imperial College London Linus Chuang Jihan School of Medicine at Mount Sinai

Mona Jeffreys University of Bristol Mona Saraiya Centers for Disease Control Monika Arora Public Health Foundation of India Omalkhair Abulkhair Ministry of National Guard Health Affairs Pandora Patterson CanTeen Australia

352

Sandra Bento Hospital de Santarem Sondra Davoren Cancer Council Victoria Stephani Smolucha LIVESTRONG Foundation Stephen Connor Worldwide Palliative Care Alliance Sukdev Nayak AIIMS, Bhubneshwar

Surendra Shastri Tata Memorial Centre Susan Carr The Womens Hospital

THE BIG SCREEN REVIEWERS

Suzanne Moore Menzies School of Health Research Terry Slevin Cancer Council Western Australia Tsigue Pleah Jhpiego Vanessa Rock Cancer Council NSW Vesna Vucic Institute for medical research Vivien Tsu PATH Vu Quoc Huy Nguyen Hue University of Medicine and Pharmacy Walter Fiedler University Medical center HamburgEppendorf Wendy Yared Association of European Cancer Leagues Yi Ba Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Thank you to the Big sCreen review panel: Kate Allen World Cancer Research Fund International Medlej Almedlej Saudi Cancer Society Mike Hill Moonshine Agency & Moonshine Movies Charanjit Jagait International Osteoporosis Foundation Iris Leung The Hong Kong Anti-Cancer Society Aaron Mills Public Health England Lilli Morgan NCDFREE

Yoke Lim Soong National Cancer Centre Singapore

Erin Schwartz The Max Foundation

Yoshihiro Kikuchi Ooki Memorial Kikuchi Cancer Center for Women

Rennie Sloan The Carter Center

Zipporah Ali Kenya Hospices and Palliative Care Association

353

INDEXES

354

SESSION CHAIRS Name

Country

Adams, Cary

Switzerland

Adewole, Isaac

Nigeria

Akaza, Hideyuki

Japan

Akkerman, Doreen

Australia

Allen, Kathryn

United Kingdom

Alleyne, George

United States

Anderson, Benjamin O. Anderson, Annie Aponte, Maria Aranda, Sanchia

United States United Kingdom Venezuela Australia

Armstrong, Tim

United States

Atkinson, Kelly Boltong, Anna Bray, Freddie Bryant, Heather Caswell, Sally Cavalli, Franco Cebon, Jonathan Chapman, Kathy Cherny, Nathan Cleary, James Cowie, Benjamin Cox, Alison Cunningham, Rob Dain, Katie Damali, Martin Dâ&#x20AC;&#x2122;Cruz, Anil Dhillon, Haryana Dollman, Kenneth Downing, Julia

New Zealand Australia France Canada New Zealand Switzerland Australia Australia Israel United States Switzerland United Kingdom Canada United Kingdom United States India Australia South Africa South Africa

Dunn, Jeff

Australia

Edwards, Brenda Emery, Jon Fisher, Dale Folb, Kate

United States Australia Australia United States

Garvey, Gail

Australia

Galloway, Louise

Australia

Gandy, Marian

Australia

Gospodarowicz, Mary

Canada

Halloran, Stephen

United Kingdom

Sessions

Page No.

SBP.4.238 RF.5 SBP.2.253 SAT.4.231 SAT.1.380 PS.3.24 PS.1.223 CTS.1.224 UICC.4.3 PS.3.251 UICC.4.1 PS.1.164 PS.1.221 PL.0.1 PS.1.223 UICC.4.11 PS.4.227 CTS.2.225 PS.4.57 PL.0.2 PS.1.55 PS.2.205 SAT.2.313 PS.1.48 PS.3.215 PS.3.215 PS.1.234 PS.1.152 CTS.1.233 UICC.4.6 PS.4.248 AOS.6 CTS.3.85 UICC.4.2 SBP.3.53 RF.3 UICC.0.7 PS.4.57 CTS.4.32 PS.4.390 BSC.0.4 PS.4.46 PS.2.145 SBP.1.80 SAT.4.34 RF.4 CTS.4.230 UICC.4.5 PS.1.235

228 321 227 317 240 172 194 304 248 329 174 267 268 152 194 319 259 156 198 222 180 257 156 328 271 271 170 327 230 309 175 252 306 238 302 260 313 198 157 198 303 176 270 300 320 263 236 238 195

Name

Country

Sessions

Page No.

Hamill, Stephen Hansen, Chris

United States United States

Hao, Xishan

China

Harper, Todd

Australia

Hastings, Gerard Heward, Sue Hill, David Hill, Mike Hiom, Sara Honing, Cora

United Kingdom Australia Australia Australia United Kingdom Netherlands, The

Jamieson, Shelly

Canada

Jefford, Michael Jha, Prabhat Ji, Jiafu Keefe, Dorothy Keen, Deb Keyserlingk, John Khader, Jamal

Australia Canada China Australia Canada Canada Jordan

Knaul, Felicia

United States

Krishnasamy, Mei Kumar, Harpal

Australia United Kingdom

Kutluk, M. Tezer

Turkey

Lambert, Patricia Lampariello, Riccardo Lasky, Christine Lehmann Knudsen, Janne Liberman, Jonathan Lindorff, Kylie Lipczak, Henriette MacDonald, Janine McVie, Gordon Moshiri, Mahmood Nayak, Sukdev O'Sullivan, Brian Olver, Ian

United States Switzerland Canada

Pace, Loyce

United States

Perl, Rebecca Preszly, Monika Proimos, Jenny Rahal, Rami Ramdev, Swami Ritchie-Campbell, Jenny

United States Germany Australia Canada India

PS.1.228 AOS.3 SAT.4.231 SAT.2.20 SAT.1.380 CTS.3.250 AOS.5 PS.1.55 PS.1.232 AOS.2 BSC.0.3 PS.2.93 SBP.4.91 PS.1.189 PS.4.69 RF.6 CTS.4.196 SAT.2.20 PS.2.39 SBP.2.252 CTS.3.229 UICC.4.12 PS.3.241 CTS.4.196 PL.0.1 PS.2.93 UICC.4.226 WS.4.3 PS.1.49 UICC.4.12 SAT.4.302 CTS.2.92 PS.2.94 PS.3.251 CTS.1.233 PS.2.94 PS.2.41 SAT.4.311 SAT.1.395 PS.3.112 UICC.4.9 PS.4.246 AOS.1 PS.2.101 PS.1.228 CTS.2.225 UICC.4.226 AOS.7 PS.3.112

254 178 317 160 240 157 251 180 327 168 274 269 302 182 329 323 308 160 183 300 234 315 197 308 152 269 194 221 255 315 248 305 328 329 230 328 128 166 313 184 175 330 168 255 254 156 184 310 184

United Kingdom

PS.4.99

259

Denmark Australia Australia Denmark Australia Italy Canada India Canada Australia

355

Name

Country

Sessions

Page No.

SAT.1.380 SAT.4.231 PS.1.220 PS.2.44 SAT.1.395 WS.1.1 PS.1.105 SBP.1.103 CTS.2.143 CTS.3.229 CTS.4.230 PS.4.46 PS.1.83 RF.1 PS.4.115 PS.4.246

240 317 267 171 313 145 181 226 231 234 236 176 171 187 273 330

France

CTS.1.56

154

Australia Canada United States Australia United Kingdom

PS.1.90 SAT.4.256 SBP.3.187 PL.0.3 CTS.1.56 UICC.4.1 RF.2 UICC.4.2 SAT.4.347 UICC.4.11

195 250 227 299 154 174 189 238 308 317

AOS.4

179

PS.1.234 PS.2.205 PS.2.145 PS.1.222 PS.4.43 BSC.0.2 SAT.2.307 SAT.3.306

170 257 270 266 185 237 197 164

SAT.1.340

240

PS.1.165 PS.4.248 WS.4.3 PS.1.235 PS.4.7 SBP.3.187 PS.2.47 PS.2.39

170 175 221 195 271 227 256 183

Roh, Jae Kyung

Korea, Republic of

Ryel, Anne Lise Sabesan, Sabe Samimi, Haleh

Norway Australia Canada

Saraiya, Mona

United States

Sarfati, Diana Saunders, Christobel Seffrin, John Siddartha, Baxi Sinclair, Craig

New Zealand Australia United States Australia Australia

Slevin, Terry

Australia

Soerjomataram, Isabelle Stewart, Bernard Stewart, Janice Tam Ashing, Kimlin Thomas, Robert Thompson, Rachel

Torode, Julie

Switzerland

Tursan Dâ&#x20AC;&#x2122;Espaignet, Edouard

Switzerland

Ullrich, Andreas

Switzerland

Valery, Patricia Varallo, John von Dincklage, Jutta Von der Muhll, Vanessa Wang, Cheng-Hsu Wender, Richard Whang-Peng, Jacqueline William, Kelly Williams, Makeda Yalcin, Suayib Young, Graeme Yu, Peter Zhang, Amy Zorbas, Helen Zulian, Gilbert

Australia United States Australia Switzerland

356

United States

Australia United States Turkey Australia United States United States Australia Switzerland

SESSION SPEAKERS Name

Country

Sessions

Page No.

Aapro, Matti Adams, Cary

Switzerland Switzerland

Adewole, Isaac

Nigeria

Aghi, Mira B

Ali, Zipporah Allen, Kathryn

India United Arab Emirates Kenya United Kingdom

Alleyne, George

United States

Anderson, Annie Andrews, David Aponte, Maria

United Kingdom Canada Venezuela

Aranda, Sanchia

Australia

Armstrong, Bruce Armstrong, Tim Arora, Monika Ashing, Kimlin Assunta, Mary Auste, Carmen Babb, Kevin Bala Nayak, Manjula Balducci, Lodovico Barton-Burke, Margaret Battersby, Malcolm

Australia United States India United States Thailand Philippines United States India United States United States Australia

Bekele, Wondu

Ethiopia

Berner, Rebecca Bessell, Tracey Borland, Ron Boyle, Fran

Mexico Australia Australia Australia

Bradley, Kate

Australia

Bransdon, Maree Brawley, Otis

Australia United States

Bray, Freddie

France

Brierley, James Brotherton, Julia Broutet, Nathalie Brubach, April

Canada Australia Switzerland United States

Bryant, Heather

Canada

PS.2.39 PL.0.3 PS.4.248 UICC.4.12 PS.1.49 RM.2 UICC.4.2 PS.3.251 PS.1.223 SBP.4.238 CTS.4.196 PS.1.164 SAT.1.395 PS.1.221 PS.4.390 CTS.2.92 SAT.4.380 PS.1.223 PS.1.152 SBP.3.187 PS.4.7 UICC.4.2 CTS.2.225 PS.3.112 PS.2.39 SAT.4.256 SBP.3.187 RM.4 UICC.0.7 BSC.0.4 SAT.4.347 BD.0.2 CTS.3.250 WS.1.1 SBP.1.103 PS.2.44 PS.1.189 CTS.1.56 PS.4.57 CTS.4.230 UICC.4.9 SBP.1.80 SAT.4.347 BSC.0.2 PS.1.83 PS.1.189 PS.2.93

183 299 175 315 255 153 238 329 194 228 308 267 313 268 198 305 166 194 327 227 271 238 156 184 183 250 227 236 313 303 308 135,253 157 145 226 171 182 154 198 296 175 300 308 237 171 182 269

Al Madhi, Sawsan

Name

Country

Sessions

Page No.

Name

Country

Sessions

Page No.

186 230 302 194 176 170 330 124,299 197 180 182 251 234 308 172 257 256 156 145 226 170 255 266 253 160 271 197 259 237 248 271 328 156 254 234 181

Doherty, Peter. C Dollman, Kenneth Doncovio, Sally Donkin, Chris

Australia South Africa Australia Denmark

Downing, Julia

South Africa

Doyle, Colleen Driscoll, Tim Dudgeon, Deb Dumont, Dan Dunlop, Sally

United States Australia Canada Canada Australia

Dzialo, Chris

United States

Ekstedt, Mirjam Elias, Brenda Ellison-Loschmann, Lis Emery, Jon Evans, Helen Fernandez, Regina Field, Andrew Flanigan, John

Sweden Canada New Zealand Australia Switzerland United States Australia United States

Folb, Kate

United States

Frazer, Ian Freeman, Becky Fritschi, Lin Frydenberg, Mark Fukuda, Takashi Galloway, Louise Gartner, Coral Geipel, Gary Gayle, Jacob Gertig, Dorota Gi-Ming, Lai Gianotten, Woet Giles, Christine Ginsberg, Gary Gladwell, Kiarie Glass, Deborah Gomes Fernandes, Rafael Goodman, Annekathryn

Australia Australia Australia Australia Japan Australia Australia United States United States Australia Netherlands, The Australia Israel Kenya Australia

PL.0.1 UICC.4.2 PS.1.232 CTS.2.225 PS.3.215 SBP.3.53 PS.1.48 PS.4.115 PS.4.390 SAT.1.395 CTS.1.233 WS.1.1 SBP.1.103 PS.2.94 PS.4.46 PS.4.46 CTS.4.32 PS.1.234 PS.1.221 SAT.2.360 SAT.2.360 WS.1.1 SBP.1.103 PS.1.234 PS.1.228 PS.4.115 SAT.4.380 SAT.4.231 SAT.4.347 PS.1.152 SAT.4.311 UICC.4.3 SBP.1.80 SAT.1.340 PS.3.24 PS.2.47 PS.1.235 PS.1.221 PS.1.90

120,152 238 327 156 271 302 328 273 198 313 230 145 226 328 176 176 157 170 268 314 314 145 226 119,170 254 273 166 317 308 327 166 248 300 240 172 256 195 268 195

Brazil

PS.1.232

327

United States

PS.1.222 CTS.4.230 PL.0.3 CTS.4.196 PS.4.390 BD.0.1 PS.1.49 PS.1.90

266 236 299 308 198 177 255 195

Buggy, Donal

Ireland

Bull, Fiona Burhansstipanov, Linda Burton, Suzan Butt, Alison Butte, Atul C, Shiu-Yu Caswell, Sally Cable, Maria Caleffi, Maira Campbell, Kristin Canfell, Karen Carr, Susan Cavalli, Franco Cazap, Eduardo Cebon, Jonathan

Australia United States Australia Australia United States New Zealand United Kingdom Brazil Canada Australia Australia Switzerland Argentina Australia

Cecil, Jennifer

United States

Chan, Henry Chan, Sophia Chang, Linus Chapman, Simon Chen, Yong Cherny, Nathan Chien-Yuan Wu Clarke, Daryl Clayforth, Cassandra

Hong Kong Hong Kong United States Australia China Israel Samoa Australia

Cleary, Jim

United States

Cook, Greg Cotter, Trish Courneya, Kerry Cowal, Sally Cowens-Alvarado, Rebecca Cox, Alison Cremer, Miriam Croager, Emma Cross, Martin Cunningham, Joan

Australia Australia Canada United States

CTS.1.233 BSC.0.1 SBP.4.91 PS.1.223 PS.4.46 PS.1.165 PS.4.246 PL.0.3 SAT.2.307 PS.1.55 PS.2.41 RM.4 CTS.3.229 SAT.4.347 PS.3.24 PS.2.205 PS.2.47 SAT.2.313 WS.1.1 SBP.1.103 PS.1.234 PS.1.49 PS.1.222 BD.0.2 SAT.2.20 PS.3.215 SAT.2.307 PS.4.227 BSC.0.2 UICC.4.3 PS.3.215 PS.3.251 SAT.2.313 PS.1.228 CTS.3.229 PS.1.105

United States

SBP.3.187

227

United Kingdom United States Australia Australia Australia

D'Cruz, Anil

India

Dain, Katie de Leeuw, Evelyne Demaio, Alessandro Demers, Paul

United Kingdom Australia United States Canada

BSC.0.1 PS.1.222 PS.4.246 PS.2.205 PS.4.46 RM.7 CTS.4.196 UICC.4.3 PS.1.220 PS.1.223 PS.4.115

186 266 330 257 176 308 320 248 267 194 279

Gospodarowicz, Mary

Canada

Gowling, James Grainger, David Greaves, Lorraine Grogan, Paul

Canada Australia Canada Australia

357

Name

Country

Sessions

Page No.

Name

Grube, Birgitte Gueye, Serigne Magueye

United Kingdom Senegal

Gupta, Sumit

Canada

Haines, Mary Hall, Wayne

Australia Australia

Hamill, Stephen

United States

Hannisdal, Einar Hastings, Gerard Hawari, Feras

Norway United Kingdom Jordan

Hawkes, Corinna

United Kingdom

Higginson, Irene Hill, David Hiom, Sara Honing, Cora Hordern, Amanda Hughes, Clare Huy Nguyen Vu, Quoc Hynson, Jenny Jamieson, Shelly

United Kingdom Australia United Kingdom Netherlands, The Australia Australia Viet Nam Australia Canada Australia

Jemal, Ahmedin

United States

Jha, Prabhat

Canada

Johnson, Rebecca Jones, Sandra

UICC.4.226

184

Katz, Anne Keefe, Dorothy Keen, Deb

United States Australia Islamic Republic of Iran Canada Australia Canada

250 257 238 284 185 327 254 303 328 180 164 194 328 121,152 303 171 313 172 328 266 302 329 197 303 236 308 154 182 180

Lai, Jane Tsai Lam, Tai Hing Lamontagne, Scott Lawsin, Catalina Leary, Kali Ledwick, Martin Lee, Anne Lehmann Knudsen, Janne Leitzmann, Michael Levit, Laura Lewis, Stephen Li, Ling Chiu, Li-Ying Liberman, Jonathan Liew, Danny Lipczak, Henriette Livingston, Trish Long, Georgina Lorenz, Karl Lu, Enriquito R. Lyons, Claudine

Jefford, Michael

SAT.4.256 PS.2.205 UICC.4.2 UICC.4.226 PS.4.43 PS.1.152 PS.1.228 BSC.0.4 PS.2.94 PS.1.55 SAT.3.306 PS.1.223 PS.1.48 PL.0.1 BSC.0.4 PS.1.83 UICC.0.7 PS.3.24 PS.1.48 PS.1.222 SBP.3.53 PS.4.69 PS.3.241 CTS.3.85 CTS.4.230 CTS.4.196 CTS.1.56 PS.2.41 PS.1.55

Kekihembo, Constance

Uganda

Keller, Marc Kelly, Dalton Kersten, Sonja

France New Zealand Netherlands, The

Khader, Jamal

Jordan

Khayat, David Khojasteh, Omid Kielland, Tryggve Knaul, Felicia Krishnan, Suneeta Kuipers, Ernst Kumar, Harpal Kutluk, M. Tezer

France Australia Norway United States India United Kingdom United Kingdom Turkey

PS.3.24 PS.2.39 PS.1.220 UICC.4.6 UICC.4.3 RM.3 PS.4.227 PS.4.43 RM.2 UICC.4.12 PS.4.7 SAT.1.395 RM.3 PS.3.241 PS.3.241 PS.1.235 PS.4.246 UICC.4.12

172 183 267 309 248 177 259 184 153 315 271 313 177 197 197 195 330 315

Kamkar, Saba

358

Country

Sessions

Page No.

Hong Kong United States Australia Canada United Kingdom Hong Kong

SAT.1.340 CTS.1.224 SBP.1.80 CTS.3.85 PS.4.227 CTS.2.225 UICC.4.9

240 304 300 306 259 156 175

Denmark

CTS.2.92

305

Germany United States Canada China

304 152 222 160 197 267 153 328 267 177 172 266 257 198 305 327 327 170 166 302 231 304 194 329 259 197 157 313 248 255 250 267 164 166 198 308 306 177

Maher, Jane

United Kingdom

Malone, Ruth Marchant, Blanche Marsh, Louise Marshall, Villis Marston, Joan Martin, Jennifer Martin, Richard Martin, Jane Mattfeld, Elisabeth McBride, Mary

United States Australia New Zealand Australia South Africa Australia United Kingdom Australia Austria Canada

McCabe, Mary

United States

McEvoy, Ali McFarlane, Helen McGoldrick, Devon

Australia Australia United States

McKiernan, Sandy

Australia

McMikel, Ann McVie, Gordon Mery, Les Mhurchu, Cliona Miller, Annie Milne, Donna Mired, HRH Princess Dina Moore, Suzanne

United States Italy France New Zealand Australia Australia

CTS.1.224 PL.0.1 PL.0.2 SAT.2.20 SAT.2.307 PS.1.220 SAT.2.313 PS.2.94 PS.1.164 BD.0.1 PS.3.24 PS.1.222 PS.2.47 PS.4.390 CTS.2.92 PS.1.152 PS.1.232 PS.1.165 SAT.4.380 SBP.3.53 CTS.2.143 CTS.1.224 PS.1.223 PS.3.251 PS.4.99 PS.3.241 CTS.3.250 UICC.0.7 UICC.4.3 PS.2.101 SAT.4.256 PS.1.164 SAT.3.306 SAT.4.311 PS.4.57 PS.1.48 CTS.3.85 BD.0.1

Jordan

SBP.4.238

228

France

PS.4.46

176

Australia Australia Denmark Australia Australia United States United States Australia

Name

Country

Sessions

Page No.

Name

Country

Sessions

Page No.

157 256 251

Rabeneck, Linda Ramdev, Swami Rao, Raghavendra Rashbass, Jem Richard, Edwards

Canada India India United Kingdom New Zealand

Ritchie-Campbell, Jenny

United Kingdom

Robertson, Lindsay

New Zealand

Roder, David

Australia

Rodrigues, Belmira Rodriguez Hernandez, Fernando Rodriguez-Guzman, Julietta Rojhani, Ariella

South Africa

PS.1.235 PS.3.112 PS.3.112 PS.2.93 PS.1.152 CTS.2.225 CTS.3.229 PS.4.99 CTS.3.85 PS.1.165 PS.4.99 PS.4.57 RM.4

195 184 184 269 327 156 234 259 306 170 259 198 236

Mexico

PS.2.101

255

Colombia

PS.4.115

273

United States

Roxon, Nicola

Australia

Rushton, Lesley

United Kingdom

Ryel, Anne Lise

Norway

Sabesan, Sabe

Australia

Saligram, Nalini Sandelin, Kerstin Sankaranarayanan, Rengaswamy

United States Sweden

SBP.4.238 PL.0.2 BD.0.1 PS.4.115 UICC.4.6 SBP.4.91 PS.2.145 PS.2.44 SAT.3.306 PS.2.47

228 222 177 273 309 302 270 171 164 256

France

BD.0.3

326

PS.1.105 PS.3.241 UICC.4.12 PS.1.232 PS.1.105 PS.2.145 CTS.2.143

181 197 315 327 181 270 231

RM.2

153

PS.4.248 CTS.1.233 CTS.4.230 SAT.1.395 UICC.4.12 CTS.4.32 SAT.3.306 CTS.2.143 BSC.0.4 RM.7 PS.1.55

175 230 236 313 315 157 164 231 303 320 180

Morand, Maxine

Australia

Morrison, Marjorie Morton-Doherty, Rebecca Moshiri, Mahmood Muckaden, Mary Ann Nakagawahara, Akira

Canada

CTS.3.250 PS.2.47 RM.4

Switzerland

UICC.4.6

309

Canada India Japan

Nanda, Vinta

India

Nanda, Pranati Napolitano, Giulio Nayak, Sukdev Newton Rob Norma, D'Agostino Nozaki, Shinjiro O'Brien, SinĂŠad O'Brien, Inga Ocansey, Dennis Okioma, Mary Olopade, Christopher Sola

India United Kingdom India

SAT.1.395 SBP.3.53 UICC.4.226 WS.1.1 SBP.1.103 PS.3.112 UICC.4.9 PS.3.112

313 302 184 145 226 184 175 184

Australia

CTS.3.229

234

Canada Switzerland Australia New Zealand Ghana Kenya

PS.2.41 SAT.1.381 PS.4.99 CTS.2.143 PS.3.251 PS.1.49

182 240 259 231 329 255

United States

PS.4.248

175

PS.2.44 PS.4.43 PS.4.7 RM.6 SAT.4.256 PS.2.41 SAT.4.311 SAT.4.347 SAT.4.231 WS.1.1 SBP.1.103 UICC.4.9 PS.4.57 BSC.0.1 PS.1.235 SBP.1.80 BD.0.3 PS.2.41 CTS.3.250 BSC.0.4 PS.1.228 PS.4.69 PS.1.222 PS.1.90 PS.2.101 PS.1.55 PS.4.43

171 185 271 309 250 182 166 308 317 145 226 175 198 186 195 300 326 182 157 303 254 329 266 195 255 180 185

Olver, Ian

Australia

Onishi, Kazuko Osborn, Michael Paddock, Silvia Parham, Groesbeck Park, Eun-Cheol

Japan Australia United States Zambia Korea, Republic of

Parker, Demetrius

United States

Parkin, Max

United Kingdom

Paterson, Danielle

Canada

Patnick, Julietta

United Kingdom

Patterson, Pandora Penman, Sarah

Australia Australia

Perl, Rebecca

United States

Pettman, Tahna Pleah, Tsigue Portier, Christopher Pretorius, Lauren Purves, Richard Qaseem, Amir

Australia United States United States South Africa United Kingdom United States

Santini Rodrigues da Silva, Luiz Antonio

Brazil

Saraiya, Mona

United States

Sarfati, Diana

New Zealand

Al Madhi, Sawsan Schneidman, Miriam Scollo, Michelle Seffrin, John Shariat, Ladan Sharma, Kailash Shastri, Surendra Shoba, John Signal, Louise Sinclair, Craig Siregar, E. Soeminar Slevin, Terry

United Arab Emirates United States Australia United States Canada India India India New Zealand Australia Indonesia Australia

359

Name

Country

Sessions

Page No.

Name

Country

Sessions

Page No.

Soerjomataram, Isabelle Somasundaram, Saunthari Somera, Lilnabeth

France

CTS.1.56

154

Malaysia

RM.6

309

Ward, Robyn Ward, Liz

Australia Australia

Guam

156 240 317 186 237 305

Weller, David

United Kingdom

Wender, Richard White, Victoria Whiteman, David Wiafe Addai, Beatrice

United States Australia Australia Ghana

BD.0.1 PS.2.44 CTS.4.32 PS.2.93 SAT.3.306 PS.2.93 CTS.1.56 RM.4 CTS.1.56 PS.1.234 CTS.4.196 PS.4.248 PS.1.165 SAT.1.340 SAT.2.20 SAT.2.20 PS.2.93 PS.1.235 PS.4.7 SBP.3.187 SAT.2.20 SBP.2.252

177 171 157 269 164 269 154 177 154 170 308 175 170 240 160 160 269 195 271 227 160 300

Sonoda, Shigeto

Japan

Sorndamrih, Supatnuj

Thailand

Sperling, Cecilie Spielmann, Marlene Elisabeth Stairmand, Jeannine

Denmark

CTS.2.225 SAT.1.380 SAT.4.231 BSC.0.1 BSC.0.2 CTS.2.92

Denmark

CTS.3.229

234

Wild, Chris

France

New Zealand

Steele, Robert

United Kingdom Australia

Stevens, Lisa

United States

Stewart, Janice Stewart, Bernard Straif, Kurt Sugden, Cameron Sullivan, Richard Supramaniam, Rajah Termeer, Stan Thamarangsi, Thaksaphon Thompson, Rachel Tilly, Ryan Tobin, Pam Torode, Julie Towler, Bernie Trevena, Lyndal

Canada Australia France Tonga United Kingdom Australia Netherlands, The

Williams, Makeda Williams, Kelly Wu, Chien-Yuan Xiaoqing, Li Xu, Meng Young, Jane Young, Graeme Yu, Peter Zhang, Amy Zhao, Yan Zulian, Gilbert

Trimble, Edward

United States

Tsu, Vivien Davis Tucker-Longsworth, Laura Uauy, Ricardo Ugalde, Anna

United States

270 195 267 183 175 198 250 195 195 303 257 270 302 180 194 304 156 259 238 308 157 227 314 171

United States Australia

Steer, Christopher

PS.2.145 PS.1.235 PS.1.164 PS.2.39 PS.4.248 PS.4.57 SAT.4.256 PS.1.90 PS.1.90 BSC.0.4 PS.2.205 PS.2.145 SBP.4.91 PS.1.55 PS.1.223 CTS.1.224 SAT.2.313 PS.4.227 UICC.4.2 SAT.4.347 CTS.4.32 SBP.2.253 SAT.2.360 PS.1.83

Barbados

SAT.3.306

164

Chile Australia

Valery, Patricia

Australia

van Muilekom, Erik Varallo, John Vathesatogkit, Prakit Vedsted, Peter Vineis, Paolo Vines, Richard Walker, Joelle Wang, Ying

United Kingdom United States Thailand Denmark United Kingdom Australia Canada China

CTS.1.224 CTS.3.250 CTS.2.143 PS.2.145 SAT.4.256 PS.1.222 CTS.1.233 CTS.4.32 CTS.4.230 SAT.4.311 BSC.0.1 SAT.4.231

304 157 231 270 250 266 230 157 236 166 186 317

Thailand United Kingdom Australia Canada Switzerland Australia Australia

KEYWORDS Keyword Abstract Action(s) Advertising

Advocacy

Alcohol Awareness

Breast Cancer Campaign(s) Cancer Control

360

China China Australia Australia United States United States China Switzerland

Page No. 9, 19, 23, 34, 117, 168, 178, 179, 187, 189, 201-218, 251, 252, 260-263, 275-297, 310, 321-323, 332-349, 351 5, 77, 111, 128, 132, 163-164, 189, 194, 195, 198, 214, 251, 257, 267, 284, 285, 295, 309, 327, 338 254, 261, 337 23, 141, 142, 156, 157, 162, 163, 164, 168, 178, 189, 195, 197, 201, 202, 205, 207, 208, 214, 215, 230, 235, 238, 241, 242, 251, 254, 255, 261, 267, 274, 276, 279, 280, 284, 293, 294, 306, 313, 332, 333, 336, 337, 338, 346 180, 194, 212, 261, 280, 282, 283, 295, 333, 341 23, 137, 138, 139, 157, 174, 186, 187, 188, 201, 202, 205, 207, 208, 209, 212, 214, 215, 216, 218, 225, 229, 230, 237, 238, 260, 268, 269, 276, 277, 279 â&#x20AC;&#x201C; 284, 293-295, 303, 311, 321, 326, 332-342, 346, 347 80, 87, 96, 100, 104, 126, 160, 171, 173, 174, 179, 187, 188, 192, 197, 201, 203, 204, 206-209, 212-214, 217, 218, 229, 230, 233, 252, 256, 275-278, 283, 285, 286, 289, 296, 323, 324, 332-349 157, 186, 248, 254, 303, 314, 321 122, 134, 140, 144, 151, 159, 175, 177, 178, 184, 189, 198, 205, 209, 214, 221, 223, 224, 236, 251, 253, 259, 260, 268, 271, 281, 284, 285, 294, 295, 302, 310, 314, 315, 320, 323, 328, 329, 332, 335, 337, 346, 355

Keyword Cancer Information

Page No. 156, 192, 263, 280, 291

Cigarette Colorectal Cancer

77, 102, 104, 106, 112, 113, 114, 121, 141, 142, 152, 157, 162, 165, 166, 171, 174, 176, 178, 183, 184, 189, 190, 190, 191, 192, 197, 198, 202-218, 221, 227, 229, 230, 231, 233, 245, 246, 248, 252, 258, 259, 262, 263, 264, 269, 270, 271, 274, 275, 278-299, 300, 302, 305, 306, 311, 313, 328, 329, 332-345 77, 106, 119, 160, 164, 168, 170, 178, 181, 187, 188, 202-205, 208, 211, 218, 251, 264, 266, 276, 277, 279, 283, 288-297, 300, 301, 308, 323, 332, 336, 337, 342-427 135, 154, 179, 187, 212, 213, 217, 253, 255, 282, 283, 333 218, 257, 264, 277, 289, 290, 293, 295, 297, 340-345, 348 58, 127, 130, 205-207, 210, 212-217, 238, 274, 278, 278, 302, 319, 323, 332, 335, 337, 349 106, 135, 179, 187, 212, 253, 283, 303, 323, 341 168, 195, 204, 208, 210, 233, 263, 267, 286, 291, 292, 293, 324, 334, 340, 341, 343, 346-349

Communication(s)

138, 145, 172, 186, 201, 202, 218, 225, 226, 227, 336

Care

Cervical

Cessation Chemotherapy Children

Community

Cost Cultural/ Culturally Data Depression Detection Diagnosis

Diagnostics

Disparities / Disparity Distress Early Diagnosis Economic(s) Economy

5, 36, 114, 125, 128, 131, 133, 153, 155, 157, 174, 177, 178, 192, 195, 202, 204, 207, 208, 209, 212, 213, 224, 227, 233, 235, 236, 240, 251, 254, 267, 276, 283, 284, 285, 295, 306, 309, 311, 320, 323, 327, 332, 337, 338 121, 131, 134, 144, 170, 177, 215, 237, 244, 244, 258, 263, 264, 273, 313, 317, 341-346 104, 121, 131, 134, 144, 159, 170, 177, 215, 224, 233, 237, 244, 258, 263, 264, 273, 276, 313, 317, 320, 341, 342, 344, 345, 346 16, 60, 65, 86, 111, 139, 188, 209, 259, 268, 275, 286, 293, 303 13, 23, 47, 82, 124, 126, 145, 178, 188, 189, 208, 213, 215, 217, 224, 235, 236, 259, 261, 269, 273, 290, 292, 299, 317, 323, 339, 348 183, 288, 340, 343 5, 15, 17, 23, 42, 50, 52, 81, 84, 92, 93, 106, 112, 126, 168, 174, 187, 202, 211, 212, 229, 230, 231, 232, 233, 260, 266, 268, 275, 276, 277, 291, 308, 311, 324, 336, 338, 339, 340, 345, 346, 347 9, 13, 52, 79, 95, 99, 111, 112, 113, 118, 120, 126, 127, 136, 157, 174, 179 , 184 , 192, 204, 209, 210, 211, 212, 214, 229, 230, 232, 234, 244, 266, 269, 275, 276, 283, 291, 292, 295, 296, 307, 310, 312, 313, 314, 326, 334, 343, 345, 348 42, 97, 124, 223, 299, 313, 314, 357 121, 131, 187, 258, 271, 279, 285, 289, 323, 345 5, 141, 182, 217, 262, 286, 341 209, 233, 256, 283, 295, 307, 312 44, 104, 111, 112, 120, 131, 144, 187, 193, 202, 258, 263, 264, 281, 287, 289, 317, 333, 340, 347

Keyword

Page No.

Education(al)

300 50, 51, 52, 53, 81, 84, 85, 88, 90, 91, 93, 95, 96, 98, 100, 101, 111, 114, 116, 119, 140, 141, 142, 144, 145, 178, 185, 188, 189, 201, 207, 209, 212, 214, 215, 224, 225, 226, 240, 241, 242, 251, 263, 276, 278, 280, 283, 290, 293, 302, 307, 315, 321, 332, 337, 345 195, 260, 277 5, 83,154,195, 233, 260, 273, 281, 349 17, 42, 47, 50, 51, 52, 77, 79, 82, 84, 87, 90, 92, 96, 204, 207, 211, 215, 227, 262, 263, 264, 277, 285, 332, 337, 338, 348 27, 66, 216, 237, 255, 282, 284, 304, 328, 337, 338, 349 99, 121, 131, 135, 182, 189, 206, 207, 246, 253, 258, 279, 284, 285 99, 121, 131, 135, 182, 189, 206, 207, 246, 253, 258, 279, 284, 285 160, 210, 216, 263, 287, 289, 291, 343 77, 164 15, 24, 36, 42, 91, 92, 97, 114, 116, 122, 128, 130, 142, 154, 163, 178, 194, 205, 213, 222, 228, 235, 264, 265, 314, 332 15, 24, 36, 42, 91, 92, 97, 114, 116, 122, 128, 130, 142, 154, 163, 178, 194, 205, 213, 222, 228, 235, 264, 265, 314, 332 145, 151, 166, 182, 185, 188, 189, 201, 206, 227, 229, 230, 264, 289, 308, 323, 342, 346 178, 254, 337 106, 169, 170, 264

Environmental

Exposure(s) Family / Families Food Framework Fundraising Gastric Cancer Global Change Global Health Government(s)

Guideline(s) Harnessing HBV / Hepatitis B Health Systems Healthcare Systems HPV / Human papillomavirus Implementation

Implementing Incidence Indigenous Industry Innovation Innovative Intimacy

5, 17, 70, 102, 113, 120, 126, 132, 152, 174, 248, 329 157, 244 15, 119, 160, 168, 169, 170, 188, 203, 204, 205, 211, 211, 218, 224, 233, 277, 282, 288, 289, 291, 297, 300, 301, 310, 323, 336, 343, 345, 347 13, 15, 112, 116, 128, 142, 185, 194, 208, 209, 227, 236, 240, 251, 281, 283, 286, 289, 294, 310, 329, 338, 339 2, 13, 52, 96, 100, 187, 198, 211, 222, 257, 259, 285, 287, 329, 339 46, 50, 82, 84, 95, 120, 154, 202, 203, 210, 212, 216, 218, 244, 279, 282, 283, 294, 296, 317, 322, 323, 333, 335 15, 119, 147, 176, 188, 203, 205, 231, 259, 260, 261, 268, 270, 284, 323, 324 43, 45, 47, 48, 88, 89, 91, 135, 162, 243, 253, 257, 284, 337 13, 86, 97, 104, 124, 165, 166, 171, 192, 286, 287, 291, 320, 351 13, 15, 17, 23, 43, 45, 48, 52, 80, 86, 96, 102, 104, 111, 118, 133, 155, 162, 185, 202, 209, 213, 232, 240, 243, 244, 259, 261, 321

361

Keyword Knowledge Transfer Law Legal Liver Cancer Lung Cancer Mortality Multidisciplinary NCCP NCD / NCDs NGO Nurse(s) Nursing Nutrition Obesity Oncology

Ovarian

Packaging Pain Relief Palliative Care Partnership(s)

Pathology

Patient (s)

Pediatric/ Paediatric

362

Page No. 172 133, 329 33, 44, 56, 75, 92, 129, 146, 189, 209, 246, 264, 267, 284, 287, 289, 306, 323, 329, 339 177, 267, 302, 333 170, 264 3, 10, 20, 21, 22, 30, 72, 77, 83, 103, 105, 106, 107, 109, 111, 113, 132, 134, 137, 138, 141, 156, 178, 186, 237, 254, 255, 281, 283, 306, 311, 313, 321, 338 17, 50,53, 98, 154, 202, 210, 212, 216, 252, 264, 278, 279, 283, 287, 294, 295, 296, 317, 322, 335 91, 98, 126, 159, 171, 174, 191, 193, 197, 209, 332 159, 329 24, 33, 34, 36, 75, 81, 93, 106, 108, 114, 115, 122, 126, 128, 130, 132, 146, 149, 159, 164, 174, 185, 194, 200, 220, 222, 228, 237, 240, 248, 251, 257, 260, 280, 299, 304, 309, 317, 325, 329, 346, 353 44, 78, 81, 85, 93, 131, 132, 141, 197, 214, 251, 280 52, 91, 96, 205, 208, 216, 221, 233, 250, 262, 278, 279, 280, 288, 297, 301, 332, 334, 339, 340, 341 141, 171, 188, 212, 215, 221, 250, 251, 278, 289, 332, 335, 339, 341, 343, 352 106, 252, 2284, 286, 291, 304, 324, 334, 339 15, 106, 240, 254, 261, 277, 282, 304, 323, 337, 342, 351 8, 9, 22, 36, 42, 43, 45, 48, 79, 91, 97, 104, 106, 121, 141, 152, 155, 156, 162, 165, 166, 171, 183, 184, 202, 205, 210, 214, 217, 221, 233, 234, 240, 250, 251, 256, 262, 270, 271, 275, 276, 278, 279, 285, 288, 289, 315, 317, 321, 324, 332, 335, 339, 340, 341, 342, 343, 348 183, 189, 337, 344, 346 15, 106, 123, 187, 230, 333, 337 271, 329 9, 13, 22, 58, 85, 99, 111, , 113, 114, 121, 126, 152, 157, 174, 184, 204, 205, 207, 215, 221, 248, 252, 262, 263, 271, 274, 278, 284, 285, 291, 302, 329, 340, 341, 351, 352, 353 5, 8, 9, 14, 17, 33, 34, 44, 46, 52, 74, 82, 85, 86, 95, 96, 115, 132, 141, 146, 151, 159, 162, 164, 166, 171, 178, 182, 185, 192, 195, 198, 200, 207, 214, 222, 224, 233, 234, 235, 251, 259, 265, 267, 269, 280, 293, 300, 310, 321, 324, 239, 333, 345, 351 204, 282, 297, 314, 348 5, 17, 36, 42, 43, 44, 45, 46, 48, 50, 51, 53, 74, 79, 84, 87, 88, 90, 91, 92, 97, 98, 99, 100, 104, 106, 112, 113, 114, 121, 129, 153, 155, 156, 157, 162, 165, 171, 177, 182, 183, 188, 191, 192, 193, 197, 198, 202, 203, 204, 205, 206, 207, 208, 210, 214, 215, 216, 217, 218, 221, 227, 229, 230, 231, 233, 234, 238, 241, 242, 243, 244, 246, 248, 262, 263, 264, 270, 275, 278, 282, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 300, 305, 307, 313, 321, 322, 324, 328, 332, 335, 336, 339, 340, 341, 342, 343, 344, 346, 347, 348

Keyword

Page No.

Personalised Physical Activity Plan Planning Plenary

99, 127, 206, 208, 214, 215, 248, 276, 302, 315, 339 42, 97, 248, 334 100, 194, 234, 267, 283, 286, 291, 295, 304, 334, 349 15, 53, 159, 221, 257, 271, 285, 287, 290, 339 40, 46, 61, 82, 159, 175, 198, 251, 337 13, 22, 28, 56, 57, 58, 107, 111, 115, 116, 118, 120, 122, 123, 124, 138, 139, 147, 152, 157, 177, 186, 200, 222, 225, 226, 227, 228, 237, 253, 272, 273, 274, 299, 300, 302, 303, 330, 326, 331 2, 45, 47, 89, 100, 104, 130, 132, 187, 194, 206, 238, 252, 267, 284, 317, 346 10, 15, 17, 23, 31, 40, 41, 47, 49, 82, 107, 113, 114, 121, 123, 126, 130, 174, 180, 188, 189, 192, 194, 205, 207, 209, 222, 225, 240, 245, 248, 254, 267, 271, 273, 280, 281, 282, 289, 294, 306, 317, 320, 324, 328, 329, 337, 338, 351

Policies

Policy

Policymakers

Practice/ Best practice

Press

Prevention

Prognosis

Psychosocial Public Health Quality Of Life

Radiotherapy

Registries Registry Regulation Research

45, 88, 100, 114, 115, 135, 174, 251, 253, 306 23, 41, 46, 47, 82, 88, 98,101, 114, 116, 131, 132, 133, 137, 138, 141, 142, 145, 151, 174, 184, 186, 187, 188, 195, 198, 202, 203, 205, 206, 212, 217, 221, 225, 226, 248, 251, 254, 262, 264, 265, 266, 279, 286, 295, 302, 305, 317, 323, 334, 338, 339, 346, 347, 348 21, 22, 30, 52, 77, 103, 152, 224 9, 13, 15, 17, 23, 34, 41, 42, 44, 51, 53, 78, 81, 83, 84, 89, 92, 93, 94, 95, 98, 99, 100, 106, 111, 112, 118, 127, 141, 145, 149, 154, 168, 170, 175, 181, 187, 188, 194, 195, 201, 202, 205, 208, 211, 216, 217, 220, 223, 225, 226, 232, 240, 248, 251, 252, 254, 260, 262, 265, 266, 267, 268, 271, 273, 276, 277, 279, 280, 281, 293, 295, 297, 299, 300, 304, 307, 308, 310, 311, 315, 324, 327, 329, 333, 335, 336, 337, 338, 345, 346, 347 160, 263, 348, 349 112, 260, 263, 268, 306, 332, 335 9, 36, 40, 113, 122, 130, 134, 135, 136, 138, 139, 141, 145, 186, 187, 195, 204, 210, 211, 225, 226, 238, 252, 253, 269, 280, 295, 296, 300, 303, 317, 323, 326, 327, 346, 347, 351, 352, 353 42, 46, 47, 49, 50, 51, 82, 89, 94, 95, 97, 130, 155, 176, 183, 203, 207, 216, 231, 233, 243, 262, 288, 290, 293, 297, 341, 342, 348 49, 50, 87, 99, 106, 131, 159, 178, 192, 211, 215, 217, 258, 263, 264, 278, 288, 290, 293, 296, 297, 321, 324, 335, 343, 344 113, 175, 198, 229, 230, 232, 284 127, 175, 189, 198, 204, 206, 208, 216, 217, 218, 233, 285, 290, 291, 292, 335 40, 129, 135, 216, 230, 246, 253, 284, 337

Keyword

Risk/Risks

Risk Factors

Screening

Sexuality

Skin Cancer Smoking Smoking Cessation Social Marketing Social Media Stage Staging Storytelling Strategies Strategy

Supply Support

Supportive Care

Page No. 5, 8, 9, 10, 13, 15, 17, 36, 40, 41, 42, 43, 44, 45, 46, 47, 48, 51, 52, 53, 69, 74, 75, 78, 79, 80, 82, 83, 84, 85, 86, 88, 89, 90, 91, 92, 94, 95, 96, 97, 98, 100, 101, 104, 112, 113, 119, 120, 121, 123, 124, 127, 133, 135, 136, 141, 147, 151, 154, 155, 156, 160, 168, 170, 171, 174, 175, 176, 178, 179, 183, 184, 186, 188, 189, 192, 194, 195, 197, 198, 203, 205, 206, 209, 210, 212, 213, 214, 216, 217, 218, 221, 222, 223, 224, 227, 231, 233, 236, 240, 241, 242, 245, 258, 252, 253, 257, 261, 262, 263, 269, 270, 271, 273, 276, 292, 284, 285, 288, 291, 294, 302, 304, 306, 307, 308, 312, 313, 315, 316, 321, 322, 326, 327, 328, 329, 330, 332, 334, 335, 341, 348, 351, 352, 353 5, 100, 112, 113, 114, 127, 136, 138, 154, 157, 168, 171, 179, 192, 202, 212, 217, 218, 224, 233, 234, 235, 236, 237, 252, 261, 264, 277, 280, 281, 282, 283, 285, 286, 288, 291, 292, 293, 295, 297, 304, 307, 317, 319, 323, 326, 334, 342, 343, 345, 346, 347, 349 5, 112, 114, 127, 154, 212, 217, 218, 224, 235, 236, 280, 286, 288, 293, 295, 297, 343, 346 5, 9, 13, 15, 40, 57, 77, 78, 81, 83, 99, 106, 112, 118, 126, 127, 136, 137, 141, 160, 168, 171, 174, 178, 182, 188, 195, 200, 202, 204, 206, 208, 209, 213, 217, 223, 224, 231, 233, 240, 251, 252, 260, 261, 266, 267, 268, 270, 276, 277, 281, 286, 296, 298, 308, 310, 323, 326, 334, 345, 346, 348 142, 172, 208, 286 5, 87, 21, 231, 233, 261, 280, 319, 327, 344 31, 40, 78, 83, 106, 135, 154, 179, 186, 187, 188, 212, 213, 217, 230, 253, 277, 279, 282, 283, 293, 295, 323, 324, 327, 333, 338, 340, 341 179, 187, 212, 213, 217, 255, 282, 283, 333 136, 180, 201, 293, 326, 327 3, 20, 30, 72, 77, 105, 106, 107, 109, 113, 138, 141, 156, 178, 186, 255, 311, 321 43, 87, 117, 126, 159, 168, 174, 175, 215, 216, 224, 232, 235, 258, 263, 269, 275, 292, 304, 342, 344, 348 126, 175, 192, 296 58, 145, 225, 226, 330 77, 89, 112, 119, 121, 128, 131, 142, 159, 182, 184, 201, 206, 213, 214, 218, 221, 229, 230, 236, 251, 255, 257, 259, 268, 280, 281, 283, 284, 285, 302, 307, 314, 327, 333, 337, 340, 346, 42, 45, 46, 82, 97, 156, 168, 192, 213, 214, 259, 279, 281, 284, 293, 294, 310, 329, 337 170 15, 17, 20, 22, 23, 34, 36, 41, 44, 46, 47, 48, 50, 51, 52, 53, 56, 69, 74, 75, 76, 79, 80, 82, 84, 87, 88, 89, 90, 91, 92, 93, 95, 96, 99, 109, 111, 112, 122, 129, 130, 132, 135, 142, 155, 156, 168, 173, 183, 184, 192, 198, 202, 203, 206, 207, 208, 209, 214, 217, 222, 226, 229, 230, 233, 234, 237, 241, 242, 246, 253, 259, 261, 263, 264, 265, 266, 270, 279, 282, 285, 286, 287, 288, 292, 294, 297, 302, 305, 306, 307, 309, 310, 320, 322, 333, 335, 339, 340, 341, 346, 348

Keyword Survival Survivors

Survivorship Symptom System(s)

Tanning

Therapies TNM Tobacco Training

Translational Research Treatment

UICC

Vaccination

Wellness WHO Workplace

Page No. 22, 75, 91, 92, 99, 121, 183, 198, 203, 246, 270, 285, 286, 287, 306, 310, 335, 339 42, 57, 97, 100, 104, 127, 130, 155, 176, 183, 200, 203, 217, 229, 230, 232, 233, 243, 251, 263, 269, 279, 288, 293, 295, 310, 315, 323, 324, 336, 341, 343, 344 47, 50, 51, 77, 89, 102, 113, 182, 197, 207, 211, 214, 217, 218, 227, 233, 234, 262, 267, 286, 287, 294, 297, 306, 341, 342, 347, 349 9, 13, 17, 22, 42, 51, 92, 113, 118, 183, 192, 197, 203, 205, 207, 217, 223, 227, 233, 286, 287, 294, 340 113, 157, 204, 215, 262, 275, 286, 292, 293, 310, 342, 343, 346, 347 5, 9, 13, 17, 31, 49, 65, 79, 88, 97, 98, 99, 102, 106, 111, 113, 118, 120, 121, 124, 126, 132, 135, 141, 152, 155, 156, 157, 159, 170, 174, 189, 198, 202, 205, 206, 208, 216, 244, 248, 253, 259, 263, 264, 269, 273, 278, 282, 284, 285, 286, 287, 290, 292, 294, 295, 296, 320, 323, 329, 334, 335, 336, 342, 343, 344, 346, 347, 348, 351 261, 327 45, 124, 129, 155, 215, 246, 299, 307 36, 126, 175 15, 53, 83, 98, 106, 112, 123, 135, 164, 168, 170, 179, 187, 201, 202, 209, 213, 222, 224, 230, 253, 254, 255, 267, 271, 277, 279, 281, 282, 283, 284, 285, 292, 293, 324, 333, 336, 337, 342 50, 74, 79, 81, 85, 87, 91, 93, 97, 100, 101, 111, 144, 175, 187, 188, 208, 227, 229, 230, 236, 251, 257, 266, 279, 302, 315, 340 119, 147, 160, 170 9, 13, 17, 36, 41, 42, 43, 45, 48, 50, 79, 80, 83, 84, 87, 92, 95, 98, 99, 104, 106, 112, 118, 120, 122, 126, 127, 129, 134, 155, 157, 159, 160, 170, 174, 177, 184, 187, 188, 189, 192, 197, 201, 202, 203, 204, 207, 208, 211, 215, 217, 218, 224, 229, 230, 231, 232, 233, 234, 243, 244, 245, 246, 252, 256, 257, 258, 260, 265, 269, 270, 276, 281, 286, 287, 288, 289, 290, 293, 294, 295, 296, 306, 307, 310, 311, 313, 317, 323, 332, 333, 334, 336, 338, 339, 340, 342, 343, 344, 345, 348 3, 4, 5, 8, 9, 10, 12, 15, 19, 21, 22, 26, 28, 29, 30, 31, 32, 33, 34, 35, 36, 44, 53, 56, 57, 69, 72, 98, 103, 108, 109, 111, 120, 122, 124, 125, 126, 128, 130, 131, 132, 133, 144, 152, 153, 155, 174, 175, 177, 184, 189, 191, 197, 200, 206, 222, 228, 229, 236, 238, 240, 246, 248, 251, 253, 258, 265, 266, 299, 300, 308, 309, 313, 315, 316, 317, 320, 321, 331, 352 27, 81, 102, 170, 188, 205, 232, 233, 265, 279, 300 26, 102, 234, 265, 266 5, 89, 93, 106, 141, 147, 170, 228, 240, 248, 257, 308 41, 81, 102, 265, 266, 306

363

www.worldcancercongress.org #CancerCongress

UNION FOR INTERNATIONAL CANCER CONTROL 62 route de Frontenex, 1207 Geneva, Switzerland Tel +41 (0)22 809 1811 Fax +41 (0)22 809 1810 Email congress@uicc.org worldcancercongress.org